,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1029,GO:0007409,0.000543165259055982,0.99992362933802,12,17,axonogenesis,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2541,GO:0032990,0.000920879690221286,0.999835596966493,13,20,cell part morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3925,GO:0048812,0.000920879690221286,0.999835596966493,13,20,neuron projection morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3942,GO:0048858,0.000920879690221286,0.999835596966493,13,20,cell projection morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2766,GO:0035556,0.00194495364483027,0.999263663547745,34,78,intracellular signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;RABIF;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;RAB40B;RRAS2;SPTB;FZD7;FGF8;ARTN;AMOT;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;SPTBN4;NOTCH1;RND3;GUCY1B3
4970,GO:0071396,0.0021540786337647,0.999582771930826,12,19,cellular response to lipid,BP,GJB2;BMP6;WNT3;HEY1;WNT7B;WNT2;FZD7;VDR;WNT5B;CCL20;BMP4;BMP7
3883,GO:0048667,0.00226118548677362,0.999558899505926,12,19,cell morphogenesis involved in neuron differentiation,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2723,GO:0035116,0.00321558970390123,1,5,5,embryonic hindlimb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;NOTCH1
2725,GO:0035137,0.00321558970390123,1,5,5,hindlimb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;NOTCH1
1030,GO:0007411,0.00346628688952741,0.999410913501062,10,15,axon guidance,BP,WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4
5422,GO:0097485,0.00346628688952741,0.999410913501062,10,15,neuron projection guidance,BP,WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4
1891,GO:0021953,0.00396521908715266,0.999780072221441,6,7,central nervous system neuron differentiation,BP,WNT7A;WNT3;AXIN1;WNT2;FGF8;SPTBN4
2617,GO:0033993,0.00413399338409163,0.998881744854517,15,27,response to lipid,BP,WNT7A;GJB2;BMP6;WNT3;HEY1;GJB6;WNT7B;WNT2;FZD7;VDR;WNT5B;CCL20;BMP4;BMP7;NOTCH1
4753,GO:0061564,0.00421182193333255,0.999060189743213,12,20,axon development,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
23,GO:0000165,0.00436896848055258,0.998552671059423,20,40,MAPK cascade,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;BMP7;SPTBN4
4536,GO:0060561,0.006037437002634,1,4,4,apoptotic process involved in morphogenesis,BP,JAG2;VDR;BMP7;NOTCH1
5761,GO:1902742,0.006037437002634,1,4,4,apoptotic process involved in development,BP,JAG2;VDR;BMP7;NOTCH1
3840,GO:0048545,0.00811620657427185,0.998677815341869,8,12,response to steroid hormone,BP,GJB2;BMP6;HEY1;WNT7B;VDR;BMP4;BMP7;NOTCH1
52,GO:0000904,0.00910189706589194,0.997437105364668,13,24,cell morphogenesis involved in differentiation,BP,WNT7A;WNT3;SPTBN5;SPTB;FZD7;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
101,GO:0001570,0.00966095455807951,0.999404538828665,5,6,vasculogenesis,BP,WNT7A;HEY1;WNT7B;AMOT;NOTCH1
2426,GO:0032526,0.0104180019682614,0.998521875528457,7,10,response to retinoic acid,BP,GJB2;BMP6;WNT3;WNT7B;WNT2;FZD7;WNT5B
4965,GO:0071383,0.0110374574411155,0.999293083969033,5,6,cellular response to steroid hormone stimulus,BP,GJB2;HEY1;VDR;BMP4;BMP7
2040,GO:0030326,0.011943324508064,0.998680228609361,6,8,embryonic limb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
2721,GO:0035113,0.011943324508064,0.998680228609361,6,8,embryonic appendage morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
1938,GO:0023014,0.0122251157772301,0.995317241028628,20,43,signal transduction by protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;BMP7;SPTBN4
2187,GO:0031175,0.015498240066209,0.994891013510909,14,28,neuron projection development,BP,WNT7A;WNT3;WNT7B;SPTBN5;CDH1;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
958,GO:0007154,0.0166851117524413,0.992241865362658,51,142,cell communication,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
51,GO:0000902,0.0178506790292599,0.993708074807317,15,31,cell morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FZD7;FGF8;VDR;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1995,GO:0030182,0.0181954794676645,0.992432473980139,21,48,neuron differentiation,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1003,GO:0007267,0.0184040739540561,0.99237063424091,21,47,cell-cell signaling,BP,TLE1;WNT7A;GJB2;SYT5;BMP6;GJA3;WNT3;WNT7B;KCNG2;AXIN1;WNT2;FZD7;FGF8;WNT5B;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;NOTCH1
1941,GO:0023052,0.0200400864053465,0.990503979411625,51,143,signaling,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;GJA3;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;BMP4;KCNK6;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
3376,GO:0044700,0.0200400864053465,0.990503979411625,51,143,single organism signaling,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;GJA3;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;BMP4;KCNK6;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
906,GO:0006935,0.021041576575452,0.992397576064794,15,31,chemotaxis,BP,PIK3CG;WNT3;SPTBN5;SPTB;FGF8;ARTN;AMOT;CCL20;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2987,GO:0042330,0.021041576575452,0.992397576064794,15,31,taxis,BP,PIK3CG;WNT3;SPTBN5;SPTB;FGF8;ARTN;AMOT;CCL20;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1096,GO:0008091,0.0215767431573379,1,3,3,spectrin,CC,SPTBN5;SPTB;SPTBN4
4261,GO:0051693,0.0215767431573379,1,3,3,actin filament capping,BP,SPTBN5;SPTB;SPTBN4
2059,GO:0030506,0.0218027749845465,1,3,3,ankyrin binding,MF,CDH1;SPTB;SPTBN4
1033,GO:0007420,0.0219733801342654,0.993409034242342,11,21,brain development,BP,WNT7A;WNT3;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;NOTCH1
3270,GO:0043902,0.0234605177250316,1,3,3,positive regulation of multi-organism process,BP,BMP6;INHBB;NOTCH1
432,GO:0003206,0.024015757030944,0.99616050539326,6,9,cardiac chamber morphogenesis,BP,HEY1;WNT2;FGF8;BMP4;BMP7;NOTCH1
85,GO:0001501,0.0242730516445171,0.992586331355661,11,21,skeletal system development,BP,WNT7A;CLDN18;BMP6;WNT7B;JAG2;AXIN1;FGF8;VDR;WNT5B;BMP4;BMP7
4736,GO:0061383,0.0243111558128197,1,3,3,trabecula morphogenesis,BP,HEY1;BMP7;NOTCH1
4737,GO:0061384,0.0243111558128197,1,3,3,heart trabecula morphogenesis,BP,HEY1;BMP7;NOTCH1
3449,GO:0045165,0.0243774718255407,0.992548591321089,11,21,cell fate commitment,BP,WNT7A;WNT3;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;WNT5B;BMP4;NOTCH1
5280,GO:0090100,0.0252058731708866,0.996939767600093,5,7,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;INHBB;BMP4;BMP7;NOTCH1
3854,GO:0048589,0.0252173067642908,0.99224387681306,11,21,developmental growth,BP,WNT7A;ACTN3;WNT3;WNT7B;WNT2;FZD7;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
3503,GO:0045606,0.0254201511638778,1,3,3,positive regulation of epidermal cell differentiation,BP,VDR;BMP4;NOTCH1
5074,GO:0072044,0.0256045600150025,1,3,3,collecting duct development,BP,WNT7B;BMP4;NOTCH1
1248,GO:0009755,0.0258025821895973,1,3,3,hormone-mediated signaling pathway,BP,VDR;BMP4;BMP7
3190,GO:0043401,0.0258025821895973,1,3,3,steroid hormone mediated signaling pathway,BP,VDR;BMP4;BMP7
1734,GO:0017145,0.0258124761179349,1,3,3,stem cell division,BP,WNT7A;FZD7;NOTCH1
3762,GO:0048103,0.0258124761179349,1,3,3,somatic stem cell division,BP,WNT7A;FZD7;NOTCH1
3894,GO:0048704,0.026360675370146,1,3,3,embryonic skeletal system morphogenesis,BP,AXIN1;BMP4;BMP7
4430,GO:0060272,0.026360675370146,1,3,3,embryonic skeletal joint morphogenesis,BP,AXIN1;BMP4;BMP7
5196,GO:0072498,0.026360675370146,1,3,3,embryonic skeletal joint development,BP,AXIN1;BMP4;BMP7
1022,GO:0007369,0.0266472245698975,0.993587345295683,8,14,gastrulation,BP,WNT3;AXIN1;FZD7;FGF8;AMOT;DUSP5;BMP4;BMP7
3880,GO:0048663,0.0273421435435325,0.998003165341467,4,5,neuron fate commitment,BP,JAG2;AXIN1;BMP4;NOTCH1
3194,GO:0043407,0.0277878547356361,1,3,3,negative regulation of MAP kinase activity,BP,DUSP5;BMP4;BMP7
4583,GO:0060711,0.0279143386911506,0.997946259723031,4,5,labyrinthine layer development,BP,HEY1;WNT7B;WNT2;BMP7
4933,GO:0071300,0.0286810997487663,0.996378170080655,5,7,cellular response to retinoic acid,BP,WNT3;WNT7B;WNT2;FZD7;WNT5B
1032,GO:0007417,0.0287103402665725,0.989792306786861,13,27,central nervous system development,BP,WNT7A;WNT3;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;DRP2;BMP7;SPTBN4;NOTCH1
4470,GO:0060395,0.0287881009564245,0.997858489271222,4,5,SMAD protein signal transduction,BP,BMP6;INHBB;BMP4;BMP7
4827,GO:0070306,0.0287941953367306,1,3,3,lens fiber cell differentiation,BP,WNT7A;WNT7B;WNT5B
4828,GO:0070307,0.0287941953367306,1,3,3,lens fiber cell development,BP,WNT7A;WNT7B;WNT5B
3812,GO:0048471,0.0287948531446741,0.991433519416719,10,19,perinuclear region of cytoplasm,CC,GJB2;SYT5;AXIN1;CDH1;RAB40B;INHBB;PKN3;HRAS;TPD52;TF
428,GO:0003197,0.0293801147875186,0.996262350986814,5,7,endocardial cushion development,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
2718,GO:0035107,0.0295033169925663,0.995013592095385,6,9,appendage morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
2719,GO:0035108,0.0295033169925663,0.995013592095385,6,9,limb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
237,GO:0002088,0.029780066632694,0.996195664818285,5,7,lens development in camera-type eye,BP,WNT7A;WNT7B;WNT2;WNT5B;BMP4
2128,GO:0030858,0.029818605399251,0.996189223052472,5,7,positive regulation of epithelial cell differentiation,BP,BMP6;VDR;BMP4;GDNF;NOTCH1
3108,GO:0043087,0.0304932615024825,0.989618394589889,12,24,regulation of GTPase activity,BP,RABIF;AXIN1;SPTBN5;SPTB;FGF8;ARTN;AMOT;CCL20;FGF17;HRAS;GDNF;SPTBN4
451,GO:0003272,0.0310519369171898,0.99762627026598,4,5,endocardial cushion formation,BP,HEY1;FGF8;BMP7;NOTCH1
2350,GO:0032259,0.0313230808595247,1,3,3,methylation,BP,RAB3D;PIK3CA;PNMT
1035,GO:0007423,0.0317554154923808,0.988514720647446,13,27,sensory organ development,BP,WNT7A;GJB2;BMP6;GJB6;WNT7B;JAG2;AXIN1;WNT2;FGF8;WNT5B;BMP4;BMP7;NOTCH1
3868,GO:0048638,0.0322020911345316,0.99191306260725,8,14,regulation of developmental growth,BP,ACTN3;WNT3;WNT2;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
1947,GO:0030004,0.0325631563998329,1,3,3,cellular monovalent inorganic cation homeostasis,BP,RAB39A;RAB38;RAB20
2081,GO:0030641,0.0325631563998329,1,3,3,regulation of cellular pH,BP,RAB39A;RAB38;RAB20
3577,GO:0045851,0.0325631563998329,1,3,3,pH reduction,BP,RAB39A;RAB38;RAB20
4218,GO:0051452,0.0325631563998329,1,3,3,intracellular pH reduction,BP,RAB39A;RAB38;RAB20
4219,GO:0051453,0.0325631563998329,1,3,3,regulation of intracellular pH,BP,RAB39A;RAB38;RAB20
5335,GO:0090383,0.0325631563998329,1,3,3,phagosome acidification,BP,RAB39A;RAB38;RAB20
681,GO:0005794,0.0345058183607967,0.986279481642749,15,33,Golgi apparatus,CC,WNT7A;WNT3;WNT7B;CDH1;SPTB;RAB39A;WNT5B;PKN3;HRAS;RNF144A;RAB38;FSTL3;NOTCH1;RND3;RAB20
3858,GO:0048598,0.0347920489267156,0.986147403641432,15,33,embryonic morphogenesis,BP,WNT7A;WNT3;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;AMOT;DUSP5;BMP4;GDNF;BMP7;NOTCH1
89,GO:0001505,0.0370759700949363,1,3,3,regulation of neurotransmitter levels,BP,WNT7A;SYT5;GDNF
876,GO:0006836,0.0370759700949363,1,3,3,neurotransmitter transport,BP,WNT7A;SYT5;GDNF
5519,GO:0099531,0.0370759700949363,1,3,3,presynaptic process involved in chemical synaptic transmission,BP,WNT7A;SYT5;GDNF
5449,GO:0098588,0.0376293050044124,0.983256531875154,19,44,bounding membrane of organelle,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;SPTBN5;FZD7;RAB39A;WNT5B;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;NOTCH1;RND3;RAB20;TF
4387,GO:0060070,0.0384946186509855,0.988634797272616,9,17,canonical Wnt signaling pathway,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;NOTCH1
175,GO:0001890,0.0397150105193699,0.991898038413235,6,10,placenta development,BP,GJB2;HEY1;WNT7B;WNT2;VDR;BMP7
3969,GO:0050679,0.0399288388811129,0.990563262836683,7,12,positive regulation of epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;HRAS;BMP4;NOTCH1
3892,GO:0048699,0.0404734412419237,0.981069795934944,21,51,generation of neurons,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3236,GO:0043547,0.0407173596021987,0.986018411419606,11,22,positive regulation of GTPase activity,BP,RABIF;AXIN1;SPTBN5;SPTB;FGF8;ARTN;CCL20;FGF17;HRAS;GDNF;SPTBN4
5659,GO:1901701,0.0413970732950438,0.982405304848506,16,37,cellular response to oxygen-containing compound,BP,GJB2;PIK3CG;BMP6;WNT3;GJB6;WNT7B;WNT2;CDH1;FZD7;VDR;WNT5B;INHBB;CCL20;PIK3CA;BMP7;GUCY1B3
1981,GO:0030139,0.0414342271804886,0.987570494388183,9,17,endocytic vesicle,CC,WNT7A;WNT3;WNT7B;RAB39A;AMOT;WNT5B;RAB38;RAB20;TF
2088,GO:0030666,0.0415731418913953,0.990073608441617,7,12,endocytic vesicle membrane,CC,WNT7A;WNT3;WNT7B;RAB39A;WNT5B;RAB38;RAB20
3860,GO:0048608,0.0424961218092917,0.98364307399803,13,28,reproductive structure development,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
4749,GO:0061458,0.0424961218092917,0.98364307399803,13,28,reproductive system development,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
1913,GO:0022411,0.043430645021687,0.992572275313861,5,8,cellular component disassembly,BP,AXIN1;SPTBN5;CDH1;SPTB;SPTBN4
4266,GO:0051716,0.044795788650808,0.976659597055286,50,144,cellular response to stimulus,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3;TF
1599,GO:0016055,0.0449618305855477,0.985033989240107,10,20,Wnt signaling pathway,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;NOTCH1
5537,GO:0198738,0.0449618305855477,0.985033989240107,10,20,cell-cell signaling by wnt,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;NOTCH1
1611,GO:0016202,0.0455619127627664,0.990341939509406,6,10,regulation of striated muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;NOTCH1
3865,GO:0048634,0.0455619127627664,0.990341939509406,6,10,regulation of muscle organ development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;NOTCH1
5667,GO:1901861,0.0455619127627664,0.990341939509406,6,10,regulation of muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;NOTCH1
1270,GO:0009913,0.0469816694203529,0.987813742197997,7,13,epidermal cell differentiation,BP,JAG2;POU3F1;VDR;DSG3;PKP1;BMP4;NOTCH1
3869,GO:0048639,0.0471242305090536,0.989915189323201,6,10,positive regulation of developmental growth,BP,ACTN3;WNT3;WNT2;FGF8;SPTBN4;NOTCH1
3352,GO:0044431,0.0471881829489764,0.984135352051947,10,20,Golgi apparatus part,CC,WNT7A;WNT3;WNT7B;CDH1;RAB39A;WNT5B;HRAS;RAB38;NOTCH1;RND3
2141,GO:0030900,0.047295099771544,0.986475025241449,8,15,forebrain development,BP,WNT7A;WNT7B;AXIN1;POU3F1;CDH1;FGF8;BMP4;NOTCH1
570,GO:0005109,0.0480359370096744,0.989664087637809,6,10,frizzled binding,MF,WNT7A;WNT3;WNT7B;WNT2;FZD7;WNT5B
4774,GO:0065009,0.0487903819751943,0.974965713723773,27,69,regulation of molecular function,BP,MAGEC2;PIK3CG;RABIF;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;SPTB;FGF8;VDR;ARTN;AMOT;WNK4;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;TSPAN13;NOTCH1
3964,GO:0050673,0.0491979633539362,0.985798850016008,8,15,epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;VDR;HRAS;BMP4;NOTCH1
3968,GO:0050678,0.0491979633539362,0.985798850016008,8,15,regulation of epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;VDR;HRAS;BMP4;NOTCH1
1528,GO:0015031,0.0499699474034326,0.97872848416259,15,34,protein transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;FZD7;RAB39A;INHBB;RAB3D;BMP4;RAB38;BMP7;NOTCH1;RAB20;TF
5958,GO:1905114,0.0513175028281412,0.981257765627827,11,23,cell surface receptor signaling pathway involved in cell-cell signaling,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;BMP4;NOTCH1
4199,GO:0051345,0.0519428027806592,0.97927502030551,13,28,positive regulation of hydrolase activity,BP,RABIF;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;ARTN;CCL20;FGF17;HRAS;GDNF;SPTBN4
3907,GO:0048736,0.0526200482554845,0.988379007250097,6,10,appendage development,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
4413,GO:0060173,0.0526200482554845,0.988379007250097,6,10,limb development,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
1900,GO:0022008,0.0526403804054126,0.974014400241461,22,55,neurogenesis,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;POU3F1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3294,GO:0044093,0.0538003554757727,0.97380148713894,21,51,positive regulation of molecular function,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;SPTB;FGF8;VDR;ARTN;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;SPTBN4
5476,GO:0098772,0.0550297784303658,0.975515584874848,16,37,molecular function regulator,MF,WNT7A;RABIF;WNT3;AXIN1;WNT2;SPTBN5;SPTB;FGF8;ARTN;WNK4;FGF17;GDNF;PIK3CA;SPTBN4;TSPAN13;NOTCH1
3349,GO:0044428,0.0553384009893348,0.976609847828143,14,32,nuclear part,CC,MAGEC2;TLE1;HEY1;MAPK12;POU3F1;RAB40B;VDR;AMOT;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;PM20D2
3882,GO:0048666,0.0556723943303687,0.976443845441944,14,32,neuron development,BP,WNT7A;WNT3;WNT7B;SPTBN5;CDH1;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2539,GO:0032984,0.0556850999272606,0.992354939934374,4,6,macromolecular complex disassembly,BP,AXIN1;SPTBN5;SPTB;SPTBN4
3152,GO:0043241,0.0556850999272606,0.992354939934374,4,6,protein complex disassembly,BP,AXIN1;SPTBN5;SPTB;SPTBN4
563,GO:0005085,0.0569821141487742,0.982961687466352,8,15,guanyl-nucleotide exchange factor activity,MF,RABIF;SPTBN5;SPTB;FGF8;ARTN;FGF17;GDNF;SPTBN4
4474,GO:0060411,0.0571226996261146,0.989338790297003,5,8,cardiac septum morphogenesis,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
4333,GO:0055024,0.0582303952310417,0.989063917788161,5,8,regulation of cardiac muscle tissue development,BP,WNT2;FZD7;FGF8;BMP4;NOTCH1
2126,GO:0030856,0.0588089106205402,0.988919604049732,5,8,regulation of epithelial cell differentiation,BP,BMP6;VDR;BMP4;GDNF;NOTCH1
1487,GO:0014070,0.0603867185591372,0.974986798223603,13,29,response to organic cyclic compound,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;WNT7B;PMAIP1;CDH1;FGF8;VDR;BMP4;BMP7;NOTCH1
1388,GO:0010721,0.0608293812831507,0.988411554084222,5,8,negative regulation of cell development,BP,WNT7A;CLDN18;WNT3;BMP7;NOTCH1
4730,GO:0061351,0.061200782489091,0.988317487559958,5,8,neural precursor cell proliferation,BP,WNT7A;WNT2;FGF8;ARTN;NOTCH1
967,GO:0007165,0.0620407347810885,0.965820298147272,46,132,signal transduction,BP,RHPN1;TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3
3774,GO:0048193,0.0621786277238189,0.991102070874264,4,6,Golgi vesicle transport,BP,RABIF;SPTBN5;SPTB;SPTBN4
576,GO:0005125,0.0624204555271746,0.982571795239184,7,13,cytokine activity,MF,WNT7A;BMP6;WNT2;INHBB;CCL20;BMP4;BMP7
4009,GO:0050794,0.062509378428231,0.968075714298064,57,170,regulation of cellular process,BP,MAGEC2;RHPN1;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF;PM20D2
1461,GO:0012506,0.0625525395638877,0.974990443598728,12,26,vesicle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;RAB39A;WNT5B;PKP1;RAB3D;RNF144A;RAB38;RAB20;TF
2084,GO:0030659,0.0625525395638877,0.974990443598728,12,26,cytoplasmic vesicle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;RAB39A;WNT5B;PKP1;RAB3D;RNF144A;RAB38;RAB20;TF
1350,GO:0010604,0.0628600418551909,0.966108644204675,29,77,positive regulation of macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1
881,GO:0006873,0.0634219734360748,0.98221729589842,7,13,cellular ion homeostasis,BP,PIK3CG;BMP6;VDR;RAB39A;RAB38;RAB20;TF
1946,GO:0030003,0.0634219734360748,0.98221729589842,7,13,cellular cation homeostasis,BP,PIK3CG;BMP6;VDR;RAB39A;RAB38;RAB20;TF
1098,GO:0008104,0.0638234661209122,0.967529151682979,22,56,protein localization,BP,WNT7A;CLDN18;RABIF;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;FZD7;RAB39A;AMOT;WNK4;INHBB;TSPAN15;RAB3D;BMP4;RAB38;BMP7;SPTBN4;NOTCH1;RAB20;TF
371,GO:0003002,0.0645352209991717,0.978066228861696,9,18,regionalization,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FGF8;BMP4;GDNF;NOTCH1
3895,GO:0048705,0.0652345206140677,0.987282504308371,5,8,skeletal system morphogenesis,BP,WNT7A;BMP6;AXIN1;BMP4;BMP7
4446,GO:0060322,0.0660006253356477,0.974292702802889,11,24,head development,BP,WNT7A;WNT3;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;NOTCH1
1569,GO:0015833,0.0661028218987318,0.970287110455012,15,35,peptide transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;FZD7;RAB39A;INHBB;RAB3D;BMP4;RAB38;BMP7;NOTCH1;RAB20;TF
3078,GO:0042886,0.0661028218987318,0.970287110455012,15,35,amide transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;FZD7;RAB39A;INHBB;RAB3D;BMP4;RAB38;BMP7;NOTCH1;RAB20;TF
1423,GO:0010862,0.0665228820736487,0.990232434305359,4,6,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
4466,GO:0060389,0.0665228820736487,0.990232434305359,4,6,pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
4469,GO:0060393,0.0665228820736487,0.990232434305359,4,6,regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
2967,GO:0042221,0.0677449091643248,0.962413923057544,33,90,response to chemical,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;GUCY1B3;TF
3996,GO:0050768,0.0683404862999756,0.989861296780515,4,6,negative regulation of neurogenesis,BP,WNT7A;WNT3;BMP7;NOTCH1
2119,GO:0030835,0.0686883683205844,0.994114288244686,3,4,negative regulation of actin filament depolymerization,BP,SPTBN5;SPTB;SPTBN4
3153,GO:0043242,0.0686883683205844,0.994114288244686,3,4,negative regulation of protein complex disassembly,BP,SPTBN5;SPTB;SPTBN4
5671,GO:1901880,0.0686883683205844,0.994114288244686,3,4,negative regulation of protein depolymerization,BP,SPTBN5;SPTB;SPTBN4
1960,GO:0030041,0.0689890827012336,0.994076462284848,3,4,actin filament polymerization,BP,SPTBN5;SPTB;SPTBN4
2117,GO:0030833,0.0689890827012336,0.994076462284848,3,4,regulation of actin filament polymerization,BP,SPTBN5;SPTB;SPTBN4
2121,GO:0030837,0.0689890827012336,0.994076462284848,3,4,negative regulation of actin filament polymerization,BP,SPTBN5;SPTB;SPTBN4
2217,GO:0031333,0.0689890827012336,0.994076462284848,3,4,negative regulation of protein complex assembly,BP,SPTBN5;SPTB;SPTBN4
2355,GO:0032272,0.0689890827012336,0.994076462284848,3,4,negative regulation of protein polymerization,BP,SPTBN5;SPTB;SPTBN4
1257,GO:0009887,0.0693578880507676,0.966351986313424,18,44,animal organ morphogenesis,BP,TLE1;WNT7A;BMP6;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;VDR;WNK4;HRAS;BMP4;GDNF;BMP7;NOTCH1
5733,GO:1902531,0.0694648304383992,0.965155196865099,20,50,regulation of intracellular signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;PMAIP1;AXIN1;FZD7;FGF8;AMOT;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
1162,GO:0008593,0.0696573085757473,0.989589766416094,4,6,regulation of Notch signaling pathway,BP,HEY1;JAG2;BMP7;NOTCH1
583,GO:0005160,0.0697479766514859,0.989570989165427,4,6,transforming growth factor beta receptor binding,MF,BMP6;INHBB;BMP4;BMP7
430,GO:0003203,0.0700893444094827,0.989500198549978,4,6,endocardial cushion morphogenesis,BP,HEY1;FGF8;BMP7;NOTCH1
3300,GO:0044238,0.0703607466193687,0.960523063263513,45,130,primary metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;RHBDL3;MBOAT2;BMP6;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;GUCY1B3;PM20D2
1095,GO:0008083,0.0705876459577019,0.975506973003472,9,18,growth factor activity,MF,BMP6;JAG2;FGF8;ARTN;INHBB;FGF17;BMP4;GDNF;BMP7
1025,GO:0007389,0.0706969084200157,0.973621477117537,10,21,pattern specification process,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
3493,GO:0045595,0.0710558478595303,0.965393849254569,18,44,regulation of cell differentiation,BP,WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;AXIN1;MAPK12;WNT2;FZD7;FGF8;VDR;WNT5B;BMP4;GDNF;BMP7;FSTL3;NOTCH1
6085,GO:2000209,0.0717729384179359,0.993722285761991,3,4,regulation of anoikis,BP,TLE1;PIK3CA;NOTCH1
6157,GO:2000811,0.0717729384179359,0.993722285761991,3,4,negative regulation of anoikis,BP,TLE1;PIK3CA;NOTCH1
4443,GO:0060317,0.071830447936819,0.989136843652039,4,6,cardiac epithelial to mesenchymal transition,BP,HEY1;WNT2;FGF8;NOTCH1
3581,GO:0045862,0.0720367355311795,0.989093539617458,4,6,positive regulation of proteolysis,BP,PMAIP1;AXIN1;MAPK12;RNF144A
1040,GO:0007492,0.0727230100019447,0.988949091756648,4,6,endoderm development,BP,FGF8;DUSP5;BMP4;NOTCH1
889,GO:0006888,0.073027728729305,0.993560296196118,3,4,ER to Golgi vesicle-mediated transport,BP,SPTBN5;SPTB;SPTBN4
82,GO:0001191,0.0733859197860323,0.993513788645727,3,4,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,TLE1;POU3F1;NOTCH1
431,GO:0003205,0.0744530852916332,0.980530857934379,6,11,cardiac chamber development,BP,HEY1;WNT2;FGF8;BMP4;BMP7;NOTCH1
2061,GO:0030509,0.07463110954696,0.980470463585003,6,11,BMP signaling pathway,BP,BMP6;FGF8;BMP4;BMP7;FSTL3;NOTCH1
5023,GO:0071772,0.07463110954696,0.980470463585003,6,11,response to BMP,BP,BMP6;FGF8;BMP4;BMP7;FSTL3;NOTCH1
5024,GO:0071773,0.07463110954696,0.980470463585003,6,11,cellular response to BMP stimulus,BP,BMP6;FGF8;BMP4;BMP7;FSTL3;NOTCH1
3934,GO:0048844,0.0746527821150879,0.98853975577661,4,6,artery morphogenesis,BP,HEY1;FGF8;BMP4;NOTCH1
4611,GO:0060840,0.0746527821150879,0.98853975577661,4,6,artery development,BP,HEY1;FGF8;BMP4;NOTCH1
1877,GO:0021871,0.0755862345154521,0.988340094600472,4,6,forebrain regionalization,BP,WNT7B;AXIN1;FGF8;BMP4
5015,GO:0071704,0.0757401006923634,0.957356205619304,47,137,organic substance metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;RHBDL3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PNMT;GUCY1B3;PM20D2
2540,GO:0032989,0.0763621786175529,0.964585308335737,15,36,cellular component morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FZD7;FGF8;VDR;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
3533,GO:0045684,0.0770550452516046,0.993030626955179,3,4,positive regulation of epidermis development,BP,VDR;BMP4;NOTCH1
4132,GO:0051179,0.0772289386783975,0.956271873809008,46,134,localization,BP,SLC2A14;WNT7A;GJB2;PIK3CG;SYT5;CLDN18;RABIF;BMP6;GJA3;WNT3;JAG2;PMAIP1;KCNG2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;AMOT;WNT5B;WNK4;INHBB;CCL20;PKN3;PKP1;TSPAN15;HRAS;RAB3D;BMP4;KCNK6;CLDN15;GDNF;RAB38;PIK3CA;BMP7;TPD52;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
3501,GO:0045604,0.0786301511209127,0.992819458034175,3,4,regulation of epidermal cell differentiation,BP,VDR;BMP4;NOTCH1
1269,GO:0009912,0.0786406660344992,1,2,2,auditory receptor cell fate commitment,BP,JAG2;NOTCH1
4400,GO:0060120,0.0786406660344992,1,2,2,inner ear receptor cell fate commitment,BP,JAG2;NOTCH1
2004,GO:0030216,0.0786570359554967,0.982017092755174,5,9,keratinocyte differentiation,BP,POU3F1;VDR;DSG3;PKP1;NOTCH1
3506,GO:0045616,0.0787519891533016,1,2,2,regulation of keratinocyte differentiation,BP,VDR;NOTCH1
3507,GO:0045618,0.0787519891533016,1,2,2,positive regulation of keratinocyte differentiation,BP,VDR;NOTCH1
3896,GO:0048706,0.0790222850146825,0.992766537756583,3,4,embryonic skeletal system development,BP,AXIN1;BMP4;BMP7
1276,GO:0009952,0.0790381557322755,0.978960151645734,6,11,anterior/posterior pattern specification,BP,WNT3;AXIN1;WNT2;FGF8;BMP4;NOTCH1
5067,GO:0072017,0.0790383711936118,1,2,2,distal tubule development,BP,WNK4;NOTCH1
3593,GO:0045927,0.0791912137153476,0.978907176842377,6,11,positive regulation of growth,BP,ACTN3;WNT3;WNT2;FGF8;SPTBN4;NOTCH1
4348,GO:0055082,0.0792523899503248,0.971160993866811,9,19,cellular chemical homeostasis,BP,PIK3CG;BMP6;GJB6;VDR;RAB39A;RAB38;PIK3CA;RAB20;TF
2125,GO:0030855,0.0797198442840503,0.96183721571709,16,39,epithelial cell differentiation,BP,WNT7A;BMP6;HEY1;WNT7B;JAG2;POU3F1;FZD7;FGF8;VDR;DSG3;WNT5B;PKP1;BMP4;GDNF;BMP7;NOTCH1
2586,GO:0033280,0.0800179989372928,1,2,2,response to vitamin D,BP,VDR;BMP7
5718,GO:1902337,0.0800179989372928,1,2,2,regulation of apoptotic process involved in morphogenesis,BP,VDR;BMP7
5928,GO:1904748,0.0800179989372928,1,2,2,regulation of apoptotic process involved in development,BP,VDR;BMP7
1627,GO:0016307,0.0803052357333732,1,2,2,phosphatidylinositol phosphate kinase activity,MF,PIK3CG;PIK3CA
2704,GO:0035005,0.0803052357333732,1,2,2,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3CG;PIK3CA
3918,GO:0048771,0.0804777693631804,0.987276325991261,4,6,tissue remodeling,BP,CLDN18;FGF8;VDR;RAB3D
3613,GO:0045995,0.0806018209976987,0.974982500778748,7,14,regulation of embryonic development,BP,WNT2;FZD7;AMOT;BMP4;GDNF;BMP7;NOTCH1
4566,GO:0060669,0.0806319570279666,1,2,2,embryonic placenta morphogenesis,BP,WNT7B;BMP7
4582,GO:0060710,0.0806319570279666,1,2,2,chorio-allantoic fusion,BP,WNT7B;BMP7
4585,GO:0060713,0.0806319570279666,1,2,2,labyrinthine layer morphogenesis,BP,WNT7B;BMP7
3073,GO:0042787,0.0810860735503698,1,2,2,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
1104,GO:0008152,0.0812541994125692,0.954011694459601,48,141,metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;RHBDL3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PNMT;GUCY1B3;PM20D2
3494,GO:0045596,0.0813094284793673,0.970233608648765,9,19,negative regulation of cell differentiation,BP,WNT7A;CLDN18;WNT3;AXIN1;FZD7;BMP4;BMP7;FSTL3;NOTCH1
2621,GO:0034103,0.0815670582211619,1,2,2,regulation of tissue remodeling,BP,CLDN18;VDR
2605,GO:0033612,0.0818255908055652,0.992384196383201,3,4,receptor serine/threonine kinase binding,MF,BMP6;BMP4;BMP7
4883,GO:0070696,0.0818255908055652,0.992384196383201,3,4,transmembrane receptor protein serine/threonine kinase binding,MF,BMP6;BMP4;BMP7
4884,GO:0070700,0.0818255908055652,0.992384196383201,3,4,BMP receptor binding,MF,BMP6;BMP4;BMP7
254,GO:0002244,0.0821376010813181,0.992341206679952,3,4,hematopoietic progenitor cell differentiation,BP,BMP4;FSTL3;NOTCH1
3114,GO:0043124,0.0822923138117823,1,2,2,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TLE1;BMP7
81,GO:0001190,0.0827078250462373,1,2,2,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1
5487,GO:0098811,0.0827078250462373,1,2,2,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,POU3F1;NOTCH1
3106,GO:0043085,0.0829325160570888,0.957236235754747,20,50,positive regulation of catalytic activity,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;VDR;ARTN;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;SPTBN4
1511,GO:0014855,0.0829995821842237,1,2,2,striated muscle cell proliferation,BP,WNT2;NOTCH1
4369,GO:0060038,0.0829995821842237,1,2,2,cardiac muscle cell proliferation,BP,WNT2;NOTCH1
4373,GO:0060043,0.0829995821842237,1,2,2,regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
4374,GO:0060045,0.0829995821842237,1,2,2,positive regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
3195,GO:0043408,0.0831035480976639,0.963121064494705,13,30,regulation of MAPK cascade,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;BMP7
2421,GO:0032501,0.0834345725008454,0.953334961404503,51,152,multicellular organismal process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;RAB3D;BMP4;KCNK6;GDNF;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;GUCY1B3;TF
5658,GO:1901700,0.083588860717454,0.957345840829217,19,48,response to oxygen-containing compound,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;GJB6;WNT7B;WNT2;CDH1;FZD7;VDR;WNT5B;INHBB;CCL20;PIK3CA;BMP7;NOTCH1;GUCY1B3
652,GO:0005654,0.0845816437949471,0.964908094107792,11,25,nucleoplasm,CC,TLE1;HEY1;MAPK12;POU3F1;VDR;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;PM20D2
3205,GO:0043457,0.0847943910912371,1,2,2,regulation of cellular respiration,BP,ACTN3;PIK3CA
3474,GO:0045333,0.0847943910912371,1,2,2,cellular respiration,BP,ACTN3;PIK3CA
417,GO:0003177,0.0853237860280233,0.991897251978151,3,4,pulmonary valve development,BP,HEY1;BMP4;NOTCH1
422,GO:0003184,0.0853237860280233,0.991897251978151,3,4,pulmonary valve morphogenesis,BP,HEY1;BMP4;NOTCH1
5967,GO:1905314,0.0853237860280233,0.991897251978151,3,4,semi-lunar valve development,BP,HEY1;BMP4;NOTCH1
3062,GO:0042733,0.0853596346718431,0.991892205780693,3,4,embryonic digit morphogenesis,BP,WNT7A;BMP4;NOTCH1
3499,GO:0045601,0.0859841314266604,0.991804117247072,3,4,regulation of endothelial cell differentiation,BP,BMP6;BMP4;NOTCH1
3500,GO:0045603,0.0859841314266604,0.991804117247072,3,4,positive regulation of endothelial cell differentiation,BP,BMP6;BMP4;NOTCH1
3826,GO:0048518,0.0865624590060111,0.949831882151255,39,111,positive regulation of biological process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;RRAS2;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;DUSP5;INHBB;CCL20;PKP1;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;TF
2822,GO:0035904,0.086691144022085,0.991703974748302,3,4,aorta development,BP,HEY1;FGF8;NOTCH1
2824,GO:0035909,0.086691144022085,0.991703974748302,3,4,aorta morphogenesis,BP,HEY1;FGF8;NOTCH1
3484,GO:0045445,0.086739156857319,0.991697158179396,3,4,myoblast differentiation,BP,MAPK12;BMP4;NOTCH1
434,GO:0003208,0.0869438625317168,1,2,2,cardiac ventricle morphogenesis,BP,HEY1;NOTCH1
4715,GO:0061314,0.0869438625317168,1,2,2,Notch signaling involved in heart development,BP,HEY1;NOTCH1
2302,GO:0031981,0.0869635906907822,0.962142740408912,12,28,nuclear lumen,CC,MAGEC2;TLE1;HEY1;MAPK12;POU3F1;VDR;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;PM20D2
885,GO:0006879,0.0873310264821953,1,2,2,cellular iron ion homeostasis,BP,BMP6;TF
1295,GO:0010039,0.0873310264821953,1,2,2,response to iron ion,BP,BMP6;TF
4929,GO:0071281,0.0873310264821953,1,2,2,cellular response to iron ion,BP,BMP6;TF
5810,GO:1903305,0.08749512198657,0.991589563885265,3,4,regulation of regulated secretory pathway,BP,SYT5;RAB3D;NOTCH1
4902,GO:0070887,0.0876426346451724,0.951357603103816,26,70,cellular response to chemical stimulus,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;WNT2;CDH1;FZD7;FGF8;VDR;WNT5B;INHBB;CCL20;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3;TF
3548,GO:0045746,0.0882481158503059,1,2,2,negative regulation of Notch signaling pathway,BP,HEY1;BMP7
404,GO:0003156,0.0885946741784373,0.975587139520637,6,11,regulation of animal organ formation,BP,WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
3268,GO:0043900,0.0887307694292149,0.991412618829715,3,4,regulation of multi-organism process,BP,BMP6;INHBB;NOTCH1
1280,GO:0009967,0.0888313602472807,0.954220925549279,19,48,positive regulation of signal transduction,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
1368,GO:0010647,0.0888313602472807,0.954220925549279,19,48,positive regulation of cell communication,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
1942,GO:0023056,0.0888313602472807,0.954220925549279,19,48,positive regulation of signaling,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
3226,GO:0043523,0.08889298973188,0.98537890898248,4,6,regulation of neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
3227,GO:0043524,0.08889298973188,0.98537890898248,4,6,negative regulation of neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
4208,GO:0051402,0.08889298973188,0.98537890898248,4,6,neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
429,GO:0003198,0.089067476542128,0.991364170649742,3,4,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,HEY1;FGF8;NOTCH1
4924,GO:0071241,0.0899215334571393,0.978494915371583,5,9,cellular response to inorganic substance,BP,BMP6;CDH1;FSTL3;GUCY1B3;TF
2976,GO:0042306,0.0899929257323971,0.978472029076687,5,9,regulation of protein import into nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3691,GO:0046822,0.0899929257323971,0.978472029076687,5,9,regulation of nucleocytoplasmic transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
5846,GO:1903533,0.0899929257323971,0.978472029076687,5,9,regulation of protein targeting,BP,BMP6;CDH1;FZD7;BMP4;BMP7
5917,GO:1904589,0.0899929257323971,0.978472029076687,5,9,regulation of protein import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4308,GO:0051962,0.0901436991146599,0.971149081056356,7,14,positive regulation of nervous system development,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
711,GO:0005921,0.0903118655147284,0.991184259137886,3,4,gap junction,CC,GJB2;GJA3;GJB6
712,GO:0005922,0.0903118655147284,0.991184259137886,3,4,connexin complex,CC,GJB2;GJA3;GJB6
1737,GO:0017156,0.0908688657016696,1,2,2,calcium ion regulated exocytosis,BP,SYT5;NOTCH1
1739,GO:0017158,0.0908688657016696,1,2,2,regulation of calcium ion-dependent exocytosis,BP,SYT5;NOTCH1
1028,GO:0007405,0.0911807527750079,1,2,2,neuroblast proliferation,BP,ARTN;NOTCH1
277,GO:0002320,0.0912675365471693,1,2,2,lymphoid progenitor cell differentiation,BP,BMP4;NOTCH1
416,GO:0003176,0.0912675365471693,1,2,2,aortic valve development,BP,BMP4;NOTCH1
419,GO:0003180,0.0912675365471693,1,2,2,aortic valve morphogenesis,BP,BMP4;NOTCH1
2064,GO:0030513,0.0912675365471693,1,2,2,positive regulation of BMP signaling pathway,BP,BMP4;NOTCH1
4640,GO:0060976,0.0912675365471693,1,2,2,coronary vasculature development,BP,BMP4;NOTCH1
6070,GO:2000136,0.0912675365471693,1,2,2,regulation of cell proliferation involved in heart morphogenesis,BP,BMP4;NOTCH1
1617,GO:0016247,0.0914000480813345,1,2,2,channel regulator activity,MF,WNK4;TSPAN13
5513,GO:0099106,0.0914000480813345,1,2,2,ion channel regulator activity,MF,WNK4;TSPAN13
5334,GO:0090382,0.0914221827458089,0.991022593207229,3,4,phagosome maturation,BP,RAB39A;RAB38;RAB20
2091,GO:0030670,0.0914732521455639,0.991015131561707,3,4,phagocytic vesicle membrane,CC,RAB39A;RAB38;RAB20
2226,GO:0031396,0.0922358144324299,1,2,2,regulation of protein ubiquitination,BP,MAGEC2;AXIN1
2227,GO:0031398,0.0922358144324299,1,2,2,positive regulation of protein ubiquitination,BP,MAGEC2;AXIN1
4213,GO:0051438,0.0922358144324299,1,2,2,regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
4214,GO:0051443,0.0922358144324299,1,2,2,positive regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1
5817,GO:1903320,0.0922358144324299,1,2,2,regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
5818,GO:1903322,0.0922358144324299,1,2,2,positive regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1
3200,GO:0043414,0.0922922262273484,1,2,2,macromolecule methylation,BP,RAB3D;PIK3CA
3575,GO:0045843,0.0923165453685779,0.99089159259213,3,4,negative regulation of striated muscle tissue development,BP,FZD7;FGF8;BMP4
3866,GO:0048635,0.0923165453685779,0.99089159259213,3,4,negative regulation of muscle organ development,BP,FZD7;FGF8;BMP4
5668,GO:1901862,0.0923165453685779,0.99089159259213,3,4,negative regulation of muscle tissue development,BP,FZD7;FGF8;BMP4
162,GO:0001837,0.0924017961870968,0.977695741489601,5,9,epithelial to mesenchymal transition,BP,HEY1;WNT2;FGF8;BMP7;NOTCH1
1228,GO:0009605,0.0924994736590774,0.950133531894843,22,57,response to external stimulus,BP,GJB2;PIK3CG;BMP6;WNT3;GJB6;PMAIP1;SPTBN5;SPTB;FGF8;VDR;ARTN;AMOT;INHBB;CCL20;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;SPTBN4;NOTCH1
3573,GO:0045839,0.0925902993263935,1,2,2,negative regulation of mitotic nuclear division,BP,BMP4;BMP7
4499,GO:0060442,0.0925902993263935,1,2,2,branching involved in prostate gland morphogenesis,BP,BMP4;BMP7
4575,GO:0060687,0.0925902993263935,1,2,2,regulation of branching involved in prostate gland morphogenesis,BP,BMP4;BMP7
4936,GO:0071310,0.0926561071425085,0.949421790062676,23,61,cellular response to organic substance,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;WNT2;CDH1;FZD7;FGF8;VDR;WNT5B;INHBB;CCL20;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
2969,GO:0042246,0.0926820247497842,0.990837859963412,3,4,tissue regeneration,BP,WNT7A;FZD7;NOTCH1
4368,GO:0060037,0.0927599221354342,0.990826392573473,3,4,pharyngeal system development,BP,FGF8;BMP4;BMP7
4491,GO:0060433,0.0927637436404111,1,2,2,bronchus development,BP,WNT7B;BMP4
4495,GO:0060438,0.0927637436404111,1,2,2,trachea development,BP,WNT7B;BMP4
4496,GO:0060439,0.0927637436404111,1,2,2,trachea morphogenesis,BP,WNT7B;BMP4
5154,GO:0072205,0.0927637436404111,1,2,2,metanephric collecting duct development,BP,WNT7B;BMP4
1313,GO:0010453,0.0928717873823536,1,2,2,regulation of cell fate commitment,BP,FZD7;BMP4
4603,GO:0060795,0.0928717873823536,1,2,2,cell fate commitment involved in formation of primary germ layer,BP,FZD7;BMP4
896,GO:0006906,0.0928883163809249,0.990807480007515,3,4,vesicle fusion,BP,SYT5;RAB39A;RAB20
3789,GO:0048284,0.0928883163809249,0.990807480007515,3,4,organelle fusion,BP,SYT5;RAB39A;RAB20
5294,GO:0090174,0.0928883163809249,0.990807480007515,3,4,organelle membrane fusion,BP,SYT5;RAB39A;RAB20
4161,GO:0051241,0.0929662092216334,0.956233684848693,14,34,negative regulation of multicellular organismal process,BP,WNT7A;PIK3CG;CLDN18;WNT3;FZD7;FGF8;AMOT;WNK4;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
2169,GO:0031090,0.0930782562732722,0.951663578229011,19,48,organelle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;SPTBN5;FZD7;RAB39A;WNT5B;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;NOTCH1;RND3;RAB20;TF
1475,GO:0014045,0.0933758572234513,1,2,2,establishment of endothelial blood-brain barrier,BP,WNT7A;WNT7B
1901,GO:0022009,0.0933758572234513,1,2,2,central nervous system vasculogenesis,BP,WNT7A;WNT7B
2428,GO:0032536,0.0933758572234513,1,2,2,regulation of cell projection size,BP,WNT7A;WNT7B
4619,GO:0060856,0.0933758572234513,1,2,2,establishment of blood-brain barrier,BP,WNT7A;WNT7B
3486,GO:0045453,0.0933780390927644,1,2,2,bone resorption,BP,CLDN18;RAB3D
3699,GO:0046849,0.0933780390927644,1,2,2,bone remodeling,BP,CLDN18;RAB3D
1509,GO:0014834,0.0934841045071368,1,2,2,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A;FZD7
3191,GO:0043403,0.0934841045071368,1,2,2,skeletal muscle tissue regeneration,BP,WNT7A;FZD7
6193,GO:2001235,0.0935383133626672,1,2,2,positive regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB
106,GO:0001649,0.093593310390315,0.969730797228117,7,14,osteoblast differentiation,BP,BMP6;WNT3;WNT7B;RRAS2;BMP4;BMP7;NOTCH1
4993,GO:0071542,0.0941990041092277,0.99061359978746,3,4,dopaminergic neuron differentiation,BP,WNT3;WNT2;FGF8
4006,GO:0050790,0.0946675522544791,0.948254067432676,23,60,regulation of catalytic activity,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;VDR;ARTN;AMOT;DUSP5;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
649,GO:0005634,0.0952092452289249,0.948903419350522,21,55,nucleus,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;HEY1;PMAIP1;AXIN1;MAPK12;POU3F1;RAB40B;VDR;AMOT;DUSP5;PKN3;PKP1;HRAS;FSTL3;SPTBN4;NOTCH1;PM20D2
767,GO:0006261,0.095291344015617,1,2,2,DNA-dependent DNA replication,BP,BMP6;BMP4
977,GO:0007184,0.095291344015617,1,2,2,SMAD protein import into nucleus,BP,BMP6;BMP4
4467,GO:0060390,0.095291344015617,1,2,2,regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
4468,GO:0060391,0.095291344015617,1,2,2,positive regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
5333,GO:0090329,0.095291344015617,1,2,2,regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
6060,GO:2000105,0.095291344015617,1,2,2,positive regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
685,GO:0005802,0.0954073539309172,1,2,2,trans-Golgi network,CC,CDH1;RAB38
5478,GO:0098791,0.0954073539309172,1,2,2,Golgi subcompartment,CC,CDH1;RAB38
4518,GO:0060502,0.09656918430758,1,2,2,epithelial cell proliferation involved in lung morphogenesis,BP,WNT2;BMP4
2295,GO:0031960,0.0968231170078811,0.976250525339899,5,9,response to corticosteroid,BP,GJB2;BMP6;HEY1;WNT7B;NOTCH1
3526,GO:0045667,0.096883235607024,0.976230693879256,5,9,regulation of osteoblast differentiation,BP,BMP6;WNT7B;BMP4;BMP7;NOTCH1
4019,GO:0050808,0.096895243734257,0.97622673215471,5,9,synapse organization,BP,WNT7A;WNT7B;CDH1;GDNF;DRP2
1297,GO:0010092,0.0972698527747906,0.983407877692866,4,6,specification of animal organ identity,BP,WNT2;FGF8;BMP4;GDNF
5336,GO:0090385,0.098398687762276,1,2,2,phagosome-lysosome fusion,BP,RAB39A;RAB20
886,GO:0006885,0.0985526031971826,0.98995899816668,3,4,regulation of pH,BP,RAB39A;RAB38;RAB20
1042,GO:0007498,0.0986659588059354,0.975640443047053,5,9,mesoderm development,BP,WNT3;AXIN1;FGF8;BMP4;BMP7
5742,GO:1902582,0.0987129813629043,0.964245745521506,8,17,single-organism intracellular transport,BP,WNT7A;PIK3CG;SYT5;BMP6;CDH1;FZD7;BMP4;BMP7
3454,GO:0045184,0.0990668422643584,0.948655840330225,18,46,establishment of protein localization,BP,RABIF;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;FZD7;RAB39A;INHBB;TSPAN15;RAB3D;BMP4;RAB38;BMP7;SPTBN4;NOTCH1;RAB20;TF
5949,GO:1904954,0.0991262280540487,1,2,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
6031,GO:1990909,0.0991262280540487,1,2,2,Wnt signalosome,CC,WNT3;WNT2
3123,GO:0043170,0.100721257847749,0.940486667560184,42,122,macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;RHBDL3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PM20D2
6147,GO:2000736,0.101187950271044,1,2,2,regulation of stem cell differentiation,BP,GDNF;NOTCH1
3088,GO:0043009,0.101562252061836,0.957762450593776,10,23,chordate embryonic development,BP,HEY1;WNT7B;JAG2;AXIN1;WNT2;FGF8;AMOT;BMP4;BMP7;NOTCH1
1139,GO:0008344,0.101774770390716,1,2,2,adult locomotory behavior,BP,GDNF;SPTBN4
2070,GO:0030534,0.101774770390716,1,2,2,adult behavior,BP,GDNF;SPTBN4
372,GO:0003006,0.101854533722547,0.952605786944469,13,31,developmental process involved in reproduction,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
3377,GO:0044702,0.103081261693609,0.947118705294331,17,43,single organism reproductive process,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
1172,GO:0008654,0.104850401004432,0.973560436162758,5,9,phospholipid biosynthetic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
1005,GO:0007269,0.10540838982427,1,2,2,neurotransmitter secretion,BP,WNT7A;SYT5
2876,GO:0036465,0.10540838982427,1,2,2,synaptic vesicle recycling,BP,WNT7A;SYT5
5530,GO:0099643,0.10540838982427,1,2,2,signal release from synapse,BP,WNT7A;SYT5
122,GO:0001704,0.105522968689126,0.967865266624128,6,12,formation of primary germ layer,BP,WNT3;AXIN1;FZD7;DUSP5;BMP4;BMP7
108,GO:0001654,0.10646894314582,0.960667715157461,8,17,eye development,BP,WNT7A;BMP6;WNT7B;AXIN1;WNT2;WNT5B;BMP4;BMP7
564,GO:0005088,0.1069185464697,0.964097270640587,7,14,Ras guanyl-nucleotide exchange factor activity,MF,SPTBN5;SPTB;FGF8;ARTN;FGF17;GDNF;SPTBN4
1810,GO:0019725,0.10696254902121,0.957469758780402,9,20,cellular homeostasis,BP,PIK3CG;BMP6;GJB6;VDR;RAB39A;RAB38;PIK3CA;RAB20;TF
5463,GO:0098657,0.107081115856778,1,2,2,import into cell,BP,GDNF;TF
1367,GO:0010646,0.107463549057964,0.937730223235521,28,77,regulation of cell communication,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;FZD7;FGF8;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
2097,GO:0030742,0.107774227295631,1,2,2,GTP-dependent protein binding,MF,RAB3D;RAB38
2722,GO:0035115,0.10844448345529,1,2,2,embryonic forelimb morphogenesis,BP,WNT7A;WNT3
2724,GO:0035136,0.10844448345529,1,2,2,forelimb morphogenesis,BP,WNT7A;WNT3
5445,GO:0098542,0.109780943548212,0.988196371643427,3,4,defense response to other organism,BP,PMAIP1;CCL20;HRAS
3382,GO:0044710,0.110060929812488,0.936357198296982,27,74,single-organism metabolic process,BP,GLDC;WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;VDR;ARTN;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;GUCY1B3
3304,GO:0044249,0.110219465744242,0.936646387965739,26,71,cellular biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
1279,GO:0009966,0.110511230254237,0.93605803409299,27,74,regulation of signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
5215,GO:0072594,0.11078670985335,0.965747336520345,6,12,establishment of protein localization to organelle,BP,BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
3485,GO:0045446,0.110983477513024,0.965667455031326,6,12,endothelial cell differentiation,BP,WNT7A;BMP6;HEY1;WNT7B;BMP4;NOTCH1
3906,GO:0048732,0.11120525129392,0.950569203754331,11,26,gland development,BP,WNT3;WNT7B;WNT2;CDH1;FGF8;VDR;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
401,GO:0003148,0.112010229452708,1,2,2,outflow tract septum morphogenesis,BP,FGF8;BMP4
3309,GO:0044260,0.112198969469919,0.932633920576577,39,113,cellular macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PM20D2
4005,GO:0050789,0.112401125351033,0.938496064273751,58,177,regulation of biological process,BP,MAGEC2;RHPN1;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF;PM20D2
1876,GO:0021846,0.112654360292293,1,2,2,cell proliferation in forebrain,BP,WNT7A;FGF8
2554,GO:0033036,0.113672554166423,0.936437202536431,22,59,macromolecule localization,BP,WNT7A;CLDN18;RABIF;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;FZD7;RAB39A;AMOT;WNK4;INHBB;TSPAN15;RAB3D;BMP4;RAB38;BMP7;SPTBN4;NOTCH1;RAB20;TF
964,GO:0007162,0.11496257029421,0.975473706056666,4,7,negative regulation of cell adhesion,BP,CDH1;FZD7;BMP4;NOTCH1
373,GO:0003007,0.1155964752915,0.963780241187274,6,12,heart morphogenesis,BP,HEY1;WNT2;FGF8;BMP4;BMP7;NOTCH1
176,GO:0001892,0.116193799506327,0.975103518507715,4,7,embryonic placenta development,BP,HEY1;WNT7B;WNT2;BMP7
14,GO:0000122,0.116602863859028,0.958739632572606,7,15,negative regulation of transcription from RNA polymerase II promoter,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;NOTCH1
5740,GO:1902580,0.11667432067765,0.945584789371465,12,29,single-organism cellular localization,BP,WNT7A;PIK3CG;SYT5;BMP6;PMAIP1;CDH1;RAB40B;FZD7;TSPAN15;BMP4;BMP7;SPTBN4
5866,GO:1903707,0.11727303663017,0.974777537930401,4,7,negative regulation of hemopoiesis,BP,CLDN18;BMP4;FSTL3;NOTCH1
2511,GO:0032879,0.117960060641484,0.930631315653539,28,78,regulation of localization,BP,WNT7A;PIK3CG;SYT5;CLDN18;BMP6;WNT3;JAG2;PMAIP1;KCNG2;CDH1;RRAS2;FZD7;AMOT;WNT5B;WNK4;INHBB;CCL20;HRAS;RAB3D;BMP4;KCNK6;GDNF;BMP7;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
4196,GO:0051336,0.118003077232259,0.941818813059908,14,34,regulation of hydrolase activity,BP,RABIF;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;ARTN;AMOT;CCL20;FGF17;HRAS;GDNF;SPTBN4
2300,GO:0031974,0.118170647265468,0.936663938629877,18,47,membrane-enclosed lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;WNT3;HEY1;WNT7B;MAPK12;POU3F1;VDR;WNT5B;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;TF;PM20D2
3148,GO:0043233,0.118170647265468,0.936663938629877,18,47,organelle lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;WNT3;HEY1;WNT7B;MAPK12;POU3F1;VDR;WNT5B;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;TF;PM20D2
4776,GO:0070013,0.118170647265468,0.936663938629877,18,47,intracellular organelle lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;WNT3;HEY1;WNT7B;MAPK12;POU3F1;VDR;WNT5B;DUSP5;PKP1;FSTL3;SPTBN4;NOTCH1;TF;PM20D2
3874,GO:0048645,0.118668715638739,0.968735807781611,5,9,animal organ formation,BP,WNT2;FGF8;BMP4;GDNF;BMP7
4153,GO:0051223,0.119797601838254,0.957278592696304,7,15,regulation of protein transport,BP,BMP6;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
4307,GO:0051961,0.120340605523362,0.973843410551432,4,7,negative regulation of nervous system development,BP,WNT7A;WNT3;BMP7;NOTCH1
4909,GO:0070997,0.120415453562377,0.968108906752397,5,9,neuron death,BP,RRAS2;FGF8;HRAS;GDNF;PIK3CA
5608,GO:1901214,0.120415453562377,0.968108906752397,5,9,regulation of neuron death,BP,RRAS2;FGF8;HRAS;GDNF;PIK3CA
4104,GO:0051093,0.120671180291488,0.945376272027699,11,26,negative regulation of developmental process,BP,WNT7A;CLDN18;WNT3;AXIN1;FZD7;FGF8;AMOT;BMP4;BMP7;FSTL3;NOTCH1
1263,GO:0009893,0.121801548212486,0.927381345376332,30,84,positive regulation of metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1
3576,GO:0045844,0.122153922067101,0.973285977685643,4,7,positive regulation of striated muscle tissue development,BP,ACTN3;WNT2;BMP4;NOTCH1
3867,GO:0048636,0.122153922067101,0.973285977685643,4,7,positive regulation of muscle organ development,BP,ACTN3;WNT2;BMP4;NOTCH1
5669,GO:1901863,0.122153922067101,0.973285977685643,4,7,positive regulation of muscle tissue development,BP,ACTN3;WNT2;BMP4;NOTCH1
3903,GO:0048729,0.122329905708837,0.936217461682241,16,41,tissue morphogenesis,BP,WNT7A;WNT3;HEY1;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;VDR;ARTN;WNK4;BMP4;GDNF;BMP7;NOTCH1
1356,GO:0010628,0.122817231986182,0.932784543235387,19,50,positive regulation of gene expression,BP,TLE1;WNT7A;BMP6;WNT3;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3584,GO:0045893,0.123183705541717,0.9369761367158,15,38,positive regulation of transcription, DNA-templated,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5756,GO:1902680,0.123183705541717,0.9369761367158,15,38,positive regulation of RNA biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5834,GO:1903508,0.123183705541717,0.9369761367158,15,38,positive regulation of nucleic acid-templated transcription,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
780,GO:0006357,0.123857394027794,0.936564772250196,15,38,regulation of transcription from RNA polymerase II promoter,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5093,GO:0072089,0.123884432219399,0.972750383171073,4,7,stem cell proliferation,BP,WNT3;WNT7B;ARTN;NOTCH1
665,GO:0005768,0.123903070924131,0.948896869281093,9,20,endosome,CC,SYT5;CDH1;RAB40B;FZD7;TSPAN15;RNF144A;RAB38;RAB20;TF
3299,GO:0044237,0.124277829627182,0.924795171059958,45,134,cellular metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PNMT;GUCY1B3;PM20D2
2184,GO:0031128,0.126331629559712,0.965957768147726,5,9,developmental induction,BP,WNT3;WNT2;FGF8;BMP4;GDNF
1337,GO:0010557,0.126366308744287,0.933710936163544,16,41,positive regulation of macromolecule biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3146,GO:0043231,0.126465690646582,0.922789809575407,38,111,intracellular membrane-bounded organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;PIK3CG;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;CDH1;RAB40B;RRAS2;SPTB;VDR;RAB39A;AMOT;WNT5B;DUSP5;PKN3;PKP1;HRAS;RAB3D;RNF144A;RAB38;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;PM20D2
4206,GO:0051384,0.12727715222673,0.971690132960175,4,7,response to glucocorticoid,BP,GJB2;BMP6;HEY1;WNT7B
1363,GO:0010639,0.127958186742275,0.963209796331377,5,10,negative regulation of organelle organization,BP,SPTBN5;SPTB;BMP4;BMP7;SPTBN4
1977,GO:0030111,0.12919651043275,0.952905099215287,7,15,regulation of Wnt signaling pathway,BP,TLE1;WNT7A;WNT3;AXIN1;WNT2;WNT5B;NOTCH1
1251,GO:0009792,0.130584126124975,0.941794831351662,10,24,embryo development ending in birth or egg hatching,BP,HEY1;WNT7B;JAG2;AXIN1;WNT2;FGF8;AMOT;BMP4;BMP7;NOTCH1
4535,GO:0060560,0.133402101560554,0.969742097557584,4,7,developmental growth involved in morphogenesis,BP,WNT3;WNT7B;BMP4;NOTCH1
5485,GO:0098805,0.134467866220095,0.928626321254909,16,41,whole membrane,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;CDH1;FZD7;RAB39A;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;RAB20;TF
2351,GO:0032268,0.134680067442973,0.924170843048198,20,53,regulation of cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7;SPTBN4;PM20D2
5231,GO:0080090,0.135724893995042,0.917412369923534,31,88,regulation of primary metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PM20D2
4012,GO:0050801,0.136243242364001,0.945220937660196,8,18,ion homeostasis,BP,PIK3CG;BMP6;VDR;RAB39A;WNK4;RAB38;RAB20;TF
5016,GO:0071705,0.136410303734369,0.927396757894824,16,41,nitrogen compound transport,BP,RABIF;BMP6;KCNG2;CDH1;RAB40B;FZD7;RAB39A;INHBB;RAB3D;BMP4;GDNF;RAB38;BMP7;NOTCH1;RAB20;TF
2573,GO:0033157,0.137312481100525,0.959509668246128,5,10,regulation of intracellular protein transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
5774,GO:1902904,0.137570360421176,0.976803508850279,3,5,negative regulation of supramolecular fiber organization,BP,SPTBN5;SPTB;SPTBN4
1961,GO:0030042,0.137703472198432,0.976769798117154,3,5,actin filament depolymerization,BP,SPTBN5;SPTB;SPTBN4
2118,GO:0030834,0.137703472198432,0.976769798117154,3,5,regulation of actin filament depolymerization,BP,SPTBN5;SPTB;SPTBN4
3155,GO:0043244,0.137703472198432,0.976769798117154,3,5,regulation of protein complex disassembly,BP,SPTBN5;SPTB;SPTBN4
3261,GO:0043624,0.137703472198432,0.976769798117154,3,5,cellular protein complex disassembly,BP,SPTBN5;SPTB;SPTBN4
4174,GO:0051261,0.137703472198432,0.976769798117154,3,5,protein depolymerization,BP,SPTBN5;SPTB;SPTBN4
5670,GO:1901879,0.137703472198432,0.976769798117154,3,5,regulation of protein depolymerization,BP,SPTBN5;SPTB;SPTBN4
4655,GO:0061025,0.138460011006635,0.968100809976317,4,7,membrane fusion,BP,SYT5;RABIF;RAB39A;RAB20
1122,GO:0008219,0.139056669409012,0.920254804535142,21,57,cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;RRAS2;FGF8;VDR;DSG3;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
818,GO:0006606,0.139281205146114,0.958717296652828,5,10,protein import into nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
900,GO:0006913,0.139281205146114,0.958717296652828,5,10,nucleocytoplasmic transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
1724,GO:0017038,0.139281205146114,0.958717296652828,5,10,protein import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3389,GO:0044744,0.139281205146114,0.958717296652828,5,10,protein targeting to nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4126,GO:0051169,0.139281205146114,0.958717296652828,5,10,nuclear transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4127,GO:0051170,0.139281205146114,0.958717296652828,5,10,nuclear import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
5745,GO:1902593,0.139281205146114,0.958717296652828,5,10,single-organism nuclear import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
1626,GO:0016303,0.139639758759024,0.967713770205821,4,7,1-phosphatidylinositol-3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
2857,GO:0036092,0.139639758759024,0.967713770205821,4,7,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
4317,GO:0052742,0.139639758759024,0.967713770205821,4,7,phosphatidylinositol kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
87,GO:0001503,0.139901435156638,0.943340091530628,8,18,ossification,BP,BMP6;WNT3;WNT7B;RRAS2;BMP4;BMP7;FSTL3;NOTCH1
4748,GO:0061448,0.143306825976686,0.941574911129537,8,18,connective tissue development,BP,WNT7A;BMP6;WNT7B;WNT5B;BMP4;PIK3CA;BMP7;NOTCH1
3850,GO:0048583,0.143713197307136,0.912827607083502,28,79,regulation of response to stimulus,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;ARTN;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
70,GO:0001076,0.144954074339851,0.974905733408244,3,5,transcription factor activity, RNA polymerase II transcription factor binding,MF,TLE1;POU3F1;NOTCH1
4484,GO:0060425,0.145255002406379,0.965849880962812,4,7,lung morphogenesis,BP,WNT7B;WNT2;FGF8;BMP4
2022,GO:0030278,0.145338361733907,0.956250058656226,5,10,regulation of ossification,BP,BMP6;WNT7B;BMP4;BMP7;NOTCH1
795,GO:0006468,0.145345295495053,0.914492322269882,23,63,protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4
3167,GO:0043276,0.145876714275207,0.974664621674139,3,5,anoikis,BP,TLE1;PIK3CA;NOTCH1
4576,GO:0060688,0.146644186493878,0.965383254773314,4,7,regulation of morphogenesis of a branching structure,BP,WNT2;BMP4;GDNF;BMP7
454,GO:0003279,0.147498205563682,0.955359656292892,5,10,cardiac septum development,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
2427,GO:0032535,0.147743383880202,0.94822155952391,6,13,regulation of cellular component size,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;SPTBN4
3851,GO:0048584,0.147824618466734,0.915222469305388,20,54,positive regulation of response to stimulus,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;ARTN;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
2662,GO:0034504,0.148091951903808,0.948059446149826,6,13,protein localization to nucleus,BP,CLDN18;BMP6;CDH1;FZD7;BMP4;BMP7
5556,GO:1900180,0.148091951903808,0.948059446149826,6,13,regulation of protein localization to nucleus,BP,CLDN18;BMP6;CDH1;FZD7;BMP4;BMP7
3604,GO:0045944,0.148341976725938,0.926604675706135,12,30,positive regulation of transcription from RNA polymerase II promoter,BP,WNT7A;BMP6;HEY1;POU3F1;WNT2;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1277,GO:0009953,0.14867550886043,0.964697018971615,4,7,dorsal/ventral pattern formation,BP,WNT7A;WNT3;FGF8;BMP4
4170,GO:0051254,0.148700777112554,0.920732816418325,15,39,positive regulation of RNA metabolic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
2354,GO:0032271,0.14921869155241,0.973783910430174,3,5,regulation of protein polymerization,BP,SPTBN5;SPTB;SPTBN4
1940,GO:0023051,0.149252044224142,0.90893135191225,28,79,regulation of signaling,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;FZD7;FGF8;AMOT;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
3612,GO:0045992,0.151512637934371,0.973172725667443,3,5,negative regulation of embryonic development,BP,FZD7;BMP4;BMP7
782,GO:0006366,0.151625186158906,0.918857514743842,15,39,transcription from RNA polymerase II promoter,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5638,GO:1901576,0.152041466406714,0.907908481069838,26,73,organic substance biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
3823,GO:0048513,0.152458107017665,0.904969227708456,33,96,animal organ development,BP,TLE1;WNT7A;GJB2;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;ARTN;DSG3;WNT5B;WNK4;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;TPD52;NOTCH1
3380,GO:0044707,0.152491634249751,0.905838074823127,48,146,single-multicellular organism process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;FGF17;HRAS;RAB3D;BMP4;KCNK6;GDNF;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;TF
120,GO:0001701,0.152552355082197,0.940325050156812,7,16,in utero embryonic development,BP,HEY1;WNT7B;JAG2;WNT2;AMOT;BMP7;NOTCH1
2977,GO:0042307,0.153574043286446,0.972618882829947,3,5,positive regulation of protein import into nucleus,BP,BMP6;CDH1;BMP4
5919,GO:1904591,0.153574043286446,0.972618882829947,3,5,positive regulation of protein import,BP,BMP6;CDH1;BMP4
3524,GO:0045665,0.154141263975158,0.97246572095887,3,5,negative regulation of neuron differentiation,BP,WNT3;BMP7;NOTCH1
2558,GO:0033077,0.154212085414197,0.972446574460813,3,5,T cell differentiation in thymus,BP,JAG2;FZD7;BMP4
2062,GO:0030510,0.155444801962444,0.972112487177153,3,5,regulation of BMP signaling pathway,BP,BMP4;FSTL3;NOTCH1
1320,GO:0010467,0.15594623481956,0.907029701380517,23,64,gene expression,BP,TLE1;WNT7A;RHBDL3;BMP6;WNT3;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;TSPAN15;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
2213,GO:0031328,0.156249336197105,0.914320939737213,16,42,positive regulation of cellular biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1217,GO:0009306,0.156562355198692,0.951562604852214,5,10,protein secretion,BP,BMP6;KCNG2;RAB40B;INHBB;NOTCH1
4428,GO:0060255,0.156572073412648,0.902572654106507,31,89,regulation of macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PM20D2
1317,GO:0010463,0.157160237469007,0.971644984400831,3,5,mesenchymal cell proliferation,BP,WNT2;BMP4;BMP7
4162,GO:0051246,0.158252286309844,0.908135877519687,20,54,regulation of protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7;SPTBN4;PM20D2
3632,GO:0046330,0.159028692101207,0.950512709442262,5,10,positive regulation of JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
2507,GO:0032870,0.159378480306693,0.932062440379957,8,19,cellular response to hormone stimulus,BP,GJB2;HEY1;VDR;INHBB;BMP4;PIK3CA;BMP7;NOTCH1
406,GO:0003158,0.159421942205424,0.942711489141999,6,13,endothelium development,BP,WNT7A;BMP6;HEY1;WNT7B;BMP4;NOTCH1
3997,GO:0050769,0.159862645407402,0.942500414704019,6,13,positive regulation of neurogenesis,BP,BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
5968,GO:1905330,0.159989226087456,0.950101897358469,5,10,regulation of morphogenesis of an epithelium,BP,WNT2;FZD7;BMP4;GDNF;BMP7
1284,GO:0009987,0.160276178819842,0.931521565240088,68,216,cellular process,BP,MAGEC2;SLC2A14;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;GDNF;RNF144A;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF;PM20D2
5698,GO:1902106,0.160287133037314,0.970785077081675,3,5,negative regulation of leukocyte differentiation,BP,CLDN18;BMP4;FSTL3
622,GO:0005509,0.160325212692763,0.931545301262564,8,19,calcium ion binding,MF,SYT5;ACTN3;RHBDL3;JAG2;CDH1;DSG3;TPD52;NOTCH1
4772,GO:0065007,0.160683422992828,0.90823260629489,59,183,biological regulation,BP,MAGEC2;RHPN1;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF;PM20D2
1324,GO:0010498,0.160863293363788,0.970625541318979,3,5,proteasomal protein catabolic process,BP,PMAIP1;AXIN1;RNF144A
4245,GO:0051603,0.160863293363788,0.970625541318979,3,5,proteolysis involved in cellular protein catabolic process,BP,PMAIP1;AXIN1;RNF144A
3100,GO:0043065,0.160902362096207,0.942001544374912,6,13,positive regulation of apoptotic process,BP,PMAIP1;VDR;INHBB;BMP4;BMP7;NOTCH1
3196,GO:0043409,0.161349711603864,0.970490590962571,3,5,negative regulation of MAPK cascade,BP,DUSP5;BMP4;BMP7
141,GO:0001759,0.161511089836027,0.960254075509412,4,7,organ induction,BP,WNT2;FGF8;BMP4;GDNF
2867,GO:0036294,0.161889743773468,0.970340483411999,3,5,cellular response to decreased oxygen levels,BP,PMAIP1;BMP7;NOTCH1
4981,GO:0071453,0.161889743773468,0.970340483411999,3,5,cellular response to oxygen levels,BP,PMAIP1;BMP7;NOTCH1
4982,GO:0071456,0.161889743773468,0.970340483411999,3,5,cellular response to hypoxia,BP,PMAIP1;BMP7;NOTCH1
3362,GO:0044446,0.161992093174141,0.897564850951544,36,106,intracellular organelle part,CC,MAGEC2;GLDC;TLE1;WNT7A;SYT5;ACTN3;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;MAPK12;POU3F1;SPTBN5;CDH1;RAB40B;SPTB;FZD7;VDR;RAB39A;AMOT;WNT5B;DUSP5;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;SPTBN4;NOTCH1;RND3;RAB20;TF;PM20D2
3495,GO:0045597,0.162066844074137,0.918197994254221,12,30,positive regulation of cell differentiation,BP,BMP6;WNT3;WNT7B;MAPK12;WNT2;FGF8;VDR;WNT5B;BMP4;GDNF;BMP7;NOTCH1
5277,GO:0090087,0.162732889168598,0.935089120349927,7,16,regulation of peptide transport,BP,BMP6;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
4334,GO:0055025,0.162759931162541,0.970097980180832,3,5,positive regulation of cardiac muscle tissue development,BP,WNT2;BMP4;NOTCH1
1628,GO:0016310,0.162901081584508,0.901449071834355,24,67,phosphorylation,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4
5279,GO:0090092,0.16314831698615,0.940919604861879,6,13,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;INHBB;BMP4;BMP7;FSTL3;NOTCH1
178,GO:0001894,0.163539057132122,0.969880199091545,3,5,tissue homeostasis,BP,CLDN18;RAB3D;TF
4972,GO:0071407,0.163702973131881,0.934583954211503,7,16,cellular response to organic cyclic compound,BP,GJB2;PIK3CG;HEY1;CDH1;VDR;BMP4;BMP7
2353,GO:0032270,0.163731679243484,0.906623362409053,18,48,positive regulation of cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7
4105,GO:0051094,0.163874633802144,0.909288950539275,16,42,positive regulation of developmental process,BP,WNT7A;ACTN3;BMP6;WNT3;WNT7B;MAPK12;WNT2;FGF8;VDR;AMOT;WNT5B;BMP4;GDNF;BMP7;SPTBN4;NOTCH1
1459,GO:0012501,0.164096111407652,0.903931534456528,20,55,programmed cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;FGF8;VDR;DSG3;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
4799,GO:0070201,0.166699165505576,0.928037305798781,8,19,regulation of establishment of protein localization,BP,BMP6;PMAIP1;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
866,GO:0006810,0.167913591570703,0.893363005309547,35,103,transport,BP,SLC2A14;WNT7A;GJB2;PIK3CG;SYT5;RABIF;BMP6;GJA3;PMAIP1;KCNG2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;VDR;RAB39A;WNK4;INHBB;PKP1;HRAS;RAB3D;BMP4;KCNK6;CLDN15;GDNF;RAB38;PIK3CA;BMP7;TPD52;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
4159,GO:0051239,0.168477063441869,0.896124035160205,26,74,regulation of multicellular organismal process,BP,WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT7B;KCNG2;WNT2;FZD7;FGF8;VDR;AMOT;WNK4;INHBB;CCL20;HRAS;BMP4;KCNK6;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
110,GO:0001656,0.168545869020145,0.946395038781465,5,10,metanephros development,BP,WNT7B;FGF8;BMP4;GDNF;BMP7
3354,GO:0044433,0.168634986373264,0.909637819273929,14,36,cytoplasmic vesicle part,CC,WNT7A;SYT5;WNT3;WNT7B;FZD7;RAB39A;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;RAB20;TF
3931,GO:0048839,0.169933482154052,0.937615511699114,6,13,inner ear development,BP,GJB2;GJB6;JAG2;FGF8;BMP4;NOTCH1
2123,GO:0030850,0.170276166476072,0.967971285891603,3,5,prostate gland development,BP,BMP4;BMP7;NOTCH1
4521,GO:0060512,0.170276166476072,0.967971285891603,3,5,prostate gland morphogenesis,BP,BMP4;BMP7;NOTCH1
4587,GO:0060740,0.170276166476072,0.967971285891603,3,5,prostate gland epithelium morphogenesis,BP,BMP4;BMP7;NOTCH1
2925,GO:0040019,0.171044199274235,0.967750741694281,3,5,positive regulation of embryonic development,BP,WNT2;AMOT;GDNF
482,GO:0003674,0.171058482852402,0.950846421797838,71,228,molecular_function,MF,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RHBDL3;CLDN18;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;MB21D2;RAB20;GUCY1B3;TF;PM20D2
5052,GO:0071901,0.171071099997781,0.96774300618053,3,5,negative regulation of protein serine/threonine kinase activity,BP,DUSP5;BMP4;BMP7
3598,GO:0045934,0.171423199122082,0.917590193406086,10,25,negative regulation of nucleobase-containing compound metabolic process,BP,TLE1;ACTN3;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
1336,GO:0010556,0.1714399098382,0.898832173609667,20,55,regulation of macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3476,GO:0045335,0.171508154563976,0.967617224895952,3,5,phagocytic vesicle,CC,RAB39A;RAB38;RAB20
3843,GO:0048562,0.171696631223293,0.936748256578314,6,13,embryonic organ morphogenesis,BP,GJB6;AXIN1;FGF8;BMP4;BMP7;NOTCH1
1177,GO:0009058,0.175151776989045,0.891310110851147,26,74,biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;INHBB;CCL20;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
1265,GO:0009895,0.175197702625435,0.951384730002491,4,8,negative regulation of catabolic process,BP,PIK3CG;ACTN3;PKP1;PIK3CA
1800,GO:0019538,0.175295330926757,0.888610752456866,32,93,protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;RHBDL3;BMP6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;TSPAN15;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4;PM20D2
4149,GO:0051216,0.175445082508889,0.93489266267778,6,13,cartilage development,BP,WNT7A;BMP6;WNT7B;WNT5B;BMP4;BMP7
779,GO:0006355,0.175637561823927,0.898239759610282,18,49,regulation of transcription, DNA-templated,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1797,GO:0019438,0.175682899607002,0.895863663976723,20,55,aromatic compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
567,GO:0005102,0.175963945715012,0.894654039963346,21,58,receptor binding,MF,WNT7A;PIK3CG;ACTN3;BMP6;WNT3;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;ARTN;WNT5B;INHBB;CCL20;FGF17;BMP4;GDNF;BMP7;NOTCH1;TF
5350,GO:0090596,0.177314573817605,0.933961228071566,6,13,sensory organ morphogenesis,BP,GJB6;AXIN1;WNT2;FGF8;BMP4;BMP7
2210,GO:0031325,0.17742164498576,0.889107736159039,27,77,positive regulation of cellular metabolic process,BP,MAGEC2;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1
3245,GO:0043565,0.177759629563163,0.950363129860778,4,8,sequence-specific DNA binding,MF,HEY1;POU3F1;VDR;NOTCH1
1836,GO:0019932,0.177873401787084,0.965763418880902,3,5,second-messenger-mediated signaling,BP,ACTN3;CCL20;GUCY1B3
902,GO:0006915,0.178780758461244,0.896065305514683,18,49,apoptotic process,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3404,GO:0044801,0.179178431296741,0.965378279507568,3,5,single-organism membrane fusion,BP,SYT5;RAB39A;RAB20
4486,GO:0060428,0.179598036270572,0.965254080259638,3,5,lung epithelium development,BP,WNT7B;WNT2;BMP4
3847,GO:0048568,0.180809984354767,0.915654148273028,9,22,embryonic organ development,BP,HEY1;GJB6;WNT7B;AXIN1;WNT2;FGF8;BMP4;BMP7;NOTCH1
5340,GO:0090407,0.181314885480179,0.931954849205921,6,13,organophosphate biosynthetic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA;GUCY1B3
2,GO:0000003,0.184283444154097,0.893653706205919,17,46,reproduction,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
1915,GO:0022414,0.184283444154097,0.893653706205919,17,46,reproductive process,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;SPTBN4;NOTCH1
4925,GO:0071248,0.184320015685876,0.94771316861125,4,8,cellular response to metal ion,BP,BMP6;CDH1;FSTL3;TF
1634,GO:0016331,0.184967572203291,0.923243194950219,7,16,morphogenesis of embryonic epithelium,BP,WNT7B;JAG2;WNT2;FGF8;BMP4;GDNF;BMP7
3156,GO:0043254,0.185157354680204,0.947371438501163,4,8,regulation of protein complex assembly,BP,PMAIP1;SPTBN5;SPTB;SPTBN4
114,GO:0001664,0.185685122684533,0.922851712872981,7,16,G-protein coupled receptor binding,MF,WNT7A;WNT3;WNT7B;WNT2;FZD7;WNT5B;CCL20
5233,GO:0080135,0.185749532951038,0.922816544071223,7,16,regulation of cellular response to stress,BP,WNT7A;WNT7B;PMAIP1;AXIN1;FZD7;HRAS;BMP7
3313,GO:0044267,0.186056545245604,0.881313461250566,30,87,cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4;PM20D2
125,GO:0001707,0.186442321851943,0.9468454876668,4,8,mesoderm formation,BP,WNT3;AXIN1;BMP4;BMP7
3799,GO:0048332,0.186442321851943,0.9468454876668,4,8,mesoderm morphogenesis,BP,WNT3;AXIN1;BMP4;BMP7
3830,GO:0048522,0.189378820183092,0.877626282203191,34,100,positive regulation of cellular process,BP,MAGEC2;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;RRAS2;FZD7;FGF8;VDR;WNT5B;DUSP5;INHBB;CCL20;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;NOTCH1;TF
5738,GO:1902578,0.189810346567095,0.879918436447142,27,78,single-organism localization,BP,SLC2A14;WNT7A;PIK3CG;SYT5;BMP6;PMAIP1;KCNG2;CDH1;RAB40B;FZD7;VDR;RAB39A;WNK4;INHBB;PKP1;TSPAN15;RAB3D;BMP4;KCNK6;GDNF;PIK3CA;BMP7;TPD52;SPTBN4;NOTCH1;RAB20;TF
1889,GO:0021915,0.190652143597751,0.945109346221526,4,8,neural tube development,BP,FGF8;BMP4;BMP7;NOTCH1
1909,GO:0022407,0.190939719136193,0.933688349522901,5,11,regulation of cell-cell adhesion,BP,CDH1;BMP4;PIK3CA;BMP7;FSTL3
228,GO:0002067,0.191168418081858,0.944895062535751,4,8,glandular epithelial cell differentiation,BP,BMP6;FGF8;BMP4;NOTCH1
3916,GO:0048762,0.191337428825138,0.91974812455646,7,16,mesenchymal cell differentiation,BP,HEY1;WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
4163,GO:0051247,0.191400409073376,0.887245170314217,18,49,positive regulation of protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;RNF144A;PIK3CA;BMP7
3720,GO:0046903,0.193268714619194,0.890860316728957,15,40,secretion,BP,WNT7A;PIK3CG;SYT5;BMP6;KCNG2;RAB40B;VDR;WNK4;INHBB;PKP1;RAB3D;GDNF;TPD52;NOTCH1;TF
6047,GO:2000027,0.193300054385766,0.912913322180047,8,19,regulation of organ morphogenesis,BP,WNT2;FZD7;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
470,GO:0003344,0.193473906524153,0.978098274174567,2,3,pericardium morphogenesis,BP,BMP7;NOTCH1
593,GO:0005200,0.193761427476937,0.978042881634786,2,3,structural constituent of cytoskeleton,MF,SPTB;SPTBN4
1406,GO:0010812,0.193871581947915,0.978021642448311,2,3,negative regulation of cell-substrate adhesion,BP,FZD7;NOTCH1
1818,GO:0019842,0.194482706989037,0.977903635596182,2,3,vitamin binding,MF,GLDC;VDR
5431,GO:0097651,0.195080239646325,0.977787967990883,2,3,phosphatidylinositol 3-kinase complex, class I,CC,PIK3CG;PIK3CA
5734,GO:1902532,0.195472821900611,0.931501007829355,5,11,negative regulation of intracellular signal transduction,BP,TLE1;ACTN3;DUSP5;BMP4;BMP7
3307,GO:0044257,0.195667927225639,0.943014857597393,4,8,cellular protein catabolic process,BP,MAGEC2;PMAIP1;AXIN1;RNF144A
4168,GO:0051252,0.196012846092113,0.882408646809697,19,53,regulation of RNA metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
573,GO:0005112,0.196250636604575,0.9775605898653,2,3,Notch binding,MF,JAG2;NOTCH1
1742,GO:0018105,0.196664966247962,0.930921911280248,5,11,peptidyl-serine phosphorylation,BP,AXIN1;MAPK12;PKN3;PIK3CA;SPTBN4
1752,GO:0018209,0.196664966247962,0.930921911280248,5,11,peptidyl-serine modification,BP,AXIN1;MAPK12;PKN3;PIK3CA;SPTBN4
1400,GO:0010799,0.197299856043909,0.977355832134502,2,3,regulation of peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
1401,GO:0010800,0.197299856043909,0.977355832134502,2,3,positive regulation of peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
126,GO:0001708,0.197445164380919,0.977327406159996,2,3,cell fate specification,BP,FZD7;NOTCH1
996,GO:0007257,0.197539310108836,0.97730897995707,2,3,activation of JUN kinase activity,BP,WNT7B;AXIN1
5116,GO:0072132,0.197671257588447,0.942170438860236,4,8,mesenchyme morphogenesis,BP,HEY1;FGF8;BMP7;NOTCH1
4123,GO:0051154,0.198438381810614,0.977132660031597,2,3,negative regulation of striated muscle cell differentiation,BP,FZD7;NOTCH1
793,GO:0006464,0.198475199755843,0.87348381306736,27,78,cellular protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
2863,GO:0036211,0.198475199755843,0.87348381306736,27,78,protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
3044,GO:0042592,0.198717039491599,0.886755441726825,15,41,homeostatic process,BP,PIK3CG;CLDN18;BMP6;GJB6;WNT7B;PMAIP1;VDR;RAB39A;WNK4;RAB3D;BMP4;RAB38;PIK3CA;RAB20;TF
3528,GO:0045669,0.198758862602149,0.941710127463384,4,8,positive regulation of osteoblast differentiation,BP,BMP6;WNT7B;BMP4;BMP7
3564,GO:0045822,0.200170897054608,0.976791084319568,2,3,negative regulation of heart contraction,BP,PIK3CG;SPTBN4
5841,GO:1903523,0.200170897054608,0.976791084319568,2,3,negative regulation of blood circulation,BP,PIK3CG;SPTBN4
218,GO:0002028,0.200695156807825,0.97668725430155,2,3,regulation of sodium ion transport,BP,WNK4;SPTBN4
870,GO:0006814,0.200695156807825,0.97668725430155,2,3,sodium ion transport,BP,WNK4;SPTBN4
4091,GO:0051049,0.201022333611719,0.878814561436135,19,53,regulation of transport,BP,PIK3CG;SYT5;BMP6;PMAIP1;KCNG2;CDH1;FZD7;WNK4;INHBB;RAB3D;BMP4;KCNK6;GDNF;BMP7;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
3283,GO:0044060,0.201796243598514,0.976468473216974,2,3,regulation of endocrine process,BP,BMP6;INHBB
4644,GO:0060986,0.201796243598514,0.976468473216974,2,3,endocrine hormone secretion,BP,BMP6;INHBB
2065,GO:0030514,0.202251067866961,0.976377820741148,2,3,negative regulation of BMP signaling pathway,BP,FSTL3;NOTCH1
1158,GO:0008544,0.202648265344429,0.912008451059301,7,17,epidermis development,BP,JAG2;POU3F1;VDR;DSG3;PKP1;BMP4;NOTCH1
16,GO:0000139,0.202654638416672,0.94005047486853,4,8,Golgi membrane,CC,RAB39A;HRAS;NOTCH1;RND3
4169,GO:0051253,0.202715116781673,0.901518065283721,9,23,negative regulation of RNA metabolic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
5796,GO:1903052,0.202863890599535,0.976255417252938,2,3,positive regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;RNF144A
2211,GO:0031326,0.202996258350835,0.876160279379459,20,56,regulation of cellular biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
76,GO:0001104,0.203264807056041,0.976175177870968,2,3,RNA polymerase II transcription cofactor activity,MF,TLE1;POU3F1
5832,GO:1903506,0.203448011780148,0.878429464999648,18,50,regulation of nucleic acid-templated transcription,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
6187,GO:2001141,0.203448011780148,0.878429464999648,18,50,regulation of RNA biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5897,GO:1904019,0.203504029192572,0.976127239123014,2,3,epithelial cell apoptotic process,BP,PIK3CG;JAG2
5735,GO:1902533,0.203681178316169,0.88821187919535,13,34,positive regulation of intracellular signal transduction,BP,WNT7A;PIK3CG;WNT7B;PMAIP1;AXIN1;FZD7;FGF8;DUSP5;CCL20;HRAS;BMP4;PIK3CA;NOTCH1
653,GO:0005667,0.203690652945902,0.976089809203816,2,3,transcription factor complex,CC,POU3F1;VDR
3312,GO:0044265,0.203815396493041,0.927414961411271,5,11,cellular macromolecule catabolic process,BP,MAGEC2;PMAIP1;AXIN1;PKP1;RNF144A
4775,GO:0070011,0.203851857870954,0.976057455086022,2,3,peptidase activity, acting on L-amino acid peptides,MF,RHBDL3;PM20D2
777,GO:0006352,0.204556790856522,0.975915731009982,2,3,DNA-templated transcription, initiation,BP,VDR;NOTCH1
783,GO:0006367,0.204556790856522,0.975915731009982,2,3,transcription initiation from RNA polymerase II promoter,BP,VDR;NOTCH1
3722,GO:0046907,0.204599402199047,0.892805621919225,11,29,intracellular transport,BP,WNT7A;PIK3CG;SYT5;BMP6;SPTBN5;CDH1;SPTB;FZD7;BMP4;BMP7;SPTBN4
2583,GO:0033273,0.204630033161883,0.975900983259014,2,3,response to vitamin,BP,VDR;BMP7
1954,GO:0030030,0.204830577506213,0.884604630386965,14,38,cell projection organization,BP,WNT7A;WNT3;WNT7B;SPTBN5;CDH1;SPTB;FGF8;ARTN;HRAS;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2590,GO:0033365,0.204869078271551,0.910735248709599,7,17,protein localization to organelle,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
862,GO:0006796,0.204906219915081,0.869282035938333,26,75,phosphate-containing compound metabolic process,BP,WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;GUCY1B3
3334,GO:0044346,0.205045869114096,0.975817171444866,2,3,fibroblast apoptotic process,BP,PIK3CG;PIK3CA
6093,GO:2000269,0.205045869114096,0.975817171444866,2,3,regulation of fibroblast apoptotic process,BP,PIK3CG;PIK3CA
6094,GO:2000270,0.205045869114096,0.975817171444866,2,3,negative regulation of fibroblast apoptotic process,BP,PIK3CG;PIK3CA
776,GO:0006351,0.206096373607667,0.876529513380191,18,50,transcription, DNA-templated,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3726,GO:0046916,0.206333615456065,0.975556752897052,2,3,cellular transition metal ion homeostasis,BP,BMP6;TF
2035,GO:0030316,0.206335513428476,0.975556368099148,2,3,osteoclast differentiation,BP,CLDN18;FSTL3
3529,GO:0045670,0.206335513428476,0.975556368099148,2,3,regulation of osteoclast differentiation,BP,CLDN18;FSTL3
3530,GO:0045671,0.206335513428476,0.975556368099148,2,3,negative regulation of osteoclast differentiation,BP,CLDN18;FSTL3
3681,GO:0046697,0.206777784817394,0.975466623064715,2,3,decidualization,BP,GJB2;VDR
5845,GO:1903532,0.207436744434011,0.937990133758965,4,8,positive regulation of secretion by cell,BP,BMP6;INHBB;RAB3D;GDNF
5557,GO:1900181,0.207516919150931,0.975316291172708,2,3,negative regulation of protein localization to nucleus,BP,CLDN18;BMP7
1983,GO:0030154,0.207962580109312,0.863302272438745,35,105,cell differentiation,BP,SLC2A14;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;INHBB;PKP1;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
4609,GO:0060837,0.208137706952463,0.975189693202571,2,3,blood vessel endothelial cell differentiation,BP,HEY1;NOTCH1
4613,GO:0060842,0.208137706952463,0.975189693202571,2,3,arterial endothelial cell differentiation,BP,HEY1;NOTCH1
1586,GO:0015980,0.20817897102276,0.975181267281238,2,3,energy derivation by oxidation of organic compounds,BP,ACTN3;PIK3CA
3208,GO:0043467,0.20817897102276,0.975181267281238,2,3,regulation of generation of precursor metabolites and energy,BP,ACTN3;PIK3CA
424,GO:0003188,0.208531697943593,0.97510918674787,2,3,heart valve formation,BP,HEY1;NOTCH1
425,GO:0003190,0.208531697943593,0.97510918674787,2,3,atrioventricular valve formation,BP,HEY1;NOTCH1
1633,GO:0016328,0.208555314027883,0.937504537576622,4,8,lateral plasma membrane,CC,GJB2;AXIN1;CDH1;CLDN15
1594,GO:0016050,0.2089514617935,0.937332227896297,4,8,vesicle organization,BP,SYT5;RAB39A;RAB38;RAB20
4129,GO:0051172,0.209909927442356,0.892879846869764,10,26,negative regulation of nitrogen compound metabolic process,BP,TLE1;ACTN3;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
2137,GO:0030879,0.210344449688114,0.924162756763343,5,11,mammary gland development,BP,WNT3;WNT7B;WNT2;VDR;BMP4
4342,GO:0055072,0.210743612946248,0.974654913248064,2,3,iron ion homeostasis,BP,BMP6;TF
833,GO:0006661,0.210867837849628,0.936496216681375,4,8,phosphatidylinositol biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
3417,GO:0045017,0.210867837849628,0.936496216681375,4,8,glycerolipid biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
3648,GO:0046474,0.210867837849628,0.936496216681375,4,8,glycerophospholipid biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
3950,GO:0048878,0.212225760623006,0.887783589661773,11,29,chemical homeostasis,BP,PIK3CG;BMP6;GJB6;WNT7B;VDR;RAB39A;WNK4;RAB38;PIK3CA;RAB20;TF
4573,GO:0060685,0.212448714830171,0.974302058749752,2,3,regulation of prostatic bud formation,BP,BMP4;BMP7
4574,GO:0060686,0.212448714830171,0.974302058749752,2,3,negative regulation of prostatic bud formation,BP,BMP4;BMP7
5969,GO:1905331,0.212448714830171,0.974302058749752,2,3,negative regulation of morphogenesis of an epithelium,BP,BMP4;BMP7
1293,GO:0010035,0.212783320796958,0.913521426219273,6,14,response to inorganic substance,BP,BMP6;CDH1;BMP7;FSTL3;GUCY1B3;TF
4328,GO:0055017,0.213486560672585,0.974086147849768,2,3,cardiac muscle tissue growth,BP,WNT2;NOTCH1
4331,GO:0055021,0.213486560672585,0.974086147849768,2,3,regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1
4332,GO:0055023,0.213486560672585,0.974086147849768,2,3,positive regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1
4275,GO:0051784,0.213831017065783,0.974014297388188,2,3,negative regulation of nuclear division,BP,BMP4;BMP7
4062,GO:0050922,0.214108694763053,0.973956307170707,2,3,negative regulation of chemotaxis,BP,WNT3;NOTCH1
3521,GO:0045661,0.214220889062784,0.973932858989638,2,3,regulation of myoblast differentiation,BP,BMP4;NOTCH1
3522,GO:0045662,0.214220889062784,0.973932858989638,2,3,negative regulation of myoblast differentiation,BP,BMP4;NOTCH1
1292,GO:0010033,0.214631921508063,0.863443516878752,24,69,response to organic substance,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;WNT2;CDH1;FZD7;FGF8;VDR;WNT5B;INHBB;CCL20;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
4054,GO:0050896,0.215094694123944,0.861610337496768,51,158,response to stimulus,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;SPTBN4;TSPAN13;NOTCH1;RND3;GUCY1B3;TF
849,GO:0006725,0.215250291653894,0.863839500161906,23,66,cellular aromatic compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
5607,GO:1901213,0.216561970294398,0.973441279785439,2,3,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,BMP4;NOTCH1
3715,GO:0046887,0.216706156732359,0.97341085984349,2,3,positive regulation of hormone secretion,BP,BMP6;INHBB
2143,GO:0030902,0.216920760660369,0.973365552562227,2,3,hindbrain development,BP,WNT7A;BMP7
4008,GO:0050793,0.217080200922717,0.863423055811858,22,63,regulation of developmental process,BP,WNT7A;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT7B;AXIN1;MAPK12;WNT2;FZD7;FGF8;VDR;AMOT;WNT5B;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
4457,GO:0060348,0.217130231767794,0.933735899597587,4,8,bone development,BP,CLDN18;BMP6;FGF8;BMP4
1318,GO:0010464,0.217961219283765,0.973145366075993,2,3,regulation of mesenchymal cell proliferation,BP,WNT2;BMP4
5113,GO:0072125,0.218084884872617,0.973119137581865,2,3,negative regulation of glomerular mesangial cell proliferation,BP,BMP4;BMP7
5301,GO:0090185,0.218084884872617,0.973119137581865,2,3,negative regulation of kidney development,BP,BMP4;BMP7
5309,GO:0090194,0.218084884872617,0.973119137581865,2,3,negative regulation of glomerulus development,BP,BMP4;BMP7
5661,GO:1901723,0.218084884872617,0.973119137581865,2,3,negative regulation of cell proliferation involved in kidney development,BP,BMP4;BMP7
2305,GO:0031984,0.218145272237622,0.973106325432614,2,3,organelle subcompartment,CC,CDH1;RAB38
4254,GO:0051649,0.218385913611102,0.877669958490118,13,35,establishment of localization in cell,BP,WNT7A;PIK3CG;SYT5;BMP6;PMAIP1;SPTBN5;CDH1;SPTB;FZD7;BMP4;GDNF;BMP7;SPTBN4
4586,GO:0060716,0.218593221341328,0.973011194315972,2,3,labyrinthine layer blood vessel development,BP,HEY1;WNT2
1261,GO:0009891,0.218835645534242,0.870681331049029,16,44,positive regulation of biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5014,GO:0071702,0.218955677918041,0.868819089919622,17,47,organic substance transport,BP,SLC2A14;RABIF;BMP6;KCNG2;CDH1;RAB40B;FZD7;RAB39A;INHBB;RAB3D;BMP4;GDNF;RAB38;BMP7;NOTCH1;RAB20;TF
2639,GO:0034260,0.219054927744242,0.972912972707548,2,3,negative regulation of GTPase activity,BP,AMOT;HRAS
831,GO:0006644,0.219250161302362,0.919650215603565,5,11,phospholipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
832,GO:0006650,0.219250161302362,0.919650215603565,5,11,glycerophospholipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
170,GO:0001845,0.22003482075782,0.972703945904564,2,3,phagolysosome assembly,BP,RAB39A;RAB20
940,GO:0007040,0.22003482075782,0.972703945904564,2,3,lysosome organization,BP,RAB39A;RAB20
5234,GO:0080171,0.22003482075782,0.972703945904564,2,3,lytic vacuole organization,BP,RAB39A;RAB20
4940,GO:0071322,0.220040656364057,0.972702698761965,2,3,cellular response to carbohydrate stimulus,BP,GJB6;PIK3CA
4941,GO:0071326,0.220040656364057,0.972702698761965,2,3,cellular response to monosaccharide stimulus,BP,GJB6;PIK3CA
4942,GO:0071331,0.220040656364057,0.972702698761965,2,3,cellular response to hexose stimulus,BP,GJB6;PIK3CA
4943,GO:0071333,0.220040656364057,0.972702698761965,2,3,cellular response to glucose stimulus,BP,GJB6;PIK3CA
2510,GO:0032874,0.220054718435493,0.919238214873028,5,11,positive regulation of stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4826,GO:0070304,0.220054718435493,0.919238214873028,5,11,positive regulation of stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
2941,GO:0042074,0.220108015876233,0.972688301200684,2,3,cell migration involved in gastrulation,BP,FGF8;AMOT
1892,GO:0021954,0.220502385262766,0.972603934567844,2,3,central nervous system neuron development,BP,FGF8;SPTBN4
1910,GO:0022408,0.220768236109755,0.97254699096773,2,3,negative regulation of cell-cell adhesion,BP,CDH1;BMP4
1944,GO:0023061,0.220854955647885,0.91882771622393,5,11,signal release,BP,WNT7A;SYT5;BMP6;KCNG2;INHBB
1089,GO:0008064,0.221075203321695,0.945088290515219,3,6,regulation of actin polymerization or depolymerization,BP,SPTBN5;SPTB;SPTBN4
1105,GO:0008154,0.221075203321695,0.945088290515219,3,6,actin polymerization or depolymerization,BP,SPTBN5;SPTB;SPTBN4
2116,GO:0030832,0.221075203321695,0.945088290515219,3,6,regulation of actin filament length,BP,SPTBN5;SPTB;SPTBN4
995,GO:0007254,0.221085676017202,0.918709231848258,5,11,JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
3630,GO:0046328,0.221085676017202,0.918709231848258,5,11,regulation of JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
1291,GO:0010008,0.221224691564941,0.918637813259272,5,11,endosome membrane,CC,SYT5;FZD7;TSPAN15;RNF144A;TF
3358,GO:0044440,0.221224691564941,0.918637813259272,5,11,endosomal part,CC,SYT5;FZD7;TSPAN15;RNF144A;TF
2142,GO:0030901,0.221476519985543,0.972395003033927,2,3,midbrain development,BP,WNT3;WNT2
5945,GO:1904948,0.221476519985543,0.972395003033927,2,3,midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
5948,GO:1904953,0.221476519985543,0.972395003033927,2,3,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
1781,GO:0019219,0.221580192091878,0.861123537739647,21,60,regulation of nucleobase-containing compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
4128,GO:0051171,0.221580192091878,0.861123537739647,21,60,regulation of nitrogen compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
4226,GO:0051494,0.22247975486008,0.944549866346355,3,6,negative regulation of cytoskeleton organization,BP,SPTBN5;SPTB;SPTBN4
4531,GO:0060541,0.222693950353891,0.900325328404269,7,17,respiratory system development,BP,WNT7B;AXIN1;WNT2;FGF8;BMP4;FSTL3;NOTCH1
1379,GO:0010676,0.222872615089126,0.972094236078513,2,3,positive regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
1436,GO:0010907,0.222872615089126,0.972094236078513,2,3,positive regulation of glucose metabolic process,BP,ACTN3;PMAIP1
5083,GO:0072073,0.223017576619838,0.900133213249252,7,17,kidney epithelium development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;NOTCH1
1008,GO:0007275,0.223182466956111,0.851591123078691,42,129,multicellular organism development,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
1878,GO:0021872,0.223580083591127,0.971941222640525,2,3,forebrain generation of neurons,BP,AXIN1;FGF8
1880,GO:0021879,0.223580083591127,0.971941222640525,2,3,forebrain neuron differentiation,BP,AXIN1;FGF8
6191,GO:2001233,0.223604301378892,0.930836695227125,4,8,regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB;BMP4;GDNF
2208,GO:0031323,0.223745399248498,0.852245867007513,31,92,regulation of cellular metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PM20D2
202,GO:0001958,0.224272070580498,0.971791166604556,2,3,endochondral ossification,BP,BMP6;BMP4
2854,GO:0036075,0.224272070580498,0.971791166604556,2,3,replacement ossification,BP,BMP6;BMP4
4719,GO:0061326,0.224421248392994,0.907053650896637,6,14,renal tubule development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
5062,GO:0072009,0.224421248392994,0.907053650896637,6,14,nephron epithelium development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
5090,GO:0072080,0.224421248392994,0.907053650896637,6,14,nephron tubule development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
224,GO:0002062,0.225291094576283,0.930073722051352,4,8,chondrocyte differentiation,BP,WNT7A;BMP6;WNT5B;BMP4
864,GO:0006807,0.225292286313118,0.85444923216982,25,73,nitrogen compound metabolic process,BP,GLDC;TLE1;WNT7A;ACTN3;MBOAT2;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
1238,GO:0009653,0.225400267015128,0.852322912855703,28,83,anatomical structure morphogenesis,BP,TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;SPTBN5;SPTB;FZD7;FGF8;VDR;ARTN;AMOT;WNK4;DUSP5;HRAS;BMP4;GDNF;PIK3CA;BMP7;TPD52;SPTBN4;NOTCH1
599,GO:0005243,0.225480004568333,0.971528301170479,2,3,gap junction channel activity,MF,GJB2;GJA3
1927,GO:0022829,0.225480004568333,0.971528301170479,2,3,wide pore channel activity,MF,GJB2;GJA3
74,GO:0001101,0.225694472935106,0.898539891060597,7,17,response to acid chemical,BP,GJB2;BMP6;WNT3;WNT7B;WNT2;FZD7;WNT5B
4347,GO:0055080,0.226237454122309,0.898215782388568,7,17,cation homeostasis,BP,PIK3CG;BMP6;VDR;RAB39A;RAB38;RAB20;TF
5475,GO:0098771,0.226237454122309,0.898215782388568,7,17,inorganic ion homeostasis,BP,PIK3CG;BMP6;VDR;RAB39A;RAB38;RAB20;TF
3164,GO:0043269,0.226286973808744,0.898186208380581,7,17,regulation of ion transport,BP,PIK3CG;KCNG2;WNK4;KCNK6;GDNF;SPTBN4;TSPAN13
3198,GO:0043412,0.226415169719298,0.852221313846853,27,79,macromolecule modification,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;RAB40B;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;RAB3D;BMP4;GDNF;RNF144A;PIK3CA;BMP7;SPTBN4
4335,GO:0055026,0.226587637295386,0.971286225628532,2,3,negative regulation of cardiac muscle tissue development,BP,FZD7;FGF8
1056,GO:0007586,0.227090276087054,0.971176045224126,2,3,digestion,BP,VDR;WNK4
1916,GO:0022600,0.227090276087054,0.971176045224126,2,3,digestive system process,BP,VDR;WNK4
1602,GO:0016070,0.227355709629902,0.859324476620039,19,54,RNA metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4487,GO:0060429,0.227906911000081,0.858915030289302,19,54,epithelium development,BP,WNT7A;BMP6;WNT3;HEY1;WNT7B;JAG2;POU3F1;WNT2;FZD7;FGF8;VDR;DSG3;WNT5B;WNK4;PKP1;BMP4;GDNF;BMP7;NOTCH1
2370,GO:0032330,0.228055142713557,0.970963969097183,2,3,regulation of chondrocyte differentiation,BP,BMP6;BMP4
5609,GO:1901215,0.229833596983096,0.928003453584345,4,8,negative regulation of neuron death,BP,FGF8;HRAS;GDNF;PIK3CA
5516,GO:0099504,0.230753320757461,0.970366905264869,2,3,synaptic vesicle cycle,BP,WNT7A;SYT5
2737,GO:0035264,0.230775291711547,0.970362019175249,2,3,multicellular organism growth,BP,PIK3CA;SPTBN4
2922,GO:0040014,0.230775291711547,0.970362019175249,2,3,regulation of multicellular organism growth,BP,PIK3CA;SPTBN4
5287,GO:0090132,0.230853690924982,0.89544782756878,7,17,epithelium migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;PIK3CA;NOTCH1
1249,GO:0009790,0.230928887494731,0.861604070585982,16,45,embryo development,BP,WNT7A;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;AMOT;DUSP5;BMP4;GDNF;BMP7;NOTCH1
4667,GO:0061046,0.230939980797641,0.970325381707084,2,3,regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4
4668,GO:0061047,0.230939980797641,0.970325381707084,2,3,positive regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4
3405,GO:0044802,0.231622351397139,0.883168274778922,9,23,single-organism membrane organization,BP,SYT5;PMAIP1;CDH1;RAB40B;RAB39A;TSPAN15;GDNF;SPTBN4;RAB20
4966,GO:0071384,0.231850307651151,0.970122468473482,2,3,cellular response to corticosteroid stimulus,BP,GJB2;HEY1
4967,GO:0071385,0.231850307651151,0.970122468473482,2,3,cellular response to glucocorticoid stimulus,BP,GJB2;HEY1
1027,GO:0007399,0.232032650587332,0.850102790813489,24,70,nervous system development,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;POU3F1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;ARTN;WNT5B;FGF17;HRAS;BMP4;GDNF;PIK3CA;DRP2;BMP7;SPTBN4;NOTCH1
1984,GO:0030155,0.232100817621468,0.88194263894306,9,24,regulation of cell adhesion,BP,PIK3CG;JAG2;CDH1;FZD7;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
2483,GO:0032768,0.232255266255611,0.97003198593868,2,3,regulation of monooxygenase activity,BP,VDR;GDNF
1009,GO:0007276,0.232789383752615,0.894280520706073,7,17,gamete generation,BP,SLC2A14;WNT3;JAG2;INHBB;BMP4;FSTL3;NOTCH1
3870,GO:0048640,0.233260871142019,0.969806719712373,2,3,negative regulation of developmental growth,BP,WNT3;BMP4
2215,GO:0031330,0.233305866076504,0.940327487609148,3,6,negative regulation of cellular catabolic process,BP,PIK3CG;PKP1;PIK3CA
3998,GO:0050770,0.234118116073752,0.969614037203169,2,3,regulation of axonogenesis,BP,WNT7A;WNT3
1746,GO:0018130,0.235121712730346,0.853532851728168,19,54,heterocycle biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;GUCY1B3
2678,GO:0034654,0.235121712730346,0.853532851728168,19,54,nucleobase-containing compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;GUCY1B3
3315,GO:0044271,0.235121712730346,0.853532851728168,19,54,cellular nitrogen compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;GUCY1B3
6064,GO:2000112,0.2360190992957,0.85436673480195,18,51,regulation of cellular macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1840,GO:0019953,0.236103106787937,0.885698005481011,8,20,sexual reproduction,BP,SLC2A14;WNT3;JAG2;INHBB;BMP4;FSTL3;SPTBN4;NOTCH1
2485,GO:0032774,0.236174062375078,0.854251322630063,18,51,RNA biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5432,GO:0097659,0.236174062375078,0.854251322630063,18,51,nucleic acid-templated transcription,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1970,GO:0030073,0.23674867752757,0.969019024453422,2,3,insulin secretion,BP,KCNG2;INHBB
4011,GO:0050796,0.23674867752757,0.969019024453422,2,3,regulation of insulin secretion,BP,KCNG2;INHBB
5320,GO:0090276,0.23674867752757,0.969019024453422,2,3,regulation of peptide hormone secretion,BP,KCNG2;INHBB
5619,GO:1901362,0.237014582523683,0.850745668479456,20,57,organic cyclic compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
3819,GO:0048489,0.237326393755048,0.968887592380942,2,3,synaptic vesicle transport,BP,WNT7A;SYT5
5421,GO:0097480,0.237326393755048,0.968887592380942,2,3,establishment of synaptic vesicle localization,BP,WNT7A;SYT5
5504,GO:0099003,0.237326393755048,0.968887592380942,2,3,vesicle-mediated transport in synapse,BP,WNT7A;SYT5
3089,GO:0043010,0.238008890006688,0.899317225905868,6,14,camera-type eye development,BP,WNT7A;WNT7B;WNT2;WNT5B;BMP4;BMP7
3393,GO:0044765,0.238169194667193,0.845391805180053,24,70,single-organism transport,BP,SLC2A14;WNT7A;PIK3CG;SYT5;BMP6;KCNG2;CDH1;RAB40B;FZD7;VDR;RAB39A;WNK4;INHBB;PKP1;RAB3D;BMP4;KCNK6;GDNF;PIK3CA;BMP7;TPD52;NOTCH1;RAB20;TF
4645,GO:0060993,0.238216189122205,0.899197660905846,6,14,kidney morphogenesis,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7
1846,GO:0021532,0.239534528418833,0.968382718205182,2,3,neural tube patterning,BP,FGF8;BMP4
1449,GO:0010952,0.240077453219455,0.968257970441228,2,3,positive regulation of peptidase activity,BP,PMAIP1;MAPK12
2130,GO:0030863,0.24053597872763,0.918927607401212,4,9,cortical cytoskeleton,CC,SPTBN5;CDH1;SPTB;SPTBN4
2131,GO:0030864,0.24053597872763,0.918927607401212,4,9,cortical actin cytoskeleton,CC,SPTBN5;CDH1;SPTB;SPTBN4
3183,GO:0043331,0.24074559783521,0.968104119055875,2,3,response to dsRNA,BP,PMAIP1;BMP4
1609,GO:0016192,0.240787096628971,0.852499870904648,17,48,vesicle-mediated transport,BP,WNT7A;PIK3CG;SYT5;RABIF;SPTBN5;RAB40B;SPTB;RAB39A;PKP1;HRAS;RAB3D;RAB38;PIK3CA;SPTBN4;NOTCH1;RAB20;TF
3905,GO:0048731,0.24234378924152,0.836327696187505,40,123,system development,BP,TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
3531,GO:0045682,0.24326964723279,0.936328317187383,3,6,regulation of epidermis development,BP,VDR;BMP4;NOTCH1
2005,GO:0030217,0.24343922253837,0.936259315470722,3,6,T cell differentiation,BP,JAG2;FZD7;BMP4
3016,GO:0042487,0.243549727004403,0.967454422775417,2,3,regulation of odontogenesis of dentin-containing tooth,BP,FGF8;BMP4
1242,GO:0009725,0.243929694352016,0.869563333764651,10,27,response to hormone,BP,GJB2;BMP6;HEY1;WNT7B;VDR;INHBB;BMP4;PIK3CA;BMP7;NOTCH1
3303,GO:0044248,0.24446589388911,0.873784983114902,9,24,cellular catabolic process,BP,MAGEC2;GLDC;PIK3CG;PMAIP1;AXIN1;RAB39A;PKP1;RNF144A;PIK3CA
467,GO:0003337,0.244901335128243,0.967138954212351,2,3,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,BMP4;GDNF
5173,GO:0072283,0.244901335128243,0.967138954212351,2,3,metanephric renal vesicle morphogenesis,BP,BMP4;GDNF
4377,GO:0060054,0.246595647964318,0.96674137004361,2,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A;FZD7
1321,GO:0010468,0.247063086347624,0.841632039496177,21,61,regulation of gene expression,BP,TLE1;WNT7A;BMP6;WNT3;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
3693,GO:0046824,0.247117635665934,0.934754793613884,3,6,positive regulation of nucleocytoplasmic transport,BP,BMP6;CDH1;BMP4
732,GO:0006006,0.247261487137447,0.934695655524169,3,6,glucose metabolic process,BP,ACTN3;PMAIP1;PIK3CA
2919,GO:0040011,0.247725400597978,0.84238546667302,20,58,locomotion,BP,WNT7A;PIK3CG;WNT3;JAG2;SPTBN5;RRAS2;SPTB;FGF8;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
1994,GO:0030178,0.248022819031089,0.915215880923933,4,9,negative regulation of Wnt signaling pathway,BP,TLE1;AXIN1;WNT5B;NOTCH1
2025,GO:0030282,0.248095348286491,0.934352404616491,3,6,bone mineralization,BP,BMP6;BMP4;BMP7
2057,GO:0030500,0.248095348286491,0.934352404616491,3,6,regulation of bone mineralization,BP,BMP6;BMP4;BMP7
2058,GO:0030501,0.248095348286491,0.934352404616491,3,6,positive regulation of bone mineralization,BP,BMP6;BMP4;BMP7
3599,GO:0045935,0.249394450677886,0.848003923891968,16,45,positive regulation of nucleobase-containing compound metabolic process,BP,WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4130,GO:0051173,0.249394450677886,0.848003923891968,16,45,positive regulation of nitrogen compound metabolic process,BP,WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
2512,GO:0032880,0.249556182321916,0.865714987489648,10,27,regulation of protein localization,BP,WNT7A;CLDN18;BMP6;PMAIP1;KCNG2;CDH1;FZD7;INHBB;BMP4;BMP7
3197,GO:0043410,0.249578398244753,0.86652290561153,10,26,positive regulation of MAPK cascade,BP,WNT7A;PIK3CG;WNT7B;AXIN1;FZD7;FGF8;DUSP5;CCL20;HRAS;BMP4
1260,GO:0009890,0.249669003710218,0.870307665815841,9,24,negative regulation of biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;INHBB;BMP4;BMP7;NOTCH1
1338,GO:0010558,0.249669003710218,0.870307665815841,9,24,negative regulation of macromolecule biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;INHBB;BMP4;BMP7;NOTCH1
2212,GO:0031327,0.249669003710218,0.870307665815841,9,24,negative regulation of cellular biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;INHBB;BMP4;BMP7;NOTCH1
5616,GO:1901343,0.249753616950947,0.914348892486775,4,9,negative regulation of vasculature development,BP,AMOT;BMP4;BMP7;NOTCH1
4122,GO:0051153,0.250168599822273,0.933495670788177,3,6,regulation of striated muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
4475,GO:0060412,0.250697279464616,0.933276450117286,3,6,ventricular septum morphogenesis,BP,HEY1;BMP4;NOTCH1
4713,GO:0061311,0.251144749848444,0.933090664151655,3,6,cell surface receptor signaling pathway involved in heart development,BP,HEY1;BMP4;NOTCH1
4425,GO:0060249,0.252394431434497,0.932570644743763,3,6,anatomical structure homeostasis,BP,CLDN18;RAB3D;TF
706,GO:0005911,0.252741455259599,0.859466651875674,11,30,cell-cell junction,CC,TJP3;GJB2;CLDN18;GJA3;GJB6;CDH1;DSG3;AMOT;WNK4;PKP1;CLDN15
3120,GO:0043167,0.252752678577616,0.829024046474838,32,97,ion binding,MF,GLDC;PIK3CG;SYT5;ACTN3;RHBDL3;RABIF;JAG2;MAPK12;CDH1;RAB40B;RRAS2;FZD7;VDR;RAB39A;DSG3;WNK4;PKN3;HRAS;RAB3D;BMP4;RNF144A;RAB38;PIK3CA;DRP2;BMP7;TPD52;SPTBN4;NOTCH1;RND3;RAB20;GUCY1B3;TF
3583,GO:0045892,0.253242285476006,0.873479978571568,8,21,negative regulation of transcription, DNA-templated,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
5755,GO:1902679,0.253242285476006,0.873479978571568,8,21,negative regulation of RNA biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
5833,GO:1903507,0.253242285476006,0.873479978571568,8,21,negative regulation of nucleic acid-templated transcription,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
2391,GO:0032386,0.255391980358524,0.897594438109789,5,12,regulation of intracellular transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
213,GO:0002009,0.255695077956857,0.853826639089189,12,33,morphogenesis of an epithelium,BP,WNT7A;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
4113,GO:0051129,0.255919370289695,0.886778844877627,6,15,negative regulation of cellular component organization,BP,WNT3;SPTBN5;SPTB;BMP4;BMP7;SPTBN4
5304,GO:0090189,0.256558611372111,0.964355375358464,2,3,regulation of branching involved in ureteric bud morphogenesis,BP,BMP4;GDNF
4160,GO:0051240,0.257010409673159,0.840335266184552,17,48,positive regulation of multicellular organismal process,BP,WNT7A;ACTN3;BMP6;WNT3;WNT7B;WNT2;FGF8;VDR;AMOT;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;SPTBN4;NOTCH1
861,GO:0006793,0.257646611029738,0.828450748618645,26,77,phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;SPTB;FZD7;FGF8;ARTN;WNK4;DUSP5;INHBB;CCL20;PKN3;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;GUCY1B3
3855,GO:0048592,0.259020998397978,0.909649774504623,4,9,eye morphogenesis,BP,AXIN1;WNT2;BMP4;BMP7
2500,GO:0032835,0.259552218088303,0.929559134640083,3,6,glomerulus development,BP,BMP4;BMP7;NOTCH1
4742,GO:0061437,0.259552218088303,0.929559134640083,3,6,renal system vasculature development,BP,BMP4;BMP7;NOTCH1
4745,GO:0061440,0.259552218088303,0.929559134640083,3,6,kidney vasculature development,BP,BMP4;BMP7;NOTCH1
5064,GO:0072012,0.259552218088303,0.929559134640083,3,6,glomerulus vasculature development,BP,BMP4;BMP7;NOTCH1
5108,GO:0072109,0.259552218088303,0.929559134640083,3,6,glomerular mesangium development,BP,BMP4;BMP7;NOTCH1
4156,GO:0051234,0.259818507258089,0.822460176699229,36,110,establishment of localization,BP,SLC2A14;WNT7A;GJB2;PIK3CG;SYT5;RABIF;BMP6;GJA3;PMAIP1;KCNG2;SPTBN5;CDH1;RAB40B;SPTB;FZD7;VDR;RAB39A;WNK4;INHBB;PKP1;TSPAN15;HRAS;RAB3D;BMP4;KCNK6;CLDN15;GDNF;RAB38;PIK3CA;BMP7;TPD52;SPTBN4;TSPAN13;NOTCH1;RAB20;TF
3810,GO:0048468,0.259888038887034,0.829292739643914,23,68,cell development,BP,WNT7A;CLDN18;BMP6;WNT3;WNT7B;AXIN1;POU3F1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;ARTN;WNT5B;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
527,GO:0004674,0.260398978161394,0.894755495727809,5,12,protein serine/threonine kinase activity,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
1241,GO:0009719,0.2604393678047,0.83741487289124,17,49,response to endogenous stimulus,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;WNT7B;WNT2;CDH1;FGF8;VDR;INHBB;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
1229,GO:0009607,0.260763377971764,0.876976700201163,7,17,response to biotic stimulus,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;NOTCH1
3136,GO:0043207,0.260763377971764,0.876976700201163,7,17,response to external biotic stimulus,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;NOTCH1
4265,GO:0051707,0.260763377971764,0.876976700201163,7,17,response to other organism,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;NOTCH1
4336,GO:0055037,0.263396533236578,0.927918483367663,3,6,recycling endosome,CC,SYT5;FZD7;TF
3948,GO:0048871,0.263837412540721,0.892790071577403,5,12,multicellular organismal homeostasis,BP,CLDN18;BMP6;RAB3D;PIK3CA;TF
817,GO:0006605,0.263851341481761,0.892782083506576,5,12,protein targeting,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3345,GO:0044422,0.263913901700673,0.819168072031541,36,110,organelle part,CC,MAGEC2;GLDC;TLE1;WNT7A;SYT5;ACTN3;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;MAPK12;POU3F1;SPTBN5;CDH1;RAB40B;SPTB;FZD7;VDR;RAB39A;AMOT;WNT5B;DUSP5;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;SPTBN4;NOTCH1;RND3;RAB20;TF;PM20D2
226,GO:0002065,0.264719708001006,0.892283668610224,5,12,columnar/cuboidal epithelial cell differentiation,BP,BMP6;JAG2;FGF8;BMP4;NOTCH1
3752,GO:0048018,0.264986573795964,0.927235144624147,3,6,receptor agonist activity,MF,WNT7A;WNT3;WNT2
2422,GO:0032502,0.265149094141273,0.81901955507232,44,137,developmental process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
3395,GO:0044767,0.265149094141273,0.81901955507232,44,137,single-organism developmental process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
1815,GO:0019827,0.265196100948074,0.906465399444084,4,9,stem cell population maintenance,BP,WNT7A;FZD7;BMP7;NOTCH1
5469,GO:0098727,0.265196100948074,0.906465399444084,4,9,maintenance of cell number,BP,WNT7A;FZD7;BMP7;NOTCH1
1011,GO:0007283,0.265378579575381,0.906370651463854,4,9,spermatogenesis,BP,SLC2A14;JAG2;FSTL3;NOTCH1
3775,GO:0048232,0.265378579575381,0.906370651463854,4,9,male gamete generation,BP,SLC2A14;JAG2;FSTL3;NOTCH1
5227,GO:0072676,0.265387035464083,0.927062602803368,3,6,lymphocyte migration,BP,PIK3CG;ARTN;CCL20
4988,GO:0071495,0.265760421232461,0.83534869246974,16,46,cellular response to endogenous stimulus,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;WNT2;CDH1;FGF8;VDR;INHBB;FGF17;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
5446,GO:0098552,0.265838844597752,0.891640107076838,5,12,side of membrane,CC,CDH1;SPTB;FGF8;AMOT;TF
3666,GO:0046620,0.265847961902963,0.926863790723857,3,6,regulation of organ growth,BP,WNT2;FGF8;NOTCH1
3667,GO:0046622,0.265847961902963,0.926863790723857,3,6,positive regulation of organ growth,BP,WNT2;FGF8;NOTCH1
4422,GO:0060231,0.265852539571168,0.92686181505826,3,6,mesenchymal to epithelial transition,BP,FZD7;BMP4;GDNF
987,GO:0007219,0.266310301797275,0.905886295983264,4,9,Notch signaling pathway,BP,HEY1;JAG2;BMP7;NOTCH1
3422,GO:0045055,0.26729175322771,0.879835600386954,6,15,regulated exocytosis,BP,PIK3CG;SYT5;PKP1;RAB3D;NOTCH1;TF
1738,GO:0017157,0.268061304701919,0.92590584644773,3,6,regulation of exocytosis,BP,SYT5;RAB3D;NOTCH1
1988,GO:0030163,0.268568103121248,0.90470855952862,4,9,protein catabolic process,BP,MAGEC2;PMAIP1;AXIN1;RNF144A
3234,GO:0043542,0.269483324940235,0.889534881514212,5,12,endothelial cell migration,BP,WNT7A;AMOT;BMP4;PIK3CA;NOTCH1
4654,GO:0061024,0.270431733455241,0.84316368848913,12,33,membrane organization,BP,SYT5;RABIF;PMAIP1;CDH1;RAB40B;RAB39A;TSPAN15;GDNF;RAB38;SPTBN4;RAB20;TF
3525,GO:0045666,0.270773992138815,0.903552406174599,4,9,positive regulation of neuron differentiation,BP,BMP6;WNT3;BMP4;BMP7
4698,GO:0061180,0.27156007917406,0.903139088334369,4,9,mammary gland epithelium development,BP,WNT3;WNT7B;WNT2;VDR
3724,GO:0046914,0.27158163037132,0.888316236564107,5,12,transition metal ion binding,MF,RABIF;VDR;RNF144A;DRP2;TF
2423,GO:0032504,0.271939138240563,0.855128571339661,9,24,multicellular organism reproduction,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;NOTCH1
3861,GO:0048609,0.271939138240563,0.855128571339661,9,24,multicellular organismal reproductive process,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;NOTCH1
3554,GO:0045778,0.272026783585831,0.902893372738966,4,9,positive regulation of ossification,BP,BMP6;WNT7B;BMP4;BMP7
1460,GO:0012505,0.274068695765942,0.81619820513949,25,74,endomembrane system,CC,WNT7A;SYT5;MBOAT2;WNT3;WNT7B;CDH1;RAB40B;RRAS2;SPTB;FZD7;RAB39A;WNT5B;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;TPD52;NOTCH1;RND3;RAB20;TF
4539,GO:0060571,0.274371856065474,0.923144950344235,3,6,morphogenesis of an epithelial fold,BP,WNT2;BMP4;BMP7
4540,GO:0060572,0.274371856065474,0.923144950344235,3,6,morphogenesis of an epithelial bud,BP,WNT2;BMP4;BMP7
1445,GO:0010942,0.274933069995774,0.875093628352529,6,15,positive regulation of cell death,BP,PMAIP1;VDR;INHBB;BMP4;BMP7;NOTCH1
3103,GO:0043068,0.274933069995774,0.875093628352529,6,15,positive regulation of programmed cell death,BP,PMAIP1;VDR;INHBB;BMP4;BMP7;NOTCH1
5970,GO:1905332,0.275102371808202,0.922822505935932,3,6,positive regulation of morphogenesis of an epithelium,BP,WNT2;BMP4;GDNF
867,GO:0006811,0.275492973840125,0.847590465409979,10,27,ion transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;CLDN15;GDNF;SPTBN4;TSPAN13;TF
1784,GO:0019222,0.276039988871365,0.81031432801908,32,97,regulation of metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;DUSP5;INHBB;CCL20;PKP1;HRAS;BMP4;GDNF;RNF144A;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1;PM20D2
1034,GO:0007422,0.276292822618259,0.922295785082462,3,6,peripheral nervous system development,BP,POU3F1;ARTN;GDNF
3523,GO:0045664,0.276667951449724,0.874008448161303,6,15,regulation of neuron differentiation,BP,WNT7A;BMP6;WNT3;BMP4;BMP7;NOTCH1
3391,GO:0044763,0.27668524823727,0.827818029766176,60,191,single-organism cellular process,BP,SLC2A14;GLDC;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;GDNF;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;GUCY1B3;TF
868,GO:0006812,0.276940046032881,0.85165460199722,9,24,cation transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;GDNF;SPTBN4;TSPAN13;TF
924,GO:0006979,0.27715330228261,0.900178297109786,4,9,response to oxidative stress,BP,GJB2;FGF8;BMP7;GUCY1B3
1922,GO:0022612,0.277274719773527,0.884985681148675,5,12,gland morphogenesis,BP,FGF8;VDR;BMP4;BMP7;NOTCH1
756,GO:0006139,0.278286993009195,0.815850753284173,22,65,nucleobase-containing compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3
577,GO:0005126,0.278882423594612,0.884038759570374,5,12,cytokine receptor binding,MF,BMP6;INHBB;CCL20;BMP4;BMP7
568,GO:0005104,0.278925219581426,0.958695417582404,2,3,fibroblast growth factor receptor binding,MF,FGF8;FGF17
3122,GO:0043169,0.279290955077301,0.824648927413699,16,47,cation binding,MF,GLDC;SYT5;ACTN3;RHBDL3;RABIF;JAG2;MAPK12;CDH1;VDR;DSG3;RNF144A;DRP2;TPD52;NOTCH1;GUCY1B3;TF
4607,GO:0060828,0.279698764277944,0.883556866497967,5,12,regulation of canonical Wnt signaling pathway,BP,WNT7A;AXIN1;WNT2;WNT5B;NOTCH1
936,GO:0007030,0.280470785382564,1,1,1,Golgi organization,BP,SPTBN5
1825,GO:0019894,0.280470785382564,1,1,1,kinesin binding,MF,SPTBN5
2313,GO:0032029,0.280470785382564,1,1,1,myosin tail binding,MF,SPTBN5
2314,GO:0032036,0.280470785382564,1,1,1,myosin heavy chain binding,MF,SPTBN5
2660,GO:0034452,0.280470785382564,1,1,1,dynactin binding,MF,SPTBN5
3259,GO:0043621,0.280470785382564,1,1,1,protein self-association,MF,SPTBN5
3489,GO:0045505,0.280470785382564,1,1,1,dynein intermediate chain binding,MF,SPTBN5
4412,GO:0060170,0.280470785382564,1,1,1,ciliary membrane,CC,SPTBN5
5411,GO:0097381,0.280470785382564,1,1,1,photoreceptor disc membrane,CC,SPTBN5
222,GO:0002052,0.280603487488338,1,1,1,positive regulation of neuroblast proliferation,BP,NOTCH1
243,GO:0002193,0.280603487488338,1,1,1,MAML1-RBP-Jkappa- ICN1 complex,CC,NOTCH1
279,GO:0002328,0.280603487488338,1,1,1,pro-B cell differentiation,BP,NOTCH1
297,GO:0002437,0.280603487488338,1,1,1,inflammatory response to antigenic stimulus,BP,NOTCH1
408,GO:0003160,0.280603487488338,1,1,1,endocardium morphogenesis,BP,NOTCH1
409,GO:0003161,0.280603487488338,1,1,1,cardiac conduction system development,BP,NOTCH1
410,GO:0003162,0.280603487488338,1,1,1,atrioventricular node development,BP,NOTCH1
411,GO:0003169,0.280603487488338,1,1,1,coronary vein morphogenesis,BP,NOTCH1
433,GO:0003207,0.280603487488338,1,1,1,cardiac chamber formation,BP,NOTCH1
436,GO:0003211,0.280603487488338,1,1,1,cardiac ventricle formation,BP,NOTCH1
438,GO:0003214,0.280603487488338,1,1,1,cardiac left ventricle morphogenesis,BP,NOTCH1
439,GO:0003215,0.280603487488338,1,1,1,cardiac right ventricle morphogenesis,BP,NOTCH1
440,GO:0003219,0.280603487488338,1,1,1,cardiac right ventricle formation,BP,NOTCH1
441,GO:0003222,0.280603487488338,1,1,1,ventricular trabecula myocardium morphogenesis,BP,NOTCH1
443,GO:0003229,0.280603487488338,1,1,1,ventricular cardiac muscle tissue development,BP,NOTCH1
446,GO:0003241,0.280603487488338,1,1,1,growth involved in heart morphogenesis,BP,NOTCH1
447,GO:0003256,0.280603487488338,1,1,1,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,NOTCH1
448,GO:0003264,0.280603487488338,1,1,1,regulation of cardioblast proliferation,BP,NOTCH1
449,GO:0003266,0.280603487488338,1,1,1,regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
450,GO:0003270,0.280603487488338,1,1,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
452,GO:0003273,0.280603487488338,1,1,1,cell migration involved in endocardial cushion formation,BP,NOTCH1
989,GO:0007221,0.280603487488338,1,1,1,positive regulation of transcription of Notch receptor target,BP,NOTCH1
1038,GO:0007440,0.280603487488338,1,1,1,foregut morphogenesis,BP,NOTCH1
1290,GO:0010002,0.280603487488338,1,1,1,cardioblast differentiation,BP,NOTCH1
1349,GO:0010596,0.280603487488338,1,1,1,negative regulation of endothelial cell migration,BP,NOTCH1
1360,GO:0010633,0.280603487488338,1,1,1,negative regulation of epithelial cell migration,BP,NOTCH1
1417,GO:0010830,0.280603487488338,1,1,1,regulation of myotube differentiation,BP,NOTCH1
1418,GO:0010832,0.280603487488338,1,1,1,negative regulation of myotube differentiation,BP,NOTCH1
1465,GO:0014009,0.280603487488338,1,1,1,glial cell proliferation,BP,NOTCH1
1467,GO:0014014,0.280603487488338,1,1,1,negative regulation of gliogenesis,BP,NOTCH1
1524,GO:0014902,0.280603487488338,1,1,1,myotube differentiation,BP,NOTCH1
1845,GO:0021515,0.280603487488338,1,1,1,cell differentiation in spinal cord,BP,NOTCH1
2023,GO:0030279,0.280603487488338,1,1,1,negative regulation of ossification,BP,NOTCH1
2385,GO:0032354,0.280603487488338,1,1,1,response to follicle-stimulating hormone,BP,NOTCH1
2419,GO:0032495,0.280603487488338,1,1,1,response to muramyl dipeptide,BP,NOTCH1
2796,GO:0035767,0.280603487488338,1,1,1,endothelial cell chemotaxis,BP,NOTCH1
2826,GO:0035914,0.280603487488338,1,1,1,skeletal muscle cell differentiation,BP,NOTCH1
3233,GO:0043537,0.280603487488338,1,1,1,negative regulation of blood vessel endothelial cell migration,BP,NOTCH1
3271,GO:0043903,0.280603487488338,1,1,1,regulation of symbiosis, encompassing mutualism through parasitism,BP,NOTCH1
3426,GO:0045069,0.280603487488338,1,1,1,regulation of viral genome replication,BP,NOTCH1
3427,GO:0045070,0.280603487488338,1,1,1,positive regulation of viral genome replication,BP,NOTCH1
3527,GO:0045668,0.280603487488338,1,1,1,negative regulation of osteoblast differentiation,BP,NOTCH1
3535,GO:0045686,0.280603487488338,1,1,1,negative regulation of glial cell differentiation,BP,NOTCH1
3589,GO:0045920,0.280603487488338,1,1,1,negative regulation of exocytosis,BP,NOTCH1
3605,GO:0045955,0.280603487488338,1,1,1,negative regulation of calcium ion-dependent exocytosis,BP,NOTCH1
3656,GO:0046532,0.280603487488338,1,1,1,regulation of photoreceptor cell differentiation,BP,NOTCH1
3657,GO:0046533,0.280603487488338,1,1,1,negative regulation of photoreceptor cell differentiation,BP,NOTCH1
3832,GO:0048524,0.280603487488338,1,1,1,positive regulation of viral process,BP,NOTCH1
3901,GO:0048713,0.280603487488338,1,1,1,regulation of oligodendrocyte differentiation,BP,NOTCH1
3902,GO:0048715,0.280603487488338,1,1,1,negative regulation of oligodendrocyte differentiation,BP,NOTCH1
4007,GO:0050792,0.280603487488338,1,1,1,regulation of viral process,BP,NOTCH1
4326,GO:0055010,0.280603487488338,1,1,1,ventricular cardiac muscle tissue morphogenesis,BP,NOTCH1
4426,GO:0060251,0.280603487488338,1,1,1,regulation of glial cell proliferation,BP,NOTCH1
4427,GO:0060253,0.280603487488338,1,1,1,negative regulation of glial cell proliferation,BP,NOTCH1
4465,GO:0060379,0.280603487488338,1,1,1,cardiac muscle cell myoblast differentiation,BP,NOTCH1
4523,GO:0060525,0.280603487488338,1,1,1,prostate glandular acinus development,BP,NOTCH1
4524,GO:0060528,0.280603487488338,1,1,1,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,NOTCH1
4588,GO:0060742,0.280603487488338,1,1,1,epithelial cell differentiation involved in prostate gland development,BP,NOTCH1
4599,GO:0060767,0.280603487488338,1,1,1,epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
4600,GO:0060768,0.280603487488338,1,1,1,regulation of epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
4614,GO:0060843,0.280603487488338,1,1,1,venous endothelial cell differentiation,BP,NOTCH1
4631,GO:0060947,0.280603487488338,1,1,1,cardiac vascular smooth muscle cell differentiation,BP,NOTCH1
4632,GO:0060948,0.280603487488338,1,1,1,cardiac vascular smooth muscle cell development,BP,NOTCH1
4639,GO:0060973,0.280603487488338,1,1,1,cell migration involved in heart development,BP,NOTCH1
4641,GO:0060977,0.280603487488338,1,1,1,coronary vasculature morphogenesis,BP,NOTCH1
4642,GO:0060979,0.280603487488338,1,1,1,vasculogenesis involved in coronary vascular morphogenesis,BP,NOTCH1
4643,GO:0060982,0.280603487488338,1,1,1,coronary artery morphogenesis,BP,NOTCH1
4739,GO:0061418,0.280603487488338,1,1,1,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
4740,GO:0061419,0.280603487488338,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
4959,GO:0071372,0.280603487488338,1,1,1,cellular response to follicle-stimulating hormone stimulus,BP,NOTCH1
5217,GO:0072602,0.280603487488338,1,1,1,interleukin-4 secretion,BP,NOTCH1
5272,GO:0090049,0.280603487488338,1,1,1,regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
5273,GO:0090051,0.280603487488338,1,1,1,negative regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
5371,GO:0097084,0.280603487488338,1,1,1,vascular smooth muscle cell development,BP,NOTCH1
5606,GO:1901201,0.280603487488338,1,1,1,regulation of extracellular matrix assembly,BP,NOTCH1
5627,GO:1901532,0.280603487488338,1,1,1,regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
5628,GO:1901533,0.280603487488338,1,1,1,negative regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
5711,GO:1902263,0.280603487488338,1,1,1,apoptotic process involved in embryonic digit morphogenesis,BP,NOTCH1
5760,GO:1902692,0.280603487488338,1,1,1,regulation of neuroblast proliferation,BP,NOTCH1
5811,GO:1903306,0.280603487488338,1,1,1,negative regulation of regulated secretory pathway,BP,NOTCH1
5863,GO:1903671,0.280603487488338,1,1,1,negative regulation of sprouting angiogenesis,BP,NOTCH1
5892,GO:1903900,0.280603487488338,1,1,1,regulation of viral life cycle,BP,NOTCH1
5893,GO:1903902,0.280603487488338,1,1,1,positive regulation of viral life cycle,BP,NOTCH1
5975,GO:1905456,0.280603487488338,1,1,1,regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
5976,GO:1905457,0.280603487488338,1,1,1,negative regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
6078,GO:2000179,0.280603487488338,1,1,1,positive regulation of neural precursor cell proliferation,BP,NOTCH1
6148,GO:2000737,0.280603487488338,1,1,1,negative regulation of stem cell differentiation,BP,NOTCH1
6168,GO:2000973,0.280603487488338,1,1,1,regulation of pro-B cell differentiation,BP,NOTCH1
6169,GO:2000974,0.280603487488338,1,1,1,negative regulation of pro-B cell differentiation,BP,NOTCH1
6175,GO:2001026,0.280603487488338,1,1,1,regulation of endothelial cell chemotaxis,BP,NOTCH1
6176,GO:2001027,0.280603487488338,1,1,1,negative regulation of endothelial cell chemotaxis,BP,NOTCH1
2917,GO:0040007,0.280748272732414,0.839421400045365,11,30,growth,BP,WNT7A;ACTN3;WNT3;WNT7B;WNT2;FZD7;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
1494,GO:0014731,0.280804275513896,1,1,1,spectrin-associated cytoskeleton,CC,SPTB
2198,GO:0031235,0.280804275513896,1,1,1,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB
3135,GO:0043204,0.281426382177065,1,1,1,perikaryon,CC,DRP2
1387,GO:0010720,0.28153621514894,0.870946412277767,6,15,positive regulation of cell development,BP,BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
472,GO:0003365,0.281589211319091,1,1,1,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT
1108,GO:0008180,0.281589211319091,1,1,1,COP9 signalosome,CC,AMOT
2751,GO:0035329,0.281589211319091,1,1,1,hippo signaling,BP,AMOT
3229,GO:0043532,0.281589211319091,1,1,1,angiostatin binding,MF,AMOT
2037,GO:0030323,0.282330443006661,0.870444496095633,6,15,respiratory tube development,BP,WNT7B;WNT2;FGF8;BMP4;FSTL3;NOTCH1
2038,GO:0030324,0.282330443006661,0.870444496095633,6,15,lung development,BP,WNT7B;WNT2;FGF8;BMP4;FSTL3;NOTCH1
2253,GO:0031624,0.282382913303799,1,1,1,ubiquitin conjugating enzyme binding,MF,RNF144A
3338,GO:0044390,0.282382913303799,1,1,1,ubiquitin-like protein conjugating enzyme binding,MF,RNF144A
4761,GO:0061630,0.282382913303799,1,1,1,ubiquitin protein ligase activity,MF,RNF144A
4765,GO:0061659,0.282382913303799,1,1,1,ubiquitin-like protein ligase activity,MF,RNF144A
1253,GO:0009799,0.282400854573445,0.897368711163464,4,9,specification of symmetry,BP,AXIN1;FGF8;BMP4;NOTCH1
932,GO:0007016,0.282549034398265,1,1,1,cytoskeletal anchoring at plasma membrane,BP,SPTBN4
1076,GO:0007628,0.282549034398265,1,1,1,adult walking behavior,BP,SPTBN4
1315,GO:0010459,0.282549034398265,1,1,1,negative regulation of heart rate,BP,SPTBN4
1642,GO:0016363,0.282549034398265,1,1,1,nuclear matrix,CC,SPTBN4
1679,GO:0016605,0.282549034398265,1,1,1,PML body,CC,SPTBN4
1890,GO:0021952,0.282549034398265,1,1,1,central nervous system projection neuron axonogenesis,BP,SPTBN4
1893,GO:0021955,0.282549034398265,1,1,1,central nervous system neuron axonogenesis,BP,SPTBN4
2581,GO:0033268,0.282549034398265,1,1,1,node of Ranvier,CC,SPTBN4
2582,GO:0033270,0.282549034398265,1,1,1,paranode region of axon,CC,SPTBN4
2656,GO:0034399,0.282549034398265,1,1,1,nuclear periphery,CC,SPTBN4
2924,GO:0040018,0.282549034398265,1,1,1,positive regulation of multicellular organism growth,BP,SPTBN4
3032,GO:0042551,0.282549034398265,1,1,1,neuron maturation,BP,SPTBN4
3127,GO:0043194,0.282549034398265,1,1,1,axon initial segment,CC,SPTBN4
3134,GO:0043203,0.282549034398265,1,1,1,axon hillock,CC,SPTBN4
3447,GO:0045161,0.282549034398265,1,1,1,neuronal ion channel clustering,BP,SPTBN4
3448,GO:0045162,0.282549034398265,1,1,1,clustering of voltage-gated sodium channels,BP,SPTBN4
4897,GO:0070852,0.282549034398265,1,1,1,cell body fiber,CC,SPTBN4
5353,GO:0090659,0.282549034398265,1,1,1,walking behavior,BP,SPTBN4
628,GO:0005521,0.282703483792749,1,1,1,lamin binding,MF,PKP1
697,GO:0005882,0.282703483792749,1,1,1,intermediate filament,CC,PKP1
1777,GO:0019215,0.282703483792749,1,1,1,intermediate filament binding,MF,PKP1
2024,GO:0030280,0.282703483792749,1,1,1,structural constituent of epidermis,MF,PKP1
3435,GO:0045103,0.282703483792749,1,1,1,intermediate filament-based process,BP,PKP1
3436,GO:0045104,0.282703483792749,1,1,1,intermediate filament cytoskeleton organization,BP,PKP1
3437,GO:0045109,0.282703483792749,1,1,1,intermediate filament organization,BP,PKP1
3438,GO:0045110,0.282703483792749,1,1,1,intermediate filament bundle assembly,BP,PKP1
3439,GO:0045111,0.282703483792749,1,1,1,intermediate filament cytoskeleton,CC,PKP1
5533,GO:0101003,0.282703483792749,1,1,1,ficolin-1-rich granule membrane,CC,PKP1
5059,GO:0072006,0.28270555773444,0.861118525392867,7,18,nephron development,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;NOTCH1
323,GO:0002675,0.282746700303476,1,1,1,positive regulation of acute inflammatory response,BP,PIK3CG
324,GO:0002679,0.282746700303476,1,1,1,respiratory burst involved in defense response,BP,PIK3CG
720,GO:0005944,0.282746700303476,1,1,1,phosphatidylinositol 3-kinase complex, class IB,CC,PIK3CG
1433,GO:0010896,0.282746700303476,1,1,1,regulation of triglyceride catabolic process,BP,PIK3CG
1434,GO:0010897,0.282746700303476,1,1,1,negative regulation of triglyceride catabolic process,BP,PIK3CG
1796,GO:0019433,0.282746700303476,1,1,1,triglyceride catabolic process,BP,PIK3CG
2349,GO:0032252,0.282746700303476,1,1,1,secretory granule localization,BP,PIK3CG
2794,GO:0035747,0.282746700303476,1,1,1,natural killer cell chemotaxis,BP,PIK3CG
3442,GO:0045123,0.282746700303476,1,1,1,cellular extravasation,BP,PIK3CG
3538,GO:0045730,0.282746700303476,1,1,1,respiratory burst,BP,PIK3CG
3645,GO:0046461,0.282746700303476,1,1,1,neutral lipid catabolic process,BP,PIK3CG
3646,GO:0046464,0.282746700303476,1,1,1,acylglycerol catabolic process,BP,PIK3CG
3654,GO:0046503,0.282746700303476,1,1,1,glycerolipid catabolic process,BP,PIK3CG
5226,GO:0072672,0.282746700303476,1,1,1,neutrophil extravasation,BP,PIK3CG
5314,GO:0090207,0.282746700303476,1,1,1,regulation of triglyceride metabolic process,BP,PIK3CG
5315,GO:0090209,0.282746700303476,1,1,1,negative regulation of triglyceride metabolic process,BP,PIK3CG
5403,GO:0097284,0.282746700303476,1,1,1,hepatocyte apoptotic process,BP,PIK3CG
156,GO:0001822,0.282927375349855,0.847464054397096,9,24,kidney development,BP,BMP6;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
3019,GO:0042492,0.283124956074707,1,1,1,gamma-delta T cell differentiation,BP,JAG2
3425,GO:0045061,0.283124956074707,1,1,1,thymic T cell selection,BP,JAG2
3669,GO:0046629,0.283124956074707,1,1,1,gamma-delta T cell activation,BP,JAG2
6003,GO:1990134,0.283124956074707,1,1,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,JAG2
1258,GO:0009888,0.283256306567686,0.808675617077028,25,75,tissue development,BP,WNT7A;GJB2;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;POU3F1;WNT2;FZD7;FGF8;VDR;ARTN;DSG3;WNT5B;WNK4;DUSP5;PKP1;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
702,GO:0005901,0.283383797354504,1,1,1,caveola,CC,CDH1
1304,GO:0010226,0.283383797354504,1,1,1,response to lithium ion,BP,CDH1
1677,GO:0016600,0.283383797354504,1,1,1,flotillin complex,CC,CDH1
2780,GO:0035635,0.283383797354504,1,1,1,entry of bacterium into host cell,BP,CDH1
4931,GO:0071285,0.283383797354504,1,1,1,cellular response to lithium ion,BP,CDH1
5006,GO:0071680,0.283383797354504,1,1,1,response to indole-3-methanol,BP,CDH1
5007,GO:0071681,0.283383797354504,1,1,1,cellular response to indole-3-methanol,BP,CDH1
489,GO:0003707,0.283521539268077,1,1,1,steroid hormone receptor activity,MF,VDR
552,GO:0004879,0.283521539268077,1,1,1,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,VDR
617,GO:0005496,0.283521539268077,1,1,1,steroid binding,MF,VDR
618,GO:0005499,0.283521539268077,1,1,1,vitamin D binding,MF,VDR
859,GO:0006775,0.283521539268077,1,1,1,fat-soluble vitamin metabolic process,BP,VDR
1149,GO:0008434,0.283521539268077,1,1,1,calcitriol receptor activity,MF,VDR
1187,GO:0009110,0.283521539268077,1,1,1,vitamin biosynthetic process,BP,VDR
1456,GO:0010979,0.283521539268077,1,1,1,regulation of vitamin D 24-hydroxylase activity,BP,VDR
1457,GO:0010980,0.283521539268077,1,1,1,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
2068,GO:0030522,0.283521539268077,1,1,1,intracellular receptor signaling pathway,BP,VDR
2082,GO:0030656,0.283521539268077,1,1,1,regulation of vitamin metabolic process,BP,VDR
2316,GO:0032052,0.283521539268077,1,1,1,bile acid binding,MF,VDR
2623,GO:0034105,0.283521539268077,1,1,1,positive regulation of tissue remodeling,BP,VDR
2736,GO:0035257,0.283521539268077,1,1,1,nuclear hormone receptor binding,MF,VDR
2908,GO:0038181,0.283521539268077,1,1,1,bile acid receptor activity,MF,VDR
2909,GO:0038183,0.283521539268077,1,1,1,bile acid signaling pathway,BP,VDR
2910,GO:0038186,0.283521539268077,1,1,1,lithocholic acid receptor activity,MF,VDR
2992,GO:0042359,0.283521539268077,1,1,1,vitamin D metabolic process,BP,VDR
2993,GO:0042362,0.283521539268077,1,1,1,fat-soluble vitamin biosynthetic process,BP,VDR
2994,GO:0042368,0.283521539268077,1,1,1,vitamin D biosynthetic process,BP,VDR
3080,GO:0042974,0.283521539268077,1,1,1,retinoic acid receptor binding,MF,VDR
3402,GO:0044798,0.283521539268077,1,1,1,nuclear transcription factor complex,CC,VDR
3734,GO:0046965,0.283521539268077,1,1,1,retinoid X receptor binding,MF,VDR
4053,GO:0050892,0.283521539268077,1,1,1,intestinal absorption,BP,VDR
4378,GO:0060056,0.283521539268077,1,1,1,mammary gland involution,BP,VDR
4379,GO:0060057,0.283521539268077,1,1,1,apoptotic process involved in mammary gland involution,BP,VDR
4380,GO:0060058,0.283521539268077,1,1,1,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
4533,GO:0060556,0.283521539268077,1,1,1,regulation of vitamin D biosynthetic process,BP,VDR
4534,GO:0060558,0.283521539268077,1,1,1,regulation of calcidiol 1-monooxygenase activity,BP,VDR
4864,GO:0070561,0.283521539268077,1,1,1,vitamin D receptor signaling pathway,BP,VDR
4870,GO:0070644,0.283521539268077,1,1,1,vitamin D response element binding,MF,VDR
4934,GO:0071305,0.283521539268077,1,1,1,cellular response to vitamin D,BP,VDR
5348,GO:0090575,0.283521539268077,1,1,1,RNA polymerase II transcription factor complex,CC,VDR
5444,GO:0098531,0.283521539268077,1,1,1,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,VDR
5696,GO:1902098,0.283521539268077,1,1,1,calcitriol binding,MF,VDR
5704,GO:1902121,0.283521539268077,1,1,1,lithocholic acid binding,MF,VDR
5712,GO:1902271,0.283521539268077,1,1,1,D3 vitamins binding,MF,VDR
5720,GO:1902339,0.283521539268077,1,1,1,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
5777,GO:1902930,0.283521539268077,1,1,1,regulation of alcohol biosynthetic process,BP,VDR
5838,GO:1903519,0.283521539268077,1,1,1,regulation of mammary gland involution,BP,VDR
5839,GO:1903521,0.283521539268077,1,1,1,positive regulation of mammary gland involution,BP,VDR
5927,GO:1904747,0.283521539268077,1,1,1,positive regulation of apoptotic process involved in development,BP,VDR
1126,GO:0008238,0.283532509307363,1,1,1,exopeptidase activity,MF,PM20D2
1702,GO:0016805,0.283532509307363,1,1,1,dipeptidase activity,MF,PM20D2
3650,GO:0046486,0.283627077962925,0.881227810447851,5,12,glycerolipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
391,GO:0003096,0.284539966313794,1,1,1,renal sodium ion transport,BP,WNK4
1112,GO:0008200,0.284539966313794,1,1,1,ion channel inhibitor activity,MF,WNK4
1396,GO:0010766,0.284539966313794,1,1,1,negative regulation of sodium ion transport,BP,WNK4
1618,GO:0016248,0.284539966313794,1,1,1,channel inhibitor activity,MF,WNK4
1729,GO:0017081,0.284539966313794,1,1,1,chloride channel regulator activity,MF,WNK4
1821,GO:0019869,0.284539966313794,1,1,1,chloride channel inhibitor activity,MF,WNK4
1985,GO:0030157,0.284539966313794,1,1,1,pancreatic juice secretion,BP,WNK4
4506,GO:0060457,0.284539966313794,1,1,1,negative regulation of digestive system process,BP,WNK4
4821,GO:0070294,0.284539966313794,1,1,1,renal sodium ion absorption,BP,WNK4
5125,GO:0072156,0.284539966313794,1,1,1,distal tubule morphogenesis,BP,WNK4
5302,GO:0090186,0.284539966313794,1,1,1,regulation of pancreatic juice secretion,BP,WNK4
5303,GO:0090188,0.284539966313794,1,1,1,negative regulation of pancreatic juice secretion,BP,WNK4
1543,GO:0015267,0.285062147824298,0.895932066642637,4,9,channel activity,MF,GJB2;GJA3;KCNG2;KCNK6
1925,GO:0022803,0.285062147824298,0.895932066642637,4,9,passive transmembrane transporter activity,MF,GJB2;GJA3;KCNG2;KCNK6
39,GO:0000303,0.285104362904613,1,1,1,response to superoxide,BP,BMP7
40,GO:0000305,0.285104362904613,1,1,1,response to oxygen radical,BP,BMP7
167,GO:0001842,0.285104362904613,1,1,1,neural fold formation,BP,BMP7
1373,GO:0010658,0.285104362904613,1,1,1,striated muscle cell apoptotic process,BP,BMP7
1375,GO:0010662,0.285104362904613,1,1,1,regulation of striated muscle cell apoptotic process,BP,BMP7
1376,GO:0010664,0.285104362904613,1,1,1,negative regulation of striated muscle cell apoptotic process,BP,BMP7
1795,GO:0019430,0.285104362904613,1,1,1,removal of superoxide radicals,BP,BMP7
1843,GO:0021502,0.285104362904613,1,1,1,neural fold elevation formation,BP,BMP7
2324,GO:0032088,0.285104362904613,1,1,1,negative regulation of NF-kappaB transcription factor activity,BP,BMP7
2626,GO:0034114,0.285104362904613,1,1,1,regulation of heterotypic cell-cell adhesion,BP,BMP7
2627,GO:0034116,0.285104362904613,1,1,1,positive regulation of heterotypic cell-cell adhesion,BP,BMP7
2859,GO:0036118,0.285104362904613,1,1,1,hyaluranon cable assembly,BP,BMP7
2989,GO:0042345,0.285104362904613,1,1,1,regulation of NF-kappaB import into nucleus,BP,BMP7
2990,GO:0042347,0.285104362904613,1,1,1,negative regulation of NF-kappaB import into nucleus,BP,BMP7
2991,GO:0042348,0.285104362904613,1,1,1,NF-kappaB import into nucleus,BP,BMP7
3084,GO:0042992,0.285104362904613,1,1,1,negative regulation of transcription factor import into nucleus,BP,BMP7
4855,GO:0070486,0.285104362904613,1,1,1,leukocyte aggregation,BP,BMP7
4856,GO:0070487,0.285104362904613,1,1,1,monocyte aggregation,BP,BMP7
4979,GO:0071450,0.285104362904613,1,1,1,cellular response to oxygen radical,BP,BMP7
4980,GO:0071451,0.285104362904613,1,1,1,cellular response to superoxide,BP,BMP7
5071,GO:0072038,0.285104362904613,1,1,1,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,BMP7
5072,GO:0072039,0.285104362904613,1,1,1,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5073,GO:0072040,0.285104362904613,1,1,1,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5086,GO:0072076,0.285104362904613,1,1,1,nephrogenic mesenchyme development,BP,BMP7
5115,GO:0072131,0.285104362904613,1,1,1,kidney mesenchyme morphogenesis,BP,BMP7
5117,GO:0072133,0.285104362904613,1,1,1,metanephric mesenchyme morphogenesis,BP,BMP7
5118,GO:0072134,0.285104362904613,1,1,1,nephrogenic mesenchyme morphogenesis,BP,BMP7
5119,GO:0072135,0.285104362904613,1,1,1,kidney mesenchymal cell proliferation,BP,BMP7
5120,GO:0072136,0.285104362904613,1,1,1,metanephric mesenchymal cell proliferation involved in metanephros development,BP,BMP7
5331,GO:0090322,0.285104362904613,1,1,1,regulation of superoxide metabolic process,BP,BMP7
5382,GO:0097152,0.285104362904613,1,1,1,mesenchymal cell apoptotic process,BP,BMP7
5538,GO:1900006,0.285104362904613,1,1,1,positive regulation of dendrite development,BP,BMP7
5549,GO:1900104,0.285104362904613,1,1,1,regulation of hyaluranon cable assembly,BP,BMP7
5550,GO:1900106,0.285104362904613,1,1,1,positive regulation of hyaluranon cable assembly,BP,BMP7
5602,GO:1901145,0.285104362904613,1,1,1,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5719,GO:1902338,0.285104362904613,1,1,1,negative regulation of apoptotic process involved in morphogenesis,BP,BMP7
5727,GO:1902455,0.285104362904613,1,1,1,negative regulation of stem cell population maintenance,BP,BMP7
5891,GO:1903867,0.285104362904613,1,1,1,extraembryonic membrane development,BP,BMP7
5921,GO:1904672,0.285104362904613,1,1,1,regulation of somatic stem cell population maintenance,BP,BMP7
5922,GO:1904673,0.285104362904613,1,1,1,negative regulation of somatic stem cell population maintenance,BP,BMP7
5926,GO:1904746,0.285104362904613,1,1,1,negative regulation of apoptotic process involved in development,BP,BMP7
5957,GO:1905069,0.285104362904613,1,1,1,allantois development,BP,BMP7
6048,GO:2000036,0.285104362904613,1,1,1,regulation of stem cell population maintenance,BP,BMP7
6068,GO:2000121,0.285104362904613,1,1,1,regulation of removal of superoxide radicals,BP,BMP7
6179,GO:2001053,0.285104362904613,1,1,1,regulation of mesenchymal cell apoptotic process,BP,BMP7
6180,GO:2001054,0.285104362904613,1,1,1,negative regulation of mesenchymal cell apoptotic process,BP,BMP7
968,GO:0007166,0.285364137234297,0.80540811464388,27,81,cell surface receptor signaling pathway,BP,TLE1;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;FZD7;FGF8;WNT5B;INHBB;CCL20;TSPAN15;FGF17;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;TSPAN13;NOTCH1
3594,GO:0045930,0.285426132986098,0.918202475897849,3,6,negative regulation of mitotic cell cycle,BP,HRAS;BMP4;BMP7
1635,GO:0016332,0.285691085823713,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
2387,GO:0032364,0.285691085823713,1,1,1,oxygen homeostasis,BP,WNT7B
2591,GO:0033483,0.285691085823713,1,1,1,gas homeostasis,BP,WNT7B
4510,GO:0060482,0.285691085823713,1,1,1,lobar bronchus development,BP,WNT7B
4525,GO:0060534,0.285691085823713,1,1,1,trachea cartilage development,BP,WNT7B
4526,GO:0060535,0.285691085823713,1,1,1,trachea cartilage morphogenesis,BP,WNT7B
4527,GO:0060536,0.285691085823713,1,1,1,cartilage morphogenesis,BP,WNT7B
5078,GO:0072053,0.285691085823713,1,1,1,renal inner medulla development,BP,WNT7B
5079,GO:0072054,0.285691085823713,1,1,1,renal outer medulla development,BP,WNT7B
5080,GO:0072060,0.285691085823713,1,1,1,outer medullary collecting duct development,BP,WNT7B
5081,GO:0072061,0.285691085823713,1,1,1,inner medullary collecting duct development,BP,WNT7B
5164,GO:0072236,0.285691085823713,1,1,1,metanephric loop of Henle development,BP,WNT7B
952,GO:0007088,0.285791718986979,0.91803670263481,3,6,regulation of mitotic nuclear division,BP,FGF8;BMP4;BMP7
123,GO:0001705,0.286056173231506,1,1,1,ectoderm formation,BP,FZD7
129,GO:0001712,0.286056173231506,1,1,1,ectodermal cell fate commitment,BP,FZD7
130,GO:0001715,0.286056173231506,1,1,1,ectodermal cell fate specification,BP,FZD7
1026,GO:0007398,0.286056173231506,1,1,1,ectoderm development,BP,FZD7
1288,GO:0009996,0.286056173231506,1,1,1,negative regulation of cell fate specification,BP,FZD7
1314,GO:0010454,0.286056173231506,1,1,1,negative regulation of cell fate commitment,BP,FZD7
1323,GO:0010470,0.286056173231506,1,1,1,regulation of gastrulation,BP,FZD7
1377,GO:0010668,0.286056173231506,1,1,1,ectodermal cell differentiation,BP,FZD7
2758,GO:0035411,0.286056173231506,1,1,1,catenin import into nucleus,BP,FZD7
2759,GO:0035412,0.286056173231506,1,1,1,regulation of catenin import into nucleus,BP,FZD7
3053,GO:0042659,0.286056173231506,1,1,1,regulation of cell fate specification,BP,FZD7
3054,GO:0042665,0.286056173231506,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
3055,GO:0042666,0.286056173231506,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
6105,GO:2000383,0.286056173231506,1,1,1,regulation of ectoderm development,BP,FZD7
6106,GO:2000384,0.286056173231506,1,1,1,negative regulation of ectoderm development,BP,FZD7
6123,GO:2000542,0.286056173231506,1,1,1,negative regulation of gastrulation,BP,FZD7
515,GO:0004375,0.28617902526881,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
722,GO:0005960,0.28617902526881,1,1,1,glycine cleavage complex,CC,GLDC
811,GO:0006520,0.28617902526881,1,1,1,cellular amino acid metabolic process,BP,GLDC
812,GO:0006544,0.28617902526881,1,1,1,glycine metabolic process,BP,GLDC
813,GO:0006546,0.28617902526881,1,1,1,glycine catabolic process,BP,GLDC
1174,GO:0009055,0.28617902526881,1,1,1,electron carrier activity,MF,GLDC
1181,GO:0009063,0.28617902526881,1,1,1,cellular amino acid catabolic process,BP,GLDC
1182,GO:0009069,0.28617902526881,1,1,1,serine family amino acid metabolic process,BP,GLDC
1183,GO:0009071,0.28617902526881,1,1,1,serine family amino acid catabolic process,BP,GLDC
1675,GO:0016594,0.28617902526881,1,1,1,glycine binding,MF,GLDC
1685,GO:0016638,0.28617902526881,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLDC
1686,GO:0016642,0.28617902526881,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
1799,GO:0019464,0.28617902526881,1,1,1,glycine decarboxylation via glycine cleavage system,BP,GLDC
1991,GO:0030170,0.28617902526881,1,1,1,pyridoxal phosphate binding,MF,GLDC
3651,GO:0046487,0.28617902526881,1,1,1,glyoxylate metabolic process,BP,GLDC
4819,GO:0070279,0.28617902526881,1,1,1,vitamin B6 binding,MF,GLDC
5639,GO:1901605,0.28617902526881,1,1,1,alpha-amino acid metabolic process,BP,GLDC
5640,GO:1901606,0.28617902526881,1,1,1,alpha-amino acid catabolic process,BP,GLDC
6007,GO:1990204,0.28617902526881,1,1,1,oxidoreductase complex,CC,GLDC
498,GO:0003841,0.286274003594678,1,1,1,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
1143,GO:0008374,0.286274003594678,1,1,1,O-acyltransferase activity,MF,MBOAT2
1645,GO:0016411,0.286274003594678,1,1,1,acylglycerol O-acyltransferase activity,MF,MBOAT2
2860,GO:0036151,0.286274003594678,1,1,1,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2
2861,GO:0036152,0.286274003594678,1,1,1,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2
2962,GO:0042171,0.286274003594678,1,1,1,lysophosphatidic acid acyltransferase activity,MF,MBOAT2
3647,GO:0046470,0.286274003594678,1,1,1,phosphatidylcholine metabolic process,BP,MBOAT2
3738,GO:0047144,0.286274003594678,1,1,1,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
5001,GO:0071617,0.286274003594678,1,1,1,lysophospholipid acyltransferase activity,MF,MBOAT2
771,GO:0006304,0.286889824290334,1,1,1,DNA modification,BP,PIK3CA
772,GO:0006305,0.286889824290334,1,1,1,DNA alkylation,BP,PIK3CA
773,GO:0006306,0.286889824290334,1,1,1,DNA methylation,BP,PIK3CA
2886,GO:0038028,0.286889824290334,1,1,1,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,PIK3CA
3277,GO:0044028,0.286889824290334,1,1,1,DNA hypomethylation,BP,PIK3CA
3278,GO:0044029,0.286889824290334,1,1,1,hypomethylation of CpG island,BP,PIK3CA
3279,GO:0044030,0.286889824290334,1,1,1,regulation of DNA methylation,BP,PIK3CA
3387,GO:0044728,0.286889824290334,1,1,1,DNA methylation or demethylation,BP,PIK3CA
4556,GO:0060612,0.286889824290334,1,1,1,adipose tissue development,BP,PIK3CA
4992,GO:0071514,0.286889824290334,1,1,1,genetic imprinting,BP,PIK3CA
6135,GO:2000653,0.286889824290334,1,1,1,regulation of genetic imprinting,BP,PIK3CA
766,GO:0006260,0.287171629114714,0.917409649441523,3,6,DNA replication,BP,BMP6;HRAS;BMP4
768,GO:0006275,0.287171629114714,0.917409649441523,3,6,regulation of DNA replication,BP,BMP6;HRAS;BMP4
3543,GO:0045740,0.287171629114714,0.917409649441523,3,6,positive regulation of DNA replication,BP,BMP6;HRAS;BMP4
3703,GO:0046872,0.287885468531025,0.820304487512165,15,44,metal ion binding,MF,SYT5;ACTN3;RHBDL3;RABIF;JAG2;MAPK12;CDH1;VDR;DSG3;RNF144A;DRP2;TPD52;NOTCH1;GUCY1B3;TF
2173,GO:0031098,0.28797695908826,0.878629228130307,5,12,stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
2508,GO:0032872,0.28797695908826,0.878629228130307,5,12,regulation of stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4209,GO:0051403,0.28797695908826,0.878629228130307,5,12,stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4824,GO:0070302,0.28797695908826,0.878629228130307,5,12,regulation of stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
640,GO:0005578,0.288863550018067,0.866290730639539,6,15,proteinaceous extracellular matrix,CC,WNT7A;WNT3;WNT7B;WNT2;WNT5B;BMP4
1993,GO:0030177,0.289910658501817,0.893294330033599,4,9,positive regulation of Wnt signaling pathway,BP,WNT7A;WNT3;AXIN1;WNT2
135,GO:0001743,0.289991376628148,1,1,1,optic placode formation,BP,AXIN1
778,GO:0006354,0.289991376628148,1,1,1,DNA-templated transcription, elongation,BP,AXIN1
784,GO:0006368,0.289991376628148,1,1,1,transcription elongation from RNA polymerase II promoter,BP,AXIN1
1874,GO:0021797,0.289991376628148,1,1,1,forebrain anterior/posterior pattern specification,BP,AXIN1
1879,GO:0021877,0.289991376628148,1,1,1,forebrain neuron fate commitment,BP,AXIN1
1881,GO:0021881,0.289991376628148,1,1,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,AXIN1
1886,GO:0021898,0.289991376628148,1,1,1,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,AXIN1
1899,GO:0021999,0.289991376628148,1,1,1,neural plate anterior/posterior regionalization,BP,AXIN1
1986,GO:0030159,0.289991376628148,1,1,1,receptor signaling complex scaffold activity,MF,AXIN1
2135,GO:0030877,0.289991376628148,1,1,1,beta-catenin destruction complex,CC,AXIN1
2145,GO:0030910,0.289991376628148,1,1,1,olfactory placode formation,BP,AXIN1
2487,GO:0032784,0.289991376628148,1,1,1,regulation of DNA-templated transcription, elongation,BP,AXIN1
2488,GO:0032785,0.289991376628148,1,1,1,negative regulation of DNA-templated transcription, elongation,BP,AXIN1
2531,GO:0032947,0.289991376628148,1,1,1,protein complex scaffold,MF,AXIN1
2635,GO:0034243,0.289991376628148,1,1,1,regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
2636,GO:0034244,0.289991376628148,1,1,1,negative regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
3796,GO:0048318,0.289991376628148,1,1,1,axial mesoderm development,BP,AXIN1
3797,GO:0048319,0.289991376628148,1,1,1,axial mesoderm morphogenesis,BP,AXIN1
3798,GO:0048320,0.289991376628148,1,1,1,axial mesoderm formation,BP,AXIN1
4602,GO:0060788,0.289991376628148,1,1,1,ectodermal placode formation,BP,AXIN1
4606,GO:0060823,0.289991376628148,1,1,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,AXIN1
4623,GO:0060896,0.289991376628148,1,1,1,neural plate pattern specification,BP,AXIN1
4624,GO:0060897,0.289991376628148,1,1,1,neural plate regionalization,BP,AXIN1
4777,GO:0070016,0.289991376628148,1,1,1,armadillo repeat domain binding,MF,AXIN1
4848,GO:0070411,0.289991376628148,1,1,1,I-SMAD binding,MF,AXIN1
5010,GO:0071696,0.289991376628148,1,1,1,ectodermal placode development,BP,AXIN1
5011,GO:0071697,0.289991376628148,1,1,1,ectodermal placode morphogenesis,BP,AXIN1
5012,GO:0071698,0.289991376628148,1,1,1,olfactory placode development,BP,AXIN1
5013,GO:0071699,0.289991376628148,1,1,1,olfactory placode morphogenesis,BP,AXIN1
5935,GO:1904885,0.289991376628148,1,1,1,beta-catenin destruction complex assembly,BP,AXIN1
5936,GO:1904886,0.289991376628148,1,1,1,beta-catenin destruction complex disassembly,BP,AXIN1
6054,GO:2000058,0.289991376628148,1,1,1,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
6055,GO:2000060,0.289991376628148,1,1,1,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1
531,GO:0004697,0.290069271398714,1,1,1,protein kinase C activity,MF,PKN3
357,GO:0002790,0.290315384829232,0.877223767321244,5,12,peptide secretion,BP,BMP6;KCNG2;RAB40B;INHBB;NOTCH1
3012,GO:0042475,0.290379824532548,0.893037693158777,4,9,odontogenesis of dentin-containing tooth,BP,JAG2;FGF8;BMP4;BMP7
2622,GO:0034104,0.290544194758012,1,1,1,negative regulation of tissue remodeling,BP,CLDN18
2852,GO:0036035,0.290544194758012,1,1,1,osteoclast development,BP,CLDN18
3443,GO:0045124,0.290544194758012,1,1,1,regulation of bone resorption,BP,CLDN18
3555,GO:0045779,0.290544194758012,1,1,1,negative regulation of bone resorption,BP,CLDN18
3700,GO:0046850,0.290544194758012,1,1,1,regulation of bone remodeling,BP,CLDN18
3701,GO:0046851,0.290544194758012,1,1,1,negative regulation of bone remodeling,BP,CLDN18
5035,GO:0071847,0.290544194758012,1,1,1,TNFSF11-mediated signaling pathway,BP,CLDN18
5782,GO:1903010,0.290544194758012,1,1,1,regulation of bone development,BP,CLDN18
5783,GO:1903011,0.290544194758012,1,1,1,negative regulation of bone development,BP,CLDN18
6188,GO:2001204,0.290544194758012,1,1,1,regulation of osteoclast development,BP,CLDN18
6189,GO:2001205,0.290544194758012,1,1,1,negative regulation of osteoclast development,BP,CLDN18
2386,GO:0032355,0.290593836352236,0.915845396160474,3,6,response to estradiol,BP,WNT7A;GJB2;BMP7
5932,GO:1904837,0.291500803107006,1,1,1,beta-catenin-TCF complex assembly,BP,TLE1
3946,GO:0048869,0.291775754327719,0.796574309417695,35,108,cellular developmental process,BP,SLC2A14;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RRAS2;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;INHBB;PKP1;HRAS;BMP4;GDNF;RAB38;PIK3CA;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
999,GO:0007263,0.29184929943281,1,1,1,nitric oxide mediated signal transduction,BP,GUCY1B3
1837,GO:0019934,0.29184929943281,1,1,1,cGMP-mediated signaling,BP,GUCY1B3
1838,GO:0019935,0.29184929943281,1,1,1,cyclic-nucleotide-mediated signaling,BP,GUCY1B3
2890,GO:0038060,0.29184929943281,1,1,1,nitric oxide-cGMP-mediated signaling pathway,BP,GUCY1B3
5020,GO:0071731,0.29184929943281,1,1,1,response to nitric oxide,BP,GUCY1B3
5021,GO:0071732,0.29184929943281,1,1,1,cellular response to nitric oxide,BP,GUCY1B3
5705,GO:1902170,0.29184929943281,1,1,1,cellular response to reactive nitrogen species,BP,GUCY1B3
5068,GO:0072028,0.291921704979666,0.876254877169776,5,12,nephron morphogenesis,BP,FGF8;WNK4;BMP4;GDNF;BMP7
5285,GO:0090130,0.292505000265552,0.854585361109134,7,18,tissue migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;PIK3CA;NOTCH1
2096,GO:0030728,0.292679091784325,1,1,1,ovulation,BP,INHBB
2357,GO:0032274,0.292679091784325,1,1,1,gonadotropin secretion,BP,INHBB
2358,GO:0032276,0.292679091784325,1,1,1,regulation of gonadotropin secretion,BP,INHBB
2359,GO:0032277,0.292679091784325,1,1,1,negative regulation of gonadotropin secretion,BP,INHBB
2360,GO:0032278,0.292679091784325,1,1,1,positive regulation of gonadotropin secretion,BP,INHBB
2442,GO:0032605,0.292679091784325,1,1,1,hepatocyte growth factor production,BP,INHBB
2455,GO:0032646,0.292679091784325,1,1,1,regulation of hepatocyte growth factor production,BP,INHBB
2466,GO:0032686,0.292679091784325,1,1,1,negative regulation of hepatocyte growth factor production,BP,INHBB
3326,GO:0044320,0.292679091784325,1,1,1,cellular response to leptin stimulus,BP,INHBB
3676,GO:0046676,0.292679091784325,1,1,1,negative regulation of insulin secretion,BP,INHBB
3687,GO:0046789,0.292679091784325,1,1,1,host cell surface receptor binding,MF,INHBB
3689,GO:0046812,0.292679091784325,1,1,1,host cell surface binding,MF,INHBB
3708,GO:0046880,0.292679091784325,1,1,1,regulation of follicle-stimulating hormone secretion,BP,INHBB
3709,GO:0046881,0.292679091784325,1,1,1,positive regulation of follicle-stimulating hormone secretion,BP,INHBB
3710,GO:0046882,0.292679091784325,1,1,1,negative regulation of follicle-stimulating hormone secretion,BP,INHBB
3712,GO:0046884,0.292679091784325,1,1,1,follicle-stimulating hormone secretion,BP,INHBB
3769,GO:0048175,0.292679091784325,1,1,1,hepatocyte growth factor biosynthetic process,BP,INHBB
3770,GO:0048176,0.292679091784325,1,1,1,regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
3771,GO:0048178,0.292679091784325,1,1,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
4431,GO:0060278,0.292679091784325,1,1,1,regulation of ovulation,BP,INHBB
4432,GO:0060279,0.292679091784325,1,1,1,positive regulation of ovulation,BP,INHBB
5321,GO:0090278,0.292679091784325,1,1,1,negative regulation of peptide hormone secretion,BP,INHBB
1444,GO:0010941,0.29408688870465,0.81352569694573,16,46,regulation of cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;RRAS2;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
365,GO:0002831,0.294152712600066,1,1,1,regulation of response to biotic stimulus,BP,BMP6
366,GO:0002833,0.294152712600066,1,1,1,positive regulation of response to biotic stimulus,BP,BMP6
2265,GO:0031664,0.294152712600066,1,1,1,regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
2266,GO:0031666,0.294152712600066,1,1,1,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
2312,GO:0032026,0.294152712600066,1,1,1,response to magnesium ion,BP,BMP6
2372,GO:0032332,0.294152712600066,1,1,1,positive regulation of chondrocyte differentiation,BP,BMP6
2828,GO:0035929,0.294152712600066,1,1,1,steroid hormone secretion,BP,BMP6
2829,GO:0035930,0.294152712600066,1,1,1,corticosteroid hormone secretion,BP,BMP6
2830,GO:0035931,0.294152712600066,1,1,1,mineralocorticoid secretion,BP,BMP6
2831,GO:0035932,0.294152712600066,1,1,1,aldosterone secretion,BP,BMP6
4546,GO:0060586,0.294152712600066,1,1,1,multicellular organismal iron ion homeostasis,BP,BMP6
6160,GO:2000831,0.294152712600066,1,1,1,regulation of steroid hormone secretion,BP,BMP6
6161,GO:2000833,0.294152712600066,1,1,1,positive regulation of steroid hormone secretion,BP,BMP6
6162,GO:2000846,0.294152712600066,1,1,1,regulation of corticosteroid hormone secretion,BP,BMP6
6163,GO:2000848,0.294152712600066,1,1,1,positive regulation of corticosteroid hormone secretion,BP,BMP6
6164,GO:2000855,0.294152712600066,1,1,1,regulation of mineralocorticoid secretion,BP,BMP6
6165,GO:2000857,0.294152712600066,1,1,1,positive regulation of mineralocorticoid secretion,BP,BMP6
6166,GO:2000858,0.294152712600066,1,1,1,regulation of aldosterone secretion,BP,BMP6
6167,GO:2000860,0.294152712600066,1,1,1,positive regulation of aldosterone secretion,BP,BMP6
142,GO:0001763,0.294584818792729,0.8531862700595,7,18,morphogenesis of a branching structure,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
3914,GO:0048754,0.294584818792729,0.8531862700595,7,18,branching morphogenesis of an epithelial tube,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
4687,GO:0061138,0.294584818792729,0.8531862700595,7,18,morphogenesis of a branching epithelium,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
4015,GO:0050804,0.294820681695803,0.913895322552244,3,6,modulation of synaptic transmission,BP,WNT7A;HRAS;GDNF
4252,GO:0051641,0.296080601270113,0.807564096367056,18,53,cellular localization,BP,WNT7A;PIK3CG;SYT5;CLDN18;BMP6;PMAIP1;SPTBN5;CDH1;RAB40B;SPTB;FZD7;AMOT;TSPAN15;BMP4;GDNF;RAB38;BMP7;SPTBN4
77,GO:0001105,0.297366176014261,1,1,1,RNA polymerase II transcription coactivator activity,MF,POU3F1
5328,GO:0090304,0.297888663394643,0.802829842629849,20,59,nucleic acid metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1
4058,GO:0050918,0.298069598638704,0.912382846104599,3,6,positive chemotaxis,BP,FGF8;ARTN;BMP4
234,GO:0002082,0.298349062773716,1,1,1,regulation of oxidative phosphorylation,BP,ACTN3
375,GO:0003009,0.298349062773716,1,1,1,skeletal muscle contraction,BP,ACTN3
745,GO:0006089,0.298349062773716,1,1,1,lactate metabolic process,BP,ACTN3
751,GO:0006110,0.298349062773716,1,1,1,regulation of glycolytic process,BP,ACTN3
754,GO:0006113,0.298349062773716,1,1,1,fermentation,BP,ACTN3
755,GO:0006119,0.298349062773716,1,1,1,oxidative phosphorylation,BP,ACTN3
1179,GO:0009060,0.298349062773716,1,1,1,aerobic respiration,BP,ACTN3
1380,GO:0010677,0.298349062773716,1,1,1,negative regulation of cellular carbohydrate metabolic process,BP,ACTN3
1493,GO:0014728,0.298349062773716,1,1,1,regulation of the force of skeletal muscle contraction,BP,ACTN3
1495,GO:0014732,0.298349062773716,1,1,1,skeletal muscle atrophy,BP,ACTN3
1496,GO:0014733,0.298349062773716,1,1,1,regulation of skeletal muscle adaptation,BP,ACTN3
1502,GO:0014819,0.298349062773716,1,1,1,regulation of skeletal muscle contraction,BP,ACTN3
1510,GO:0014854,0.298349062773716,1,1,1,response to inactivity,BP,ACTN3
1512,GO:0014862,0.298349062773716,1,1,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,ACTN3
1514,GO:0014870,0.298349062773716,1,1,1,response to muscle inactivity,BP,ACTN3
1515,GO:0014874,0.298349062773716,1,1,1,response to stimulus involved in regulation of muscle adaptation,BP,ACTN3
1516,GO:0014877,0.298349062773716,1,1,1,response to muscle inactivity involved in regulation of muscle adaptation,BP,ACTN3
1517,GO:0014883,0.298349062773716,1,1,1,transition between fast and slow fiber,BP,ACTN3
1518,GO:0014888,0.298349062773716,1,1,1,striated muscle adaptation,BP,ACTN3
1519,GO:0014889,0.298349062773716,1,1,1,muscle atrophy,BP,ACTN3
1520,GO:0014891,0.298349062773716,1,1,1,striated muscle atrophy,BP,ACTN3
1521,GO:0014894,0.298349062773716,1,1,1,response to denervation involved in regulation of muscle adaptation,BP,ACTN3
1802,GO:0019659,0.298349062773716,1,1,1,glucose catabolic process to lactate,BP,ACTN3
1803,GO:0019660,0.298349062773716,1,1,1,glycolytic fermentation,BP,ACTN3
1804,GO:0019661,0.298349062773716,1,1,1,glucose catabolic process to lactate via pyruvate,BP,ACTN3
2577,GO:0033173,0.298349062773716,1,1,1,calcineurin-NFAT signaling cascade,BP,ACTN3
3207,GO:0043465,0.298349062773716,1,1,1,regulation of fermentation,BP,ACTN3
3209,GO:0043470,0.298349062773716,1,1,1,regulation of carbohydrate catabolic process,BP,ACTN3
3220,GO:0043501,0.298349062773716,1,1,1,skeletal muscle adaptation,BP,ACTN3
3563,GO:0045820,0.298349062773716,1,1,1,negative regulation of glycolytic process,BP,ACTN3
3587,GO:0045912,0.298349062773716,1,1,1,negative regulation of carbohydrate metabolic process,BP,ACTN3
4046,GO:0050879,0.298349062773716,1,1,1,multicellular organismal movement,BP,ACTN3
4048,GO:0050881,0.298349062773716,1,1,1,musculoskeletal movement,BP,ACTN3
4139,GO:0051193,0.298349062773716,1,1,1,regulation of cofactor metabolic process,BP,ACTN3
4140,GO:0051194,0.298349062773716,1,1,1,positive regulation of cofactor metabolic process,BP,ACTN3
4141,GO:0051195,0.298349062773716,1,1,1,negative regulation of cofactor metabolic process,BP,ACTN3
4142,GO:0051196,0.298349062773716,1,1,1,regulation of coenzyme metabolic process,BP,ACTN3
4143,GO:0051197,0.298349062773716,1,1,1,positive regulation of coenzyme metabolic process,BP,ACTN3
4144,GO:0051198,0.298349062773716,1,1,1,negative regulation of coenzyme metabolic process,BP,ACTN3
4900,GO:0070884,0.298349062773716,1,1,1,regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
4901,GO:0070885,0.298349062773716,1,1,1,negative regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
5332,GO:0090324,0.298349062773716,1,1,1,negative regulation of oxidative phosphorylation,BP,ACTN3
5436,GO:0097720,0.298349062773716,1,1,1,calcineurin-mediated signaling,BP,ACTN3
5758,GO:1902688,0.298349062773716,1,1,1,regulation of NAD metabolic process,BP,ACTN3
5759,GO:1902690,0.298349062773716,1,1,1,positive regulation of NAD metabolic process,BP,ACTN3
5857,GO:1903578,0.298349062773716,1,1,1,regulation of ATP metabolic process,BP,ACTN3
5858,GO:1903579,0.298349062773716,1,1,1,negative regulation of ATP metabolic process,BP,ACTN3
5859,GO:1903580,0.298349062773716,1,1,1,positive regulation of ATP metabolic process,BP,ACTN3
5868,GO:1903715,0.298349062773716,1,1,1,regulation of aerobic respiration,BP,ACTN3
5898,GO:1904023,0.298349062773716,1,1,1,regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
5899,GO:1904025,0.298349062773716,1,1,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
442,GO:0003228,0.298368686784014,1,1,1,atrial cardiac muscle tissue development,BP,WNT2
4325,GO:0055009,0.298368686784014,1,1,1,atrial cardiac muscle tissue morphogenesis,BP,WNT2
4517,GO:0060501,0.298368686784014,1,1,1,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
6153,GO:2000794,0.298368686784014,1,1,1,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
253,GO:0002237,0.299008976200483,0.871946511963928,5,12,response to molecule of bacterial origin,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
2420,GO:0032496,0.299008976200483,0.871946511963928,5,12,response to lipopolysaccharide,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
3081,GO:0042981,0.299617691097627,0.811612297819832,15,43,regulation of apoptotic process,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3107,GO:0043086,0.299768342867396,0.859257679614365,6,15,negative regulation of catalytic activity,BP,AMOT;DUSP5;HRAS;BMP4;BMP7;NOTCH1
620,GO:0005506,0.299775536648792,1,1,1,iron ion binding,MF,TF
1110,GO:0008198,0.299775536648792,1,1,1,ferrous iron binding,MF,TF
1111,GO:0008199,0.299775536648792,1,1,1,ferric iron binding,MF,TF
1272,GO:0009925,0.299775536648792,1,1,1,basal plasma membrane,CC,TF
1533,GO:0015091,0.299775536648792,1,1,1,ferric iron transmembrane transporter activity,MF,TF
1555,GO:0015682,0.299775536648792,1,1,1,ferric iron transport,BP,TF
1556,GO:0015684,0.299775536648792,1,1,1,ferrous iron transport,BP,TF
2196,GO:0031232,0.299775536648792,1,1,1,extrinsic component of external side of plasma membrane,CC,TF
2599,GO:0033572,0.299775536648792,1,1,1,transferrin transport,BP,TF
3784,GO:0048260,0.299775536648792,1,1,1,positive regulation of receptor-mediated endocytosis,BP,TF
4868,GO:0070627,0.299775536648792,1,1,1,ferrous iron import,BP,TF
5200,GO:0072510,0.299775536648792,1,1,1,trivalent inorganic cation transmembrane transporter activity,MF,TF
5202,GO:0072512,0.299775536648792,1,1,1,trivalent inorganic cation transport,BP,TF
5404,GO:0097286,0.299775536648792,1,1,1,iron ion import,BP,TF
5418,GO:0097459,0.299775536648792,1,1,1,iron ion import into cell,BP,TF
5419,GO:0097460,0.299775536648792,1,1,1,ferrous iron import into cell,BP,TF
5464,GO:0098659,0.299775536648792,1,1,1,inorganic cation import into cell,BP,TF
5525,GO:0099587,0.299775536648792,1,1,1,inorganic ion import into cell,BP,TF
6017,GO:1990459,0.299775536648792,1,1,1,transferrin receptor binding,MF,TF
6019,GO:1990712,0.299775536648792,1,1,1,HFE-transferrin receptor complex,CC,TF
2228,GO:0031399,0.300708809342427,0.808331135029599,16,46,regulation of protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
1252,GO:0009798,0.300824617333977,0.887260439786755,4,9,axis specification,BP,WNT7A;WNT3;BMP4;NOTCH1
2726,GO:0035148,0.302612210253324,0.869735144268612,5,12,tube formation,BP,FGF8;BMP4;GDNF;BMP7;NOTCH1
1259,GO:0009889,0.302737935920114,0.798925916772139,20,59,regulation of biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
387,GO:0003085,0.303117608190096,1,1,1,negative regulation of systemic arterial blood pressure,BP,KCNK6
4389,GO:0060075,0.303117608190096,1,1,1,regulation of resting membrane potential,BP,KCNK6
1130,GO:0008284,0.30317157276475,0.827560960709425,10,27,positive regulation of cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;FGF8;FGF17;HRAS;BMP4;GDNF;NOTCH1
2232,GO:0031410,0.303175993253134,0.798572391332526,20,59,cytoplasmic vesicle,CC,WNT7A;SYT5;WNT3;WNT7B;AXIN1;CDH1;RAB40B;FZD7;RAB39A;AMOT;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;FSTL3;NOTCH1;RAB20;TF
5434,GO:0097708,0.303175993253134,0.798572391332526,20,59,intracellular vesicle,CC,WNT7A;SYT5;WNT3;WNT7B;AXIN1;CDH1;RAB40B;FZD7;RAB39A;AMOT;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;FSTL3;NOTCH1;RAB20;TF
5637,GO:1901575,0.303818159685607,0.837796284258385,8,22,organic substance catabolic process,BP,MAGEC2;GLDC;PIK3CG;ACTN3;PMAIP1;AXIN1;PKP1;RNF144A
6194,GO:2001236,0.304806464299893,0.909208901749539,3,6,regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;BMP4;GDNF
28,GO:0000188,0.305959260201557,1,1,1,inactivation of MAPK activity,BP,DUSP5
1101,GO:0008138,0.305959260201557,1,1,1,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP5
1722,GO:0017017,0.305959260201557,1,1,1,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP5
2593,GO:0033549,0.305959260201557,1,1,1,MAP kinase phosphatase activity,MF,DUSP5
2835,GO:0035970,0.305959260201557,1,1,1,peptidyl-threonine dephosphorylation,BP,DUSP5
4511,GO:0060485,0.306052239064716,0.845393670224758,7,18,mesenchyme development,BP,HEY1;WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
892,GO:0006892,0.30844358967393,1,1,1,post-Golgi vesicle-mediated transport,BP,RABIF
369,GO:0002931,0.310925570048072,1,1,1,response to ischemia,BP,GJB2
680,GO:0005793,0.310925570048072,1,1,1,endoplasmic reticulum-Golgi intermediate compartment,CC,GJB2
2436,GO:0032570,0.310925570048072,1,1,1,response to progesterone,BP,GJB2
3390,GO:0044752,0.310925570048072,1,1,1,response to human chorionic gonadotropin,BP,GJB2
3677,GO:0046677,0.310925570048072,1,1,1,response to antibiotic,BP,GJB2
4995,GO:0071549,0.310925570048072,1,1,1,cellular response to dexamethasone stimulus,BP,GJB2
5412,GO:0097386,0.310925570048072,1,1,1,glial cell projection,CC,GJB2
5416,GO:0097449,0.310925570048072,1,1,1,astrocyte projection,CC,GJB2
5617,GO:1901360,0.310960094212546,0.788093842591766,23,69,organic cyclic compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;PNMT;GUCY1B3
3649,GO:0046483,0.311057402006343,0.789195876551362,22,66,heterocycle metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3
62,GO:0000983,0.311683271571155,1,1,1,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,HEY1
487,GO:0003696,0.311683271571155,1,1,1,satellite DNA binding,MF,HEY1
2823,GO:0035907,0.311683271571155,1,1,1,dorsal aorta development,BP,HEY1
2825,GO:0035912,0.311683271571155,1,1,1,dorsal aorta morphogenesis,BP,HEY1
2832,GO:0035939,0.311683271571155,1,1,1,microsatellite binding,MF,HEY1
2869,GO:0036304,0.311683271571155,1,1,1,umbilical cord morphogenesis,BP,HEY1
3188,GO:0043392,0.311683271571155,1,1,1,negative regulation of DNA binding,BP,HEY1
4455,GO:0060343,0.311683271571155,1,1,1,trabecula formation,BP,HEY1
4456,GO:0060347,0.311683271571155,1,1,1,heart trabecula formation,BP,HEY1
4656,GO:0061027,0.311683271571155,1,1,1,umbilical cord development,BP,HEY1
6139,GO:2000678,0.311683271571155,1,1,1,negative regulation of transcription regulatory region DNA binding,BP,HEY1
6158,GO:2000820,0.311683271571155,1,1,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,HEY1
6190,GO:2001212,0.311683271571155,1,1,1,regulation of vasculogenesis,BP,HEY1
612,GO:0005355,0.31426157535827,1,1,1,glucose transmembrane transporter activity,MF,SLC2A14
1538,GO:0015145,0.31426157535827,1,1,1,monosaccharide transmembrane transporter activity,MF,SLC2A14
1539,GO:0015149,0.31426157535827,1,1,1,hexose transmembrane transporter activity,MF,SLC2A14
2632,GO:0034219,0.31426157535827,1,1,1,carbohydrate transmembrane transport,BP,SLC2A14
2761,GO:0035428,0.31426157535827,1,1,1,hexose transmembrane transport,BP,SLC2A14
4338,GO:0055056,0.31426157535827,1,1,1,D-glucose transmembrane transporter activity,MF,SLC2A14
5920,GO:1904659,0.31426157535827,1,1,1,glucose transmembrane transport,BP,SLC2A14
5996,GO:1905950,0.31426157535827,1,1,1,monosaccharide transmembrane transport,BP,SLC2A14
1004,GO:0007268,0.31652189973582,0.878347312983053,4,9,chemical synaptic transmission,BP,WNT7A;SYT5;HRAS;GDNF
5501,GO:0098916,0.31652189973582,0.878347312983053,4,9,anterograde trans-synaptic signaling,BP,WNT7A;SYT5;HRAS;GDNF
5520,GO:0099536,0.31652189973582,0.878347312983053,4,9,synaptic signaling,BP,WNT7A;SYT5;HRAS;GDNF
5521,GO:0099537,0.31652189973582,0.878347312983053,4,9,trans-synaptic signaling,BP,WNT7A;SYT5;HRAS;GDNF
1918,GO:0022603,0.316604600213118,0.807831907846574,12,34,regulation of anatomical structure morphogenesis,BP,WNT7A;WNT3;HEY1;WNT2;FZD7;FGF8;VDR;AMOT;BMP4;GDNF;BMP7;NOTCH1
1491,GO:0014706,0.317908197523905,0.835531421240074,7,19,striated muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
4244,GO:0051602,0.318419284099707,1,1,1,response to electrical stimulus,BP,GJB6
631,GO:0005525,0.31853707156671,0.821839708039343,9,24,GTP binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
1760,GO:0019001,0.31853707156671,0.821839708039343,9,24,guanyl nucleotide binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2430,GO:0032549,0.31853707156671,0.821839708039343,9,24,ribonucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2431,GO:0032550,0.31853707156671,0.821839708039343,9,24,purine ribonucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2435,GO:0032561,0.31853707156671,0.821839708039343,9,24,guanyl ribonucleotide binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2750,GO:0035315,0.319706853742148,0.929478397388426,2,4,hair cell differentiation,BP,JAG2;NOTCH1
3018,GO:0042491,0.319706853742148,0.929478397388426,2,4,auditory receptor cell differentiation,BP,JAG2;NOTCH1
3082,GO:0042990,0.319814692028572,0.929436348783877,2,4,regulation of transcription factor import into nucleus,BP,CDH1;BMP7
3083,GO:0042991,0.319814692028572,0.929436348783877,2,4,transcription factor import into nucleus,BP,CDH1;BMP7
718,GO:0005942,0.320321203489057,0.929238675730186,2,4,phosphatidylinositol 3-kinase complex,CC,PIK3CG;PIK3CA
1664,GO:0016525,0.320775597097415,0.92906109995716,2,4,negative regulation of angiogenesis,BP,AMOT;NOTCH1
2209,GO:0031324,0.321119671878128,0.796995400015832,14,41,negative regulation of cellular metabolic process,BP,TLE1;PIK3CG;ACTN3;BMP6;HEY1;AXIN1;VDR;DUSP5;INHBB;PKP1;BMP4;PIK3CA;BMP7;NOTCH1
5054,GO:0071944,0.321193807613602,0.773032206032835,44,139,cell periphery,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;PIK3CG;SYT5;CLDN18;GJA3;WNT3;GJB6;WNT7B;JAG2;KCNG2;AXIN1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;RAB39A;DSG3;AMOT;WNT5B;INHBB;PKP1;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;RNF144A;RAB38;PIK3CA;DRP2;SPTBN4;TSPAN13;NOTCH1;RAB20;GUCY1B3;TF
1945,GO:0030001,0.321580447384129,0.825048351608564,8,22,metal ion transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;SPTBN4;TSPAN13;TF
169,GO:0001844,0.321618786662083,1,1,1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
903,GO:0006919,0.321618786662083,1,1,1,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
928,GO:0007006,0.321618786662083,1,1,1,mitochondrial membrane organization,BP,PMAIP1
1412,GO:0010822,0.321618786662083,1,1,1,positive regulation of mitochondrion organization,BP,PMAIP1
1437,GO:0010917,0.321618786662083,1,1,1,negative regulation of mitochondrial membrane potential,BP,PMAIP1
2416,GO:0032459,0.321618786662083,1,1,1,regulation of protein oligomerization,BP,PMAIP1
2417,GO:0032461,0.321618786662083,1,1,1,positive regulation of protein oligomerization,BP,PMAIP1
2802,GO:0035794,0.321618786662083,1,1,1,positive regulation of mitochondrial membrane permeability,BP,PMAIP1
3224,GO:0043516,0.321618786662083,1,1,1,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3225,GO:0043517,0.321618786662083,1,1,1,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3572,GO:0045837,0.321618786662083,1,1,1,negative regulation of membrane potential,BP,PMAIP1
3719,GO:0046902,0.321618786662083,1,1,1,regulation of mitochondrial membrane permeability,BP,PMAIP1
4145,GO:0051204,0.321618786662083,1,1,1,protein insertion into mitochondrial membrane,BP,PMAIP1
4248,GO:0051607,0.321618786662083,1,1,1,defense response to virus,BP,PMAIP1
4282,GO:0051881,0.321618786662083,1,1,1,regulation of mitochondrial membrane potential,BP,PMAIP1
4780,GO:0070059,0.321618786662083,1,1,1,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1
5311,GO:0090200,0.321618786662083,1,1,1,positive regulation of release of cytochrome c from mitochondria,BP,PMAIP1
5347,GO:0090559,0.321618786662083,1,1,1,regulation of membrane permeability,BP,PMAIP1
5409,GO:0097345,0.321618786662083,1,1,1,mitochondrial outer membrane permeabilization,BP,PMAIP1
5580,GO:1900739,0.321618786662083,1,1,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
5581,GO:1900740,0.321618786662083,1,1,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
5591,GO:1901028,0.321618786662083,1,1,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
5592,GO:1901030,0.321618786662083,1,1,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
5664,GO:1901798,0.321618786662083,1,1,1,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
5693,GO:1902041,0.321618786662083,1,1,1,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5694,GO:1902043,0.321618786662083,1,1,1,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5700,GO:1902108,0.321618786662083,1,1,1,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
5701,GO:1902110,0.321618786662083,1,1,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
5709,GO:1902235,0.321618786662083,1,1,1,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
5710,GO:1902237,0.321618786662083,1,1,1,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
5757,GO:1902686,0.321618786662083,1,1,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PMAIP1
5875,GO:1903747,0.321618786662083,1,1,1,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
5876,GO:1903749,0.321618786662083,1,1,1,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
5985,GO:1905710,0.321618786662083,1,1,1,positive regulation of membrane permeability,BP,PMAIP1
6196,GO:2001238,0.321618786662083,1,1,1,positive regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1
6201,GO:2001244,0.321618786662083,1,1,1,positive regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
2060,GO:0030507,0.321703280129427,0.928697851558329,2,4,spectrin binding,MF,SPTBN5;SPTBN4
602,GO:0005246,0.322508713184444,1,1,1,calcium channel regulator activity,MF,TSPAN13
1707,GO:0016829,0.322910513492185,0.92822370733854,2,4,lyase activity,MF,GLDC;GUCY1B3
801,GO:0006479,0.323148654002669,1,1,1,protein methylation,BP,RAB3D
1120,GO:0008213,0.323148654002669,1,1,1,protein alkylation,BP,RAB3D
1745,GO:0018125,0.323148654002669,1,1,1,peptidyl-cysteine methylation,BP,RAB3D
1749,GO:0018198,0.323148654002669,1,1,1,peptidyl-cysteine modification,BP,RAB3D
3042,GO:0042588,0.323148654002669,1,1,1,zymogen granule,CC,RAB3D
3908,GO:0048738,0.323154370518068,0.841572004958755,6,16,cardiac muscle tissue development,BP,WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
3363,GO:0044448,0.323485118607911,0.869947509391437,4,10,cell cortex part,CC,SPTBN5;CDH1;SPTB;SPTBN4
69,GO:0001071,0.323764001039656,0.869779881956125,4,10,nucleic acid binding transcription factor activity,MF,HEY1;POU3F1;VDR;NOTCH1
488,GO:0003700,0.323764001039656,0.869779881956125,4,10,transcription factor activity, sequence-specific DNA binding,MF,HEY1;POU3F1;VDR;NOTCH1
1178,GO:0009059,0.324295907734568,0.781102726804654,20,60,macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;INHBB;CCL20;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
635,GO:0005544,0.324512429667759,1,1,1,calcium-dependent phospholipid binding,MF,SYT5
1604,GO:0016079,0.324512429667759,1,1,1,synaptic vesicle exocytosis,BP,SYT5
2021,GO:0030276,0.324512429667759,1,1,1,clathrin binding,MF,SYT5
2161,GO:0031045,0.324512429667759,1,1,1,dense core granule,CC,SYT5
3818,GO:0048488,0.324512429667759,1,1,1,synaptic vesicle endocytosis,BP,SYT5
3920,GO:0048791,0.324512429667759,1,1,1,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT5
6021,GO:1990769,0.324512429667759,1,1,1,proximal neuron projection,CC,SYT5
1080,GO:0008013,0.325488657998735,0.927205694841301,2,4,beta-catenin binding,MF,AXIN1;CDH1
3837,GO:0048537,0.325514693692564,1,1,1,mucosal-associated lymphoid tissue development,BP,ARTN
3839,GO:0048541,0.325514693692564,1,1,1,Peyer's patch development,BP,ARTN
4690,GO:0061146,0.325514693692564,1,1,1,Peyer's patch morphogenesis,BP,ARTN
5361,GO:0097021,0.325514693692564,1,1,1,lymphocyte migration into lymphoid organs,BP,ARTN
128,GO:0001710,0.325793138892771,1,1,1,mesodermal cell fate commitment,BP,BMP4
221,GO:0002043,0.325793138892771,1,1,1,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,BMP4
238,GO:0002089,0.325793138892771,1,1,1,lens morphogenesis in camera-type eye,BP,BMP4
394,GO:0003128,0.325793138892771,1,1,1,heart field specification,BP,BMP4
399,GO:0003139,0.325793138892771,1,1,1,secondary heart field specification,BP,BMP4
402,GO:0003149,0.325793138892771,1,1,1,membranous septum morphogenesis,BP,BMP4
976,GO:0007182,0.325793138892771,1,1,1,common-partner SMAD protein phosphorylation,BP,BMP4
1043,GO:0007500,0.325793138892771,1,1,1,mesodermal cell fate determination,BP,BMP4
1298,GO:0010159,0.325793138892771,1,1,1,specification of animal organ position,BP,BMP4
1650,GO:0016441,0.325793138892771,1,1,1,posttranscriptional gene silencing,BP,BMP4
1654,GO:0016458,0.325793138892771,1,1,1,gene silencing,BP,BMP4
2009,GO:0030224,0.325793138892771,1,1,1,monocyte differentiation,BP,BMP4
2162,GO:0031047,0.325793138892771,1,1,1,gene silencing by RNA,BP,BMP4
2163,GO:0031050,0.325793138892771,1,1,1,dsRNA fragmentation,BP,BMP4
2371,GO:0032331,0.325793138892771,1,1,1,negative regulation of chondrocyte differentiation,BP,BMP4
2561,GO:0033081,0.325793138892771,1,1,1,regulation of T cell differentiation in thymus,BP,BMP4
2562,GO:0033083,0.325793138892771,1,1,1,regulation of immature T cell proliferation,BP,BMP4
2563,GO:0033084,0.325793138892771,1,1,1,regulation of immature T cell proliferation in thymus,BP,BMP4
2564,GO:0033085,0.325793138892771,1,1,1,negative regulation of T cell differentiation in thymus,BP,BMP4
2565,GO:0033087,0.325793138892771,1,1,1,negative regulation of immature T cell proliferation,BP,BMP4
2566,GO:0033088,0.325793138892771,1,1,1,negative regulation of immature T cell proliferation in thymus,BP,BMP4
2729,GO:0035194,0.325793138892771,1,1,1,posttranscriptional gene silencing by RNA,BP,BMP4
2730,GO:0035195,0.325793138892771,1,1,1,gene silencing by miRNA,BP,BMP4
2731,GO:0035196,0.325793138892771,1,1,1,production of miRNAs involved in gene silencing by miRNA,BP,BMP4
2812,GO:0035844,0.325793138892771,1,1,1,cloaca development,BP,BMP4
2838,GO:0035989,0.325793138892771,1,1,1,tendon development,BP,BMP4
2839,GO:0035990,0.325793138892771,1,1,1,tendon cell differentiation,BP,BMP4
2840,GO:0035992,0.325793138892771,1,1,1,tendon formation,BP,BMP4
2841,GO:0035993,0.325793138892771,1,1,1,deltoid tuberosity development,BP,BMP4
2927,GO:0040029,0.325793138892771,1,1,1,regulation of gene expression, epigenetic,BP,BMP4
3491,GO:0045580,0.325793138892771,1,1,1,regulation of T cell differentiation,BP,BMP4
3492,GO:0045581,0.325793138892771,1,1,1,negative regulation of T cell differentiation,BP,BMP4
3509,GO:0045620,0.325793138892771,1,1,1,negative regulation of lymphocyte differentiation,BP,BMP4
3805,GO:0048389,0.325793138892771,1,1,1,intermediate mesoderm development,BP,BMP4
3806,GO:0048390,0.325793138892771,1,1,1,intermediate mesoderm morphogenesis,BP,BMP4
3807,GO:0048391,0.325793138892771,1,1,1,intermediate mesoderm formation,BP,BMP4
3808,GO:0048392,0.325793138892771,1,1,1,intermediate mesodermal cell differentiation,BP,BMP4
3893,GO:0048701,0.325793138892771,1,1,1,embryonic cranial skeleton morphogenesis,BP,BMP4
4329,GO:0055018,0.325793138892771,1,1,1,regulation of cardiac muscle fiber development,BP,BMP4
4330,GO:0055020,0.325793138892771,1,1,1,positive regulation of cardiac muscle fiber development,BP,BMP4
4408,GO:0060147,0.325793138892771,1,1,1,regulation of posttranscriptional gene silencing,BP,BMP4
4409,GO:0060148,0.325793138892771,1,1,1,positive regulation of posttranscriptional gene silencing,BP,BMP4
4418,GO:0060197,0.325793138892771,1,1,1,cloacal septation,BP,BMP4
4423,GO:0060235,0.325793138892771,1,1,1,lens induction in camera-type eye,BP,BMP4
4461,GO:0060363,0.325793138892771,1,1,1,cranial suture morphogenesis,BP,BMP4
4497,GO:0060440,0.325793138892771,1,1,1,trachea formation,BP,BMP4
4519,GO:0060503,0.325793138892771,1,1,1,bud dilation involved in lung branching,BP,BMP4
4570,GO:0060677,0.325793138892771,1,1,1,ureteric bud elongation,BP,BMP4
4571,GO:0060681,0.325793138892771,1,1,1,branch elongation involved in ureteric bud branching,BP,BMP4
4628,GO:0060914,0.325793138892771,1,1,1,heart formation,BP,BMP4
4635,GO:0060964,0.325793138892771,1,1,1,regulation of gene silencing by miRNA,BP,BMP4
4636,GO:0060966,0.325793138892771,1,1,1,regulation of gene silencing by RNA,BP,BMP4
4637,GO:0060968,0.325793138892771,1,1,1,regulation of gene silencing,BP,BMP4
4646,GO:0060994,0.325793138892771,1,1,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,BMP4
4649,GO:0061004,0.325793138892771,1,1,1,pattern specification involved in kidney development,BP,BMP4
4663,GO:0061037,0.325793138892771,1,1,1,negative regulation of cartilage development,BP,BMP4
4691,GO:0061149,0.325793138892771,1,1,1,BMP signaling pathway involved in ureter morphogenesis,BP,BMP4
4692,GO:0061150,0.325793138892771,1,1,1,renal system segmentation,BP,BMP4
4693,GO:0061151,0.325793138892771,1,1,1,BMP signaling pathway involved in renal system segmentation,BP,BMP4
4695,GO:0061155,0.325793138892771,1,1,1,pulmonary artery endothelial tube morphogenesis,BP,BMP4
4704,GO:0061216,0.325793138892771,1,1,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,BMP4
4706,GO:0061218,0.325793138892771,1,1,1,negative regulation of mesonephros development,BP,BMP4
4707,GO:0061227,0.325793138892771,1,1,1,pattern specification involved in mesonephros development,BP,BMP4
4717,GO:0061323,0.325793138892771,1,1,1,cell proliferation involved in heart morphogenesis,BP,BMP4
4718,GO:0061325,0.325793138892771,1,1,1,cell proliferation involved in outflow tract morphogenesis,BP,BMP4
4743,GO:0061438,0.325793138892771,1,1,1,renal system vasculature morphogenesis,BP,BMP4
4744,GO:0061439,0.325793138892771,1,1,1,kidney vasculature morphogenesis,BP,BMP4
4760,GO:0061626,0.325793138892771,1,1,1,pharyngeal arch artery morphogenesis,BP,BMP4
4802,GO:0070229,0.325793138892771,1,1,1,negative regulation of lymphocyte apoptotic process,BP,BMP4
4806,GO:0070233,0.325793138892771,1,1,1,negative regulation of T cell apoptotic process,BP,BMP4
4810,GO:0070244,0.325793138892771,1,1,1,negative regulation of thymocyte apoptotic process,BP,BMP4
4904,GO:0070918,0.325793138892771,1,1,1,production of small RNA involved in gene silencing by RNA,BP,BMP4
4905,GO:0070920,0.325793138892771,1,1,1,regulation of production of small RNA involved in gene silencing by RNA,BP,BMP4
5049,GO:0071893,0.325793138892771,1,1,1,BMP signaling pathway involved in nephric duct formation,BP,BMP4
5066,GO:0072015,0.325793138892771,1,1,1,glomerular visceral epithelial cell development,BP,BMP4
5075,GO:0072048,0.325793138892771,1,1,1,renal system pattern specification,BP,BMP4
5076,GO:0072049,0.325793138892771,1,1,1,comma-shaped body morphogenesis,BP,BMP4
5095,GO:0072095,0.325793138892771,1,1,1,regulation of branch elongation involved in ureteric bud branching,BP,BMP4
5096,GO:0072096,0.325793138892771,1,1,1,negative regulation of branch elongation involved in ureteric bud branching,BP,BMP4
5097,GO:0072097,0.325793138892771,1,1,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,BMP4
5098,GO:0072098,0.325793138892771,1,1,1,anterior/posterior pattern specification involved in kidney development,BP,BMP4
5099,GO:0072099,0.325793138892771,1,1,1,anterior/posterior pattern specification involved in ureteric bud development,BP,BMP4
5100,GO:0072100,0.325793138892771,1,1,1,specification of ureteric bud anterior/posterior symmetry,BP,BMP4
5101,GO:0072101,0.325793138892771,1,1,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,BMP4
5102,GO:0072102,0.325793138892771,1,1,1,glomerulus morphogenesis,BP,BMP4
5103,GO:0072103,0.325793138892771,1,1,1,glomerulus vasculature morphogenesis,BP,BMP4
5104,GO:0072104,0.325793138892771,1,1,1,glomerular capillary formation,BP,BMP4
5140,GO:0072179,0.325793138892771,1,1,1,nephric duct formation,BP,BMP4
5142,GO:0072189,0.325793138892771,1,1,1,ureter development,BP,BMP4
5143,GO:0072190,0.325793138892771,1,1,1,ureter urothelium development,BP,BMP4
5144,GO:0072191,0.325793138892771,1,1,1,ureter smooth muscle development,BP,BMP4
5145,GO:0072192,0.325793138892771,1,1,1,ureter epithelial cell differentiation,BP,BMP4
5146,GO:0072193,0.325793138892771,1,1,1,ureter smooth muscle cell differentiation,BP,BMP4
5147,GO:0072197,0.325793138892771,1,1,1,ureter morphogenesis,BP,BMP4
5148,GO:0072198,0.325793138892771,1,1,1,mesenchymal cell proliferation involved in ureter development,BP,BMP4
5149,GO:0072199,0.325793138892771,1,1,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
5150,GO:0072200,0.325793138892771,1,1,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
5172,GO:0072278,0.325793138892771,1,1,1,metanephric comma-shaped body morphogenesis,BP,BMP4
5180,GO:0072310,0.325793138892771,1,1,1,glomerular epithelial cell development,BP,BMP4
5306,GO:0090191,0.325793138892771,1,1,1,negative regulation of branching involved in ureteric bud morphogenesis,BP,BMP4
5373,GO:0097094,0.325793138892771,1,1,1,craniofacial suture morphogenesis,BP,BMP4
5678,GO:1901963,0.325793138892771,1,1,1,regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
5679,GO:1901964,0.325793138892771,1,1,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
5802,GO:1903131,0.325793138892771,1,1,1,mononuclear cell differentiation,BP,BMP4
5880,GO:1903798,0.325793138892771,1,1,1,regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
5881,GO:1903800,0.325793138892771,1,1,1,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
5937,GO:1904888,0.325793138892771,1,1,1,cranial skeletal system development,BP,BMP4
6034,GO:2000004,0.325793138892771,1,1,1,regulation of metanephric S-shaped body morphogenesis,BP,BMP4
6035,GO:2000005,0.325793138892771,1,1,1,negative regulation of metanephric S-shaped body morphogenesis,BP,BMP4
6036,GO:2000006,0.325793138892771,1,1,1,regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
6037,GO:2000007,0.325793138892771,1,1,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
6071,GO:2000137,0.325793138892771,1,1,1,negative regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
6072,GO:2000138,0.325793138892771,1,1,1,positive regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
6131,GO:2000637,0.325793138892771,1,1,1,positive regulation of gene silencing by miRNA,BP,BMP4
533,GO:0004707,0.326405769079998,1,1,1,MAP kinase activity,MF,MAPK12
921,GO:0006975,0.326405769079998,1,1,1,DNA damage induced protein phosphorylation,BP,MAPK12
5688,GO:1901998,0.32646146591404,1,1,1,toxin transport,BP,RAB40B
6033,GO:1990967,0.32646146591404,1,1,1,multi-organism toxin transport,BP,RAB40B
5124,GO:0072148,0.326536205718774,0.926789936492858,2,4,epithelial cell fate commitment,BP,JAG2;NOTCH1
1099,GO:0008105,0.327742613030184,1,1,1,asymmetric protein localization,BP,WNT7A
1492,GO:0014719,0.327742613030184,1,1,1,skeletal muscle satellite cell activation,BP,WNT7A
1847,GO:0021533,0.327742613030184,1,1,1,cell differentiation in hindbrain,BP,WNT7A
1858,GO:0021681,0.327742613030184,1,1,1,cerebellar granular layer development,BP,WNT7A
1859,GO:0021683,0.327742613030184,1,1,1,cerebellar granular layer morphogenesis,BP,WNT7A
1860,GO:0021684,0.327742613030184,1,1,1,cerebellar granular layer formation,BP,WNT7A
1870,GO:0021707,0.327742613030184,1,1,1,cerebellar granule cell differentiation,BP,WNT7A
2185,GO:0031133,0.327742613030184,1,1,1,regulation of axon diameter,BP,WNT7A
2788,GO:0035659,0.327742613030184,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
4311,GO:0051965,0.327742613030184,1,1,1,positive regulation of synapse assembly,BP,WNT7A
4384,GO:0060066,0.327742613030184,1,1,1,oviduct development,BP,WNT7A
4648,GO:0060997,0.327742613030184,1,1,1,dendritic spine morphogenesis,BP,WNT7A
5489,GO:0098815,0.327742613030184,1,1,1,modulation of excitatory postsynaptic potential,BP,WNT7A
5938,GO:1904889,0.327742613030184,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
5939,GO:1904891,0.327742613030184,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
5971,GO:1905383,0.327742613030184,1,1,1,protein localization to presynapse,BP,WNT7A
5972,GO:1905384,0.327742613030184,1,1,1,regulation of protein localization to presynapse,BP,WNT7A
5973,GO:1905386,0.327742613030184,1,1,1,positive regulation of protein localization to presynapse,BP,WNT7A
6113,GO:2000463,0.327742613030184,1,1,1,positive regulation of excitatory postsynaptic potential,BP,WNT7A
1911,GO:0022409,0.327846068412662,0.890413737560605,3,7,positive regulation of cell-cell adhesion,BP,PIK3CA;BMP7;FSTL3
5397,GO:0097197,0.328049002060234,1,1,1,tetraspanin-enriched microdomain,CC,TSPAN15
5821,GO:1903364,0.328626295364062,0.925956735379465,2,4,positive regulation of cellular protein catabolic process,BP,AXIN1;RNF144A
3758,GO:0048048,0.328627299417059,0.925956333943135,2,4,embryonic eye morphogenesis,BP,AXIN1;BMP7
1054,GO:0007584,0.329463462337707,0.925621629855463,2,4,response to nutrient,BP,VDR;BMP7
647,GO:0005622,0.331489046687548,0.785394842913426,60,192,intracellular,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;GDNF;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF;PM20D2
63,GO:0000988,0.331500192503792,0.865094558300431,4,10,transcription factor activity, protein binding,MF,TLE1;HEY1;POU3F1;NOTCH1
3995,GO:0050767,0.331952398696295,0.82556539979211,7,19,regulation of neurogenesis,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
4264,GO:0051704,0.331971683217774,0.780633216738328,17,50,multi-organism process,BP,SLC2A14;GJB2;BMP6;WNT3;GJB6;JAG2;PMAIP1;CDH1;RAB40B;VDR;INHBB;CCL20;HRAS;BMP4;FSTL3;SPTBN4;NOTCH1
4154,GO:0051224,0.332847410613028,0.924259054179498,2,4,negative regulation of protein transport,BP,INHBB;BMP7
747,GO:0006091,0.33371754469814,0.923906601404337,2,4,generation of precursor metabolites and energy,BP,ACTN3;PIK3CA
5865,GO:1903706,0.333750503433217,0.8637188580191,4,10,regulation of hemopoiesis,BP,CLDN18;BMP4;FSTL3;NOTCH1
1275,GO:0009950,0.333786832067851,1,1,1,dorsal/ventral axis specification,BP,WNT3
1398,GO:0010770,0.333786832067851,1,1,1,positive regulation of cell morphogenesis involved in differentiation,BP,WNT3
3330,GO:0044338,0.333786832067851,1,1,1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
3331,GO:0044339,0.333786832067851,1,1,1,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
3332,GO:0044340,0.333786832067851,1,1,1,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
3884,GO:0048668,0.333786832067851,1,1,1,collateral sprouting,BP,WNT3
3885,GO:0048669,0.333786832067851,1,1,1,collateral sprouting in absence of injury,BP,WNT3
3886,GO:0048670,0.333786832067851,1,1,1,regulation of collateral sprouting,BP,WNT3
3887,GO:0048672,0.333786832067851,1,1,1,positive regulation of collateral sprouting,BP,WNT3
3890,GO:0048696,0.333786832067851,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
3891,GO:0048697,0.333786832067851,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
4000,GO:0050772,0.333786832067851,1,1,1,positive regulation of axonogenesis,BP,WNT3
4381,GO:0060061,0.333786832067851,1,1,1,Spemann organizer formation,BP,WNT3
4382,GO:0060064,0.333786832067851,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
5195,GO:0072497,0.333786832067851,1,1,1,mesenchymal stem cell differentiation,BP,WNT3
5977,GO:1905474,0.333786832067851,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
1920,GO:0022607,0.334225445116371,0.776398087993197,18,54,cellular component assembly,BP,TLE1;WNT7A;GJB2;ACTN3;PMAIP1;KCNG2;AXIN1;SPTBN5;CDH1;SPTB;RAB39A;PKP1;HRAS;RAB38;BMP7;SPTBN4;NOTCH1;RAB20
792,GO:0006461,0.334444542880671,0.8156251091871,8,22,protein complex assembly,BP,TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
4771,GO:0065003,0.334444542880671,0.8156251091871,8,22,macromolecular complex assembly,BP,TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
4817,GO:0070271,0.334444542880671,0.8156251091871,8,22,protein complex biogenesis,BP,TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
2231,GO:0031406,0.334792374470969,0.923470054751267,2,4,carboxylic acid binding,MF,GLDC;VDR
3124,GO:0043177,0.334792374470969,0.923470054751267,2,4,organic acid binding,MF,GLDC;VDR
2687,GO:0034698,0.335111627243284,0.923340137266697,2,4,response to gonadotropin,BP,GJB2;NOTCH1
353,GO:0002762,0.335264370445493,0.923277938796818,2,4,negative regulation of myeloid leukocyte differentiation,BP,CLDN18;FSTL3
905,GO:0006928,0.336085209894682,0.769601874184814,21,64,movement of cell or subcellular component,BP,WNT7A;PIK3CG;ACTN3;WNT3;JAG2;SPTBN5;RRAS2;SPTB;FGF8;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;BMP7;SPTBN4;NOTCH1
2413,GO:0032438,0.336292291380868,1,1,1,melanosome organization,BP,RAB38
2589,GO:0033363,0.336292291380868,1,1,1,secretory granule organization,BP,RAB38
2784,GO:0035646,0.336292291380868,1,1,1,endosome to melanosome transport,BP,RAB38
2785,GO:0035650,0.336292291380868,1,1,1,AP-1 adaptor complex binding,MF,RAB38
2786,GO:0035651,0.336292291380868,1,1,1,AP-3 adaptor complex binding,MF,RAB38
2875,GO:0036461,0.336292291380868,1,1,1,BLOC-2 complex binding,MF,RAB38
3211,GO:0043476,0.336292291380868,1,1,1,pigment accumulation,BP,RAB38
3212,GO:0043482,0.336292291380868,1,1,1,cellular pigment accumulation,BP,RAB38
3214,GO:0043485,0.336292291380868,1,1,1,endosome to pigment granule transport,BP,RAB38
3913,GO:0048753,0.336292291380868,1,1,1,pigment granule organization,BP,RAB38
3915,GO:0048757,0.336292291380868,1,1,1,pigment granule maturation,BP,RAB38
4410,GO:0060155,0.336292291380868,1,1,1,platelet dense granule organization,BP,RAB38
5809,GO:1903232,0.336292291380868,1,1,1,melanosome assembly,BP,RAB38
3017,GO:0042490,0.336396463552239,0.885818089253848,3,7,mechanoreceptor differentiation,BP,JAG2;BMP4;NOTCH1
4397,GO:0060113,0.336396463552239,0.885818089253848,3,7,inner ear receptor cell differentiation,BP,JAG2;BMP4;NOTCH1
4345,GO:0055076,0.337031949647156,0.922556241693989,2,4,transition metal ion homeostasis,BP,BMP6;TF
3102,GO:0043067,0.33738378768996,0.781100960188349,15,44,regulation of programmed cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
214,GO:0002011,0.338140214666305,0.884870255798846,3,7,morphogenesis of an epithelial sheet,BP,WNT7A;BMP7;NOTCH1
809,GO:0006511,0.338162980358423,0.92209258628713,2,4,ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
1839,GO:0019941,0.338162980358423,0.92209258628713,2,4,modification-dependent protein catabolic process,BP,AXIN1;RNF144A
3119,GO:0043161,0.338162980358423,0.92209258628713,2,4,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A
3263,GO:0043632,0.338162980358423,0.92209258628713,2,4,modification-dependent macromolecule catabolic process,BP,AXIN1;RNF144A
5795,GO:1903050,0.338162980358423,0.92209258628713,2,4,regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;RNF144A
636,GO:0005546,0.338241690994345,0.922060265534963,2,4,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT5;FZD7
177,GO:0001893,0.338607897971182,0.921909798297333,2,4,maternal placenta development,BP,GJB2;VDR
5656,GO:1901698,0.339957204826004,0.797970261441276,10,29,response to nitrogen compound,BP,GJB2;PIK3CG;PMAIP1;CDH1;INHBB;BMP4;PIK3CA;BMP7;NOTCH1;GUCY1B3
1554,GO:0015672,0.339980366231864,0.859880071021559,4,10,monovalent inorganic cation transport,BP,KCNG2;WNK4;KCNK6;SPTBN4
1066,GO:0007605,0.340243582623636,0.883722152521506,3,7,sensory perception of sound,BP,GJB2;GJB6;SPTBN4
4071,GO:0050954,0.340243582623636,0.883722152521506,3,7,sensory perception of mechanical stimulus,BP,GJB2;GJB6;SPTBN4
2767,GO:0035567,0.340322488517399,0.92120327762206,2,4,non-canonical Wnt signaling pathway,BP,WNT7A;FZD7
1046,GO:0007519,0.340365762635018,0.921185402618524,2,4,skeletal muscle tissue development,BP,ACTN3;NOTCH1
5329,GO:0090316,0.340598592224744,0.88352785602472,3,7,positive regulation of intracellular protein transport,BP,BMP6;CDH1;BMP4
3941,GO:0048856,0.341188221230862,0.75538304264191,42,133,anatomical structure development,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;SPTB;FZD7;FGF8;VDR;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;FGF17;HRAS;BMP4;GDNF;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1
569,GO:0005105,0.341463586917517,1,1,1,type 1 fibroblast growth factor receptor binding,MF,FGF17
4118,GO:0051148,0.341471414498894,0.88304952450401,3,7,negative regulation of muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
2668,GO:0034614,0.341600898557504,0.920674311625591,2,4,cellular response to reactive oxygen species,BP,BMP7;GUCY1B3
1454,GO:0010976,0.341616438339384,0.920667870281848,2,4,positive regulation of neuron projection development,BP,WNT3;BMP7
4050,GO:0050886,0.341663211602673,0.920648480787272,2,4,endocrine process,BP,BMP6;INHBB
151,GO:0001816,0.34208540275505,0.841427979692821,5,13,cytokine production,BP,PIK3CG;INHBB;CCL20;HRAS;NOTCH1
5641,GO:1901615,0.342519404648403,0.858302771518847,4,10,organic hydroxy compound metabolic process,BP,ACTN3;BMP6;VDR;PNMT
2664,GO:0034599,0.342964349771429,0.882229254014022,3,7,cellular response to oxidative stress,BP,GJB2;BMP7;GUCY1B3
1358,GO:0010631,0.34322339983058,0.827668136711524,6,16,epithelial cell migration,BP,WNT7A;AMOT;PKN3;BMP4;PIK3CA;NOTCH1
522,GO:0004603,0.343267758031957,1,1,1,phenylethanolamine N-methyltransferase activity,MF,PNMT
1106,GO:0008168,0.343267758031957,1,1,1,methyltransferase activity,MF,PNMT
1107,GO:0008170,0.343267758031957,1,1,1,N-methyltransferase activity,MF,PNMT
1173,GO:0008757,0.343267758031957,1,1,1,S-adenosylmethionine-dependent methyltransferase activity,MF,PNMT
1240,GO:0009713,0.343267758031957,1,1,1,catechol-containing compound biosynthetic process,BP,PNMT
1690,GO:0016741,0.343267758031957,1,1,1,transferase activity, transferring one-carbon groups,MF,PNMT
2998,GO:0042414,0.343267758031957,1,1,1,epinephrine metabolic process,BP,PNMT
3000,GO:0042418,0.343267758031957,1,1,1,epinephrine biosynthetic process,BP,PNMT
3001,GO:0042423,0.343267758031957,1,1,1,catecholamine biosynthetic process,BP,PNMT
4567,GO:0060674,0.343322902439231,0.919958851096466,2,4,placenta blood vessel development,BP,HEY1;WNT2
98,GO:0001562,0.34337872208934,1,1,1,response to protozoan,BP,HRAS
1346,GO:0010586,0.34337872208934,1,1,1,miRNA metabolic process,BP,HRAS
2244,GO:0031529,0.34337872208934,1,1,1,ruffle organization,BP,HRAS
2680,GO:0034660,0.34337872208934,1,1,1,ncRNA metabolic process,BP,HRAS
2820,GO:0035900,0.34337872208934,1,1,1,response to isolation stress,BP,HRAS
2942,GO:0042088,0.34337872208934,1,1,1,T-helper 1 type immune response,BP,HRAS
3077,GO:0042832,0.34337872208934,1,1,1,defense response to protozoan,BP,HRAS
3767,GO:0048168,0.34337872208934,1,1,1,regulation of neuronal synaptic plasticity,BP,HRAS
3768,GO:0048169,0.34337872208934,1,1,1,regulation of long-term neuronal synaptic plasticity,BP,HRAS
5385,GO:0097178,0.34337872208934,1,1,1,ruffle assembly,BP,HRAS
5541,GO:1900027,0.34337872208934,1,1,1,regulation of ruffle assembly,BP,HRAS
5542,GO:1900029,0.34337872208934,1,1,1,positive regulation of ruffle assembly,BP,HRAS
6091,GO:2000249,0.34337872208934,1,1,1,regulation of actin cytoskeleton reorganization,BP,HRAS
6092,GO:2000251,0.34337872208934,1,1,1,positive regulation of actin cytoskeleton reorganization,BP,HRAS
6129,GO:2000628,0.34337872208934,1,1,1,regulation of miRNA metabolic process,BP,HRAS
6130,GO:2000630,0.34337872208934,1,1,1,positive regulation of miRNA metabolic process,BP,HRAS
993,GO:0007249,0.343550168374952,0.919864173086652,2,4,I-kappaB kinase/NF-kappaB signaling,BP,TLE1;BMP7
3112,GO:0043122,0.343550168374952,0.919864173086652,2,4,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TLE1;BMP7
2542,GO:0032991,0.343939312215678,0.762797226767068,21,65,macromolecular complex,CC,GLDC;GJB2;PIK3CG;GJA3;WNT3;GJB6;KCNG2;AXIN1;POU3F1;WNT2;CDH1;SPTB;VDR;AMOT;PKP1;KCNK6;RNF144A;PIK3CA;NOTCH1;GUCY1B3;TF
5805,GO:1903169,0.344445445326311,0.919490629308678,2,4,regulation of calcium ion transmembrane transport,BP,PIK3CG;TSPAN13
4479,GO:0060419,0.344570488854729,0.919438383295948,2,4,heart growth,BP,WNT2;NOTCH1
4480,GO:0060420,0.344570488854729,0.919438383295948,2,4,regulation of heart growth,BP,WNT2;NOTCH1
4481,GO:0060421,0.344570488854729,0.919438383295948,2,4,positive regulation of heart growth,BP,WNT2;NOTCH1
3091,GO:0043025,0.344576378736699,0.881340570950301,3,7,neuronal cell body,CC,SYT5;DRP2;SPTBN4
4921,GO:0071229,0.344668038339651,0.839696377886786,5,13,cellular response to acid chemical,BP,WNT3;WNT7B;WNT2;FZD7;WNT5B
1723,GO:0017022,0.344915877592472,0.919293978957825,2,4,myosin binding,MF,SPTBN5;RAB3D
5084,GO:0072074,0.344967530252595,0.919272371627591,2,4,kidney mesenchyme development,BP,BMP4;BMP7
974,GO:0007178,0.345068323615448,0.816079127298304,7,19,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;FGF8;INHBB;BMP4;BMP7;FSTL3;NOTCH1
6088,GO:2000241,0.345150462608871,0.85666049231268,4,10,regulation of reproductive process,BP,INHBB;BMP4;BMP7;NOTCH1
229,GO:0002068,0.34530528043746,0.919131008623087,2,4,glandular epithelial cell development,BP,BMP6;BMP4
465,GO:0003309,0.34530528043746,0.919131008623087,2,4,type B pancreatic cell differentiation,BP,BMP6;BMP4
466,GO:0003323,0.34530528043746,0.919131008623087,2,4,type B pancreatic cell development,BP,BMP6;BMP4
2818,GO:0035883,0.34530528043746,0.919131008623087,2,4,enteroendocrine cell differentiation,BP,BMP6;BMP4
1124,GO:0008233,0.345964899608845,0.918854552157175,2,4,peptidase activity,MF,RHBDL3;PM20D2
4171,GO:0051258,0.346187619908917,0.880449227791382,3,7,protein polymerization,BP,SPTBN5;SPTB;SPTBN4
164,GO:0001839,0.346330182456563,1,1,1,neural plate morphogenesis,BP,FGF8
165,GO:0001840,0.346330182456563,1,1,1,neural plate development,BP,FGF8
1087,GO:0008045,0.346330182456563,1,1,1,motor neuron axon guidance,BP,FGF8
1093,GO:0008078,0.346330182456563,1,1,1,mesodermal cell migration,BP,FGF8
1851,GO:0021544,0.346330182456563,1,1,1,subpallium development,BP,FGF8
1875,GO:0021798,0.346330182456563,1,1,1,forebrain dorsal/ventral pattern formation,BP,FGF8
1887,GO:0021903,0.346330182456563,1,1,1,rostrocaudal neural tube patterning,BP,FGF8
1939,GO:0023019,0.346330182456563,1,1,1,signal transduction involved in regulation of gene expression,BP,FGF8
2147,GO:0030917,0.346330182456563,1,1,1,midbrain-hindbrain boundary development,BP,FGF8
2598,GO:0033563,0.346330182456563,1,1,1,dorsal/ventral axon guidance,BP,FGF8
3804,GO:0048382,0.346330182456563,1,1,1,mesendoderm development,BP,FGF8
5288,GO:0090133,0.346330182456563,1,1,1,mesendoderm migration,BP,FGF8
5289,GO:0090134,0.346330182456563,1,1,1,cell migration involved in mesendoderm migration,BP,FGF8
4662,GO:0061036,0.346363562015859,0.918687224461298,2,4,positive regulation of cartilage development,BP,BMP6;BMP4
2695,GO:0034762,0.346441556171045,0.855851692188011,4,10,regulation of transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
2698,GO:0034765,0.346441556171045,0.855851692188011,4,10,regulation of ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
5518,GO:0099513,0.346478148644122,0.855828741020335,4,10,polymeric cytoskeletal fiber,CC,ACTN3;AMOT;PKP1;RAB3D
6159,GO:2000826,0.346749072263056,0.918525243369046,2,4,regulation of heart morphogenesis,BP,BMP4;NOTCH1
2899,GO:0038093,0.347908438238578,0.918037079009807,2,4,Fc receptor signaling pathway,BP,HRAS;PIK3CA
2901,GO:0038095,0.347908438238578,0.918037079009807,2,4,Fc-epsilon receptor signaling pathway,BP,HRAS;PIK3CA
728,GO:0005996,0.347946184026404,0.879472849341044,3,7,monosaccharide metabolic process,BP,ACTN3;PMAIP1;PIK3CA
1788,GO:0019318,0.347946184026404,0.879472849341044,3,7,hexose metabolic process,BP,ACTN3;PMAIP1;PIK3CA
197,GO:0001947,0.349002087742156,0.917575166892881,2,4,heart looping,BP,FGF8;NOTCH1
4734,GO:0061371,0.349002087742156,0.917575166892881,2,4,determination of heart left/right asymmetry,BP,FGF8;NOTCH1
190,GO:0001935,0.34921024859527,0.878768740958163,3,7,endothelial cell proliferation,BP,BMP6;WNT2;BMP4
191,GO:0001936,0.34921024859527,0.878768740958163,3,7,regulation of endothelial cell proliferation,BP,BMP6;WNT2;BMP4
192,GO:0001938,0.34921024859527,0.878768740958163,3,7,positive regulation of endothelial cell proliferation,BP,BMP6;WNT2;BMP4
3321,GO:0044297,0.349616072791506,0.853854864205109,4,10,cell body,CC,GJB2;SYT5;DRP2;SPTBN4
5228,GO:0072678,0.35013509995596,0.91709517501753,2,4,T cell migration,BP,PIK3CG;CCL20
5109,GO:0072110,0.350453182135467,0.916960155517396,2,4,glomerular mesangial cell proliferation,BP,BMP4;BMP7
5112,GO:0072124,0.350453182135467,0.916960155517396,2,4,regulation of glomerular mesangial cell proliferation,BP,BMP4;BMP7
5307,GO:0090192,0.350453182135467,0.916960155517396,2,4,regulation of glomerulus development,BP,BMP4;BMP7
5660,GO:1901722,0.350453182135467,0.916960155517396,2,4,regulation of cell proliferation involved in kidney development,BP,BMP4;BMP7
3856,GO:0048593,0.350543765359478,0.878023874245963,3,7,camera-type eye morphogenesis,BP,WNT2;BMP4;BMP7
3192,GO:0043405,0.350572196054043,0.812046834166748,7,19,regulation of MAP kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;BMP7
2594,GO:0033554,0.350635627862313,0.780364649987996,12,35,cellular response to stress,BP,WNT7A;GJB2;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;INHBB;HRAS;BMP7;NOTCH1;GUCY1B3
225,GO:0002064,0.350667245961462,0.822403658833462,6,16,epithelial cell development,BP,WNT7A;BMP6;WNT7B;WNT5B;BMP4;NOTCH1
3249,GO:0043583,0.351252983221793,0.821986939481053,6,16,ear development,BP,GJB2;GJB6;JAG2;FGF8;BMP4;NOTCH1
1378,GO:0010675,0.351422951297803,0.916547786215039,2,4,regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
1435,GO:0010906,0.351422951297803,0.916547786215039,2,4,regulation of glucose metabolic process,BP,ACTN3;PMAIP1
1127,GO:0008270,0.351701475025365,0.852536782562116,4,10,zinc ion binding,MF,RABIF;VDR;RNF144A;DRP2
883,GO:0006875,0.351814005357362,0.85246551479859,4,10,cellular metal ion homeostasis,BP,PIK3CG;BMP6;VDR;TF
412,GO:0003170,0.351976485647569,0.87722122150917,3,7,heart valve development,BP,HEY1;BMP4;NOTCH1
418,GO:0003179,0.351976485647569,0.87722122150917,3,7,heart valve morphogenesis,BP,HEY1;BMP4;NOTCH1
1079,GO:0008009,0.35199227377266,1,1,1,chemokine activity,MF,CCL20
2278,GO:0031731,0.35199227377266,1,1,1,CCR6 chemokine receptor binding,MF,CCL20
2445,GO:0032610,0.35199227377266,1,1,1,interleukin-1 alpha production,BP,CCL20
2457,GO:0032650,0.35199227377266,1,1,1,regulation of interleukin-1 alpha production,BP,CCL20
2475,GO:0032730,0.35199227377266,1,1,1,positive regulation of interleukin-1 alpha production,BP,CCL20
2771,GO:0035584,0.35199227377266,1,1,1,calcium-mediated signaling using intracellular calcium source,BP,CCL20
2968,GO:0042222,0.35199227377266,1,1,1,interleukin-1 biosynthetic process,BP,CCL20
2995,GO:0042379,0.35199227377266,1,1,1,chemokine receptor binding,MF,CCL20
3477,GO:0045360,0.35199227377266,1,1,1,regulation of interleukin-1 biosynthetic process,BP,CCL20
3478,GO:0045362,0.35199227377266,1,1,1,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
3753,GO:0048020,0.35199227377266,1,1,1,CCR chemokine receptor binding,MF,CCL20
3984,GO:0050719,0.35199227377266,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
3985,GO:0050721,0.35199227377266,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
3986,GO:0050726,0.35199227377266,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
4271,GO:0051770,0.35199227377266,1,1,1,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
4845,GO:0070391,0.35199227377266,1,1,1,response to lipoteichoic acid,BP,CCL20
4920,GO:0071223,0.35199227377266,1,1,1,cellular response to lipoteichoic acid,BP,CCL20
5229,GO:0072679,0.35199227377266,1,1,1,thymocyte migration,BP,CCL20
4088,GO:0051046,0.352384088217365,0.802216645920051,8,22,regulation of secretion,BP,SYT5;BMP6;KCNG2;WNK4;INHBB;RAB3D;GDNF;NOTCH1
2230,GO:0031401,0.352582269246022,0.768669816107082,15,44,positive regulation of protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
2221,GO:0031346,0.352977259705829,0.876659097794373,3,7,positive regulation of cell projection organization,BP,WNT3;HRAS;BMP7
808,GO:0006508,0.353045499783096,0.820709422176974,6,16,proteolysis,BP,RHBDL3;PMAIP1;AXIN1;MAPK12;RNF144A;PM20D2
4361,GO:0060021,0.354150331103049,0.915382199975361,2,4,palate development,BP,WNT7A;JAG2
1668,GO:0016567,0.354229489759103,0.850932210299376,4,10,protein ubiquitination,BP,MAGEC2;AXIN1;RAB40B;RNF144A
2414,GO:0032446,0.354229489759103,0.850932210299376,4,10,protein modification by small protein conjugation,BP,MAGEC2;AXIN1;RAB40B;RNF144A
1075,GO:0007626,0.354871280695907,0.915072649013648,2,4,locomotory behavior,BP,GDNF;SPTBN4
3549,GO:0045747,0.354881994089678,0.915068044495255,2,4,positive regulation of Notch signaling pathway,BP,JAG2;NOTCH1
4796,GO:0070169,0.355406252939745,0.875289757038697,3,7,positive regulation of biomineral tissue development,BP,BMP6;BMP4;BMP7
3588,GO:0045913,0.355480088320615,0.91481077732794,2,4,positive regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1
603,GO:0005249,0.355530730247031,0.914788974851498,2,4,voltage-gated potassium channel activity,MF,KCNG2;KCNK6
610,GO:0005267,0.355530730247031,0.914788974851498,2,4,potassium channel activity,MF,KCNG2;KCNK6
1092,GO:0008076,0.355530730247031,0.914788974851498,2,4,voltage-gated potassium channel complex,CC,KCNG2;KCNK6
1530,GO:0015077,0.355530730247031,0.914788974851498,2,4,monovalent inorganic cation transmembrane transporter activity,MF,KCNG2;KCNK6
1531,GO:0015079,0.355530730247031,0.914788974851498,2,4,potassium ion transmembrane transporter activity,MF,KCNG2;KCNK6
2691,GO:0034705,0.355530730247031,0.914788974851498,2,4,potassium channel complex,CC,KCNG2;KCNK6
5843,GO:1903530,0.355858872918017,0.808144935687578,7,19,regulation of secretion by cell,BP,SYT5;BMP6;KCNG2;INHBB;RAB3D;GDNF;NOTCH1
88,GO:0001504,0.356430983114523,1,1,1,neurotransmitter uptake,BP,GDNF
206,GO:0001963,0.356430983114523,1,1,1,synaptic transmission, dopaminergic,BP,GDNF
1476,GO:0014046,0.356430983114523,1,1,1,dopamine secretion,BP,GDNF
1480,GO:0014059,0.356430983114523,1,1,1,regulation of dopamine secretion,BP,GDNF
1577,GO:0015872,0.356430983114523,1,1,1,dopamine transport,BP,GDNF
1873,GO:0021784,0.356430983114523,1,1,1,postganglionic parasympathetic fiber development,BP,GDNF
2054,GO:0030432,0.356430983114523,1,1,1,peristalsis,BP,GDNF
2340,GO:0032225,0.356430983114523,1,1,1,regulation of synaptic transmission, dopaminergic,BP,GDNF
2602,GO:0033603,0.356430983114523,1,1,1,positive regulation of dopamine secretion,BP,GDNF
2604,GO:0033605,0.356430983114523,1,1,1,positive regulation of catecholamine secretion,BP,GDNF
3217,GO:0043489,0.356430983114523,1,1,1,RNA stabilization,BP,GDNF
3782,GO:0048255,0.356430983114523,1,1,1,mRNA stabilization,BP,GDNF
3814,GO:0048483,0.356430983114523,1,1,1,autonomic nervous system development,BP,GDNF
3815,GO:0048484,0.356430983114523,1,1,1,enteric nervous system development,BP,GDNF
3816,GO:0048485,0.356430983114523,1,1,1,sympathetic nervous system development,BP,GDNF
3817,GO:0048486,0.356430983114523,1,1,1,parasympathetic nervous system development,BP,GDNF
4237,GO:0051580,0.356430983114523,1,1,1,regulation of neurotransmitter uptake,BP,GDNF
4238,GO:0051583,0.356430983114523,1,1,1,dopamine uptake involved in synaptic transmission,BP,GDNF
4239,GO:0051584,0.356430983114523,1,1,1,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
4240,GO:0051588,0.356430983114523,1,1,1,regulation of neurotransmitter transport,BP,GDNF
4298,GO:0051934,0.356430983114523,1,1,1,catecholamine uptake involved in synaptic transmission,BP,GDNF
4300,GO:0051940,0.356430983114523,1,1,1,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
4303,GO:0051954,0.356430983114523,1,1,1,positive regulation of amine transport,BP,GDNF
4569,GO:0060676,0.356430983114523,1,1,1,ureteric bud formation,BP,GDNF
5105,GO:0072106,0.356430983114523,1,1,1,regulation of ureteric bud formation,BP,GDNF
5106,GO:0072107,0.356430983114523,1,1,1,positive regulation of ureteric bud formation,BP,GDNF
5134,GO:0072172,0.356430983114523,1,1,1,mesonephric tubule formation,BP,GDNF
5341,GO:0090493,0.356430983114523,1,1,1,catecholamine uptake,BP,GDNF
5342,GO:0090494,0.356430983114523,1,1,1,dopamine uptake,BP,GDNF
5486,GO:0098810,0.356430983114523,1,1,1,neurotransmitter reuptake,BP,GDNF
5966,GO:1905278,0.356430983114523,1,1,1,positive regulation of epithelial tube formation,BP,GDNF
1933,GO:0022857,0.357026244875791,0.817860271954149,6,16,transmembrane transporter activity,MF,SLC2A14;GJB2;GJA3;KCNG2;KCNK6;TF
2932,GO:0042035,0.35735205828629,0.914002866885488,2,4,regulation of cytokine biosynthetic process,BP,INHBB;CCL20
2943,GO:0042089,0.35735205828629,0.914002866885488,2,4,cytokine biosynthetic process,BP,INHBB;CCL20
2949,GO:0042107,0.35735205828629,0.914002866885488,2,4,cytokine metabolic process,BP,INHBB;CCL20
3976,GO:0050708,0.35736668456322,0.874179391878446,3,7,regulation of protein secretion,BP,BMP6;KCNG2;INHBB
2154,GO:0031012,0.357780555606031,0.806719631189415,7,19,extracellular matrix,CC,WNT7A;WNT3;WNT7B;WNT2;WNT5B;BMP4;BMP7
1262,GO:0009892,0.358124064815228,0.763635757377688,15,45,negative regulation of metabolic process,BP,TLE1;PIK3CG;ACTN3;BMP6;HEY1;AXIN1;VDR;DUSP5;INHBB;PKP1;HRAS;BMP4;PIK3CA;BMP7;NOTCH1
2074,GO:0030545,0.358534884516454,0.873515535535565,3,7,receptor regulator activity,MF,WNT7A;WNT3;WNT2
2075,GO:0030546,0.358534884516454,0.873515535535565,3,7,receptor activator activity,MF,WNT7A;WNT3;WNT2
2904,GO:0038128,0.358768989625827,0.913388625039712,2,4,ERBB2 signaling pathway,BP,HRAS;PIK3CA
938,GO:0007033,0.358957398546424,0.913306772765284,2,4,vacuole organization,BP,RAB39A;RAB20
3780,GO:0048247,0.359378993915636,0.913123464675971,2,4,lymphocyte chemotaxis,BP,PIK3CG;CCL20
4253,GO:0051648,0.359791409779585,0.872799648414214,3,7,vesicle localization,BP,WNT7A;PIK3CG;SYT5
6065,GO:2000113,0.360245947836195,0.794909815925052,8,23,negative regulation of cellular macromolecule biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
1397,GO:0010769,0.360443655946696,0.912659627376342,2,4,regulation of cell morphogenesis involved in differentiation,BP,WNT7A;WNT3
2985,GO:0042326,0.361272504396125,0.846422862490368,4,10,negative regulation of phosphorylation,BP,ACTN3;DUSP5;BMP4;BMP7
1267,GO:0009897,0.362230812858826,0.871404386795651,3,7,external side of plasma membrane,CC,FGF8;AMOT;TF
699,GO:0005886,0.362387384220342,0.737475552390938,43,137,plasma membrane,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;PIK3CG;SYT5;CLDN18;GJA3;WNT3;GJB6;WNT7B;JAG2;KCNG2;AXIN1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;RAB39A;DSG3;AMOT;WNT5B;PKP1;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;RNF144A;RAB38;PIK3CA;DRP2;SPTBN4;TSPAN13;NOTCH1;RAB20;GUCY1B3;TF
42,GO:0000323,0.363983815663883,0.84467156927722,4,10,lytic vacuole,CC,PIK3CG;RAB39A;RAB3D;RAB38
662,GO:0005764,0.363983815663883,0.84467156927722,4,10,lysosome,CC,PIK3CG;RAB39A;RAB3D;RAB38
4089,GO:0051047,0.363991338034322,0.844666698519974,4,10,positive regulation of secretion,BP,BMP6;INHBB;RAB3D;GDNF
5420,GO:0097479,0.36437577920462,0.910935002638298,2,4,synaptic vesicle localization,BP,WNT7A;SYT5
667,GO:0005770,0.364819267134154,0.910739347395858,2,4,late endosome,CC,TSPAN15;TF
1274,GO:0009948,0.36529044305419,0.910531222718122,2,4,anterior/posterior axis specification,BP,WNT3;BMP4
682,GO:0005796,0.367357307155482,0.842480607751785,4,10,Golgi lumen,CC,WNT7A;WNT3;WNT7B;WNT5B
3736,GO:0046983,0.367838485668324,0.776018553840699,10,29,protein dimerization activity,MF,GLDC;SYT5;ACTN3;BMP6;HEY1;AXIN1;INHBB;GDNF;TPD52;NOTCH1
927,GO:0007005,0.368567273194414,0.909076543380073,2,4,mitochondrion organization,BP,PMAIP1;RAB38
3360,GO:0044444,0.369000394691565,0.733272543900488,46,147,cytoplasmic part,CC,MAGEC2;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;WNT3;GJB6;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;RAB39A;DSG3;AMOT;WNT5B;WNK4;INHBB;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
4337,GO:0055038,0.369762194155151,0.908542917139307,2,4,recycling endosome membrane,CC,SYT5;FZD7
894,GO:0006898,0.369909910371663,0.908476832424978,2,4,receptor-mediated endocytosis,BP,SYT5;TF
2703,GO:0035004,0.37053651840583,0.840403668178193,4,10,phosphatidylinositol 3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
3652,GO:0046488,0.37053651840583,0.840403668178193,4,10,phosphatidylinositol metabolic process,BP,PIK3CG;FGF8;FGF17;PIK3CA
3696,GO:0046834,0.37053651840583,0.840403668178193,4,10,lipid phosphorylation,BP,PIK3CG;FGF8;FGF17;PIK3CA
3702,GO:0046854,0.37053651840583,0.840403668178193,4,10,phosphatidylinositol phosphorylation,BP,PIK3CG;FGF8;FGF17;PIK3CA
3727,GO:0046934,0.37053651840583,0.840403668178193,4,10,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
4318,GO:0052813,0.37053651840583,0.840403668178193,4,10,phosphatidylinositol bisphosphate kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA
171,GO:0001882,0.370804974748517,0.780795811196406,9,25,nucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
172,GO:0001883,0.370804974748517,0.780795811196406,9,25,purine nucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
5319,GO:0090263,0.371202837377616,0.86621056640627,3,7,positive regulation of canonical Wnt signaling pathway,BP,WNT7A;AXIN1;WNT2
4522,GO:0060513,0.371916861658363,0.907576397432936,2,4,prostatic bud formation,BP,BMP4;BMP7
4552,GO:0060601,0.371916861658363,0.907576397432936,2,4,lateral sprouting from an epithelium,BP,BMP4;BMP7
4340,GO:0055067,0.372137725890109,0.86566372745499,3,7,monovalent inorganic cation homeostasis,BP,RAB39A;RAB38;RAB20
3378,GO:0044703,0.372145691436726,0.772564874866074,10,29,multi-organism reproductive process,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;SPTBN4;NOTCH1
2984,GO:0042325,0.372573431780576,0.748861222289367,16,48,regulation of phosphorylation,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
2522,GO:0032924,0.372654953520338,0.907244039292599,2,4,activin receptor signaling pathway,BP,INHBB;FSTL3
5087,GO:0072077,0.372935371801215,0.907117598257438,2,4,renal vesicle morphogenesis,BP,BMP4;GDNF
5091,GO:0072087,0.372935371801215,0.907117598257438,2,4,renal vesicle development,BP,BMP4;GDNF
4198,GO:0051341,0.373611295757502,0.906812437013459,2,4,regulation of oxidoreductase activity,BP,VDR;GDNF
4203,GO:0051353,0.373611295757502,0.906812437013459,2,4,positive regulation of oxidoreductase activity,BP,VDR;GDNF
5744,GO:1902589,0.37469228210216,0.756252138129079,13,39,single-organism organelle organization,BP,SYT5;PMAIP1;AXIN1;SPTBN5;SPTB;RAB39A;AMOT;PKP1;HRAS;SPTBN4;NOTCH1;RND3;RAB20
1233,GO:0009617,0.375492007429299,0.818461615495518,5,13,response to bacterium,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
2706,GO:0035019,0.375705115024259,0.90586366542688,2,4,somatic stem cell population maintenance,BP,WNT7A;BMP7
4172,GO:0051259,0.375842654729835,0.836910887168912,4,10,protein oligomerization,BP,PMAIP1;KCNG2;SPTBN5;HRAS
2673,GO:0034641,0.376586136720064,0.73351047447112,22,68,cellular nitrogen compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;NOTCH1;GUCY1B3
796,GO:0006469,0.376671332673326,0.862996738755306,3,7,negative regulation of protein kinase activity,BP,DUSP5;BMP4;BMP7
2610,GO:0033673,0.376671332673326,0.862996738755306,3,7,negative regulation of kinase activity,BP,DUSP5;BMP4;BMP7
4202,GO:0051348,0.376671332673326,0.862996738755306,3,7,negative regulation of transferase activity,BP,DUSP5;BMP4;BMP7
4528,GO:0060537,0.376927430990642,0.790609084714866,7,20,muscle tissue development,BP,ACTN3;WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
3013,GO:0042476,0.377438532411549,0.835853933910627,4,10,odontogenesis,BP,JAG2;FGF8;BMP4;BMP7
2813,GO:0035850,0.377482779461688,0.862516728269254,3,7,epithelial cell differentiation involved in kidney development,BP,BMP4;GDNF;NOTCH1
1848,GO:0021536,0.378140581852707,0.862127011999828,3,7,diencephalon development,BP,CDH1;FGF8;BMP4
1895,GO:0021983,0.378140581852707,0.862127011999828,3,7,pituitary gland development,BP,CDH1;FGF8;BMP4
1969,GO:0030072,0.378245835675454,0.904705326216713,2,4,peptide hormone secretion,BP,KCNG2;INHBB
3288,GO:0044087,0.378408344398633,0.780817156727504,8,23,regulation of cellular component biogenesis,BP,WNT7A;PMAIP1;SPTBN5;SPTB;HRAS;BMP7;SPTBN4;NOTCH1
1808,GO:0019722,0.379361400029245,0.904194275578335,2,4,calcium-mediated signaling,BP,ACTN3;CCL20
1352,GO:0010608,0.379872074951829,0.903959829795358,2,4,posttranscriptional regulation of gene expression,BP,BMP4;GDNF
4720,GO:0061333,0.380077396449207,0.834099636947937,4,10,renal tubule morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
5088,GO:0072078,0.380077396449207,0.834099636947937,4,10,nephron tubule morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
109,GO:0001655,0.380154861474483,0.772217277548346,9,26,urogenital system development,BP,BMP6;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5058,GO:0072001,0.380154861474483,0.772217277548346,9,26,renal system development,BP,BMP6;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
310,GO:0002521,0.380274191884775,0.798709389616839,6,17,leukocyte differentiation,BP,CLDN18;JAG2;FZD7;BMP4;FSTL3;TPD52
1036,GO:0007431,0.380586229115469,0.903631440649002,2,4,salivary gland development,BP,FGF8;BMP7
1037,GO:0007435,0.380586229115469,0.903631440649002,2,4,salivary gland morphogenesis,BP,FGF8;BMP7
2740,GO:0035272,0.380586229115469,0.903631440649002,2,4,exocrine system development,BP,FGF8;BMP7
4502,GO:0060445,0.380586229115469,0.903631440649002,2,4,branching involved in salivary gland morphogenesis,BP,FGF8;BMP7
1175,GO:0009056,0.380907700048359,0.764587741438169,10,30,catabolic process,BP,MAGEC2;GLDC;PIK3CG;ACTN3;PMAIP1;AXIN1;RAB39A;PKP1;RNF144A;PIK3CA
2525,GO:0032940,0.382043692154121,0.754723302605772,12,35,secretion by cell,BP,WNT7A;PIK3CG;SYT5;BMP6;KCNG2;RAB40B;INHBB;PKP1;RAB3D;GDNF;NOTCH1;TF
5392,GO:0097190,0.382155662830538,0.813732308277373,5,13,apoptotic signaling pathway,BP,PMAIP1;INHBB;HRAS;BMP4;GDNF
468,GO:0003338,0.384276722927754,0.858465954622552,3,7,metanephros morphogenesis,BP,WNT7B;BMP4;GDNF
675,GO:0005783,0.384718320241556,0.768557135317263,9,26,endoplasmic reticulum,CC,WNT7A;MBOAT2;WNT3;WNT7B;RRAS2;WNT5B;RAB38;TPD52;NOTCH1
500,GO:0003924,0.386010132790595,0.776242841271046,8,22,GTPase activity,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20
93,GO:0001525,0.386474442277152,0.774455964718962,8,23,angiogenesis,BP,WNT7A;PIK3CG;HEY1;FGF8;AMOT;BMP4;PIK3CA;NOTCH1
3273,GO:0043933,0.386780984867626,0.774212968277937,8,23,macromolecular complex subunit organization,BP,TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
5033,GO:0071822,0.386780984867626,0.774212968277937,8,23,protein complex subunit organization,BP,TLE1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;SPTBN4
4458,GO:0060349,0.387352163605729,0.900489581944331,2,4,bone morphogenesis,BP,BMP6;BMP4
4459,GO:0060350,0.387352163605729,0.900489581944331,2,4,endochondral bone morphogenesis,BP,BMP6;BMP4
187,GO:0001932,0.387493989864853,0.738936039382643,15,45,regulation of protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
1965,GO:0030054,0.387708528494288,0.73060226915747,18,56,cell junction,CC,TJP3;GJB2;SYT5;ACTN3;CLDN18;GJA3;GJB6;CDH1;RRAS2;DSG3;AMOT;WNK4;PKP1;CLDN15;DRP2;SPTBN4;NOTCH1;RND3
4306,GO:0051960,0.388467375975604,0.781698302736096,7,20,regulation of nervous system development,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
2951,GO:0042110,0.388921848471009,0.805936136496839,5,14,T cell activation,BP,PIK3CG;JAG2;FZD7;BMP4;PIK3CA
4705,GO:0061217,0.389250691449765,0.899597950572173,2,4,regulation of mesonephros development,BP,BMP4;GDNF
4498,GO:0060441,0.390993926495627,0.89877536165921,2,4,epithelial tube branching involved in lung morphogenesis,BP,WNT2;BMP4
2072,GO:0030539,0.391033728970075,0.898756536298262,2,4,male genitalia development,BP,BMP6;FGF8
2742,GO:0035295,0.39104658990843,0.74652223403481,12,36,tube development,BP,WNT7A;CLDN18;WNT7B;WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1357,GO:0010629,0.393003774411721,0.754679617181599,10,30,negative regulation of gene expression,BP,TLE1;BMP6;HEY1;AXIN1;VDR;PKP1;HRAS;BMP4;BMP7;NOTCH1
1103,GO:0008150,0.395446088018546,0.81920814464225,70,228,biological_process,BP,MAGEC2;SLC2A14;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RHBDL3;CLDN18;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF;PM20D2
3875,GO:0048646,0.396360993032024,0.730883652503334,15,46,anatomical structure formation involved in morphogenesis,BP,WNT7A;PIK3CG;WNT3;HEY1;AXIN1;WNT2;FZD7;FGF8;AMOT;DUSP5;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
4435,GO:0060284,0.397991474244127,0.765263541270003,8,23,regulation of cell development,BP,WNT7A;CLDN18;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
5731,GO:1902494,0.401659228420459,0.815144822200461,4,11,catalytic complex,CC,GLDC;PIK3CG;RNF144A;PIK3CA
3121,GO:0043168,0.402761765508536,0.712047364721917,21,65,anion binding,MF,GLDC;PIK3CG;SYT5;MAPK12;RAB40B;RRAS2;FZD7;VDR;RAB39A;WNK4;PKN3;HRAS;RAB3D;BMP4;RAB38;PIK3CA;BMP7;SPTBN4;RND3;RAB20;GUCY1B3
1176,GO:0009057,0.405461488858837,0.793723721156132,5,14,macromolecule catabolic process,BP,MAGEC2;PMAIP1;AXIN1;PKP1;RNF144A
690,GO:0005829,0.405826255153035,0.704942529636962,24,76,cytosol,CC,MAGEC2;RHPN1;TLE1;GJB2;PIK3CG;ACTN3;RABIF;GJB6;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;RAB39A;DSG3;AMOT;WNK4;HRAS;RAB38;PIK3CA;SPTBN4;NOTCH1;PNMT;GUCY1B3
1165,GO:0008610,0.406573692954938,0.767444552279457,7,20,lipid biosynthetic process,BP,PIK3CG;MBOAT2;BMP6;FGF8;VDR;FGF17;PIK3CA
3174,GO:0043296,0.410524550519524,0.775590396962428,6,17,apical junction complex,CC,TJP3;CLDN18;CDH1;AMOT;WNK4;CLDN15
1450,GO:0010959,0.411862673369483,0.807895620022914,4,11,regulation of metal ion transport,BP,PIK3CG;WNK4;SPTBN4;TSPAN13
3287,GO:0044085,0.413458627021818,0.708071535965935,18,56,cellular component biogenesis,BP,TLE1;WNT7A;GJB2;ACTN3;PMAIP1;KCNG2;AXIN1;SPTBN5;CDH1;SPTB;RAB39A;PKP1;HRAS;RAB38;BMP7;SPTBN4;NOTCH1;RAB20
326,GO:0002683,0.414370004386111,0.806095036138316,4,11,negative regulation of immune system process,BP,CLDN18;BMP4;FSTL3;NOTCH1
2675,GO:0034645,0.41483700984688,0.706851477238142,18,56,cellular macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;MAPK12;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;HRAS;BMP4;GDNF;BMP7;FSTL3;NOTCH1
4842,GO:0070374,0.416086036791338,0.809333769882191,4,10,positive regulation of ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4
5947,GO:1904951,0.417230488929047,0.804031543545187,4,11,positive regulation of establishment of protein localization,BP,BMP6;PMAIP1;CDH1;BMP4
4773,GO:0065008,0.420383851324506,0.689831866139364,26,82,regulation of biological quality,BP,WNT7A;PIK3CG;SYT5;CLDN18;BMP6;WNT3;GJB6;WNT7B;PMAIP1;KCNG2;SPTBN5;SPTB;VDR;RAB39A;WNK4;INHBB;HRAS;RAB3D;BMP4;KCNK6;GDNF;RAB38;PIK3CA;SPTBN4;RAB20;TF
2670,GO:0034622,0.421744461970264,0.800755035725892,4,11,cellular macromolecular complex assembly,BP,AXIN1;SPTBN5;SPTB;SPTBN4
3260,GO:0043623,0.421744461970264,0.800755035725892,4,11,cellular protein complex assembly,BP,AXIN1;SPTBN5;SPTB;SPTBN4
4354,GO:0055114,0.422082499670929,0.82769099644512,3,8,oxidation-reduction process,BP,GLDC;ACTN3;PIK3CA
309,GO:0002520,0.42460872770142,0.742151330431618,8,24,immune system development,BP,CLDN18;JAG2;FZD7;ARTN;BMP4;FSTL3;TPD52;NOTCH1
3835,GO:0048534,0.42460872770142,0.742151330431618,8,24,hematopoietic or lymphoid organ development,BP,CLDN18;JAG2;FZD7;ARTN;BMP4;FSTL3;TPD52;NOTCH1
648,GO:0005623,0.424744119341903,0.778989148447758,69,225,cell,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;FSTL3;TMEM206;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF;PM20D2
3371,GO:0044464,0.424744119341903,0.778989148447758,69,225,cell part,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;FSTL3;TMEM206;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF;PM20D2
4117,GO:0051147,0.425181028966712,0.798243915099703,4,11,regulation of muscle cell differentiation,BP,MAPK12;FZD7;BMP4;NOTCH1
5278,GO:0090090,0.426776373818928,0.824530363119451,3,8,negative regulation of canonical Wnt signaling pathway,BP,AXIN1;WNT5B;NOTCH1
3193,GO:0043406,0.427233970630189,0.777174506858616,5,14,positive regulation of MAP kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS
2569,GO:0033135,0.42926330985148,0.822844096705643,3,8,regulation of peptidyl-serine phosphorylation,BP,AXIN1;PIK3CA;SPTBN4
2739,GO:0035270,0.430856003776396,0.774368678823561,5,14,endocrine system development,BP,BMP6;CDH1;FGF8;BMP4;FSTL3
5558,GO:1900182,0.431104853832905,0.821590204831879,3,8,positive regulation of protein localization to nucleus,BP,BMP6;CDH1;BMP4
1100,GO:0008134,0.431320749144546,0.821442911334633,3,8,transcription factor binding,MF,TLE1;HEY1;VDR
4152,GO:0051222,0.43184654723222,0.821083931410165,3,8,positive regulation of protein transport,BP,BMP6;CDH1;BMP4
4538,GO:0060563,0.431991706816343,0.820984761950997,3,8,neuroepithelial cell differentiation,BP,JAG2;FGF8;NOTCH1
1294,GO:0010038,0.432804160478467,0.792621978561953,4,11,response to metal ion,BP,BMP6;CDH1;FSTL3;TF
2393,GO:0032388,0.432822563827157,0.820416606320389,3,8,positive regulation of intracellular transport,BP,BMP6;CDH1;BMP4
4893,GO:0070838,0.433466997679366,0.792129767541735,4,11,divalent metal ion transport,BP,PIK3CG;VDR;TSPAN13;TF
5201,GO:0072511,0.433466997679366,0.792129767541735,4,11,divalent inorganic cation transport,BP,PIK3CG;VDR;TSPAN13;TF
4872,GO:0070647,0.433763651986707,0.791909301719315,4,11,protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1;RAB40B;RNF144A
317,GO:0002573,0.435498061517458,0.818580857225567,3,8,myeloid leukocyte differentiation,BP,CLDN18;BMP4;FSTL3
4319,GO:0055001,0.437551721339682,0.817165344825212,3,8,muscle cell development,BP,AXIN1;BMP4;NOTCH1
1048,GO:0007548,0.438241894384101,0.768600112666217,5,14,sex differentiation,BP,WNT7A;BMP6;FGF8;INHBB;FSTL3
1000,GO:0007264,0.439299615580157,0.75268428830064,6,17,small GTPase mediated signal transduction,BP,RABIF;RRAS2;AMOT;HRAS;RAB38;RND3
2219,GO:0031344,0.439937209508291,0.787296560790198,4,11,regulation of cell projection organization,BP,WNT7A;WNT3;HRAS;BMP7
5697,GO:1902105,0.440012206587178,0.815462049391901,3,8,regulation of leukocyte differentiation,BP,CLDN18;BMP4;FSTL3
2955,GO:0042127,0.44027235182808,0.692332293983646,15,46,regulation of cell proliferation,BP,WNT7A;BMP6;WNT3;GJB6;JAG2;WNT2;FZD7;FGF8;VDR;FGF17;HRAS;BMP4;GDNF;BMP7;NOTCH1
6079,GO:2000181,0.440979253103574,0.8585492466212,2,5,negative regulation of blood vessel morphogenesis,BP,AMOT;NOTCH1
445,GO:0003231,0.441703703367826,0.814286419108359,3,8,cardiac ventricle development,BP,HEY1;BMP4;NOTCH1
455,GO:0003281,0.441703703367826,0.814286419108359,3,8,ventricular septum development,BP,HEY1;BMP4;NOTCH1
1129,GO:0008283,0.441704513875537,0.682784572590416,18,56,cell proliferation,BP,WNT7A;PIK3CG;BMP6;WNT3;GJB6;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;ARTN;FGF17;HRAS;BMP4;GDNF;BMP7;NOTCH1
99,GO:0001568,0.442465963830779,0.706341652025709,11,34,blood vessel development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
94,GO:0001533,0.443094332225445,0.857296992554755,2,5,cornified envelope,CC,DSG3;PKP1
2233,GO:0031424,0.443094332225445,0.857296992554755,2,5,keratinization,BP,DSG3;PKP1
4816,GO:0070268,0.443094332225445,0.857296992554755,2,5,cornification,BP,DSG3;PKP1
1281,GO:0009968,0.444973775987214,0.704136463932677,11,34,negative regulation of signal transduction,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;BMP4;GDNF;BMP7;FSTL3;NOTCH1
2303,GO:0031982,0.445301399919825,0.663914320621436,30,96,vesicle,CC,WNT7A;SYT5;ACTN3;BMP6;WNT3;WNT7B;KCNG2;AXIN1;SPTBN5;CDH1;RAB40B;RRAS2;FZD7;RAB39A;DSG3;AMOT;WNT5B;PKP1;TSPAN15;RAB3D;RNF144A;RAB38;BMP7;FSTL3;SPTBN4;NOTCH1;RND3;RAB20;TF;PM20D2
698,GO:0005884,0.445952371554813,0.855594813887523,2,5,actin filament,CC,ACTN3;AMOT
189,GO:0001934,0.445959886363792,0.69052731141283,14,43,positive regulation of protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
2986,GO:0042327,0.445959886363792,0.69052731141283,14,43,positive regulation of phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
4370,GO:0060039,0.446556573024812,0.855233482653639,2,5,pericardium development,BP,BMP7;NOTCH1
263,GO:0002275,0.446856825182933,0.810681303161695,3,8,myeloid cell activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
300,GO:0002444,0.446856825182933,0.810681303161695,3,8,myeloid leukocyte mediated immunity,BP,PIK3CG;PKP1;RAB3D
3176,GO:0043299,0.446856825182933,0.810681303161695,3,8,leukocyte degranulation,BP,PIK3CG;PKP1;RAB3D
5642,GO:1901617,0.446914866932688,0.810640494460726,3,8,organic hydroxy compound biosynthetic process,BP,BMP6;VDR;PNMT
3539,GO:0045732,0.447036927381042,0.85494584552399,2,5,positive regulation of protein catabolic process,BP,AXIN1;RNF144A
1268,GO:0009898,0.4470999177959,0.854908102395856,2,5,cytoplasmic side of plasma membrane,CC,CDH1;SPTB
5447,GO:0098562,0.4470999177959,0.854908102395856,2,5,cytoplasmic side of membrane,CC,CDH1;SPTB
3471,GO:0045296,0.448921317941545,0.853814295798338,2,5,cadherin binding,MF,CDH1;MB21D2
3230,GO:0043534,0.449004197109541,0.853764411773767,2,5,blood vessel endothelial cell migration,BP,AMOT;NOTCH1
669,GO:0005773,0.449214791439935,0.780275370388203,4,11,vacuole,CC,PIK3CG;RAB39A;RAB3D;RAB38
4324,GO:0055008,0.450500668535249,0.852862013971402,2,5,cardiac muscle tissue morphogenesis,BP,WNT2;NOTCH1
4477,GO:0060415,0.450500668535249,0.852862013971402,2,5,muscle tissue morphogenesis,BP,WNT2;NOTCH1
5946,GO:1904950,0.45166796417496,0.852155889437767,2,5,negative regulation of establishment of protein localization,BP,INHBB;BMP7
1935,GO:0022891,0.451709131395312,0.778369284286366,4,11,substrate-specific transmembrane transporter activity,MF,SLC2A14;KCNG2;KCNK6;TF
1936,GO:0022892,0.451709131395312,0.778369284286366,4,11,substrate-specific transporter activity,MF,SLC2A14;KCNG2;KCNK6;TF
5884,GO:1903828,0.451716427490929,0.852126530604832,2,5,negative regulation of cellular protein localization,BP,CLDN18;BMP7
435,GO:0003209,0.451853402043466,0.852043533887897,2,5,cardiac atrium morphogenesis,BP,WNT2;NOTCH1
444,GO:0003230,0.451853402043466,0.852043533887897,2,5,cardiac atrium development,BP,WNT2;NOTCH1
1743,GO:0018107,0.452926335581309,0.851392481416037,2,5,peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
1753,GO:0018210,0.452926335581309,0.851392481416037,2,5,peptidyl-threonine modification,BP,AXIN1;BMP7
676,GO:0005788,0.453191345195628,0.777232918556178,4,11,endoplasmic reticulum lumen,CC,WNT7A;WNT3;WNT7B;WNT5B
3252,GO:0043588,0.453214675673291,0.753862878183087,5,15,skin development,BP,POU3F1;VDR;DSG3;PKP1;NOTCH1
358,GO:0002791,0.453737592825519,0.805811843000153,3,8,regulation of peptide secretion,BP,BMP6;KCNG2;INHBB
2191,GO:0031214,0.454198122114045,0.805483643679722,3,8,biomineral tissue development,BP,BMP6;BMP4;BMP7
4794,GO:0070167,0.454198122114045,0.805483643679722,3,8,regulation of biomineral tissue development,BP,BMP6;BMP4;BMP7
1453,GO:0010975,0.454449792555846,0.805304167375448,3,8,regulation of neuron projection development,BP,WNT7A;WNT3;BMP7
1987,GO:0030162,0.454800651699212,0.775995976082353,4,11,regulation of proteolysis,BP,PMAIP1;AXIN1;MAPK12;RNF144A
2918,GO:0040008,0.455474666673304,0.715977680052343,8,24,regulation of growth,BP,ACTN3;WNT3;WNT2;FGF8;BMP4;PIK3CA;SPTBN4;NOTCH1
174,GO:0001889,0.455946677507087,0.849550849677792,2,5,liver development,BP,PIK3CA;NOTCH1
4651,GO:0061008,0.455946677507087,0.849550849677792,2,5,hepaticobiliary system development,BP,PIK3CA;NOTCH1
3483,GO:0045444,0.456507511564142,0.803833495661158,3,8,fat cell differentiation,BP,AXIN1;WNT5B;INHBB
1236,GO:0009636,0.456771590482706,0.849045575144247,2,5,response to toxic substance,BP,CDH1;BMP7
3516,GO:0045638,0.456999252932005,0.848905954253846,2,5,negative regulation of myeloid cell differentiation,BP,CLDN18;FSTL3
5820,GO:1903362,0.457372013405049,0.848677185506598,2,5,regulation of cellular protein catabolic process,BP,AXIN1;RNF144A
1045,GO:0007517,0.457496747018142,0.723769382095859,7,21,muscle organ development,BP,ACTN3;MAPK12;WNT2;FZD7;FGF8;BMP4;NOTCH1
5092,GO:0072088,0.457908383573761,0.773598045349131,4,11,nephron epithelium morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
914,GO:0006952,0.458054972176644,0.723293181914456,7,21,defense response,BP,PIK3CG;BMP6;PMAIP1;INHBB;CCL20;HRAS;NOTCH1
219,GO:0002040,0.458871147852949,0.847755108967755,2,5,sprouting angiogenesis,BP,BMP4;NOTCH1
27,GO:0000187,0.458896182644529,0.802119055098509,3,8,activation of MAPK activity,BP,WNT7B;AXIN1;DUSP5
1021,GO:0007368,0.458952188654352,0.80207876398814,3,8,determination of left/right symmetry,BP,AXIN1;FGF8;NOTCH1
1254,GO:0009855,0.458952188654352,0.80207876398814,3,8,determination of bilateral symmetry,BP,AXIN1;FGF8;NOTCH1
3222,GO:0043506,0.459537505227515,0.847344202754615,2,5,regulation of JUN kinase activity,BP,WNT7B;AXIN1
3223,GO:0043507,0.459537505227515,0.847344202754615,2,5,positive regulation of JUN kinase activity,BP,WNT7B;AXIN1
116,GO:0001667,0.459569101329575,0.71243415907965,8,24,ameboidal-type cell migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;GDNF;PIK3CA;NOTCH1
3845,GO:0048565,0.46045972777372,0.800992618005057,3,8,digestive tract development,BP,CLDN18;BMP4;NOTCH1
4358,GO:0055123,0.46045972777372,0.800992618005057,3,8,digestive system development,BP,CLDN18;BMP4;NOTCH1
5615,GO:1901342,0.461018222396787,0.747513361803663,5,15,regulation of vasculature development,BP,HEY1;AMOT;BMP4;BMP7;NOTCH1
413,GO:0003171,0.462159910027911,0.8457208266818,2,5,atrioventricular valve development,BP,HEY1;NOTCH1
420,GO:0003181,0.462159910027911,0.8457208266818,2,5,atrioventricular valve morphogenesis,BP,HEY1;NOTCH1
60,GO:0000981,0.462311474464856,0.845626695186683,2,5,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HEY1;VDR
2741,GO:0035282,0.462908544569384,0.845255548386478,2,5,segmentation,BP,BMP4;NOTCH1
2716,GO:0035091,0.462918652823027,0.845249260468776,2,5,phosphatidylinositol binding,MF,SYT5;FZD7
5681,GO:1901981,0.462918652823027,0.845249260468776,2,5,phosphatidylinositol phosphate binding,MF,SYT5;FZD7
5778,GO:1902936,0.462918652823027,0.845249260468776,2,5,phosphatidylinositol bisphosphate binding,MF,SYT5;FZD7
111,GO:0001657,0.462932385759615,0.769695579631498,4,11,ureteric bud development,BP,FGF8;BMP4;GDNF;BMP7
5129,GO:0072163,0.462932385759615,0.769695579631498,4,11,mesonephric epithelium development,BP,FGF8;BMP4;GDNF;BMP7
5130,GO:0072164,0.462932385759615,0.769695579631498,4,11,mesonephric tubule development,BP,FGF8;BMP4;GDNF;BMP7
4349,GO:0055085,0.463022103229368,0.719041417131528,7,21,transmembrane transport,BP,SLC2A14;GJB2;PIK3CG;GJA3;KCNG2;KCNK6;TSPAN13
5326,GO:0090288,0.463068907326009,0.845155775846977,2,5,negative regulation of cellular response to growth factor stimulus,BP,FSTL3;NOTCH1
525,GO:0004672,0.463618006933045,0.718529581190701,7,21,protein kinase activity,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
2224,GO:0031349,0.464227709289973,0.844433686524334,2,5,positive regulation of defense response,BP,PIK3CG;HRAS
5299,GO:0090183,0.464609243451064,0.797986893944916,3,8,regulation of kidney development,BP,BMP4;GDNF;BMP7
4115,GO:0051145,0.465393758053742,0.797415963938817,3,8,smooth muscle cell differentiation,BP,HEY1;BMP4;NOTCH1
2174,GO:0031099,0.465993608129008,0.796978850671916,3,8,regeneration,BP,WNT7A;FZD7;NOTCH1
2947,GO:0042098,0.466213740755033,0.843191536313022,2,5,T cell proliferation,BP,PIK3CG;BMP4
5281,GO:0090101,0.467595945904897,0.842323617430293,2,5,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FSTL3;NOTCH1
3142,GO:0043227,0.468269416438186,0.645618166055566,48,156,membrane-bounded organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;VDR;RAB39A;DSG3;AMOT;WNT5B;DUSP5;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;TF;PM20D2
4292,GO:0051924,0.468641144403828,0.841665439719921,2,5,regulation of calcium ion transport,BP,PIK3CG;TSPAN13
4650,GO:0061005,0.469207179311861,0.79462863642323,3,8,cell differentiation involved in kidney development,BP,BMP4;GDNF;NOTCH1
2156,GO:0031018,0.469558256708446,0.841086588395082,2,5,endocrine pancreas development,BP,BMP6;BMP4
3970,GO:0050680,0.469904342428933,0.840867826483146,2,5,negative regulation of epithelial cell proliferation,BP,VDR;BMP4
2330,GO:0032103,0.470492956932033,0.793684286127978,3,8,positive regulation of response to external stimulus,BP,PIK3CG;BMP6;ARTN
4454,GO:0060341,0.471600270371525,0.700589454261101,8,25,regulation of cellular localization,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;GDNF;BMP7
5137,GO:0072175,0.471658627222495,0.762840641722952,4,11,epithelial tube formation,BP,FGF8;BMP4;GDNF;BMP7
887,GO:0006886,0.471742476511705,0.738669698491289,5,15,intracellular protein transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4866,GO:0070588,0.472045848928456,0.839510217761866,2,5,calcium ion transmembrane transport,BP,PIK3CG;TSPAN13
400,GO:0003143,0.472268953991566,0.839368387851984,2,5,embryonic heart tube morphogenesis,BP,FGF8;NOTCH1
2709,GO:0035050,0.472268953991566,0.839368387851984,2,5,embryonic heart tube development,BP,FGF8;NOTCH1
5110,GO:0072111,0.472306579854073,0.839344461442612,2,5,cell proliferation involved in kidney development,BP,BMP4;BMP7
3824,GO:0048514,0.47263854858711,0.691805993885816,9,28,blood vessel morphogenesis,BP,WNT7A;PIK3CG;HEY1;WNT7B;FGF8;AMOT;BMP4;PIK3CA;NOTCH1
646,GO:0005615,0.472909373778947,0.666071657237366,14,43,extracellular space,CC,WNT7A;BMP6;WNT3;WNT7B;WNT2;ARTN;WNT5B;INHBB;CCL20;FGF17;BMP4;BMP7;FSTL3;TF
1031,GO:0007416,0.472989587788215,0.838909767596338,2,5,synapse assembly,BP,WNT7A;CDH1
888,GO:0006887,0.473134149299815,0.710304789298019,7,21,exocytosis,BP,PIK3CG;SYT5;RAB40B;PKP1;RAB3D;NOTCH1;TF
1640,GO:0016358,0.47339187630724,0.838653409274567,2,5,dendrite development,BP,WNT7A;BMP7
1934,GO:0022890,0.47359566190891,0.79139600602228,3,8,inorganic cation transmembrane transporter activity,MF,KCNG2;KCNK6;TF
3704,GO:0046873,0.47359566190891,0.79139600602228,3,8,metal ion transmembrane transporter activity,MF,KCNG2;KCNK6;TF
750,GO:0006109,0.475178329236817,0.837512070523124,2,5,regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1
4661,GO:0061035,0.475586279848907,0.837250766774141,2,5,regulation of cartilage development,BP,BMP6;BMP4
3293,GO:0044092,0.475647875862849,0.708116042471305,7,21,negative regulation of molecular function,BP,HEY1;AMOT;DUSP5;HRAS;BMP4;BMP7;NOTCH1
5961,GO:1905207,0.475795228305904,0.837116832830435,2,5,regulation of cardiocyte differentiation,BP,FZD7;BMP4
6144,GO:2000725,0.475795228305904,0.837116832830435,2,5,regulation of cardiac muscle cell differentiation,BP,FZD7;BMP4
4246,GO:0051604,0.476319827675946,0.836780281016788,2,5,protein maturation,BP,RHBDL3;TSPAN15
173,GO:0001885,0.476532372117308,0.836643807514872,2,5,endothelial cell development,BP,WNT7A;WNT7B
4657,GO:0061028,0.476532372117308,0.836643807514872,2,5,establishment of endothelial barrier,BP,WNT7A;WNT7B
1827,GO:0019898,0.476550846458635,0.754867325855672,4,12,extrinsic component of membrane,CC,PIK3CG;CDH1;PIK3CA;TF
4917,GO:0071216,0.478295104808268,0.835509349693323,2,5,cellular response to biotic stimulus,BP,BMP6;CCL20
4918,GO:0071219,0.478295104808268,0.835509349693323,2,5,cellular response to molecule of bacterial origin,BP,BMP6;CCL20
4919,GO:0071222,0.478295104808268,0.835509349693323,2,5,cellular response to lipopolysaccharide,BP,BMP6;CCL20
624,GO:0005515,0.478576005727074,0.648949071061877,56,183,protein binding,MF,MAGEC2;TJP3;GLDC;RHPN1;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;CDH1;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;MB21D2;GUCY1B3;TF
6046,GO:2000026,0.478992888266048,0.653152822417197,16,51,regulation of multicellular organismal development,BP,WNT7A;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT2;FZD7;FGF8;VDR;AMOT;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5883,GO:1903827,0.479484391604689,0.703137369936958,7,22,regulation of cellular protein localization,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
1971,GO:0030097,0.481140211153674,0.701680551517753,7,22,hemopoiesis,BP,CLDN18;JAG2;FZD7;BMP4;FSTL3;TPD52;NOTCH1
2782,GO:0035639,0.481384357032676,0.657707516506721,14,44,purine ribonucleoside triphosphate binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
600,GO:0005244,0.482380116633319,0.83286229136197,2,5,voltage-gated ion channel activity,MF,KCNG2;KCNK6
608,GO:0005261,0.482380116633319,0.83286229136197,2,5,cation channel activity,MF,KCNG2;KCNK6
1928,GO:0022832,0.482380116633319,0.83286229136197,2,5,voltage-gated channel activity,MF,KCNG2;KCNK6
1930,GO:0022836,0.482380116633319,0.83286229136197,2,5,gated channel activity,MF,KCNG2;KCNK6
1932,GO:0022843,0.482380116633319,0.83286229136197,2,5,voltage-gated cation channel activity,MF,KCNG2;KCNK6
2079,GO:0030593,0.483420668356159,0.832183977730859,2,5,neutrophil chemotaxis,BP,PIK3CG;CCL20
5002,GO:0071621,0.483420668356159,0.832183977730859,2,5,granulocyte chemotaxis,BP,PIK3CG;CCL20
5424,GO:0097530,0.483420668356159,0.832183977730859,2,5,granulocyte migration,BP,PIK3CG;CCL20
6010,GO:1990266,0.483420668356159,0.832183977730859,2,5,neutrophil migration,BP,PIK3CG;CCL20
2394,GO:0032391,0.483618498163106,0.921931384459473,1,2,photoreceptor connecting cilium,CC,SPTBN5
2816,GO:0035869,0.483618498163106,0.921931384459473,1,2,ciliary transition zone,CC,SPTBN5
3655,GO:0046530,0.48371410516959,0.921894366665644,1,2,photoreceptor cell differentiation,BP,NOTCH1
4094,GO:0051052,0.484230191363151,0.752791916750527,4,11,regulation of DNA metabolic process,BP,BMP6;HRAS;BMP4;PIK3CA
437,GO:0003213,0.484493006302311,0.92159232931241,1,2,cardiac right atrium morphogenesis,BP,NOTCH1
5094,GO:0072091,0.484807094449867,0.92147030364167,1,2,regulation of stem cell proliferation,BP,NOTCH1
6134,GO:2000648,0.484807094449867,0.92147030364167,1,2,positive regulation of stem cell proliferation,BP,NOTCH1
1341,GO:0010562,0.485718832404461,0.650307391349547,15,47,positive regulation of phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
3601,GO:0045937,0.485718832404461,0.650307391349547,15,47,positive regulation of phosphate metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7
220,GO:0002042,0.485858235728089,0.921060961331429,1,2,cell migration involved in sprouting angiogenesis,BP,NOTCH1
3935,GO:0048845,0.485858235728089,0.921060961331429,1,2,venous blood vessel morphogenesis,BP,NOTCH1
4612,GO:0060841,0.485858235728089,0.921060961331429,1,2,venous blood vessel development,BP,NOTCH1
5889,GO:1903847,0.485858235728089,0.921060961331429,1,2,regulation of aorta morphogenesis,BP,NOTCH1
5890,GO:1903849,0.485858235728089,0.921060961331429,1,2,positive regulation of aorta morphogenesis,BP,NOTCH1
5981,GO:1905651,0.485858235728089,0.921060961331429,1,2,regulation of artery morphogenesis,BP,NOTCH1
5982,GO:1905653,0.485858235728089,0.921060961331429,1,2,positive regulation of artery morphogenesis,BP,NOTCH1
1408,GO:0010818,0.486034795060821,0.920992058336615,1,2,T cell chemotaxis,BP,PIK3CG
3989,GO:0050729,0.486034795060821,0.920992058336615,1,2,positive regulation of inflammatory response,BP,PIK3CG
827,GO:0006638,0.4865076954546,0.920807299679879,1,2,neutral lipid metabolic process,BP,PIK3CG
828,GO:0006639,0.4865076954546,0.920807299679879,1,2,acylglycerol metabolic process,BP,PIK3CG
829,GO:0006641,0.4865076954546,0.920807299679879,1,2,triglyceride metabolic process,BP,PIK3CG
1849,GO:0021537,0.486822643922171,0.829954779507247,2,5,telencephalon development,BP,FGF8;BMP4
1550,GO:0015629,0.486998819956771,0.708324165194816,6,19,actin cytoskeleton,CC,ACTN3;SPTBN5;CDH1;SPTB;AMOT;SPTBN4
3852,GO:0048585,0.487003628050038,0.66061411629088,12,38,negative regulation of response to stimulus,BP,TLE1;ACTN3;WNT3;HEY1;AXIN1;WNT5B;DUSP5;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5455,GO:0098602,0.487124675039261,0.677732195596791,9,29,single organism cell adhesion,BP,PIK3CG;WNT7B;CDH1;FZD7;PKP1;BMP4;PIK3CA;BMP7;FSTL3
198,GO:0001948,0.48714475458428,0.920557927410052,1,2,glycoprotein binding,MF,CDH1
5797,GO:1903053,0.487254337589076,0.920514976543568,1,2,regulation of extracellular matrix organization,BP,NOTCH1
3705,GO:0046875,0.487395978814928,0.9204594364083,1,2,ephrin receptor binding,MF,PIK3CG
3756,GO:0048037,0.487423210423945,0.920448755276381,1,2,cofactor binding,MF,GLDC
1639,GO:0016342,0.487756398553695,0.920317986529929,1,2,catenin complex,CC,CDH1
3413,GO:0044853,0.487756398553695,0.920317986529929,1,2,plasma membrane raft,CC,CDH1
3470,GO:0045295,0.487756398553695,0.920317986529929,1,2,gamma-catenin binding,MF,CDH1
1421,GO:0010839,0.487951916984262,0.920241179883344,1,2,negative regulation of keratinocyte proliferation,BP,VDR
132,GO:0001736,0.488415535256591,0.920058846521308,1,2,establishment of planar polarity,BP,FZD7
966,GO:0007164,0.488415535256591,0.920058846521308,1,2,establishment of tissue polarity,BP,FZD7
2888,GO:0038031,0.488415535256591,0.920058846521308,1,2,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7
4388,GO:0060071,0.488415535256591,0.920058846521308,1,2,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7
5295,GO:0090175,0.488415535256591,0.920058846521308,1,2,regulation of establishment of planar polarity,BP,FZD7
4119,GO:0051149,0.488705816256916,0.828713181370537,2,5,positive regulation of muscle cell differentiation,BP,MAPK12;BMP4
719,GO:0005943,0.489032972927911,0.919815564761795,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3CA
3244,GO:0043560,0.489032972927911,0.919815564761795,1,2,insulin receptor substrate binding,MF,PIK3CA
4590,GO:0060745,0.48906320155642,0.919803640803475,1,2,mammary gland branching involved in pregnancy,BP,VDR
666,GO:0005769,0.489069765727219,0.779781671473988,3,8,early endosome,CC,RAB38;RAB20;TF
1924,GO:0022617,0.489243823631315,0.919732366837009,1,2,extracellular matrix disassembly,BP,CDH1
2843,GO:0036003,0.489317799309037,0.919703162999172,1,2,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1
3256,GO:0043618,0.489317799309037,0.919703162999172,1,2,regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1
3258,GO:0043620,0.489317799309037,0.919703162999172,1,2,regulation of DNA-templated transcription in response to stress,BP,NOTCH1
1059,GO:0007595,0.489342385820167,0.919693455177892,1,2,lactation,BP,VDR
255,GO:0002250,0.489400320975125,0.828253910080504,2,5,adaptive immune response,BP,PIK3CG;HRAS
5393,GO:0097191,0.489412321993892,0.779520715357791,3,8,extrinsic apoptotic signaling pathway,BP,PMAIP1;BMP4;GDNF
1785,GO:0019226,0.489499529243753,0.919631388668796,1,2,transmission of nerve impulse,BP,SPTBN4
3101,GO:0043066,0.489734193998499,0.669636707606042,10,31,negative regulation of apoptotic process,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
3104,GO:0043069,0.489734193998499,0.669636707606042,10,31,negative regulation of programmed cell death,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
5482,GO:0098797,0.489871149884906,0.744007115680795,4,12,plasma membrane protein complex,CC,GJB2;GJA3;GJB6;CDH1
5384,GO:0097164,0.490148570905141,0.919374681462934,1,2,ammonium ion metabolic process,BP,MBOAT2
4096,GO:0051054,0.490362504586717,0.778795995792815,3,8,positive regulation of DNA metabolic process,BP,BMP6;HRAS;BMP4
5163,GO:0072234,0.490562427819562,0.919210693410823,1,2,metanephric nephron tubule development,BP,WNT7B
5166,GO:0072243,0.490562427819562,0.919210693410823,1,2,metanephric nephron epithelium development,BP,WNT7B
235,GO:0002085,0.490820174781641,0.919108444489548,1,2,inhibition of neuroepithelial cell differentiation,BP,NOTCH1
1024,GO:0007386,0.490820174781641,0.919108444489548,1,2,compartment pattern specification,BP,NOTCH1
1499,GO:0014807,0.490820174781641,0.919108444489548,1,2,regulation of somitogenesis,BP,NOTCH1
2127,GO:0030857,0.490820174781641,0.919108444489548,1,2,negative regulation of epithelial cell differentiation,BP,NOTCH1
2928,GO:0040034,0.490820174781641,0.919108444489548,1,2,regulation of development, heterochronic,BP,NOTCH1
3502,GO:0045605,0.490820174781641,0.919108444489548,1,2,negative regulation of epidermal cell differentiation,BP,NOTCH1
3504,GO:0045607,0.490820174781641,0.919108444489548,1,2,regulation of auditory receptor cell differentiation,BP,NOTCH1
3505,GO:0045608,0.490820174781641,0.919108444489548,1,2,negative regulation of auditory receptor cell differentiation,BP,NOTCH1
3511,GO:0045631,0.490820174781641,0.919108444489548,1,2,regulation of mechanoreceptor differentiation,BP,NOTCH1
3512,GO:0045632,0.490820174781641,0.919108444489548,1,2,negative regulation of mechanoreceptor differentiation,BP,NOTCH1
3532,GO:0045683,0.490820174781641,0.919108444489548,1,2,negative regulation of epidermis development,BP,NOTCH1
3820,GO:0048505,0.490820174781641,0.919108444489548,1,2,regulation of timing of cell differentiation,BP,NOTCH1
4638,GO:0060972,0.490820174781641,0.919108444489548,1,2,left/right pattern formation,BP,NOTCH1
4908,GO:0070986,0.490820174781641,0.919108444489548,1,2,left/right axis specification,BP,NOTCH1
6170,GO:2000980,0.490820174781641,0.919108444489548,1,2,regulation of inner ear receptor cell differentiation,BP,NOTCH1
6171,GO:2000981,0.490820174781641,0.919108444489548,1,2,negative regulation of inner ear receptor cell differentiation,BP,NOTCH1
426,GO:0003192,0.491506103083605,0.918835891529175,1,2,mitral valve formation,BP,NOTCH1
2450,GO:0032633,0.491506103083605,0.918835891529175,1,2,interleukin-4 production,BP,NOTCH1
3898,GO:0048709,0.491841827809222,0.918702256409427,1,2,oligodendrocyte differentiation,BP,NOTCH1
5474,GO:0098754,0.492525600467293,0.918429602049407,1,2,detoxification,BP,BMP7
5496,GO:0098869,0.492525600467293,0.918429602049407,1,2,cellular oxidant detoxification,BP,BMP7
5593,GO:1901031,0.492525600467293,0.918429602049407,1,2,regulation of response to reactive oxygen species,BP,BMP7
6020,GO:1990748,0.492525600467293,0.918429602049407,1,2,cellular detoxification,BP,BMP7
988,GO:0007220,0.492612012242042,0.918395099584036,1,2,Notch receptor processing,BP,JAG2
3841,GO:0048546,0.492701363501272,0.826060775383598,2,5,digestive tract morphogenesis,BP,BMP4;NOTCH1
78,GO:0001106,0.492836671324546,0.91830534967088,1,2,RNA polymerase II transcription corepressor activity,MF,TLE1
1676,GO:0016597,0.493291507020281,0.918123432711794,1,2,amino acid binding,MF,GLDC
3424,GO:0045058,0.493295548886528,0.918121814840594,1,2,T cell selection,BP,JAG2
4839,GO:0070371,0.493325906240964,0.745392402212424,4,11,ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4
4840,GO:0070372,0.493325906240964,0.745392402212424,4,11,regulation of ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4
95,GO:0001541,0.493488588551553,0.918044519014581,1,2,ovarian follicle development,BP,INHBB
1917,GO:0022602,0.493488588551553,0.918044519014581,1,2,ovulation cycle process,BP,INHBB
1748,GO:0018193,0.493937491643141,0.672586121097145,9,28,peptidyl-amino acid modification,BP,AXIN1;MAPK12;FGF8;PKN3;FGF17;RAB3D;PIK3CA;BMP7;SPTBN4
517,GO:0004383,0.494146929249938,0.917780523062091,1,2,guanylate cyclase activity,MF,GUCY1B3
1091,GO:0008074,0.494146929249938,0.917780523062091,1,2,guanylate cyclase complex, soluble,CC,GUCY1B3
1282,GO:0009975,0.494146929249938,0.917780523062091,1,2,cyclase activity,MF,GUCY1B3
1710,GO:0016849,0.494146929249938,0.917780523062091,1,2,phosphorus-oxygen lyase activity,MF,GUCY1B3
3361,GO:0044445,0.494146929249938,0.917780523062091,1,2,cytosolic part,CC,GUCY1B3
5171,GO:0072273,0.494238929844564,0.82503349051146,2,5,metanephric nephron morphogenesis,BP,BMP4;GDNF
3980,GO:0050714,0.494239773319341,0.917743244205019,1,2,positive regulation of protein secretion,BP,BMP6
4958,GO:0071371,0.494307454369816,0.917716061317838,1,2,cellular response to gonadotropin stimulus,BP,NOTCH1
5082,GO:0072070,0.494435561551459,0.917664591999926,1,2,loop of Henle development,BP,WNT7B
1972,GO:0030098,0.494494131440523,0.74018367069167,4,12,lymphocyte differentiation,BP,JAG2;FZD7;BMP4;TPD52
405,GO:0003157,0.494869368617515,0.917490133616178,1,2,endocardium development,BP,NOTCH1
471,GO:0003348,0.494869368617515,0.917490133616178,1,2,cardiac endothelial cell differentiation,BP,NOTCH1
4633,GO:0060956,0.494869368617515,0.917490133616178,1,2,endocardial cell differentiation,BP,NOTCH1
5152,GO:0072202,0.495180073228107,0.824402876249654,2,5,cell differentiation involved in metanephros development,BP,BMP4;GDNF
5356,GO:0097009,0.495287403017751,0.917321771555138,1,2,energy homeostasis,BP,PIK3CA
3678,GO:0046683,0.495820157153503,0.917106854983231,1,2,response to organophosphorus,BP,PIK3CG
4241,GO:0051591,0.495820157153503,0.917106854983231,1,2,response to cAMP,BP,PIK3CG
4939,GO:0071320,0.495820157153503,0.917106854983231,1,2,cellular response to cAMP,BP,PIK3CG
4255,GO:0051650,0.495863664803103,0.823943969466895,2,5,establishment of vesicle localization,BP,WNT7A;SYT5
2819,GO:0035886,0.495991846974738,0.917037510143712,1,2,vascular smooth muscle cell differentiation,BP,NOTCH1
1735,GO:0017147,0.4960421620004,0.917017180338173,1,2,Wnt-protein binding,MF,FZD7
1989,GO:0030165,0.4960421620004,0.917017180338173,1,2,PDZ domain binding,MF,FZD7
3076,GO:0042813,0.4960421620004,0.917017180338173,1,2,Wnt-activated receptor activity,MF,FZD7
1842,GO:0020037,0.496201259115671,0.916952873915905,1,2,heme binding,MF,GUCY1B3
3721,GO:0046906,0.496201259115671,0.916952873915905,1,2,tetrapyrrole binding,MF,GUCY1B3
5962,GO:1905208,0.496419318971062,0.916864677764868,1,2,negative regulation of cardiocyte differentiation,BP,FZD7
6145,GO:2000726,0.496419318971062,0.916864677764868,1,2,negative regulation of cardiac muscle cell differentiation,BP,FZD7
2666,GO:0034612,0.496453512181182,0.823547408611328,2,5,response to tumor necrosis factor,BP,CLDN18;CCL20
4952,GO:0071356,0.496453512181182,0.823547408611328,2,5,cellular response to tumor necrosis factor,BP,CLDN18;CCL20
1431,GO:0010893,0.496674307143405,0.916761461663929,1,2,positive regulation of steroid biosynthetic process,BP,BMP6
2377,GO:0032346,0.496674307143405,0.916761461663929,1,2,positive regulation of aldosterone metabolic process,BP,BMP6
2380,GO:0032349,0.496674307143405,0.916761461663929,1,2,positive regulation of aldosterone biosynthetic process,BP,BMP6
2383,GO:0032352,0.496674307143405,0.916761461663929,1,2,positive regulation of hormone metabolic process,BP,BMP6
3603,GO:0045940,0.496674307143405,0.916761461663929,1,2,positive regulation of steroid metabolic process,BP,BMP6
3714,GO:0046886,0.496674307143405,0.916761461663929,1,2,positive regulation of hormone biosynthetic process,BP,BMP6
5268,GO:0090031,0.496674307143405,0.916761461663929,1,2,positive regulation of steroid hormone biosynthetic process,BP,BMP6
223,GO:0002053,0.49727242801752,0.916518993990833,1,2,positive regulation of mesenchymal cell proliferation,BP,WNT2
2585,GO:0033278,0.49727242801752,0.916518993990833,1,2,cell proliferation in midbrain,BP,WNT2
2412,GO:0032436,0.497434279611945,0.916453296386023,1,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF144A
5665,GO:1901800,0.497434279611945,0.916453296386023,1,2,positive regulation of proteasomal protein catabolic process,BP,RNF144A
5153,GO:0072203,0.497484199751143,0.916433025789758,1,2,cell proliferation involved in metanephros development,BP,BMP7
2425,GO:0032507,0.49755109828725,0.916405855478886,1,2,maintenance of protein location in cell,BP,SPTBN4
3455,GO:0045185,0.49755109828725,0.916405855478886,1,2,maintenance of protein location,BP,SPTBN4
4256,GO:0051651,0.49755109828725,0.916405855478886,1,2,maintenance of location in cell,BP,SPTBN4
3322,GO:0044304,0.497908687787697,0.916260517263329,1,2,main axon,CC,SPTBN4
1673,GO:0016579,0.497976848543642,0.916232793805069,1,2,protein deubiquitination,BP,AXIN1
4871,GO:0070646,0.497976848543642,0.916232793805069,1,2,protein modification by small protein removal,BP,AXIN1
3383,GO:0044711,0.49798981586015,0.668878669178235,9,28,single-organism biosynthetic process,BP,PIK3CG;MBOAT2;BMP6;FGF8;VDR;FGF17;BMP4;PIK3CA;GUCY1B3
321,GO:0002673,0.49804759105487,0.916204013379661,1,2,regulation of acute inflammatory response,BP,PIK3CG
3610,GO:0045988,0.49804759105487,0.916204013379661,1,2,negative regulation of striated muscle contraction,BP,PIK3CG
4356,GO:0055118,0.49804759105487,0.916204013379661,1,2,negative regulation of cardiac muscle contraction,BP,PIK3CG
5395,GO:0097193,0.498054813673593,0.822468092617906,2,5,intrinsic apoptotic signaling pathway,BP,PMAIP1;HRAS
2490,GO:0032794,0.498138113590586,0.916167175563604,1,2,GTPase activating protein binding,MF,CDH1
5406,GO:0097306,0.498138113590586,0.916167175563604,1,2,cellular response to alcohol,BP,CDH1
1964,GO:0030049,0.498289420464358,0.916105576174255,1,2,muscle filament sliding,BP,ACTN3
2584,GO:0033275,0.498289420464358,0.916105576174255,1,2,actin-myosin filament sliding,BP,ACTN3
380,GO:0003016,0.498313397522808,0.916095811797435,1,2,respiratory system process,BP,JAG2
2069,GO:0030529,0.498366059606174,0.91607436295343,1,2,intracellular ribonucleoprotein complex,CC,PKP1
5721,GO:1902369,0.498366059606174,0.91607436295343,1,2,negative regulation of RNA catabolic process,BP,PKP1
5722,GO:1902373,0.498366059606174,0.91607436295343,1,2,negative regulation of mRNA catabolic process,BP,PKP1
5814,GO:1903312,0.498366059606174,0.91607436295343,1,2,negative regulation of mRNA metabolic process,BP,PKP1
6002,GO:1990124,0.498366059606174,0.91607436295343,1,2,messenger ribonucleoprotein complex,CC,PKP1
6030,GO:1990904,0.498366059606174,0.91607436295343,1,2,ribonucleoprotein complex,CC,PKP1
733,GO:0006007,0.498472475167837,0.916031008893367,1,2,glucose catabolic process,BP,ACTN3
746,GO:0006090,0.498472475167837,0.916031008893367,1,2,pyruvate metabolic process,BP,ACTN3
749,GO:0006096,0.498472475167837,0.916031008893367,1,2,glycolytic process,BP,ACTN3
760,GO:0006165,0.498472475167837,0.916031008893367,1,2,nucleoside diphosphate phosphorylation,BP,ACTN3
851,GO:0006733,0.498472475167837,0.916031008893367,1,2,oxidoreduction coenzyme metabolic process,BP,ACTN3
852,GO:0006734,0.498472475167837,0.916031008893367,1,2,NADH metabolic process,BP,ACTN3
855,GO:0006757,0.498472475167837,0.916031008893367,1,2,ATP generation from ADP,BP,ACTN3
1191,GO:0009123,0.498472475167837,0.916031008893367,1,2,nucleoside monophosphate metabolic process,BP,ACTN3
1192,GO:0009126,0.498472475167837,0.916031008893367,1,2,purine nucleoside monophosphate metabolic process,BP,ACTN3
1193,GO:0009132,0.498472475167837,0.916031008893367,1,2,nucleoside diphosphate metabolic process,BP,ACTN3
1194,GO:0009135,0.498472475167837,0.916031008893367,1,2,purine nucleoside diphosphate metabolic process,BP,ACTN3
1200,GO:0009161,0.498472475167837,0.916031008893367,1,2,ribonucleoside monophosphate metabolic process,BP,ACTN3
1203,GO:0009167,0.498472475167837,0.916031008893367,1,2,purine ribonucleoside monophosphate metabolic process,BP,ACTN3
1204,GO:0009179,0.498472475167837,0.916031008893367,1,2,purine ribonucleoside diphosphate metabolic process,BP,ACTN3
1205,GO:0009185,0.498472475167837,0.916031008893367,1,2,ribonucleoside diphosphate metabolic process,BP,ACTN3
1791,GO:0019362,0.498472475167837,0.916031008893367,1,2,pyridine nucleotide metabolic process,BP,ACTN3
1805,GO:0019674,0.498472475167837,0.916031008893367,1,2,NAD metabolic process,BP,ACTN3
3614,GO:0046031,0.498472475167837,0.916031008893367,1,2,ADP metabolic process,BP,ACTN3
3615,GO:0046034,0.498472475167837,0.916031008893367,1,2,ATP metabolic process,BP,ACTN3
3653,GO:0046496,0.498472475167837,0.916031008893367,1,2,nicotinamide nucleotide metabolic process,BP,ACTN3
3729,GO:0046939,0.498472475167837,0.916031008893367,1,2,nucleotide phosphorylation,BP,ACTN3
5206,GO:0072524,0.498472475167837,0.916031008893367,1,2,pyridine-containing compound metabolic process,BP,ACTN3
5473,GO:0098751,0.49856071708277,0.915995046805739,1,2,bone cell development,BP,CLDN18
5158,GO:0072215,0.49922911348488,0.821674031707606,2,5,regulation of metanephros development,BP,BMP4;GDNF
5571,GO:1900407,0.499348027061255,0.915673703329261,1,2,regulation of cellular response to oxidative stress,BP,BMP7
484,GO:0003677,0.499743923241388,0.735807557711599,4,12,DNA binding,MF,HEY1;POU3F1;VDR;NOTCH1
2933,GO:0042036,0.500075736367389,0.915375911751821,1,2,negative regulation of cytokine biosynthetic process,BP,INHBB
713,GO:0005923,0.500378652466425,0.714376065301438,5,15,bicellular tight junction,CC,TJP3;CLDN18;AMOT;WNK4;CLDN15
4789,GO:0070160,0.500378652466425,0.714376065301438,5,15,occluding junction,CC,TJP3;CLDN18;AMOT;WNK4;CLDN15
5207,GO:0072562,0.50043456980795,0.915228796375876,1,2,blood microparticle,CC,TF
179,GO:0001895,0.50045134298536,0.915221915231025,1,2,retina homeostasis,BP,TF
403,GO:0003151,0.500689049366647,0.82068380109096,2,5,outflow tract morphogenesis,BP,FGF8;BMP4
5232,GO:0080134,0.501253077196046,0.673988821014491,8,25,regulation of response to stress,BP,WNT7A;PIK3CG;WNT7B;PMAIP1;AXIN1;FZD7;HRAS;BMP7
20,GO:0000151,0.501823385795136,0.914657694103656,1,2,ubiquitin ligase complex,CC,RNF144A
1765,GO:0019079,0.501869555307376,0.914638661674762,1,2,viral genome replication,BP,NOTCH1
4537,GO:0060562,0.502969699553926,0.672421079080253,8,25,epithelial tube morphogenesis,BP,WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
3250,GO:0043584,0.503024548631301,0.914161556451821,1,2,nose development,BP,AXIN1
2608,GO:0033628,0.503082122886191,0.914137724117649,1,2,regulation of cell adhesion mediated by integrin,BP,PIK3CG
291,GO:0002407,0.50335984363118,0.91402269799765,1,2,dendritic cell chemotaxis,BP,PIK3CG
2871,GO:0036336,0.50335984363118,0.91402269799765,1,2,dendritic cell migration,BP,PIK3CG
3862,GO:0048630,0.50343021928568,0.913993532459968,1,2,skeletal muscle tissue growth,BP,ACTN3
3863,GO:0048631,0.50343021928568,0.913993532459968,1,2,regulation of skeletal muscle tissue growth,BP,ACTN3
3864,GO:0048633,0.50343021928568,0.913993532459968,1,2,positive regulation of skeletal muscle tissue growth,BP,ACTN3
3871,GO:0048641,0.50343021928568,0.913993532459968,1,2,regulation of skeletal muscle tissue development,BP,ACTN3
3872,GO:0048643,0.50343021928568,0.913993532459968,1,2,positive regulation of skeletal muscle tissue development,BP,ACTN3
504,GO:0004175,0.503668752502129,0.913894625557169,1,2,endopeptidase activity,MF,RHBDL3
505,GO:0004252,0.503668752502129,0.913894625557169,1,2,serine-type endopeptidase activity,MF,RHBDL3
1125,GO:0008236,0.503668752502129,0.913894625557169,1,2,serine-type peptidase activity,MF,RHBDL3
1740,GO:0017171,0.503668752502129,0.913894625557169,1,2,serine hydrolase activity,MF,RHBDL3
2270,GO:0031670,0.503898625229106,0.913799233064109,1,2,cellular response to nutrient,BP,VDR
4932,GO:0071295,0.503898625229106,0.913799233064109,1,2,cellular response to vitamin,BP,VDR
4820,GO:0070293,0.504606781243909,0.913504889443471,1,2,renal absorption,BP,WNK4
2392,GO:0032387,0.504999228587059,0.913341461311966,1,2,negative regulation of intracellular transport,BP,BMP7
2978,GO:0042308,0.504999228587059,0.913341461311966,1,2,negative regulation of protein import into nucleus,BP,BMP7
3201,GO:0043433,0.504999228587059,0.913341461311966,1,2,negative regulation of sequence-specific DNA binding transcription factor activity,BP,BMP7
3692,GO:0046823,0.504999228587059,0.913341461311966,1,2,negative regulation of nucleocytoplasmic transport,BP,BMP7
5330,GO:0090317,0.504999228587059,0.913341461311966,1,2,negative regulation of intracellular protein transport,BP,BMP7
5918,GO:1904590,0.504999228587059,0.913341461311966,1,2,negative regulation of protein import,BP,BMP7
117,GO:0001669,0.505399978922224,0.913174348384962,1,2,acrosomal vesicle,CC,NOTCH1
5399,GO:0097223,0.505399978922224,0.913174348384962,1,2,sperm part,CC,NOTCH1
740,GO:0006066,0.505687472872917,0.913054321829175,1,2,alcohol metabolic process,BP,VDR
3621,GO:0046165,0.505687472872917,0.913054321829175,1,2,alcohol biosynthetic process,BP,VDR
2264,GO:0031663,0.50571069194808,0.913044622875514,1,2,lipopolysaccharide-mediated signaling pathway,BP,BMP6
2311,GO:0032008,0.506240722175116,0.91282301123839,1,2,positive regulation of TOR signaling,BP,PIK3CA
1573,GO:0015850,0.507236771206894,0.816201204851827,2,5,organic hydroxy compound transport,BP,BMP6;GDNF
2587,GO:0033293,0.507414799805859,0.91233067995518,1,2,monocarboxylic acid binding,MF,VDR
661,GO:0005759,0.507528726137007,0.912282801187092,1,2,mitochondrial matrix,CC,GLDC
1474,GO:0014044,0.507970271606396,0.912097060253243,1,2,Schwann cell development,BP,POU3F1
1902,GO:0022011,0.507970271606396,0.912097060253243,1,2,myelination in peripheral nervous system,BP,POU3F1
2363,GO:0032292,0.507970271606396,0.912097060253243,1,2,peripheral nervous system axon ensheathment,BP,POU3F1
598,GO:0005242,0.508017109805521,0.912077340762509,1,2,inward rectifier potassium channel activity,MF,KCNK6
1545,GO:0015276,0.508017109805521,0.912077340762509,1,2,ligand-gated ion channel activity,MF,KCNK6
1929,GO:0022834,0.508017109805521,0.912077340762509,1,2,ligand-gated channel activity,MF,KCNK6
5512,GO:0099094,0.508017109805521,0.912077340762509,1,2,ligand-gated cation channel activity,MF,KCNK6
374,GO:0003008,0.508207648170983,0.622553568395819,17,55,system process,BP,GJB2;PIK3CG;ACTN3;BMP6;GJA3;GJB6;JAG2;KCNG2;VDR;WNK4;INHBB;BMP4;KCNK6;GDNF;PIK3CA;SPTBN4;GUCY1B3
2578,GO:0033209,0.508781692795685,0.911754993586521,1,2,tumor necrosis factor-mediated signaling pathway,BP,CLDN18
2238,GO:0031490,0.508967485953088,0.911676535857758,1,2,chromatin DNA binding,MF,NOTCH1
4109,GO:0051101,0.509171775974045,0.911590209527449,1,2,regulation of DNA binding,BP,HEY1
6138,GO:2000677,0.509171775974045,0.911590209527449,1,2,regulation of transcription regulatory region DNA binding,BP,HEY1
2241,GO:0031503,0.509545287613211,0.911432219393543,1,2,protein complex localization,BP,BMP7
917,GO:0006959,0.510628800071782,0.910972764090076,1,2,humoral immune response,BP,NOTCH1
4030,GO:0050848,0.511014988727199,0.910808591302259,1,2,regulation of calcium-mediated signaling,BP,ACTN3
4031,GO:0050849,0.511014988727199,0.910808591302259,1,2,negative regulation of calcium-mediated signaling,BP,ACTN3
539,GO:0004721,0.511774623069344,0.910485029013324,1,2,phosphoprotein phosphatase activity,MF,DUSP5
540,GO:0004725,0.511774623069344,0.910485029013324,1,2,protein tyrosine phosphatase activity,MF,DUSP5
2752,GO:0035335,0.511774623069344,0.910485029013324,1,2,peptidyl-tyrosine dephosphorylation,BP,DUSP5
264,GO:0002279,0.512093121649641,0.910349115751517,1,2,mast cell activation involved in immune response,BP,PIK3CG
302,GO:0002448,0.512093121649641,0.910349115751517,1,2,mast cell mediated immunity,BP,PIK3CG
2405,GO:0032418,0.512093121649641,0.910349115751517,1,2,lysosome localization,BP,PIK3CG
3048,GO:0042629,0.512093121649641,0.910349115751517,1,2,mast cell granule,CC,PIK3CG
3177,GO:0043303,0.512093121649641,0.910349115751517,1,2,mast cell degranulation,BP,PIK3CG
3490,GO:0045576,0.512093121649641,0.910349115751517,1,2,mast cell activation,BP,PIK3CG
3552,GO:0045776,0.512361733849898,0.91023437537659,1,2,negative regulation of blood pressure,BP,KCNK6
863,GO:0006801,0.512650219765086,0.910111028256693,1,2,superoxide metabolic process,BP,BMP7
1371,GO:0010656,0.512650219765086,0.910111028256693,1,2,negative regulation of muscle cell apoptotic process,BP,BMP7
1372,GO:0010657,0.512650219765086,0.910111028256693,1,2,muscle cell apoptotic process,BP,BMP7
1374,GO:0010660,0.512650219765086,0.910111028256693,1,2,regulation of muscle cell apoptotic process,BP,BMP7
2524,GO:0032926,0.512982816902918,0.9099686694724,1,2,negative regulation of activin receptor signaling pathway,BP,FSTL3
3773,GO:0048185,0.512982816902918,0.9099686694724,1,2,activin binding,MF,FSTL3
6026,GO:1990837,0.513561146744875,0.909720745802016,1,2,sequence-specific double-stranded DNA binding,MF,HEY1
873,GO:0006821,0.513942198147901,0.909557125047561,1,2,chloride transport,BP,WNK4
1559,GO:0015698,0.513942198147901,0.909557125047561,1,2,inorganic anion transport,BP,WNK4
1166,GO:0008625,0.514012399704851,0.909526957734887,1,2,extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1
5991,GO:1905897,0.514012399704851,0.909526957734887,1,2,regulation of response to endoplasmic reticulum stress,BP,PMAIP1
5992,GO:1905898,0.514012399704851,0.909526957734887,1,2,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1
1537,GO:0015144,0.514166468402556,0.909460725284763,1,2,carbohydrate transmembrane transporter activity,MF,SLC2A14
4111,GO:0051119,0.514166468402556,0.909460725284763,1,2,sugar transmembrane transporter activity,MF,SLC2A14
5625,GO:1901476,0.514166468402556,0.909460725284763,1,2,carbohydrate transporter activity,MF,SLC2A14
2667,GO:0034613,0.51445723993717,0.634239099029482,12,39,cellular protein localization,BP,CLDN18;BMP6;PMAIP1;CDH1;RAB40B;FZD7;AMOT;TSPAN15;BMP4;RAB38;BMP7;SPTBN4
4886,GO:0070727,0.51445723993717,0.634239099029482,12,39,cellular macromolecule localization,BP,CLDN18;BMP6;PMAIP1;CDH1;RAB40B;FZD7;AMOT;TSPAN15;BMP4;RAB38;BMP7;SPTBN4
3909,GO:0048739,0.516430780922049,0.908483287517972,1,2,cardiac muscle fiber development,BP,BMP4
3911,GO:0048747,0.516430780922049,0.908483287517972,1,2,muscle fiber development,BP,BMP4
64,GO:0000989,0.516463810559709,0.751728265461193,3,9,transcription factor activity, transcription factor binding,MF,TLE1;POU3F1;NOTCH1
6008,GO:1990234,0.516656881094096,0.751570503296525,3,9,transferase complex,CC,PIK3CG;RNF144A;PIK3CA
4146,GO:0051205,0.516949491631295,0.908258308352607,1,2,protein insertion into membrane,BP,PMAIP1
4801,GO:0070228,0.516997771093891,0.90823734792557,1,2,regulation of lymphocyte apoptotic process,BP,BMP4
4805,GO:0070232,0.516997771093891,0.90823734792557,1,2,regulation of T cell apoptotic process,BP,BMP4
4808,GO:0070242,0.516997771093891,0.90823734792557,1,2,thymocyte apoptotic process,BP,BMP4
4809,GO:0070243,0.516997771093891,0.90823734792557,1,2,regulation of thymocyte apoptotic process,BP,BMP4
5151,GO:0072201,0.516997771093891,0.90823734792557,1,2,negative regulation of mesenchymal cell proliferation,BP,BMP4
3327,GO:0044321,0.517836435497033,0.90787269137006,1,2,response to leptin,BP,INHBB
1888,GO:0021904,0.51805107609865,0.907779196268712,1,2,dorsal/ventral neural tube patterning,BP,BMP4
3394,GO:0044766,0.518062555024262,0.907774194242969,1,2,multi-organism transport,BP,RAB40B
5739,GO:1902579,0.518062555024262,0.907774194242969,1,2,multi-organism localization,BP,RAB40B
5138,GO:0072176,0.518277683696876,0.907680414064483,1,2,nephric duct development,BP,BMP4
5139,GO:0072178,0.518277683696876,0.907680414064483,1,2,nephric duct morphogenesis,BP,BMP4
2760,GO:0035418,0.518399835065158,0.907627134431158,1,2,protein localization to synapse,BP,WNT7A
5507,GO:0099054,0.518399835065158,0.907627134431158,1,2,presynapse assembly,BP,WNT7A
5728,GO:1902473,0.518399835065158,0.907627134431158,1,2,regulation of protein localization to synapse,BP,WNT7A
5729,GO:1902474,0.518399835065158,0.907627134431158,1,2,positive regulation of protein localization to synapse,BP,WNT7A
5933,GO:1904861,0.518399835065158,0.907627134431158,1,2,excitatory synapse assembly,BP,WNT7A
3384,GO:0044712,0.518518206607662,0.750046719140597,3,9,single-organism catabolic process,BP,GLDC;PIK3CG;ACTN3
3014,GO:0042481,0.518551743253816,0.80829286941914,2,5,regulation of odontogenesis,BP,FGF8;BMP4
3926,GO:0048813,0.518650115484363,0.907517898385317,1,2,dendrite morphogenesis,BP,WNT7A
4647,GO:0060996,0.518843221661055,0.907433552469685,1,2,dendritic spine development,BP,WNT7A
1505,GO:0014823,0.518845356660327,0.907432619622742,1,2,response to activity,BP,BMP6
2390,GO:0032370,0.518845356660327,0.907432619622742,1,2,positive regulation of lipid transport,BP,BMP6
5999,GO:1905954,0.518845356660327,0.907432619622742,1,2,positive regulation of lipid localization,BP,BMP6
4482,GO:0060423,0.51897393891307,0.907376425535058,1,2,foregut regionalization,BP,WNT2
4483,GO:0060424,0.51897393891307,0.907376425535058,1,2,lung field specification,BP,WNT2
4489,GO:0060431,0.51897393891307,0.907376425535058,1,2,primary lung bud formation,BP,WNT2
4514,GO:0060492,0.51897393891307,0.907376425535058,1,2,lung induction,BP,WNT2
4675,GO:0061072,0.51897393891307,0.907376425535058,1,2,iris morphogenesis,BP,WNT2
5368,GO:0097061,0.519011352700705,0.907360070015119,1,2,dendritic spine organization,BP,WNT7A
2936,GO:0042056,0.519198368812276,0.807834641461726,2,5,chemoattractant activity,MF,FGF8;BMP4
2959,GO:0042149,0.519218972506994,0.907269270578093,1,2,cellular response to glucose starvation,BP,PMAIP1
2559,GO:0033079,0.519323740295656,0.907223427500347,1,2,immature T cell proliferation,BP,BMP4
2560,GO:0033080,0.519323740295656,0.907223427500347,1,2,immature T cell proliferation in thymus,BP,BMP4
5127,GO:0072161,0.519323740295656,0.907223427500347,1,2,mesenchymal cell differentiation involved in kidney development,BP,BMP4
6172,GO:2001012,0.519323740295656,0.907223427500347,1,2,mesenchymal cell differentiation involved in renal system development,BP,BMP4
1306,GO:0010256,0.519908826703672,0.678965233064259,6,19,endomembrane system organization,BP,SPTBN5;CDH1;RAB40B;TSPAN15;RAB38;SPTBN4
4191,GO:0051301,0.52026949585962,0.718343086632616,4,12,cell division,BP,WNT7A;FZD7;FGF8;NOTCH1
962,GO:0007159,0.520486846456152,0.748429440586453,3,9,leukocyte cell-cell adhesion,BP,BMP4;PIK3CA;BMP7
2183,GO:0031122,0.521408920720606,0.906307599398147,1,2,cytoplasmic microtubule organization,BP,AXIN1
1736,GO:0017148,0.521521040935374,0.906258170390317,1,2,negative regulation of translation,BP,BMP4
2638,GO:0034249,0.521521040935374,0.906258170390317,1,2,negative regulation of cellular amide metabolic process,BP,BMP4
3219,GO:0043500,0.521718356742787,0.906171136348099,1,2,muscle adaptation,BP,ACTN3
3221,GO:0043502,0.521718356742787,0.906171136348099,1,2,regulation of muscle adaptation,BP,ACTN3
3606,GO:0045980,0.521718356742787,0.906171136348099,1,2,negative regulation of nucleotide metabolic process,BP,ACTN3
3750,GO:0048016,0.521718356742787,0.906171136348099,1,2,inositol phosphate-mediated signaling,BP,ACTN3
5576,GO:1900543,0.521718356742787,0.906171136348099,1,2,negative regulation of purine nucleotide metabolic process,BP,ACTN3
1399,GO:0010771,0.522746743635832,0.90571657532467,1,2,negative regulation of cell morphogenesis involved in differentiation,BP,WNT3
1455,GO:0010977,0.522746743635832,0.90571657532467,1,2,negative regulation of neuron projection development,BP,WNT3
2066,GO:0030516,0.522746743635832,0.90571657532467,1,2,regulation of axon extension,BP,WNT3
2067,GO:0030517,0.522746743635832,0.90571657532467,1,2,negative regulation of axon extension,BP,WNT3
3888,GO:0048675,0.522746743635832,0.90571657532467,1,2,axon extension,BP,WNT3
3932,GO:0048841,0.522746743635832,0.90571657532467,1,2,regulation of axon extension involved in axon guidance,BP,WNT3
3933,GO:0048843,0.522746743635832,0.90571657532467,1,2,negative regulation of axon extension involved in axon guidance,BP,WNT3
3936,GO:0048846,0.522746743635832,0.90571657532467,1,2,axon extension involved in axon guidance,BP,WNT3
3999,GO:0050771,0.522746743635832,0.90571657532467,1,2,negative regulation of axonogenesis,BP,WNT3
4738,GO:0061387,0.522746743635832,0.90571657532467,1,2,regulation of extent of cell growth,BP,WNT3
5715,GO:1902284,0.522746743635832,0.90571657532467,1,2,neuron projection extension involved in neuron projection guidance,BP,WNT3
5753,GO:1902667,0.522746743635832,0.90571657532467,1,2,regulation of axon guidance,BP,WNT3
5754,GO:1902668,0.522746743635832,0.90571657532467,1,2,negative regulation of axon guidance,BP,WNT3
127,GO:0001709,0.522929521018264,0.905635618176987,1,2,cell fate determination,BP,BMP4
877,GO:0006839,0.523491455036255,0.905386405702695,1,2,mitochondrial transport,BP,PMAIP1
5461,GO:0098655,0.523574016089361,0.715477823831515,4,12,cation transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
5465,GO:0098660,0.523574016089361,0.715477823831515,4,12,inorganic ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
5467,GO:0098662,0.523574016089361,0.715477823831515,4,12,inorganic cation transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
2923,GO:0040017,0.523978476743736,0.65298331994972,8,25,positive regulation of locomotion,BP,WNT7A;RRAS2;ARTN;WNT5B;CCL20;HRAS;BMP4;NOTCH1
1852,GO:0021549,0.524314523631187,0.905020519202936,1,2,cerebellum development,BP,WNT7A
1853,GO:0021575,0.524314523631187,0.905020519202936,1,2,hindbrain morphogenesis,BP,WNT7A
1854,GO:0021587,0.524314523631187,0.905020519202936,1,2,cerebellum morphogenesis,BP,WNT7A
1865,GO:0021695,0.524314523631187,0.905020519202936,1,2,cerebellar cortex development,BP,WNT7A
1866,GO:0021696,0.524314523631187,0.905020519202936,1,2,cerebellar cortex morphogenesis,BP,WNT7A
1867,GO:0021697,0.524314523631187,0.905020519202936,1,2,cerebellar cortex formation,BP,WNT7A
1903,GO:0022037,0.524314523631187,0.905020519202936,1,2,metencephalon development,BP,WNT7A
613,GO:0005381,0.524337810241673,0.905010152437039,1,2,iron ion transmembrane transporter activity,MF,TF
3725,GO:0046915,0.524337810241673,0.905010152437039,1,2,transition metal ion transmembrane transporter activity,MF,TF
395,GO:0003129,0.52455835355206,0.904911929825884,1,2,heart induction,BP,BMP4
396,GO:0003130,0.52455835355206,0.904911929825884,1,2,BMP signaling pathway involved in heart induction,BP,BMP4
397,GO:0003133,0.52455835355206,0.904911929825884,1,2,endodermal-mesodermal cell signaling,BP,BMP4
398,GO:0003134,0.52455835355206,0.904911929825884,1,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP4
1894,GO:0021978,0.52455835355206,0.904911929825884,1,2,telencephalon regionalization,BP,BMP4
2915,GO:0039706,0.52455835355206,0.904911929825884,1,2,co-receptor binding,MF,BMP4
4702,GO:0061209,0.52455835355206,0.904911929825884,1,2,cell proliferation involved in mesonephros development,BP,BMP4
5121,GO:0072138,0.52455835355206,0.904911929825884,1,2,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP4
664,GO:0005766,0.524570462177278,0.90490653490978,1,2,primary lysosome,CC,RAB3D
2768,GO:0035577,0.524570462177278,0.90490653490978,1,2,azurophil granule membrane,CC,RAB3D
3039,GO:0042582,0.524570462177278,0.90490653490978,1,2,azurophil granule,CC,RAB3D
1952,GO:0030027,0.524974370782935,0.744721066286551,3,9,lamellipodium,CC,CDH1;AMOT;PIK3CA
3296,GO:0044232,0.524986363830767,0.904721097447592,1,2,organelle membrane contact site,CC,RAB38
3297,GO:0044233,0.524986363830767,0.904721097447592,1,2,ER-mitochondrion membrane contact site,CC,RAB38
161,GO:0001836,0.525022366371014,0.904705032676126,1,2,release of cytochrome c from mitochondria,BP,PMAIP1
259,GO:0002260,0.525022366371014,0.904705032676126,1,2,lymphocyte homeostasis,BP,PMAIP1
1169,GO:0008637,0.525022366371014,0.904705032676126,1,2,apoptotic mitochondrial changes,BP,PMAIP1
1411,GO:0010821,0.525022366371014,0.904705032676126,1,2,regulation of mitochondrion organization,BP,PMAIP1
3094,GO:0043029,0.525022366371014,0.904705032676126,1,2,T cell homeostasis,BP,PMAIP1
4865,GO:0070585,0.525022366371014,0.904705032676126,1,2,protein localization to mitochondrion,BP,PMAIP1
5220,GO:0072655,0.525022366371014,0.904705032676126,1,2,establishment of protein localization to mitochondrion,BP,PMAIP1
5310,GO:0090199,0.525022366371014,0.904705032676126,1,2,regulation of release of cytochrome c from mitochondria,BP,PMAIP1
5663,GO:1901796,0.525022366371014,0.904705032676126,1,2,regulation of signal transduction by p53 class mediator,BP,PMAIP1
6199,GO:2001242,0.525022366371014,0.904705032676126,1,2,regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
1801,GO:0019637,0.526001979183971,0.661075573657988,7,22,organophosphate metabolic process,BP,PIK3CG;ACTN3;MBOAT2;FGF8;FGF17;PIK3CA;GUCY1B3
4716,GO:0061318,0.526198843300312,0.904178987798541,1,2,renal filtration cell differentiation,BP,BMP4
5063,GO:0072010,0.526198843300312,0.904178987798541,1,2,glomerular epithelium development,BP,BMP4
5077,GO:0072050,0.526198843300312,0.904178987798541,1,2,S-shaped body morphogenesis,BP,BMP4
5111,GO:0072112,0.526198843300312,0.904178987798541,1,2,glomerular visceral epithelial cell differentiation,BP,BMP4
5160,GO:0072217,0.526198843300312,0.904178987798541,1,2,negative regulation of metanephros development,BP,BMP4
5174,GO:0072284,0.526198843300312,0.904178987798541,1,2,metanephric S-shaped body morphogenesis,BP,BMP4
5181,GO:0072311,0.526198843300312,0.904178987798541,1,2,glomerular epithelial cell differentiation,BP,BMP4
4714,GO:0061312,0.526725636288244,0.903942755090323,1,2,BMP signaling pathway involved in heart development,BP,BMP4
5812,GO:1903307,0.526952140840991,0.903841051916096,1,2,positive regulation of regulated secretory pathway,BP,RAB3D
2018,GO:0030258,0.527214176984089,0.712304099773154,4,12,lipid modification,BP,PIK3CG;FGF8;FGF17;PIK3CA
3910,GO:0048745,0.528185082268447,0.903286067950597,1,2,smooth muscle tissue development,BP,BMP4
4696,GO:0061156,0.528185082268447,0.903286067950597,1,2,pulmonary artery morphogenesis,BP,BMP4
5222,GO:0072657,0.528426189803095,0.671160423977348,6,19,protein localization to membrane,BP,PMAIP1;CDH1;RAB40B;TSPAN15;RAB38;SPTBN4
19,GO:0000149,0.528897970765909,0.902964109925857,1,2,SNARE binding,MF,SYT5
1834,GO:0019905,0.528897970765909,0.902964109925857,1,2,syntaxin binding,MF,SYT5
6195,GO:2001237,0.529059396426802,0.800761141230833,2,5,negative regulation of extrinsic apoptotic signaling pathway,BP,BMP4;GDNF
2858,GO:0036094,0.529418800679313,0.604786614754157,16,52,small molecule binding,MF,GLDC;PIK3CG;MAPK12;RAB40B;RRAS2;VDR;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
4664,GO:0061038,0.529554966810055,0.902666701067102,1,2,uterus morphogenesis,BP,WNT7A
3623,GO:0046189,0.52956496966238,0.902662167830861,1,2,phenol-containing compound biosynthetic process,BP,PNMT
4017,GO:0050806,0.529662835122846,0.902617807606181,1,2,positive regulation of synaptic transmission,BP,WNT7A
4391,GO:0060078,0.529662835122846,0.902617807606181,1,2,regulation of postsynaptic membrane potential,BP,WNT7A
4392,GO:0060079,0.529662835122846,0.902617807606181,1,2,excitatory postsynaptic potential,BP,WNT7A
248,GO:0002220,0.530670742972296,0.90216008403228,1,2,innate immune response activating cell surface receptor signaling pathway,BP,HRAS
250,GO:0002223,0.530670742972296,0.90216008403228,1,2,stimulatory C-type lectin receptor signaling pathway,BP,HRAS
3748,GO:0048013,0.530891470851925,0.902059634434943,1,2,ephrin receptor signaling pathway,BP,HRAS
816,GO:0006584,0.531016071285117,0.902002897488884,1,2,catecholamine metabolic process,BP,PNMT
1239,GO:0009712,0.531016071285117,0.902002897488884,1,2,catechol-containing compound metabolic process,BP,PNMT
2529,GO:0032945,0.531643466803794,0.901716846118047,1,2,negative regulation of mononuclear cell proliferation,BP,BMP4
2956,GO:0042129,0.531643466803794,0.901716846118047,1,2,regulation of T cell proliferation,BP,BMP4
2957,GO:0042130,0.531643466803794,0.901716846118047,1,2,negative regulation of T cell proliferation,BP,BMP4
3963,GO:0050672,0.531643466803794,0.901716846118047,1,2,negative regulation of lymphocyte proliferation,BP,BMP4
4040,GO:0050868,0.531643466803794,0.901716846118047,1,2,negative regulation of T cell activation,BP,BMP4
4876,GO:0070664,0.531643466803794,0.901716846118047,1,2,negative regulation of leukocyte proliferation,BP,BMP4
5791,GO:1903038,0.531643466803794,0.901716846118047,1,2,negative regulation of leukocyte cell-cell adhesion,BP,BMP4
605,GO:0005251,0.531707744502115,0.901687505155345,1,2,delayed rectifier potassium channel activity,MF,KCNG2
1882,GO:0021884,0.531767236677147,0.901660342925793,1,2,forebrain neuron development,BP,FGF8
3939,GO:0048853,0.531767236677147,0.901660342925793,1,2,forebrain morphogenesis,BP,FGF8
262,GO:0002274,0.532344197010769,0.738564605789434,3,9,myeloid leukocyte activation,BP,PIK3CG;PKP1;RAB3D
3944,GO:0048863,0.53234896193202,0.707795992896114,4,12,stem cell differentiation,BP,WNT7A;WNT3;GDNF;NOTCH1
871,GO:0006816,0.532364990727253,0.738547118256162,3,9,calcium ion transport,BP,PIK3CG;VDR;TSPAN13
1850,GO:0021543,0.532920125747764,0.901132882546307,1,2,pallium development,BP,FGF8
1447,GO:0010950,0.533221174053384,0.900994808119222,1,2,positive regulation of endopeptidase activity,BP,PMAIP1
3170,GO:0043280,0.533221174053384,0.900994808119222,1,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
6181,GO:2001056,0.533221174053384,0.900994808119222,1,2,positive regulation of cysteine-type endopeptidase activity,BP,PMAIP1
3508,GO:0045619,0.533288261990271,0.900964019256359,1,2,regulation of lymphocyte differentiation,BP,BMP4
3783,GO:0048259,0.534014165013539,0.900630428380657,1,2,regulation of receptor-mediated endocytosis,BP,TF
723,GO:0005975,0.535482317939691,0.735917930159945,3,9,carbohydrate metabolic process,BP,ACTN3;PMAIP1;PIK3CA
3385,GO:0044723,0.535482317939691,0.735917930159945,3,9,single-organism carbohydrate metabolic process,BP,ACTN3;PMAIP1;PIK3CA
1351,GO:0010605,0.535650277338352,0.613914068773906,12,39,negative regulation of macromolecule metabolic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;DUSP5;INHBB;PKP1;HRAS;BMP4;BMP7;NOTCH1
5186,GO:0072332,0.535709461967576,0.89984813161187,1,2,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1
407,GO:0003159,0.535739443850579,0.89983425577453,1,2,morphogenesis of an endothelium,BP,BMP4
4694,GO:0061154,0.535739443850579,0.89983425577453,1,2,endothelial tube morphogenesis,BP,BMP4
2477,GO:0032732,0.535838884428172,0.899788223802309,1,2,positive regulation of interleukin-1 production,BP,CCL20
6108,GO:2000403,0.535838884428172,0.899788223802309,1,2,positive regulation of lymphocyte migration,BP,CCL20
6109,GO:2000404,0.535838884428172,0.899788223802309,1,2,regulation of T cell migration,BP,CCL20
6110,GO:2000406,0.535838884428172,0.899788223802309,1,2,positive regulation of T cell migration,BP,CCL20
2576,GO:0033162,0.536175852260364,0.899632122357543,1,2,melanosome membrane,CC,RAB38
3416,GO:0045009,0.536175852260364,0.899632122357543,1,2,chitosome,CC,RAB38
86,GO:0001502,0.537452826893097,0.899038932515821,1,2,cartilage condensation,BP,WNT7A
5472,GO:0098743,0.537452826893097,0.899038932515821,1,2,cell aggregation,BP,WNT7A
4954,GO:0071359,0.537576829257514,0.898981192586031,1,2,cellular response to dsRNA,BP,BMP4
2166,GO:0031069,0.538986147556071,0.898323249031666,1,2,hair follicle morphogenesis,BP,NOTCH1
3904,GO:0048730,0.538986147556071,0.898323249031666,1,2,epidermis morphogenesis,BP,NOTCH1
5965,GO:1905276,0.539030693513296,0.89830240117064,1,2,regulation of epithelial tube formation,BP,GDNF
4403,GO:0060128,0.539098708667669,0.898270563444065,1,2,corticotropin hormone secreting cell differentiation,BP,FGF8
195,GO:0001944,0.539202887340367,0.615503807127574,11,36,vasculature development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
5188,GO:0072358,0.539202887340367,0.615503807127574,11,36,cardiovascular system development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
634,GO:0005543,0.539375427533791,0.73261338748064,3,9,phospholipid binding,MF,SYT5;FZD7;SPTBN4
1619,GO:0016264,0.539381012122607,0.898138339119533,1,2,gap junction assembly,BP,GJB2
5987,GO:1905867,0.539381012122607,0.898138339119533,1,2,epididymis development,BP,GJB2
193,GO:0001941,0.540165861675308,0.897770066028764,1,2,postsynaptic membrane organization,BP,GDNF
5657,GO:1901699,0.540363815860382,0.646026184374803,7,23,cellular response to nitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;BMP4;PIK3CA;GUCY1B3
469,GO:0003339,0.54120279822648,0.897281996732544,1,2,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
5107,GO:0072108,0.54120279822648,0.897281996732544,1,2,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
6140,GO:2000696,0.54120279822648,0.897281996732544,1,2,regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
6141,GO:2000698,0.54120279822648,0.897281996732544,1,2,positive regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
3282,GO:0044058,0.541521220259631,0.897131774830508,1,2,regulation of digestive system process,BP,WNK4
4273,GO:0051781,0.542220736143898,0.896801192535549,1,2,positive regulation of cell division,BP,FGF8
1658,GO:0016462,0.543795577710872,0.634215747536396,8,25,pyrophosphatase activity,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20
1705,GO:0016817,0.543795577710872,0.634215747536396,8,25,hydrolase activity, acting on acid anhydrides,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20
1706,GO:0016818,0.543795577710872,0.634215747536396,8,25,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20
1730,GO:0017111,0.543795577710872,0.634215747536396,8,25,nucleoside-triphosphatase activity,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20
696,GO:0005881,0.543856763225572,0.896024949526126,1,2,cytoplasmic microtubule,CC,RAB3D
960,GO:0007156,0.544917301710998,0.776708768040369,2,6,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH1;DSG3
3262,GO:0043627,0.544960211474532,0.895498954385518,1,2,response to estrogen,BP,WNT7A
299,GO:0002443,0.545419640587206,0.727436246784594,3,9,leukocyte mediated immunity,BP,PIK3CG;PKP1;RAB3D
257,GO:0002252,0.54543182663842,0.671248228775792,5,16,immune effector process,BP,PIK3CG;PMAIP1;PKP1;RAB3D;PIK3CA
4211,GO:0051427,0.545695569600577,0.895147324164962,1,2,hormone receptor binding,MF,VDR
1782,GO:0019220,0.545720283363884,0.588830973500978,16,52,regulation of phosphate metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
4131,GO:0051174,0.545720283363884,0.588830973500978,16,52,regulation of phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;DUSP5;INHBB;CCL20;HRAS;BMP4;PIK3CA;BMP7;SPTBN4
595,GO:0005215,0.545827993685386,0.654943772346177,6,19,transporter activity,MF,SLC2A14;GJB2;GJA3;KCNG2;KCNK6;TF
1271,GO:0009914,0.545875989136871,0.72704304210782,3,9,hormone transport,BP,BMP6;KCNG2;INHBB
3707,GO:0046879,0.545875989136871,0.72704304210782,3,9,hormone secretion,BP,BMP6;KCNG2;INHBB
3711,GO:0046883,0.545875989136871,0.72704304210782,3,9,regulation of hormone secretion,BP,BMP6;KCNG2;INHBB
550,GO:0004871,0.5461737253816,0.630604517874959,8,26,signal transducer activity,MF,WNT7A;WNT3;AXIN1;MAPK12;WNT2;FZD7;VDR;PKP1
965,GO:0007163,0.546201022799955,0.726762782971104,3,9,establishment or maintenance of cell polarity,BP,WNT7A;WNT7B;AMOT
314,GO:0002548,0.546202307083643,0.894904502564167,1,2,monocyte chemotaxis,BP,CCL20
5005,GO:0071674,0.546202307083643,0.894904502564167,1,2,mononuclear cell migration,BP,CCL20
5327,GO:0090303,0.547967844295039,0.894055206122134,1,2,positive regulation of wound healing,BP,HRAS
5789,GO:1903036,0.547967844295039,0.894055206122134,1,2,positive regulation of response to wounding,BP,HRAS
4572,GO:0060684,0.547980556551984,0.894049072497298,1,2,epithelial-mesenchymal cell signaling,BP,BMP4
1147,GO:0008406,0.548270177169149,0.72497476120493,3,9,gonad development,BP,FGF8;INHBB;FSTL3
3446,GO:0045137,0.548270177169149,0.72497476120493,3,9,development of primary sexual characteristics,BP,FGF8;INHBB;FSTL3
2997,GO:0042391,0.548829919773174,0.724489909086435,3,9,regulation of membrane potential,BP,WNT7A;PMAIP1;KCNK6
2484,GO:0032770,0.549494561502253,0.893316670797431,1,2,positive regulation of monooxygenase activity,BP,GDNF
3215,GO:0043487,0.549494561502253,0.893316670797431,1,2,regulation of RNA stability,BP,GDNF
3216,GO:0043488,0.549494561502253,0.893316670797431,1,2,regulation of mRNA stability,BP,GDNF
1347,GO:0010594,0.549560460508513,0.723856365502714,3,9,regulation of endothelial cell migration,BP,WNT7A;BMP4;NOTCH1
1006,GO:0007270,0.54981550548612,0.893160928937296,1,2,neuron-neuron synaptic transmission,BP,GDNF
1053,GO:0007569,0.550665719434436,0.892747530361224,1,2,cell aging,BP,HRAS
1310,GO:0010332,0.550665719434436,0.892747530361224,1,2,response to gamma radiation,BP,HRAS
4985,GO:0071480,0.550665719434436,0.892747530361224,1,2,cellular response to gamma radiation,BP,HRAS
5337,GO:0090398,0.550665719434436,0.892747530361224,1,2,cellular senescence,BP,HRAS
1968,GO:0030057,0.551255666514877,0.771693073554307,2,6,desmosome,CC,DSG3;PKP1
3375,GO:0044699,0.551519672398354,0.615613360924196,64,211,single-organism process,BP,SLC2A14;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;CLDN18;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;GDNF;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF
1044,GO:0007507,0.551947331125998,0.634964931515248,7,23,heart development,BP,HEY1;WNT2;FZD7;FGF8;BMP4;BMP7;NOTCH1
163,GO:0001838,0.552754882378608,0.721076140638167,3,9,embryonic epithelial tube formation,BP,BMP4;GDNF;BMP7
188,GO:0001933,0.553783708640626,0.72017725873338,3,9,negative regulation of protein phosphorylation,BP,DUSP5;BMP4;BMP7
2229,GO:0031400,0.553783708640626,0.72017725873338,3,9,negative regulation of protein modification process,BP,DUSP5;BMP4;BMP7
3827,GO:0048519,0.555639169873521,0.55701076491573,31,103,negative regulation of biological process,BP,TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;AXIN1;MAPK12;SPTBN5;CDH1;SPTB;FZD7;FGF8;VDR;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
157,GO:0001823,0.555882833293724,0.686657714517109,4,12,mesonephros development,BP,FGF8;BMP4;GDNF;BMP7
4274,GO:0051783,0.556305002524362,0.717967262461163,3,9,regulation of nuclear division,BP,FGF8;BMP4;BMP7
2733,GO:0035239,0.556768001792886,0.620351738755089,8,26,tube morphogenesis,BP,WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
3873,GO:0048644,0.557248454742308,0.7668852468816,2,6,muscle organ morphogenesis,BP,WNT2;NOTCH1
4269,GO:0051767,0.558438063854246,0.888912490801772,1,2,nitric-oxide synthase biosynthetic process,BP,CCL20
4270,GO:0051769,0.558438063854246,0.888912490801772,1,2,regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
4785,GO:0070098,0.558438063854246,0.888912490801772,1,2,chemokine-mediated signaling pathway,BP,CCL20
4862,GO:0070555,0.558438063854246,0.888912490801772,1,2,response to interleukin-1,BP,CCL20
4949,GO:0071347,0.558438063854246,0.888912490801772,1,2,cellular response to interleukin-1,BP,CCL20
5305,GO:0090190,0.558945158146161,0.888658741210315,1,2,positive regulation of branching involved in ureteric bud morphogenesis,BP,GDNF
3064,GO:0042742,0.559393652458791,0.888433950187156,1,2,defense response to bacterium,BP,CCL20
1137,GO:0008324,0.559682196039546,0.714991055975272,3,9,cation transmembrane transporter activity,MF,KCNG2;KCNK6;TF
352,GO:0002761,0.55995237002247,0.764694867637347,2,6,regulation of myeloid leukocyte differentiation,BP,CLDN18;FSTL3
1504,GO:0014821,0.561475861343955,0.887385819574839,1,2,phasic smooth muscle contraction,BP,GDNF
1558,GO:0015696,0.561475861343955,0.887385819574839,1,2,ammonium transport,BP,GDNF
717,GO:0005938,0.561769455431868,0.677363708243248,4,13,cell cortex,CC,SPTBN5;CDH1;SPTB;SPTBN4
5523,GO:0099568,0.561769455431868,0.677363708243248,4,13,cytoplasmic region,CC,SPTBN5;CDH1;SPTB;SPTBN4
2964,GO:0042176,0.5621298058764,0.762921354226364,2,6,regulation of protein catabolic process,BP,AXIN1;RNF144A
1264,GO:0009894,0.562587307317616,0.636998864655721,6,20,regulation of catabolic process,BP,PIK3CG;ACTN3;AXIN1;PKP1;RNF144A;PIK3CA
4405,GO:0060135,0.562976986695768,0.762228998352809,2,6,maternal process involved in female pregnancy,BP,GJB2;VDR
1636,GO:0016337,0.563787566611359,0.612265645226432,8,27,single organismal cell-cell adhesion,BP,PIK3CG;WNT7B;CDH1;PKP1;BMP4;PIK3CA;BMP7;FSTL3
2543,GO:0033002,0.563811849847552,0.71132668748026,3,9,muscle cell proliferation,BP,WNT2;BMP4;NOTCH1
5481,GO:0098796,0.565343865605265,0.674029645187015,4,13,membrane protein complex,CC,GJB2;GJA3;GJB6;CDH1
1982,GO:0030141,0.565373991417016,0.63628620414901,6,19,secretory granule,CC,SYT5;PKP1;RAB3D;FSTL3;NOTCH1;TF
6173,GO:2001020,0.565396391050254,0.885392072507709,1,2,regulation of response to DNA damage stimulus,BP,PMAIP1
6174,GO:2001022,0.565396391050254,0.885392072507709,1,2,positive regulation of response to DNA damage stimulus,BP,PMAIP1
1728,GO:0017076,0.565568160430674,0.575593484575653,14,46,purine nucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
2432,GO:0032553,0.565568160430674,0.575593484575653,14,46,ribonucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
2433,GO:0032555,0.565568160430674,0.575593484575653,14,46,purine ribonucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
950,GO:0007067,0.565711461568791,0.709631792687063,3,9,mitotic nuclear division,BP,FGF8;BMP4;BMP7
5885,GO:1903829,0.565896116524466,0.673512859590954,4,13,positive regulation of cellular protein localization,BP,BMP6;PMAIP1;CDH1;BMP4
592,GO:0005198,0.566547634402612,0.620801207424,7,23,structural molecule activity,MF,ACTN3;CLDN18;AXIN1;SPTB;PKP1;CLDN15;SPTBN4
4063,GO:0050926,0.567904612879805,0.884102526704937,1,2,regulation of positive chemotaxis,BP,ARTN
4064,GO:0050927,0.567904612879805,0.884102526704937,1,2,positive regulation of positive chemotaxis,BP,ARTN
4065,GO:0050930,0.567904612879805,0.884102526704937,1,2,induction of positive chemotaxis,BP,ARTN
4504,GO:0060449,0.568083875823186,0.884009940762237,1,2,bud elongation involved in lung branching,BP,BMP4
4548,GO:0060592,0.568083875823186,0.884009940762237,1,2,mammary gland formation,BP,BMP4
1052,GO:0007568,0.568100090872963,0.707492205951975,3,9,aging,BP,GJB2;GJB6;HRAS
5089,GO:0072079,0.568612457790831,0.883736609185462,1,2,nephron tubule formation,BP,GDNF
3318,GO:0044282,0.569246867799251,0.757064080440962,2,6,small molecule catabolic process,BP,GLDC;ACTN3
1369,GO:0010648,0.569497338020471,0.579929735489955,12,40,negative regulation of cell communication,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;INHBB;BMP4;GDNF;BMP7;FSTL3;NOTCH1
1943,GO:0023057,0.569497338020471,0.579929735489955,12,40,negative regulation of signaling,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;INHBB;BMP4;GDNF;BMP7;FSTL3;NOTCH1
893,GO:0006897,0.569730246923954,0.617680474461551,7,23,endocytosis,BP,PIK3CG;SYT5;RAB39A;HRAS;PIK3CA;RAB20;TF
5905,GO:1904062,0.570669335057408,0.755882208143508,2,6,regulation of cation transmembrane transport,BP,PIK3CG;TSPAN13
119,GO:0001678,0.57082703073939,0.755750953730966,2,6,cellular glucose homeostasis,BP,GJB6;PIK3CA
742,GO:0006081,0.570865968653069,0.755718537529881,2,6,cellular aldehyde metabolic process,BP,GLDC;BMP6
1826,GO:0019897,0.570902790788127,0.75568788014287,2,6,extrinsic component of plasma membrane,CC,CDH1;TF
3496,GO:0045598,0.571443637335442,0.755237291403926,2,6,regulation of fat cell differentiation,BP,AXIN1;WNT5B
166,GO:0001841,0.571517175377755,0.755175983537996,2,6,neural tube formation,BP,BMP4;BMP7
1469,GO:0014020,0.571517175377755,0.755175983537996,2,6,primary neural tube formation,BP,BMP4;BMP7
1587,GO:0016020,0.572010944295337,0.5479540583545,50,166,membrane,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;PIK3CG;SYT5;RHBDL3;CLDN18;RABIF;MBOAT2;GJA3;WNT3;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;RAB39A;DSG3;AMOT;WNT5B;WNK4;PKP1;TSPAN15;HRAS;RAB3D;KCNK6;CLDN15;RNF144A;RAB38;PIK3CA;DRP2;TMEM206;SPTBN4;TSPAN13;NOTCH1;RND3;RAB20;GUCY1B3;TF
4322,GO:0055006,0.572356621309908,0.754475432741041,2,6,cardiac cell development,BP,BMP4;NOTCH1
4414,GO:0060174,0.573230058034426,0.881327810696109,1,2,limb bud formation,BP,WNT3
4032,GO:0050851,0.573361775519383,0.753634862184422,2,6,antigen receptor-mediated signaling pathway,BP,HRAS;PIK3CA
4033,GO:0050852,0.573361775519383,0.753634862184422,2,6,T cell receptor signaling pathway,BP,HRAS;PIK3CA
4529,GO:0060538,0.573932706067021,0.753156574563454,2,6,skeletal muscle organ development,BP,ACTN3;NOTCH1
1698,GO:0016787,0.574166386158322,0.581024942797995,11,36,hydrolase activity,MF,RHBDL3;RAB40B;RRAS2;RAB39A;DUSP5;HRAS;RAB3D;RAB38;RND3;RAB20;PM20D2
2222,GO:0031347,0.574339386212735,0.752815512791813,2,6,regulation of defense response,BP,PIK3CG;HRAS
1780,GO:0019218,0.574854159622895,0.752383354134047,2,6,regulation of steroid metabolic process,BP,BMP6;VDR
4020,GO:0050810,0.574854159622895,0.752383354134047,2,6,regulation of steroid biosynthetic process,BP,BMP6;VDR
4035,GO:0050863,0.57574506441822,0.751634252951193,2,6,regulation of T cell activation,BP,BMP4;PIK3CA
5790,GO:1903037,0.57574506441822,0.751634252951193,2,6,regulation of leukocyte cell-cell adhesion,BP,BMP4;PIK3CA
915,GO:0006954,0.576968504162791,0.663056424310051,4,13,inflammatory response,BP,PIK3CG;BMP6;CCL20;NOTCH1
4101,GO:0051090,0.577834380048284,0.749871628075795,2,6,regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;BMP7
112,GO:0001658,0.577949227289718,0.69857044700132,3,9,branching involved in ureteric bud morphogenesis,BP,FGF8;BMP4;GDNF
4568,GO:0060675,0.577949227289718,0.69857044700132,3,9,ureteric bud morphogenesis,BP,FGF8;BMP4;GDNF
5133,GO:0072171,0.577949227289718,0.69857044700132,3,9,mesonephric tubule morphogenesis,BP,FGF8;BMP4;GDNF
4558,GO:0060627,0.577986177341179,0.640338719772823,5,16,regulation of vesicle-mediated transport,BP,SYT5;RAB3D;NOTCH1;RAB20;TF
1659,GO:0016477,0.578097350831217,0.559094224943125,15,50,cell migration,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;NOTCH1
572,GO:0005111,0.578171916870286,0.87870756839124,1,2,type 2 fibroblast growth factor receptor binding,MF,FGF17
227,GO:0002066,0.578405521236142,0.749388357413697,2,6,columnar/cuboidal epithelial cell development,BP,BMP6;BMP4
38,GO:0000302,0.579207760690376,0.748708499978806,2,6,response to reactive oxygen species,BP,BMP7;GUCY1B3
265,GO:0002283,0.579306303262697,0.748624905979729,2,6,neutrophil activation involved in immune response,BP,PKP1;RAB3D
301,GO:0002446,0.579306303262697,0.748624905979729,2,6,neutrophil mediated immunity,BP,PKP1;RAB3D
2864,GO:0036230,0.579306303262697,0.748624905979729,2,6,granulocyte activation,BP,PKP1;RAB3D
2954,GO:0042119,0.579306303262697,0.748624905979729,2,6,neutrophil activation,BP,PKP1;RAB3D
3178,GO:0043312,0.579306303262697,0.748624905979729,2,6,neutrophil degranulation,BP,PKP1;RAB3D
2921,GO:0040013,0.579523500470855,0.748440591782384,2,6,negative regulation of locomotion,BP,WNT3;NOTCH1
4177,GO:0051271,0.579523500470855,0.748440591782384,2,6,negative regulation of cellular component movement,BP,WNT3;NOTCH1
882,GO:0006874,0.581141338760373,0.747064868080577,2,6,cellular calcium ion homeostasis,BP,PIK3CG;VDR
4343,GO:0055074,0.581141338760373,0.747064868080577,2,6,calcium ion homeostasis,BP,PIK3CG;VDR
5197,GO:0072503,0.581141338760373,0.747064868080577,2,6,cellular divalent inorganic cation homeostasis,BP,PIK3CG;VDR
5198,GO:0072507,0.581141338760373,0.747064868080577,2,6,divalent inorganic cation homeostasis,BP,PIK3CG;VDR
2136,GO:0030878,0.581304608735817,0.877023581989056,1,2,thyroid gland development,BP,FGF8
2146,GO:0030916,0.581304608735817,0.877023581989056,1,2,otic vesicle formation,BP,FGF8
4998,GO:0071599,0.581304608735817,0.877023581989056,1,2,otic vesicle development,BP,FGF8
4999,GO:0071600,0.581304608735817,0.877023581989056,1,2,otic vesicle morphogenesis,BP,FGF8
4258,GO:0051656,0.582302023107916,0.694575870597689,3,9,establishment of organelle localization,BP,WNT7A;PIK3CG;SYT5
5479,GO:0098793,0.582931703720301,0.693995362332083,3,9,presynapse,CC,WNT7A;SYT5;RAB40B
5031,GO:0071804,0.583165865703759,0.745336287803622,2,6,cellular potassium ion transport,BP,KCNG2;KCNK6
5032,GO:0071805,0.583165865703759,0.745336287803622,2,6,potassium ion transmembrane transport,BP,KCNG2;KCNK6
2689,GO:0034703,0.583356588554938,0.745173040866537,2,6,cation channel complex,CC,KCNG2;KCNK6
286,GO:0002376,0.583415268468608,0.550279745918933,16,54,immune system process,BP,PIK3CG;CLDN18;BMP6;JAG2;PMAIP1;FZD7;ARTN;CCL20;PKP1;HRAS;RAB3D;BMP4;PIK3CA;FSTL3;TPD52;NOTCH1
2738,GO:0035265,0.585671060113384,0.691462091634678,3,9,organ growth,BP,WNT2;FGF8;NOTCH1
1062,GO:0007600,0.588301929573269,0.652163132055763,4,13,sensory perception,BP,GJB2;GJA3;GJB6;SPTBN4
1243,GO:0009743,0.589477971695775,0.739896303740621,2,6,response to carbohydrate,BP,GJB6;PIK3CA
1245,GO:0009746,0.589477971695775,0.739896303740621,2,6,response to hexose,BP,GJB6;PIK3CA
1246,GO:0009749,0.589477971695775,0.739896303740621,2,6,response to glucose,BP,GJB6;PIK3CA
2640,GO:0034284,0.589477971695775,0.739896303740621,2,6,response to monosaccharide,BP,GJB6;PIK3CA
4500,GO:0060443,0.591116219211655,0.738471781048044,2,6,mammary gland morphogenesis,BP,VDR;BMP4
639,GO:0005576,0.591388692873797,0.521932908809598,29,96,extracellular region,CC,WNT7A;ACTN3;BMP6;WNT3;WNT7B;KCNG2;WNT2;SPTBN5;CDH1;RRAS2;FGF8;ARTN;DSG3;WNT5B;INHBB;CCL20;PKP1;TSPAN15;FGF17;RAB3D;BMP4;GDNF;BMP7;FSTL3;SPTBN4;NOTCH1;RND3;TF;PM20D2
4532,GO:0060548,0.591683979822626,0.569239331154284,10,33,negative regulation of cell death,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;PIK3CA;BMP7;NOTCH1
4989,GO:0071496,0.592120500610705,0.648448756303178,4,13,cellular response to external stimulus,BP,BMP6;PMAIP1;VDR;INHBB
2214,GO:0031329,0.593154485033312,0.622867796399969,5,17,regulation of cellular catabolic process,BP,PIK3CG;AXIN1;PKP1;RNF144A;PIK3CA
3346,GO:0044424,0.594100382369893,0.535115397357704,55,183,intracellular part,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;VDR;RAB39A;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF;PM20D2
4092,GO:0051050,0.594890908082452,0.581153812496129,8,27,positive regulation of transport,BP,BMP6;PMAIP1;CDH1;INHBB;RAB3D;BMP4;GDNF;TF
1133,GO:0008289,0.595681283324073,0.644964860630592,4,13,lipid binding,MF,SYT5;FZD7;VDR;SPTBN4
1231,GO:0009612,0.596562035923674,0.733698595376517,2,6,response to mechanical stimulus,BP,BMP6;INHBB
154,GO:0001819,0.596576748594792,0.733685620660287,2,6,positive regulation of cytokine production,BP,CCL20;HRAS
2920,GO:0040012,0.597385155508022,0.556698092379882,11,37,regulation of locomotion,BP,WNT7A;WNT3;JAG2;RRAS2;ARTN;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
1342,GO:0010563,0.597538472779247,0.643139961132548,4,13,negative regulation of phosphorus metabolic process,BP,ACTN3;DUSP5;BMP4;BMP7
3600,GO:0045936,0.597538472779247,0.643139961132548,4,13,negative regulation of phosphate metabolic process,BP,ACTN3;DUSP5;BMP4;BMP7
596,GO:0005216,0.597613290235985,0.73277044091101,2,6,ion channel activity,MF,KCNG2;KCNK6
1931,GO:0022838,0.597613290235985,0.73277044091101,2,6,substrate-specific channel activity,MF,KCNG2;KCNK6
4894,GO:0070848,0.597613948767081,0.570132935415854,9,30,response to growth factor,BP,WNT7A;BMP6;WNT2;FGF8;FGF17;BMP4;BMP7;FSTL3;NOTCH1
4956,GO:0071363,0.597613948767081,0.570132935415854,9,30,cellular response to growth factor stimulus,BP,WNT7A;BMP6;WNT2;FGF8;FGF17;BMP4;BMP7;FSTL3;NOTCH1
1255,GO:0009880,0.597693118555132,0.732699870669039,2,6,embryonic pattern specification,BP,WNT7A;BMP7
5274,GO:0090066,0.597747147818495,0.602257988570306,6,20,regulation of anatomical structure size,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;SPTBN4
5620,GO:1901363,0.599204898973569,0.526556890828551,19,64,heterocyclic compound binding,MF,GLDC;PIK3CG;HEY1;MAPK12;POU3F1;RAB40B;RRAS2;VDR;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;NOTCH1;RND3;RAB20;GUCY1B3
5157,GO:0072210,0.600311841853553,0.730377812773974,2,6,metanephric nephron development,BP,BMP4;GDNF
2155,GO:0031016,0.601036913823239,0.729732458722827,2,6,pancreas development,BP,BMP6;BMP4
24,GO:0000166,0.604054455329483,0.535905227833067,14,47,nucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
5611,GO:1901265,0.604054455329483,0.535905227833067,14,47,nucleoside phosphate binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
1973,GO:0030099,0.606391741779064,0.665905546550125,3,10,myeloid cell differentiation,BP,CLDN18;BMP4;FSTL3
5405,GO:0097305,0.607533849997913,0.723902529876369,2,6,response to alcohol,BP,CLDN18;CDH1
1869,GO:0021700,0.609814510691329,0.721835662030631,2,6,developmental maturation,BP,RAB38;SPTBN4
911,GO:0006941,0.609936112805243,0.662444276538566,3,10,striated muscle contraction,BP,PIK3CG;ACTN3;PIK3CA
3344,GO:0044421,0.611126005807838,0.503853679934427,26,87,extracellular region part,CC,WNT7A;ACTN3;BMP6;WNT3;WNT7B;KCNG2;WNT2;SPTBN5;CDH1;RRAS2;ARTN;DSG3;WNT5B;INHBB;CCL20;PKP1;TSPAN15;FGF17;RAB3D;BMP4;BMP7;FSTL3;SPTBN4;RND3;TF;PM20D2
5515,GO:0099503,0.611267559817001,0.5758237432313,7,23,secretory vesicle,CC,SYT5;RAB40B;PKP1;RAB3D;FSTL3;NOTCH1;TF
3281,GO:0044057,0.611862713610292,0.563704489104515,8,27,regulation of system process,BP,PIK3CG;ACTN3;BMP6;KCNG2;WNK4;INHBB;KCNK6;SPTBN4
4790,GO:0070161,0.612665621981765,0.561711669725627,8,28,anchoring junction,CC,ACTN3;CDH1;RRAS2;DSG3;PKP1;SPTBN4;NOTCH1;RND3
3947,GO:0048870,0.615398783501827,0.520244675976514,15,51,cell motility,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;NOTCH1
4260,GO:0051674,0.615398783501827,0.520244675976514,15,51,localization of cell,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;ARTN;AMOT;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;PIK3CA;NOTCH1
3149,GO:0043234,0.616537199881277,0.526215596545745,13,45,protein complex,CC,GJB2;GJA3;WNT3;GJB6;AXIN1;POU3F1;WNT2;CDH1;SPTB;VDR;AMOT;NOTCH1;GUCY1B3
1084,GO:0008021,0.617229940834326,0.715041195080006,2,6,synaptic vesicle,CC,SYT5;RAB40B
3831,GO:0048523,0.618185235825904,0.493984522173245,29,98,negative regulation of cellular process,BP,TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;AXIN1;MAPK12;SPTBN5;CDH1;SPTB;FZD7;FGF8;VDR;WNT5B;DUSP5;INHBB;PKP1;HRAS;BMP4;GDNF;PIK3CA;BMP7;FSTL3;SPTBN4;NOTCH1
3009,GO:0042471,0.62010487875875,0.712376130129032,2,6,ear morphogenesis,BP,GJB6;FGF8
657,GO:0005739,0.620405440539551,0.595195180870169,5,17,mitochondrion,CC,GLDC;PMAIP1;MAPK12;RAB3D;RAB38
2328,GO:0032101,0.620462807416754,0.595135783860741,5,17,regulation of response to external stimulus,BP,PIK3CG;BMP6;WNT3;ARTN;NOTCH1
2268,GO:0031668,0.622341308930967,0.65015231443567,3,10,cellular response to extracellular stimulus,BP,PMAIP1;VDR;INHBB
2269,GO:0031669,0.622341308930967,0.65015231443567,3,10,cellular response to nutrient levels,BP,PMAIP1;VDR;INHBB
152,GO:0001817,0.624727699989839,0.647755556596654,3,10,regulation of cytokine production,BP,INHBB;CCL20;HRAS
497,GO:0003824,0.625736798289092,0.49186506130527,23,78,catalytic activity,MF,GLDC;PIK3CG;RHBDL3;MBOAT2;MAPK12;RAB40B;RRAS2;FGF8;RAB39A;WNK4;DUSP5;PKN3;FGF17;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;RND3;PNMT;RAB20;GUCY1B3;PM20D2
6192,GO:2001234,0.626277111460442,0.70659530298777,2,6,negative regulation of apoptotic signaling pathway,BP,BMP4;GDNF
379,GO:0003015,0.62725265287337,0.588070960630234,5,17,heart process,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4
4375,GO:0060047,0.62725265287337,0.588070960630234,5,17,heart contraction,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4
1157,GO:0008543,0.627451791822459,0.705485879872669,2,6,fibroblast growth factor receptor signaling pathway,BP,FGF8;FGF17
3333,GO:0044344,0.627451791822459,0.705485879872669,2,6,cellular response to fibroblast growth factor stimulus,BP,FGF8;FGF17
5025,GO:0071774,0.627451791822459,0.705485879872669,2,6,response to fibroblast growth factor,BP,FGF8;FGF17
536,GO:0004713,0.628451047444775,0.704539793306509,2,6,protein tyrosine kinase activity,MF,FGF8;FGF17
2532,GO:0032956,0.630261120699155,0.606571560657732,4,14,regulation of actin cytoskeleton organization,BP,SPTBN5;SPTB;HRAS;SPTBN4
4896,GO:0070851,0.632062368072574,0.70110256902777,2,6,growth factor receptor binding,MF,FGF8;FGF17
1692,GO:0016747,0.633783361986432,0.80562598488844,1,3,transferase activity, transferring acyl groups other than amino-acyl groups,MF,MBOAT2
3085,GO:0042993,0.634284390316941,0.805230544313515,1,3,positive regulation of transcription factor import into nucleus,BP,CDH1
2659,GO:0034446,0.634678119178073,0.804919341880422,1,3,substrate adhesion-dependent cell spreading,BP,FZD7
2625,GO:0034113,0.634854220949039,0.804780023414501,1,3,heterotypic cell-cell adhesion,BP,BMP7
2331,GO:0032147,0.634857610004977,0.580075480482446,5,17,activation of protein kinase activity,BP,WNT7B;AXIN1;DUSP5;BMP4;PIK3CA
139,GO:0001756,0.635728619456565,0.804087091280664,1,3,somitogenesis,BP,NOTCH1
2887,GO:0038030,0.635770039799087,0.804054218476246,1,3,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD7
295,GO:0002431,0.636087742005824,0.803801931351819,1,3,Fc receptor mediated stimulatory signaling pathway,BP,PIK3CA
296,GO:0002433,0.636087742005824,0.803801931351819,1,3,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3CA
2900,GO:0038094,0.636087742005824,0.803801931351819,1,3,Fc-gamma receptor signaling pathway,BP,PIK3CA
2902,GO:0038096,0.636087742005824,0.803801931351819,1,3,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3CA
5381,GO:0097150,0.636628358402336,0.803372032857556,1,3,neuronal stem cell population maintenance,BP,NOTCH1
5862,GO:1903670,0.636752780943189,0.803272985681824,1,3,regulation of sprouting angiogenesis,BP,NOTCH1
3432,GO:0045087,0.637089166592568,0.635170645597636,3,10,innate immune response,BP,PIK3CG;CCL20;HRAS
5132,GO:0072170,0.637304610983249,0.802833218565034,1,3,metanephric tubule development,BP,WNT7B
131,GO:0001726,0.637591822476505,0.802604022166888,1,3,ruffle,CC,AMOT
29,GO:0000209,0.637748453724588,0.802478939888197,1,3,protein polyubiquitination,BP,RNF144A
3672,GO:0046649,0.638079743424959,0.558510089693727,6,21,lymphocyte activation,BP,PIK3CG;JAG2;FZD7;BMP4;PIK3CA;TPD52
1529,GO:0015075,0.638293660579307,0.633928961443214,3,10,ion transmembrane transporter activity,MF,KCNG2;KCNK6;TF
856,GO:0006766,0.639129075022272,0.801373662701833,1,3,vitamin metabolic process,BP,VDR
121,GO:0001702,0.639135904179431,0.801368183246369,1,3,gastrulation with mouth forming second,BP,AMOT
3059,GO:0042698,0.639238322889813,0.801285991858762,1,3,ovulation cycle,BP,INHBB
3075,GO:0042803,0.639529387807921,0.57511996218169,5,17,protein homodimerization activity,MF,ACTN3;AXIN1;INHBB;GDNF;TPD52
566,GO:0005096,0.639575810990023,0.801014963698967,1,3,GTPase activator activity,MF,AXIN1
136,GO:0001750,0.63961917177071,0.800980120301479,1,3,photoreceptor outer segment,CC,SPTBN5
5437,GO:0097730,0.63961917177071,0.800980120301479,1,3,non-motile cilium,CC,SPTBN5
5438,GO:0097731,0.63961917177071,0.800980120301479,1,3,9+0 non-motile cilium,CC,SPTBN5
5439,GO:0097733,0.63961917177071,0.800980120301479,1,3,photoreceptor cell cilium,CC,SPTBN5
5626,GO:1901522,0.640387889070437,0.800361590534295,1,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,NOTCH1
1136,GO:0008307,0.640670191229732,0.800134056446349,1,3,structural constituent of muscle,MF,ACTN3
3497,GO:0045599,0.641006108335031,0.799863038006287,1,3,negative regulation of fat cell differentiation,BP,AXIN1
4060,GO:0050920,0.641963874338435,0.630128295840467,3,10,regulation of chemotaxis,BP,WNT3;ARTN;NOTCH1
1195,GO:0009141,0.641966286902178,0.799086737360283,1,3,nucleoside triphosphate metabolic process,BP,ACTN3
1196,GO:0009144,0.641966286902178,0.799086737360283,1,3,purine nucleoside triphosphate metabolic process,BP,ACTN3
1208,GO:0009199,0.641966286902178,0.799086737360283,1,3,ribonucleoside triphosphate metabolic process,BP,ACTN3
1209,GO:0009205,0.641966286902178,0.799086737360283,1,3,purine ribonucleoside triphosphate metabolic process,BP,ACTN3
3857,GO:0048596,0.642026824571166,0.799037711962983,1,3,embryonic camera-type eye morphogenesis,BP,BMP7
3328,GO:0044325,0.642102885090563,0.798976102024557,1,3,ion channel binding,MF,ACTN3
1305,GO:0010243,0.642185724597134,0.540307132259029,7,25,response to organonitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;PIK3CA;BMP7;NOTCH1
5085,GO:0072075,0.642252030549797,0.798855248336921,1,3,metanephric mesenchyme development,BP,BMP7
1286,GO:0009991,0.642399051436768,0.593810604836012,4,14,response to extracellular stimulus,BP,PMAIP1;VDR;INHBB;BMP7
2267,GO:0031667,0.642399051436768,0.593810604836012,4,14,response to nutrient levels,BP,PMAIP1;VDR;INHBB;BMP7
2186,GO:0031143,0.642637194446364,0.798542876933328,1,3,pseudopodium,CC,ACTN3
1326,GO:0010507,0.642941287099209,0.798295979560042,1,3,negative regulation of autophagy,BP,PIK3CA
1616,GO:0016242,0.642941287099209,0.798295979560042,1,3,negative regulation of macroautophagy,BP,PIK3CA
5235,GO:0085029,0.64324432767325,0.798049694264171,1,3,extracellular matrix assembly,BP,NOTCH1
787,GO:0006401,0.643315952126467,0.797991448728684,1,3,RNA catabolic process,BP,PKP1
788,GO:0006402,0.643315952126467,0.797991448728684,1,3,mRNA catabolic process,BP,PKP1
1603,GO:0016071,0.643315952126467,0.797991448728684,1,3,mRNA metabolic process,BP,PKP1
4652,GO:0061013,0.643315952126467,0.797991448728684,1,3,regulation of mRNA catabolic process,BP,PKP1
5813,GO:1903311,0.643315952126467,0.797991448728684,1,3,regulation of mRNA metabolic process,BP,PKP1
414,GO:0003174,0.643572963019596,0.797782334233465,1,3,mitral valve development,BP,NOTCH1
421,GO:0003183,0.643572963019596,0.797782334233465,1,3,mitral valve morphogenesis,BP,NOTCH1
3960,GO:0050663,0.64366415096745,0.797708098142178,1,3,cytokine secretion,BP,NOTCH1
1844,GO:0021510,0.644022071223738,0.797416503141691,1,3,spinal cord development,BP,NOTCH1
2827,GO:0035924,0.644022071223738,0.797416503141691,1,3,cellular response to vascular endothelial growth factor stimulus,BP,NOTCH1
3301,GO:0044242,0.64403970250005,0.797402130324935,1,3,cellular lipid catabolic process,BP,PIK3CG
1385,GO:0010717,0.644313034397948,0.79717920812896,1,3,regulation of epithelial to mesenchymal transition,BP,NOTCH1
1386,GO:0010718,0.644313034397948,0.79717920812896,1,3,positive regulation of epithelial to mesenchymal transition,BP,NOTCH1
5767,GO:1902882,0.645219298157376,0.796438668345838,1,3,regulation of response to oxidative stress,BP,BMP7
3675,GO:0046661,0.645416185320185,0.62652956526491,3,10,male sex differentiation,BP,BMP6;FGF8;FSTL3
2607,GO:0033627,0.645534587886345,0.7961805232417,1,3,cell adhesion mediated by integrin,BP,PIK3CG
1016,GO:0007346,0.645687422209807,0.5938860291761,4,13,regulation of mitotic cell cycle,BP,FGF8;HRAS;BMP4;BMP7
1598,GO:0016054,0.645756967318283,0.795998290043946,1,3,organic acid catabolic process,BP,GLDC
3639,GO:0046395,0.645756967318283,0.795998290043946,1,3,carboxylic acid catabolic process,BP,GLDC
5632,GO:1901565,0.646196537194904,0.795637688736474,1,3,organonitrogen compound catabolic process,BP,GLDC
4859,GO:0070527,0.646296737795041,0.795555417109546,1,3,platelet aggregation,BP,PIK3CG
4751,GO:0061515,0.646422729734514,0.795451931023185,1,3,myeloid cell development,BP,CLDN18
360,GO:0002793,0.646675314179831,0.795244338031951,1,3,positive regulation of peptide secretion,BP,BMP6
4339,GO:0055065,0.647147375923193,0.588750556632479,4,14,metal ion homeostasis,BP,PIK3CG;BMP6;VDR;TF
2044,GO:0030335,0.647366231666044,0.536109260960163,7,24,positive regulation of cell migration,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;NOTCH1
4178,GO:0051272,0.647366231666044,0.536109260960163,7,24,positive regulation of cellular component movement,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;NOTCH1
6075,GO:2000147,0.647366231666044,0.536109260960163,7,24,positive regulation of cell motility,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;NOTCH1
3231,GO:0043535,0.647652589058607,0.794439533913936,1,3,regulation of blood vessel endothelial cell migration,BP,NOTCH1
3717,GO:0046889,0.648131665234868,0.794044071574842,1,3,positive regulation of lipid biosynthetic process,BP,BMP6
3634,GO:0046332,0.648992408339876,0.793332006518887,1,3,SMAD binding,MF,AXIN1
4076,GO:0050995,0.649095680600361,0.793246438765285,1,3,negative regulation of lipid catabolic process,BP,PIK3CG
2645,GO:0034332,0.649188988683393,0.674067542648255,2,7,adherens junction organization,BP,ACTN3;CDH1
1488,GO:0014074,0.649227022862064,0.793137571683597,1,3,response to purine-containing compound,BP,PIK3CG
124,GO:0001706,0.649230916777313,0.793134343382264,1,3,endoderm formation,BP,DUSP5
359,GO:0002792,0.649294014656336,0.793082025562854,1,3,negative regulation of peptide secretion,BP,INHBB
3977,GO:0050709,0.649294014656336,0.793082025562854,1,3,negative regulation of protein secretion,BP,INHBB
2580,GO:0033267,0.650369571113304,0.792188571007451,1,3,axon part,CC,SPTBN4
4157,GO:0051235,0.65043632291421,0.792133017823136,1,3,maintenance of location,BP,SPTBN4
115,GO:0001666,0.65060107907316,0.621081114605329,3,10,response to hypoxia,BP,PMAIP1;BMP7;NOTCH1
1701,GO:0016791,0.651624209150207,0.791142396226438,1,3,phosphatase activity,MF,DUSP5
5410,GO:0097367,0.651740158414466,0.475562475657987,17,58,carbohydrate derivative binding,MF,PIK3CG;MAPK12;CDH1;RAB40B;RRAS2;RAB39A;WNK4;PKN3;HRAS;RAB3D;BMP4;RAB38;PIK3CA;BMP7;RND3;RAB20;GUCY1B3
656,GO:0005737,0.652219234810142,0.463650171289255,49,165,cytoplasm,CC,MAGEC2;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;RAB39A;DSG3;AMOT;WNT5B;WNK4;INHBB;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;PIK3CA;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF
3515,GO:0045637,0.652643277072688,0.670549545287425,2,7,regulation of myeloid cell differentiation,BP,CLDN18;FSTL3
2411,GO:0032434,0.65286830602061,0.790100782206248,1,3,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF144A
4686,GO:0061136,0.65286830602061,0.790100782206248,1,3,regulation of proteasomal protein catabolic process,BP,RNF144A
705,GO:0005905,0.653782927381587,0.789332322143071,1,3,clathrin-coated pit,CC,TF
4889,GO:0070820,0.653966033593844,0.789178201787177,1,3,tertiary granule,CC,PKP1
5647,GO:1901652,0.653976383715156,0.557226360005229,5,18,response to peptide,BP,GJB2;INHBB;PIK3CA;BMP7;NOTCH1
4001,GO:0050773,0.654061312672311,0.789097969052501,1,3,regulation of dendrite development,BP,BMP7
1596,GO:0016052,0.654476486647121,0.788748067628066,1,3,carbohydrate catabolic process,BP,ACTN3
1790,GO:0019320,0.654476486647121,0.788748067628066,1,3,hexose catabolic process,BP,ACTN3
3386,GO:0044724,0.654476486647121,0.788748067628066,1,3,single-organism carbohydrate catabolic process,BP,ACTN3
3636,GO:0046365,0.654476486647121,0.788748067628066,1,3,monosaccharide catabolic process,BP,ACTN3
4766,GO:0061695,0.654845257529888,0.668292624577753,2,7,transferase complex, transferring phosphorus-containing groups,CC,PIK3CG;PIK3CA
3800,GO:0048333,0.65501113259583,0.788296778660951,1,3,mesodermal cell differentiation,BP,BMP4
2086,GO:0030662,0.655116740013711,0.788207543410512,1,3,coated vesicle membrane,CC,TF
2087,GO:0030665,0.655116740013711,0.788207543410512,1,3,clathrin-coated vesicle membrane,CC,TF
997,GO:0007259,0.65513687517972,0.788190526279583,1,3,JAK-STAT cascade,BP,NOTCH1
3640,GO:0046425,0.65513687517972,0.788190526279583,1,3,regulation of JAK-STAT cascade,BP,NOTCH1
3641,GO:0046427,0.65513687517972,0.788190526279583,1,3,positive regulation of JAK-STAT cascade,BP,NOTCH1
5433,GO:0097696,0.65513687517972,0.788190526279583,1,3,STAT cascade,BP,NOTCH1
5940,GO:1904892,0.65513687517972,0.788190526279583,1,3,regulation of STAT cascade,BP,NOTCH1
5941,GO:1904894,0.65513687517972,0.788190526279583,1,3,positive regulation of STAT cascade,BP,NOTCH1
4251,GO:0051640,0.655466275278882,0.615920371997575,3,10,organelle localization,BP,WNT7A;PIK3CG;SYT5
5508,GO:0099068,0.656385969228076,0.787132671021842,1,3,postsynapse assembly,BP,WNT7A
491,GO:0003713,0.656803021612384,0.786778508241203,1,3,transcription coactivator activity,MF,POU3F1
1473,GO:0014037,0.657629059682315,0.786075606803483,1,3,Schwann cell differentiation,BP,POU3F1
1235,GO:0009628,0.657945360219057,0.524584707503684,7,24,response to abiotic stimulus,BP,BMP6;GJB6;PMAIP1;INHBB;HRAS;BMP7;NOTCH1
4287,GO:0051896,0.658620561392434,0.785229396986112,1,3,regulation of protein kinase B signaling,BP,PIK3CG
4288,GO:0051897,0.658620561392434,0.785229396986112,1,3,positive regulation of protein kinase B signaling,BP,PIK3CG
1055,GO:0007585,0.658638653153459,0.785213930837107,1,3,respiratory gaseous exchange,BP,JAG2
486,GO:0003690,0.658713700315521,0.785149765308041,1,3,double-stranded DNA binding,MF,HEY1
797,GO:0006470,0.658975107040612,0.784926138801894,1,3,protein dephosphorylation,BP,DUSP5
2220,GO:0031345,0.659091175681743,0.784826783834799,1,3,negative regulation of cell projection organization,BP,WNT3
37,GO:0000287,0.659316291900084,0.784633976345703,1,3,magnesium ion binding,MF,MAPK12
2616,GO:0033762,0.65952672017849,0.784453620292472,1,3,response to glucagon,BP,GJB2
4961,GO:0071377,0.65952672017849,0.784453620292472,1,3,cellular response to glucagon stimulus,BP,GJB2
3351,GO:0044430,0.659778437544917,0.510262047909073,8,29,cytoskeletal part,CC,ACTN3;SPTBN5;CDH1;SPTB;AMOT;PKP1;RAB3D;SPTBN4
3353,GO:0044432,0.659901128782663,0.534866580033539,6,21,endoplasmic reticulum part,CC,WNT7A;MBOAT2;WNT3;WNT7B;WNT5B;NOTCH1
3596,GO:0045932,0.660482792757922,0.783632613295574,1,3,negative regulation of muscle contraction,BP,PIK3CG
6004,GO:1990138,0.660492899982175,0.783623920194806,1,3,neuron projection extension,BP,WNT3
2570,GO:0033138,0.660848415849903,0.662082349401443,2,7,positive regulation of peptidyl-serine phosphorylation,BP,AXIN1;PIK3CA
2010,GO:0030225,0.661085365262604,0.783113844776997,1,3,macrophage differentiation,BP,BMP4
786,GO:0006396,0.661146531402953,0.783061128164299,1,3,RNA processing,BP,BMP4
490,GO:0003712,0.661169469357277,0.661747835063845,2,7,transcription cofactor activity,MF,TLE1;POU3F1
2633,GO:0034220,0.661449633737014,0.573272420131751,4,14,ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
3218,GO:0043491,0.661652039980152,0.661244573128521,2,7,protein kinase B signaling,BP,PIK3CG;PIK3CA
294,GO:0002429,0.661807419102354,0.661082414451902,2,7,immune response-activating cell surface receptor signaling pathway,BP,HRAS;PIK3CA
356,GO:0002768,0.661807419102354,0.661082414451902,2,7,immune response-regulating cell surface receptor signaling pathway,BP,HRAS;PIK3CA
659,GO:0005741,0.661930463795901,0.78238455220692,1,3,mitochondrial outer membrane,CC,PMAIP1
1820,GO:0019867,0.661930463795901,0.78238455220692,1,3,outer membrane,CC,PMAIP1
2298,GO:0031968,0.661930463795901,0.78238455220692,1,3,organelle outer membrane,CC,PMAIP1
3498,GO:0045600,0.661946088927474,0.782371049195603,1,3,positive regulation of fat cell differentiation,BP,WNT5B
43,GO:0000578,0.662122410116186,0.782218627033883,1,3,embryonic axis specification,BP,WNT7A
4800,GO:0070227,0.662397175410579,0.781980928400477,1,3,lymphocyte apoptotic process,BP,BMP4
4804,GO:0070231,0.662397175410579,0.781980928400477,1,3,T cell apoptotic process,BP,BMP4
1773,GO:0019209,0.662641925204967,0.781769015637329,1,3,kinase activator activity,MF,PIK3CA
2028,GO:0030295,0.662641925204967,0.781769015637329,1,3,protein kinase activator activity,MF,PIK3CA
56,GO:0000975,0.662680822529481,0.660169837227834,2,7,regulatory region DNA binding,MF,VDR;NOTCH1
68,GO:0001067,0.662680822529481,0.660169837227834,2,7,regulatory region nucleic acid binding,MF,VDR;NOTCH1
3295,GO:0044212,0.662680822529481,0.660169837227834,2,7,transcription regulatory region DNA binding,MF,VDR;NOTCH1
4383,GO:0060065,0.663544433230432,0.780986121040621,1,3,uterus development,BP,WNT7A
2388,GO:0032368,0.663693917869819,0.780856224285819,1,3,regulation of lipid transport,BP,BMP6
5997,GO:1905952,0.663693917869819,0.780856224285819,1,3,regulation of lipid localization,BP,BMP6
2592,GO:0033500,0.664198293583908,0.658579992479202,2,7,carbohydrate homeostasis,BP,GJB6;PIK3CA
3045,GO:0042593,0.664198293583908,0.658579992479202,2,7,glucose homeostasis,BP,GJB6;PIK3CA
5060,GO:0072007,0.664307018963457,0.780322794158566,1,3,mesangial cell differentiation,BP,NOTCH1
5061,GO:0072008,0.664307018963457,0.780322794158566,1,3,glomerular mesangial cell differentiation,BP,NOTCH1
5122,GO:0072143,0.664307018963457,0.780322794158566,1,3,mesangial cell development,BP,NOTCH1
5123,GO:0072144,0.664307018963457,0.780322794158566,1,3,glomerular mesangial cell development,BP,NOTCH1
5908,GO:1904238,0.664307018963457,0.780322794158566,1,3,pericyte cell differentiation,BP,NOTCH1
3556,GO:0045785,0.66435626650702,0.601309824203572,3,11,positive regulation of cell adhesion,BP,PIK3CA;BMP7;FSTL3
67,GO:0001047,0.664539380524213,0.780120346598264,1,3,core promoter binding,MF,NOTCH1
1759,GO:0018958,0.664593495737295,0.780073175938707,1,3,phenol-containing compound metabolic process,BP,PNMT
2237,GO:0031489,0.66490758107995,0.779799231231502,1,3,myosin V binding,MF,RAB3D
789,GO:0006412,0.665571831658762,0.779218940934197,1,3,translation,BP,BMP4
790,GO:0006417,0.665571831658762,0.779218940934197,1,3,regulation of translation,BP,BMP4
2637,GO:0034248,0.665571831658762,0.779218940934197,1,3,regulation of cellular amide metabolic process,BP,BMP4
3098,GO:0043043,0.665571831658762,0.779218940934197,1,3,peptide biosynthetic process,BP,BMP4
3254,GO:0043604,0.665571831658762,0.779218940934197,1,3,amide biosynthetic process,BP,BMP4
1483,GO:0014065,0.665807446005904,0.568484213629556,4,14,phosphatidylinositol 3-kinase signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA
3749,GO:0048015,0.665807446005904,0.568484213629556,4,14,phosphatidylinositol-mediated signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA
3751,GO:0048017,0.665807446005904,0.568484213629556,4,14,inositol lipid-mediated signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA
2006,GO:0030218,0.665821907978548,0.779000145403947,1,3,erythrocyte differentiation,BP,BMP4
2620,GO:0034101,0.665821907978548,0.779000145403947,1,3,erythrocyte homeostasis,BP,BMP4
247,GO:0002218,0.665822412983796,0.778999703385245,1,3,activation of innate immune response,BP,HRAS
351,GO:0002758,0.665822412983796,0.778999703385245,1,3,innate immune response-activating signal transduction,BP,HRAS
3940,GO:0048854,0.665960574032049,0.778878746839096,1,3,brain morphogenesis,BP,FGF8
4,GO:0000041,0.666360864687948,0.778527991958685,1,3,transition metal ion transport,BP,TF
874,GO:0006826,0.666360864687948,0.778527991958685,1,3,iron ion transport,BP,TF
6062,GO:2000107,0.66642923576455,0.778468035584705,1,3,negative regulation of leukocyte apoptotic process,BP,BMP4
334,GO:0002695,0.666517771922186,0.778390375888859,1,3,negative regulation of leukocyte activation,BP,BMP4
4166,GO:0051250,0.666517771922186,0.778390375888859,1,3,negative regulation of lymphocyte activation,BP,BMP4
4120,GO:0051150,0.666757019092419,0.778180406501239,1,3,regulation of smooth muscle cell differentiation,BP,BMP4
3453,GO:0045178,0.667444408677754,0.777576215435272,1,3,basal part of cell,CC,TF
4994,GO:0071548,0.667630616964162,0.777412309513206,1,3,response to dexamethasone,BP,GJB2
3759,GO:0048066,0.668501170332253,0.776644688587377,1,3,developmental pigmentation,BP,RAB38
4066,GO:0050931,0.668501170332253,0.776644688587377,1,3,pigment cell differentiation,BP,RAB38
6107,GO:2000401,0.669485346689887,0.775774223684009,1,3,regulation of lymphocyte migration,BP,CCL20
1382,GO:0010712,0.669852197601441,0.775449035416949,1,3,regulation of collagen metabolic process,BP,BMP4
1383,GO:0010714,0.669852197601441,0.775449035416949,1,3,positive regulation of collagen metabolic process,BP,BMP4
2533,GO:0032963,0.669852197601441,0.775449035416949,1,3,collagen metabolic process,BP,BMP4
2534,GO:0032964,0.669852197601441,0.775449035416949,1,3,collagen biosynthetic process,BP,BMP4
2535,GO:0032965,0.669852197601441,0.775449035416949,1,3,regulation of collagen biosynthetic process,BP,BMP4
2536,GO:0032967,0.669852197601441,0.775449035416949,1,3,positive regulation of collagen biosynthetic process,BP,BMP4
3298,GO:0044236,0.669852197601441,0.775449035416949,1,3,multicellular organism metabolic process,BP,BMP4
3302,GO:0044246,0.669852197601441,0.775449035416949,1,3,regulation of multicellular organismal metabolic process,BP,BMP4
3305,GO:0044253,0.669852197601441,0.775449035416949,1,3,positive regulation of multicellular organismal metabolic process,BP,BMP4
3308,GO:0044259,0.669852197601441,0.775449035416949,1,3,multicellular organismal macromolecule metabolic process,BP,BMP4
2749,GO:0035313,0.669933904335368,0.775376554396907,1,3,wound healing, spreading of epidermal cells,BP,WNT7A
841,GO:0006694,0.670817216762537,0.651580771767968,2,7,steroid biosynthetic process,BP,BMP6;VDR
1114,GO:0008202,0.670817216762537,0.651580771767968,2,7,steroid metabolic process,BP,BMP6;VDR
5383,GO:0097159,0.671191857199918,0.449391198404367,19,66,organic cyclic compound binding,MF,GLDC;PIK3CG;HEY1;MAPK12;POU3F1;RAB40B;RRAS2;VDR;RAB39A;WNK4;PKN3;HRAS;RAB3D;RAB38;PIK3CA;NOTCH1;RND3;RAB20;GUCY1B3
5522,GO:0099565,0.67128583736808,0.774174430919179,1,3,chemical synaptic transmission, postsynaptic,BP,WNT7A
3766,GO:0048167,0.671679680353646,0.773823220003332,1,3,regulation of synaptic plasticity,BP,HRAS
3590,GO:0045921,0.671975992419961,0.773558681333387,1,3,positive regulation of exocytosis,BP,RAB3D
1896,GO:0021984,0.671990706359958,0.773545538412633,1,3,adenohypophysis development,BP,FGF8
4404,GO:0060129,0.671990706359958,0.773545538412633,1,3,thyroid-stimulating hormone-secreting cell differentiation,BP,FGF8
4680,GO:0061101,0.671990706359958,0.773545538412633,1,3,neuroendocrine cell differentiation,BP,FGF8
4124,GO:0051155,0.672281364110927,0.773285783415623,1,3,positive regulation of striated muscle cell differentiation,BP,BMP4
5963,GO:1905209,0.672281364110927,0.773285783415623,1,3,positive regulation of cardiocyte differentiation,BP,BMP4
6146,GO:2000727,0.672281364110927,0.773285783415623,1,3,positive regulation of cardiac muscle cell differentiation,BP,BMP4
1419,GO:0010837,0.672538765803366,0.773055540307163,1,3,regulation of keratinocyte proliferation,BP,VDR
3255,GO:0043616,0.672538765803366,0.773055540307163,1,3,keratinocyte proliferation,BP,VDR
2950,GO:0042108,0.672593990479796,0.77300611689094,1,3,positive regulation of cytokine biosynthetic process,BP,CCL20
532,GO:0004702,0.673483357598288,0.772208932292547,1,3,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MAPK12
4926,GO:0071260,0.673953568991072,0.77178650959912,1,3,cellular response to mechanical stimulus,BP,BMP6
26,GO:0000186,0.674271015112876,0.771500954441697,1,3,activation of MAPKK activity,BP,BMP4
3310,GO:0044262,0.674658852441316,0.647469578067851,2,7,cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
4309,GO:0051963,0.674692072185807,0.771121734001637,1,3,regulation of synapse assembly,BP,WNT7A
869,GO:0006813,0.674736780048799,0.64738580710636,2,7,potassium ion transport,BP,KCNG2;KCNK6
4173,GO:0051260,0.674911758321458,0.647197653570096,2,7,protein homooligomerization,BP,KCNG2;SPTBN5
2878,GO:0036477,0.675413614066068,0.589130949701693,3,11,somatodendritic compartment,CC,SYT5;DRP2;SPTBN4
2218,GO:0031334,0.675559583677229,0.770338750436296,1,3,positive regulation of protein complex assembly,BP,PMAIP1
2710,GO:0035051,0.675813978317312,0.588685232148715,3,11,cardiocyte differentiation,BP,FZD7;BMP4;NOTCH1
1085,GO:0008022,0.676187591562524,0.769770528049022,1,3,protein C-terminus binding,MF,HRAS
4192,GO:0051302,0.676675964691982,0.769327829023106,1,3,regulation of cell division,BP,FGF8
1948,GO:0030010,0.676997063282362,0.644949499420729,2,7,establishment of cell polarity,BP,WNT7A;AMOT
2281,GO:0031902,0.677230336854364,0.768824433699399,1,3,late endosome membrane,CC,TSPAN15
650,GO:0005635,0.677374959384078,0.76869295747696,1,3,nuclear envelope,CC,RAB40B
1058,GO:0007589,0.678995554735215,0.642784791431597,2,7,body fluid secretion,BP,VDR;WNK4
2447,GO:0032612,0.67929912848747,0.766937676193333,1,3,interleukin-1 production,BP,CCL20
2459,GO:0032652,0.67929912848747,0.766937676193333,1,3,regulation of interleukin-1 production,BP,CCL20
3745,GO:0048010,0.679812400341841,0.641897133408283,2,7,vascular endothelial growth factor receptor signaling pathway,BP,MAPK12;PIK3CA
2526,GO:0032941,0.679836620394848,0.766445352430143,1,3,secretion by tissue,BP,WNK4
762,GO:0006182,0.679936969744675,0.766353338428863,1,3,cGMP biosynthetic process,BP,GUCY1B3
1013,GO:0007292,0.680873300202804,0.765493300628239,1,3,female gamete generation,BP,INHBB
1287,GO:0009994,0.680873300202804,0.765493300628239,1,3,oocyte differentiation,BP,INHBB
3813,GO:0048477,0.680873300202804,0.765493300628239,1,3,oogenesis,BP,INHBB
3859,GO:0048599,0.680873300202804,0.765493300628239,1,3,oocyte development,BP,INHBB
2688,GO:0034702,0.681150945398664,0.640438926954434,2,7,ion channel complex,CC,KCNG2;KCNK6
5732,GO:1902495,0.681150945398664,0.640438926954434,2,7,transmembrane transporter complex,CC,KCNG2;KCNK6
6012,GO:1990351,0.681150945398664,0.640438926954434,2,7,transporter complex,CC,KCNG2;KCNK6
2092,GO:0030672,0.682189749679135,0.764279573030333,1,3,synaptic vesicle membrane,CC,SYT5
5514,GO:0099501,0.682189749679135,0.764279573030333,1,3,exocytic vesicle membrane,CC,SYT5
5212,GO:0072583,0.682582707549639,0.76391624461276,1,3,clathrin-dependent endocytosis,BP,SYT5
2555,GO:0033043,0.683450969528331,0.483862971688693,8,29,regulation of organelle organization,BP,PMAIP1;SPTBN5;SPTB;FGF8;HRAS;BMP4;BMP7;SPTBN4
150,GO:0001786,0.684345753226389,0.762280261077502,1,3,phosphatidylserine binding,MF,SYT5
3145,GO:0043230,0.685167353541587,0.438259566436077,17,60,extracellular organelle,CC,WNT7A;ACTN3;WNT3;WNT7B;KCNG2;SPTBN5;CDH1;RRAS2;DSG3;WNT5B;PKP1;TSPAN15;RAB3D;SPTBN4;RND3;TF;PM20D2
4781,GO:0070062,0.685167353541587,0.438259566436077,17,60,extracellular exosome,CC,WNT7A;ACTN3;WNT3;WNT7B;KCNG2;SPTBN5;CDH1;RRAS2;DSG3;WNT5B;PKP1;TSPAN15;RAB3D;SPTBN4;RND3;TF;PM20D2
5856,GO:1903561,0.685167353541587,0.438259566436077,17,60,extracellular vesicle,CC,WNT7A;ACTN3;WNT3;WNT7B;KCNG2;SPTBN5;CDH1;RRAS2;DSG3;WNT5B;PKP1;TSPAN15;RAB3D;SPTBN4;RND3;TF;PM20D2
916,GO:0006955,0.687042114045618,0.479791742565156,8,29,immune response,BP,PIK3CG;BMP6;CCL20;PKP1;HRAS;RAB3D;PIK3CA;NOTCH1
5423,GO:0097529,0.6871017213127,0.63390120923061,2,7,myeloid leukocyte migration,BP,PIK3CG;CCL20
3473,GO:0045321,0.687347317339736,0.479444912851943,8,29,leukocyte activation,BP,PIK3CG;JAG2;FZD7;PKP1;RAB3D;BMP4;PIK3CA;TPD52
100,GO:0001569,0.687942632240214,0.758912573423883,1,3,branching involved in blood vessel morphogenesis,BP,FGF8
3763,GO:0048144,0.687979803089776,0.632928852065966,2,7,fibroblast proliferation,BP,WNT7B;WNT2
4090,GO:0051048,0.688072272371313,0.574874077672874,3,11,negative regulation of secretion,BP,WNK4;INHBB;NOTCH1
897,GO:0006909,0.688076267594338,0.574869523834408,3,11,phagocytosis,BP,RAB39A;PIK3CA;RAB20
2523,GO:0032925,0.688623864567926,0.758270169217362,1,3,regulation of activin receptor signaling pathway,BP,FSTL3
3574,GO:0045840,0.688639733302969,0.758255187460375,1,3,positive regulation of mitotic nuclear division,BP,FGF8
3811,GO:0048469,0.689286642053507,0.757643758248127,1,3,cell maturation,BP,SPTBN4
4703,GO:0061213,0.690679744127161,0.756322544935664,1,3,positive regulation of mesonephros development,BP,GDNF
1232,GO:0009615,0.691079428677782,0.755942342903209,1,3,response to virus,BP,PMAIP1
474,GO:0003401,0.691203540057,0.755824177353678,1,3,axis elongation,BP,BMP4
4553,GO:0060602,0.691203540057,0.755824177353678,1,3,branch elongation of an epithelium,BP,BMP4
305,GO:0002460,0.691741695559432,0.755311232624994,1,3,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,HRAS
3056,GO:0042692,0.691884028859075,0.49721072931999,6,22,muscle cell differentiation,BP,HEY1;AXIN1;MAPK12;FZD7;BMP4;NOTCH1
1470,GO:0014031,0.693093456331336,0.62722645599636,2,7,mesenchymal cell development,BP,GDNF;NOTCH1
5300,GO:0090184,0.693268331097853,0.627030240365023,2,7,positive regulation of kidney development,BP,BMP4;GDNF
261,GO:0002263,0.693447054816867,0.568716295748565,3,11,cell activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
283,GO:0002366,0.693447054816867,0.568716295748565,3,11,leukocyte activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
3922,GO:0048806,0.693597265533091,0.626660946638653,2,7,genitalia development,BP,BMP6;FGF8
1250,GO:0009791,0.694002429616238,0.753146229911852,1,3,post-embryonic development,BP,BMP4
4186,GO:0051291,0.694181062262785,0.75297445764559,1,3,protein heterooligomerization,BP,HRAS
591,GO:0005179,0.694999892792244,0.75218574866514,1,3,hormone activity,MF,INHBB
5051,GO:0071900,0.695216175537568,0.481293991757891,7,25,regulation of protein serine/threonine kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;BMP7
895,GO:0006904,0.695515433456104,0.751688053710758,1,3,vesicle docking involved in exocytosis,BP,RAB40B
3788,GO:0048278,0.695515433456104,0.751688053710758,1,3,vesicle docking,BP,RAB40B
5325,GO:0090287,0.69826617953059,0.563140958443459,3,11,regulation of cellular response to growth factor stimulus,BP,BMP4;FSTL3;NOTCH1
5053,GO:0071902,0.699382204086463,0.506081464996845,5,18,positive regulation of protein serine/threonine kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS
483,GO:0003676,0.699440306621474,0.527214154127218,4,15,nucleic acid binding,MF,HEY1;POU3F1;VDR;NOTCH1
3663,GO:0046579,0.699513012691201,0.747799273345858,1,3,positive regulation of Ras protein signal transduction,BP,HRAS
4099,GO:0051057,0.699513012691201,0.747799273345858,1,3,positive regulation of small GTPase mediated signal transduction,BP,HRAS
1113,GO:0008201,0.700128136638352,0.619269408388363,2,7,heparin binding,MF,BMP4;BMP7
929,GO:0007009,0.700608226042189,0.525847966093889,4,15,plasma membrane organization,BP,CDH1;RAB40B;TSPAN15;SPTBN4
5223,GO:0072659,0.700608226042189,0.525847966093889,4,15,protein localization to plasma membrane,BP,CDH1;RAB40B;TSPAN15;SPTBN4
6023,GO:1990778,0.700608226042189,0.525847966093889,4,15,protein localization to cell periphery,BP,CDH1;RAB40B;TSPAN15;SPTBN4
765,GO:0006259,0.70133552967805,0.528128477048555,4,14,DNA metabolic process,BP,BMP6;HRAS;BMP4;PIK3CA
210,GO:0001974,0.702109394155242,0.745245187688766,1,3,blood vessel remodeling,BP,FGF8
4843,GO:0070382,0.703402050730093,0.615521008054078,2,7,exocytic vesicle,CC,SYT5;RAB40B
3945,GO:0048864,0.706642274956883,0.611782438671542,2,7,stem cell development,BP,WNT7A;GDNF
3735,GO:0046982,0.707955543599607,0.517191258304494,4,15,protein heterodimerization activity,MF,SYT5;BMP6;TPD52;NOTCH1
4314,GO:0052547,0.710930063927543,0.606790655775194,2,7,regulation of peptidase activity,BP,PMAIP1;MAPK12
1484,GO:0014066,0.711864429131347,0.547125725890773,3,11,regulation of phosphatidylinositol 3-kinase signaling,BP,FGF8;FGF17;PIK3CA
5598,GO:1901099,0.712079313077143,0.735224825694258,1,3,negative regulation of signal transduction in absence of ligand,BP,GDNF
6197,GO:2001239,0.712079313077143,0.735224825694258,1,3,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
6198,GO:2001240,0.712079313077143,0.735224825694258,1,3,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
4674,GO:0061061,0.713767389965024,0.440228810593749,9,33,muscle structure development,BP,ACTN3;HEY1;AXIN1;MAPK12;WNT2;FZD7;FGF8;BMP4;NOTCH1
1591,GO:0016043,0.714226369622056,0.387636374082757,35,121,cellular component organization,BP,TLE1;WNT7A;GJB2;SYT5;ACTN3;RABIF;WNT3;WNT7B;PMAIP1;KCNG2;AXIN1;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;AMOT;PKP1;TSPAN15;HRAS;BMP4;GDNF;RAB38;PIK3CA;DRP2;BMP7;SPTBN4;NOTCH1;RND3;RAB20;TF
5034,GO:0071840,0.714226369622056,0.387636374082757,35,121,cellular component organization or biogenesis,BP,TLE1;WNT7A;GJB2;SYT5;ACTN3;RABIF;WNT3;WNT7B;PMAIP1;KCNG2;AXIN1;SPTBN5;CDH1;RAB40B;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;AMOT;PKP1;TSPAN15;HRAS;BMP4;GDNF;RAB38;PIK3CA;DRP2;BMP7;SPTBN4;NOTCH1;RND3;RAB20;TF
2245,GO:0031532,0.718159601300888,0.728943142022168,1,3,actin cytoskeleton reorganization,BP,HRAS
5417,GO:0097458,0.718207170437596,0.453134192782891,7,26,neuron part,CC,WNT7A;SYT5;SPTBN5;RAB40B;DRP2;FSTL3;SPTBN4
616,GO:0005488,0.71991453817391,0.427796004495896,62,208,binding,MF,MAGEC2;TJP3;GLDC;RHPN1;TLE1;WNT7A;PIK3CG;SYT5;ACTN3;RHBDL3;CLDN18;RABIF;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;MB21D2;RAB20;GUCY1B3;TF
2866,GO:0036293,0.720630392938776,0.536573342377652,3,11,response to decreased oxygen levels,BP,PMAIP1;BMP7;NOTCH1
5633,GO:1901566,0.720896734925581,0.536249848591692,3,11,organonitrogen compound biosynthetic process,BP,BMP4;PNMT;GUCY1B3
3150,GO:0043235,0.72136917905847,0.531391235088996,3,12,receptor complex,CC,VDR;NOTCH1;TF
4201,GO:0051347,0.723453819340927,0.437469640015846,8,29,positive regulation of transferase activity,BP,MAGEC2;PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA
3550,GO:0045765,0.725300374951112,0.581412153948081,2,8,regulation of angiogenesis,BP,AMOT;NOTCH1
2506,GO:0032869,0.727063334584381,0.579251566149685,2,8,cellular response to insulin stimulus,BP,INHBB;PIK3CA
5451,GO:0098590,0.728939120773259,0.45193811657781,6,23,plasma membrane region,CC,GJB6;SPTBN5;CDH1;DRP2;NOTCH1;TF
913,GO:0006950,0.729971697454551,0.384845316081208,18,64,response to stress,BP,WNT7A;GJB2;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;WNT5B;INHBB;CCL20;HRAS;PIK3CA;BMP7;NOTCH1;GUCY1B3
3290,GO:0044089,0.730894162349806,0.489452199472494,4,15,positive regulation of cellular component biogenesis,BP,WNT7A;PMAIP1;HRAS;BMP7
2398,GO:0032403,0.731212810344812,0.449177018748308,6,23,protein complex binding,MF,ACTN3;SPTB;PKP1;RAB38;FSTL3;MB21D2
5456,GO:0098609,0.732193348215924,0.405399106149938,11,41,cell-cell adhesion,BP,PIK3CG;CLDN18;WNT7B;CDH1;DSG3;PKP1;BMP4;CLDN15;PIK3CA;BMP7;FSTL3
4197,GO:0051338,0.733019857033798,0.417442226899449,9,33,regulation of transferase activity,BP,MAGEC2;PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;BMP7
5450,GO:0098589,0.733078588959745,0.571810612652208,2,8,membrane region,CC,CDH1;TF
4176,GO:0051270,0.734107809796317,0.409065230856611,10,37,regulation of cellular component movement,BP,WNT7A;WNT3;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
258,GO:0002253,0.735467735543432,0.568825204668978,2,8,activation of immune response,BP,HRAS;PIK3CA
350,GO:0002757,0.735467735543432,0.568825204668978,2,8,immune response-activating signal transduction,BP,HRAS;PIK3CA
355,GO:0002764,0.735467735543432,0.568825204668978,2,8,immune response-regulating signaling pathway,BP,HRAS;PIK3CA
2199,GO:0031252,0.736896527823382,0.512160525405216,3,12,cell leading edge,CC,CDH1;AMOT;PIK3CA
496,GO:0003779,0.737028807849773,0.479146203456973,4,16,actin binding,MF,ACTN3;SPTBN5;SPTB;SPTBN4
5773,GO:1902903,0.737484311529259,0.511420815142697,3,12,regulation of supramolecular fiber organization,BP,SPTBN5;SPTB;SPTBN4
133,GO:0001738,0.739037787389631,0.681112395710648,1,4,morphogenesis of a polarized epithelium,BP,FZD7
1088,GO:0008047,0.739508578769225,0.563736419476541,2,8,enzyme activator activity,MF,AXIN1;PIK3CA
1631,GO:0016324,0.739870022681531,0.508409472567264,3,12,apical plasma membrane,CC,GJB6;NOTCH1;TF
4501,GO:0060444,0.740320779795039,0.679581706513801,1,4,branching involved in mammary gland duct morphogenesis,BP,VDR
2537,GO:0032970,0.741031167460284,0.474133558386308,4,16,regulation of actin filament-based process,BP,SPTBN5;SPTB;HRAS;SPTBN4
4672,GO:0061053,0.74107821650873,0.678674899496954,1,4,somite development,BP,NOTCH1
1266,GO:0009896,0.74149230587361,0.506353474804446,3,12,positive regulation of catabolic process,BP,ACTN3;AXIN1;RNF144A
850,GO:0006732,0.743449259819244,0.675821103876235,1,4,coenzyme metabolic process,BP,ACTN3
4137,GO:0051186,0.743449259819244,0.675821103876235,1,4,cofactor metabolic process,BP,ACTN3
3718,GO:0046890,0.743481796668312,0.558683749612427,2,8,regulation of lipid biosynthetic process,BP,BMP6;VDR
5292,GO:0090150,0.743630366695407,0.470859194799105,4,16,establishment of protein localization to membrane,BP,PMAIP1;CDH1;TSPAN15;SPTBN4
3464,GO:0045211,0.743715363376865,0.67549937754914,1,4,postsynaptic membrane,CC,DRP2
912,GO:0006942,0.744034827548693,0.557976569142664,2,8,regulation of striated muscle contraction,BP,PIK3CG;ACTN3
3350,GO:0044429,0.744407711022923,0.557499207935835,2,8,mitochondrial part,CC,GLDC;PMAIP1
1663,GO:0016491,0.744628730288048,0.674392864051135,1,4,oxidoreductase activity,MF,GLDC
3987,GO:0050727,0.744670205377363,0.674342536281628,1,4,regulation of inflammatory response,BP,PIK3CG
5631,GO:1901564,0.745175388338264,0.432016795335934,6,23,organonitrogen compound metabolic process,BP,GLDC;ACTN3;MBOAT2;BMP4;PNMT;GUCY1B3
2204,GO:0031294,0.745544381620424,0.673280106755604,1,4,lymphocyte costimulation,BP,PIK3CA
2205,GO:0031295,0.745544381620424,0.673280106755604,1,4,T cell costimulation,BP,PIK3CA
4041,GO:0050870,0.745544381620424,0.673280106755604,1,4,positive regulation of T cell activation,BP,PIK3CA
5792,GO:1903039,0.745544381620424,0.673280106755604,1,4,positive regulation of leukocyte cell-cell adhesion,BP,PIK3CA
5155,GO:0072207,0.745917378391391,0.672825816182761,1,4,metanephric epithelium development,BP,WNT7B
1798,GO:0019439,0.745976128244236,0.672754208972026,1,4,aromatic compound catabolic process,BP,PKP1
2679,GO:0034655,0.745976128244236,0.672754208972026,1,4,nucleobase-containing compound catabolic process,BP,PKP1
3314,GO:0044270,0.745976128244236,0.672754208972026,1,4,cellular nitrogen compound catabolic process,BP,PKP1
3682,GO:0046700,0.745976128244236,0.672754208972026,1,4,heterocycle catabolic process,BP,PKP1
5618,GO:1901361,0.745976128244236,0.672754208972026,1,4,organic cyclic compound catabolic process,BP,PKP1
6090,GO:2000243,0.747233331269084,0.671218404067965,1,4,positive regulation of reproductive process,BP,INHBB
1160,GO:0008585,0.747388610308016,0.671028254137721,1,4,female gonad development,BP,INHBB
3660,GO:0046545,0.747388610308016,0.671028254137721,1,4,development of primary female sexual characteristics,BP,INHBB
2624,GO:0034109,0.747611753082477,0.670754822646048,1,4,homotypic cell-cell adhesion,BP,PIK3CG
3086,GO:0042995,0.747639057834494,0.392138515921342,10,38,cell projection,CC,GJB2;SYT5;ACTN3;SPTBN5;CDH1;AMOT;PIK3CA;DRP2;FSTL3;SPTBN4
5536,GO:0120025,0.747639057834494,0.392138515921342,10,38,plasma membrane bounded cell projection,CC,GJB2;SYT5;ACTN3;SPTBN5;CDH1;AMOT;PIK3CA;DRP2;FSTL3;SPTBN4
4974,GO:0071417,0.74779365256857,0.443480543879852,5,20,cellular response to organonitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;PIK3CA
2254,GO:0031625,0.74779953335588,0.553136880112998,2,8,ubiquitin protein ligase binding,MF,MAGEC2;AXIN1
3337,GO:0044389,0.74779953335588,0.553136880112998,2,8,ubiquitin-like protein ligase binding,MF,MAGEC2;AXIN1
2939,GO:0042060,0.747915063708279,0.406915504159997,8,30,wound healing,BP,WNT7A;PIK3CG;FZD7;WNT5B;CCL20;HRAS;PIK3CA;NOTCH1
1691,GO:0016746,0.74822561297662,0.670001536653324,1,4,transferase activity, transferring acyl groups,MF,MBOAT2
3821,GO:0048511,0.748403088543782,0.669783454457672,1,4,rhythmic process,BP,INHBB
492,GO:0003714,0.749159728514811,0.668852197925416,1,4,transcription corepressor activity,MF,TLE1
4721,GO:0061337,0.749211329745455,0.551310342822896,2,8,cardiac conduction,BP,KCNK6;SPTBN4
6076,GO:2000177,0.749833585492596,0.668020782582471,1,4,regulation of neural precursor cell proliferation,BP,NOTCH1
4106,GO:0051098,0.750016322912626,0.550266008642675,2,8,regulation of binding,BP,HEY1;BMP4
3400,GO:0044782,0.750954782943726,0.666633140565494,1,4,cilium organization,BP,NOTCH1
4429,GO:0060271,0.750954782943726,0.666633140565494,1,4,cilium assembly,BP,NOTCH1
1283,GO:0009986,0.751031586827297,0.403080632962223,8,30,cell surface,CC,WNT7A;FGF8;AMOT;WNT5B;TSPAN15;TMEM206;NOTCH1;TF
1590,GO:0016042,0.75176544578054,0.665626475824862,1,4,lipid catabolic process,BP,PIK3CG
4075,GO:0050994,0.75176544578054,0.665626475824862,1,4,regulation of lipid catabolic process,BP,PIK3CG
5189,GO:0072359,0.752051652377065,0.376623730735144,12,45,circulatory system development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FZD7;FGF8;AMOT;BMP4;PIK3CA;BMP7;NOTCH1
3317,GO:0044281,0.752473016415346,0.410327170478454,7,27,small molecule metabolic process,BP,GLDC;ACTN3;BMP6;PMAIP1;VDR;PIK3CA;GUCY1B3
6089,GO:2000242,0.752584072879063,0.546920841254615,2,8,negative regulation of reproductive process,BP,BMP4;BMP7
485,GO:0003682,0.752754414891665,0.664394563773427,1,4,chromatin binding,MF,NOTCH1
2503,GO:0032845,0.753506342912931,0.663455093253129,1,4,negative regulation of homeostatic process,BP,CLDN18
843,GO:0006700,0.75353650227651,0.663417360541275,1,4,C21-steroid hormone biosynthetic process,BP,BMP6
846,GO:0006705,0.75353650227651,0.663417360541275,1,4,mineralocorticoid biosynthetic process,BP,BMP6
1116,GO:0008207,0.75353650227651,0.663417360541275,1,4,C21-steroid hormone metabolic process,BP,BMP6
1119,GO:0008212,0.75353650227651,0.663417360541275,1,4,mineralocorticoid metabolic process,BP,BMP6
1345,GO:0010566,0.75353650227651,0.663417360541275,1,4,regulation of ketone biosynthetic process,BP,BMP6
2373,GO:0032341,0.75353650227651,0.663417360541275,1,4,aldosterone metabolic process,BP,BMP6
2374,GO:0032342,0.75353650227651,0.663417360541275,1,4,aldosterone biosynthetic process,BP,BMP6
2375,GO:0032344,0.75353650227651,0.663417360541275,1,4,regulation of aldosterone metabolic process,BP,BMP6
2378,GO:0032347,0.75353650227651,0.663417360541275,1,4,regulation of aldosterone biosynthetic process,BP,BMP6
2381,GO:0032350,0.75353650227651,0.663417360541275,1,4,regulation of hormone metabolic process,BP,BMP6
2693,GO:0034754,0.75353650227651,0.663417360541275,1,4,cellular hormone metabolic process,BP,BMP6
2966,GO:0042181,0.75353650227651,0.663417360541275,1,4,ketone biosynthetic process,BP,BMP6
3004,GO:0042445,0.75353650227651,0.663417360541275,1,4,hormone metabolic process,BP,BMP6
3005,GO:0042446,0.75353650227651,0.663417360541275,1,4,hormone biosynthetic process,BP,BMP6
3622,GO:0046184,0.75353650227651,0.663417360541275,1,4,aldehyde biosynthetic process,BP,BMP6
3713,GO:0046885,0.75353650227651,0.663417360541275,1,4,regulation of hormone biosynthetic process,BP,BMP6
5267,GO:0090030,0.75353650227651,0.663417360541275,1,4,regulation of steroid hormone biosynthetic process,BP,BMP6
5415,GO:0097435,0.753652218370381,0.436071963270004,5,20,supramolecular fiber organization,BP,AXIN1;SPTBN5;SPTB;PKP1;SPTBN4
2045,GO:0030336,0.754017037545502,0.662815624399924,1,4,negative regulation of cell migration,BP,NOTCH1
6074,GO:2000146,0.754017037545502,0.662815624399924,1,4,negative regulation of cell motility,BP,NOTCH1
1407,GO:0010817,0.754148049123042,0.490079075571756,3,12,regulation of hormone levels,BP,BMP6;KCNG2;INHBB
2043,GO:0030334,0.754334795310956,0.390778686816466,9,34,regulation of cell migration,BP,WNT7A;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
6073,GO:2000145,0.754334795310956,0.390778686816466,9,34,regulation of cell motility,BP,WNT7A;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;NOTCH1
2702,GO:0034976,0.755211111339624,0.661316023561248,1,4,response to endoplasmic reticulum stress,BP,PMAIP1
1872,GO:0021782,0.755326435788786,0.661170861055887,1,4,glial cell development,BP,POU3F1
1662,GO:0016485,0.755587424849594,0.660842130686766,1,4,protein processing,BP,RHBDL3
153,GO:0001818,0.756315115532396,0.659923983690798,1,4,negative regulation of cytokine production,BP,INHBB
3369,GO:0044459,0.756403900080887,0.353324977680007,18,66,plasma membrane part,CC,GJB2;GJA3;GJB6;JAG2;KCNG2;AXIN1;SPTBN5;CDH1;SPTB;FGF8;AMOT;TSPAN15;KCNK6;CLDN15;DRP2;TSPAN13;NOTCH1;TF
4450,GO:0060326,0.756783314412122,0.48663670991497,3,12,cell chemotaxis,BP,PIK3CG;CCL20;NOTCH1
3578,GO:0045859,0.756810995371972,0.395926218629321,8,30,regulation of protein kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;BMP7
1063,GO:0007601,0.756951746798497,0.659118816295572,1,4,visual perception,BP,GJA3
4070,GO:0050953,0.756951746798497,0.659118816295572,1,4,sensory perception of light stimulus,BP,GJA3
1996,GO:0030183,0.757179213032076,0.658830698675929,1,4,B cell differentiation,BP,TPD52
3381,GO:0044708,0.757494910364763,0.540463224982439,2,8,single-organism behavior,BP,GDNF;SPTBN4
1468,GO:0014015,0.757616882752797,0.658275684885414,1,4,positive regulation of gliogenesis,BP,NOTCH1
3534,GO:0045685,0.757616882752797,0.658275684885414,1,4,regulation of glial cell differentiation,BP,NOTCH1
3536,GO:0045687,0.757616882752797,0.658275684885414,1,4,positive regulation of glial cell differentiation,BP,NOTCH1
3899,GO:0048710,0.757616882752797,0.658275684885414,1,4,regulation of astrocyte differentiation,BP,NOTCH1
3900,GO:0048711,0.757616882752797,0.658275684885414,1,4,positive regulation of astrocyte differentiation,BP,NOTCH1
5980,GO:1905477,0.757744953293316,0.65811311666161,1,4,positive regulation of protein localization to membrane,BP,PMAIP1
318,GO:0002576,0.758440230256436,0.657229285264833,1,4,platelet degranulation,BP,TF
939,GO:0007034,0.758813557093352,0.656753826854218,1,4,vacuolar transport,BP,SPTBN5
941,GO:0007041,0.758813557093352,0.656753826854218,1,4,lysosomal transport,BP,SPTBN5
2175,GO:0031100,0.759526166364067,0.655844540434518,1,4,animal organ regeneration,BP,NOTCH1
1625,GO:0016301,0.759822871867561,0.401131207621381,7,27,kinase activity,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
1695,GO:0016772,0.759822871867561,0.401131207621381,7,27,transferase activity, transferring phosphorus-containing groups,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
1696,GO:0016773,0.759822871867561,0.401131207621381,7,27,phosphotransferase activity, alcohol group as acceptor,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA
4906,GO:0070925,0.760639606737369,0.449050274437182,4,16,organelle assembly,BP,RAB39A;RAB38;NOTCH1;RAB20
1919,GO:0022604,0.760930679286445,0.535897712967956,2,8,regulation of cell morphogenesis,BP,WNT7A;WNT3
1689,GO:0016740,0.761040288924057,0.375752151211925,10,38,transferase activity,MF,PIK3CG;MBOAT2;MAPK12;FGF8;WNK4;PKN3;FGF17;RNF144A;PIK3CA;PNMT
4102,GO:0051091,0.761318357999952,0.653547639143272,1,4,positive regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2
3433,GO:0045088,0.761391954453787,0.653453007259965,1,4,regulation of innate immune response,BP,HRAS
3434,GO:0045089,0.761391954453787,0.653453007259965,1,4,positive regulation of innate immune response,BP,HRAS
6061,GO:2000106,0.761826944007562,0.652893187795348,1,4,regulation of leukocyte apoptotic process,BP,BMP4
1348,GO:0010595,0.762149665549781,0.534268356143101,2,8,positive regulation of endothelial cell migration,BP,WNT7A;BMP4
5650,GO:1901655,0.76296140926469,0.651429121432153,1,4,cellular response to ketone,BP,GJB2
2474,GO:0032729,0.763770954549669,0.650380788438383,1,4,positive regulation of interferon-gamma production,BP,HRAS
207,GO:0001968,0.763949464227957,0.650149221084355,1,4,fibronectin binding,MF,FSTL3
194,GO:0001942,0.764007504420082,0.650073898382088,1,4,hair follicle development,BP,NOTCH1
1906,GO:0022404,0.764007504420082,0.650073898382088,1,4,molting cycle process,BP,NOTCH1
1907,GO:0022405,0.764007504420082,0.650073898382088,1,4,hair cycle process,BP,NOTCH1
2975,GO:0042303,0.764007504420082,0.650073898382088,1,4,molting cycle,BP,NOTCH1
3049,GO:0042633,0.764007504420082,0.650073898382088,1,4,hair cycle,BP,NOTCH1
312,GO:0002526,0.764141214131911,0.649900315394461,1,4,acute inflammatory response,BP,PIK3CG
4916,GO:0071214,0.765365471974504,0.529945674867089,2,8,cellular response to abiotic stimulus,BP,BMP6;HRAS
3325,GO:0044319,0.76561269644414,0.647984591850508,1,4,wound healing, spreading of cells,BP,WNT7A
5343,GO:0090504,0.76561269644414,0.647984591850508,1,4,epiboly,BP,WNT7A
5344,GO:0090505,0.76561269644414,0.647984591850508,1,4,epiboly involved in wound healing,BP,WNT7A
707,GO:0005912,0.765724665827627,0.404733346404194,6,24,adherens junction,CC,ACTN3;CDH1;RRAS2;SPTBN4;NOTCH1;RND3
4200,GO:0051346,0.766853851567792,0.527932971905927,2,8,negative regulation of hydrolase activity,BP,AMOT;HRAS
1783,GO:0019221,0.766970781845258,0.527774524890386,2,8,cytokine-mediated signaling pathway,BP,CLDN18;CCL20
4038,GO:0050866,0.767248001889819,0.645843831007148,1,4,negative regulation of cell activation,BP,BMP4
1824,GO:0019887,0.767284923851853,0.645795353187283,1,4,protein kinase regulator activity,MF,PIK3CA
4108,GO:0051100,0.767544432727483,0.645454443433102,1,4,negative regulation of binding,BP,HEY1
2326,GO:0032092,0.767613933068999,0.645363089292521,1,4,positive regulation of protein binding,BP,BMP4
4107,GO:0051099,0.767613933068999,0.645363089292521,1,4,positive regulation of binding,BP,BMP4
560,GO:0005057,0.767913331362381,0.644969289341759,1,4,signal transducer activity, downstream of receptor,MF,MAPK12
4014,GO:0050803,0.76832620556193,0.644425545077117,1,4,regulation of synapse structure or activity,BP,WNT7A
4018,GO:0050807,0.76832620556193,0.644425545077117,1,4,regulation of synapse organization,BP,WNT7A
663,GO:0005765,0.768372337403534,0.644364741002945,1,4,lysosomal membrane,CC,RAB3D
670,GO:0005774,0.768372337403534,0.644364741002945,1,4,vacuolar membrane,CC,RAB3D
5491,GO:0098852,0.768372337403534,0.644364741002945,1,4,lytic vacuole membrane,CC,RAB3D
810,GO:0006518,0.76933092511996,0.643099009250505,1,4,peptide metabolic process,BP,BMP4
3853,GO:0048588,0.769463333289092,0.642923835311149,1,4,developmental cell growth,BP,WNT3
2527,GO:0032943,0.769705498734185,0.524055248582005,2,8,mononuclear cell proliferation,BP,PIK3CG;BMP4
3673,GO:0046651,0.769705498734185,0.524055248582005,2,8,lymphocyte proliferation,BP,PIK3CG;BMP4
2089,GO:0030667,0.769859708344907,0.523844740482631,2,8,secretory granule membrane,CC,PKP1;RAB3D
1359,GO:0010632,0.771022741946699,0.467703680481179,3,12,regulation of epithelial cell migration,BP,WNT7A;BMP4;NOTCH1
3618,GO:0046068,0.771508898265164,0.640207024226853,1,4,cGMP metabolic process,BP,GUCY1B3
2168,GO:0031076,0.771566826646156,0.640129796793672,1,4,embryonic camera-type eye development,BP,BMP7
3323,GO:0044306,0.771883812779785,0.639706921445582,1,4,neuron projection terminus,CC,FSTL3
985,GO:0007204,0.771948903907035,0.639620027122054,1,4,positive regulation of cytosolic calcium ion concentration,BP,PIK3CG
1222,GO:0009566,0.772341350129477,0.639095695227109,1,4,fertilization,BP,SPTBN4
4055,GO:0050900,0.773017933797144,0.411064597459848,5,20,leukocyte migration,BP,PIK3CG;ARTN;CCL20;HRAS;PIK3CA
1082,GO:0008016,0.773157477238268,0.432559934940717,4,16,regulation of heart contraction,BP,PIK3CG;KCNG2;KCNK6;SPTBN4
1300,GO:0010171,0.77492554598068,0.635624517460491,1,4,body morphogenesis,BP,WNT3
4447,GO:0060323,0.77492554598068,0.635624517460491,1,4,head morphogenesis,BP,WNT3
3171,GO:0043281,0.775018373765659,0.635499225857785,1,4,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1
6066,GO:2000116,0.775018373765659,0.635499225857785,1,4,regulation of cysteine-type endopeptidase activity,BP,PMAIP1
5159,GO:0072216,0.775423989155421,0.634951265492428,1,4,positive regulation of metanephros development,BP,GDNF
632,GO:0005539,0.775640462460332,0.515892708064104,2,8,glycosaminoglycan binding,MF,BMP4;BMP7
4513,GO:0060491,0.775666761550697,0.634622911352715,1,4,regulation of cell projection assembly,BP,HRAS
2557,GO:0033059,0.776051961359963,0.634101329942856,1,4,cellular pigmentation,BP,RAB38
3415,GO:0044877,0.776054399828225,0.391392617027913,6,24,macromolecular complex binding,MF,ACTN3;SPTB;PKP1;RAB38;FSTL3;MB21D2
5655,GO:1901681,0.77634360815297,0.514917285808969,2,8,sulfur compound binding,MF,BMP4;BMP7
2648,GO:0034341,0.777001228566933,0.632812863570044,1,4,response to interferon-gamma,BP,CCL20
4948,GO:0071346,0.777001228566933,0.632812863570044,1,4,cellular response to interferon-gamma,BP,CCL20
1446,GO:0010948,0.77743490848451,0.513399852693668,2,8,negative regulation of cell cycle process,BP,BMP4;BMP7
931,GO:0007015,0.777693765047973,0.455034401009165,3,13,actin filament organization,BP,SPTBN5;SPTB;SPTBN4
4854,GO:0070482,0.780144307804197,0.455269625155072,3,12,response to oxygen levels,BP,PMAIP1;BMP7;NOTCH1
2030,GO:0030307,0.782409805152381,0.625386222670281,1,4,positive regulation of cell growth,BP,WNT3
759,GO:0006164,0.782723059042177,0.624951576420784,1,4,purine nucleotide biosynthetic process,BP,GUCY1B3
1198,GO:0009152,0.782723059042177,0.624951576420784,1,4,purine ribonucleotide biosynthetic process,BP,GUCY1B3
1201,GO:0009165,0.782723059042177,0.624951576420784,1,4,nucleotide biosynthetic process,BP,GUCY1B3
1207,GO:0009190,0.782723059042177,0.624951576420784,1,4,cyclic nucleotide biosynthetic process,BP,GUCY1B3
1213,GO:0009260,0.782723059042177,0.624951576420784,1,4,ribonucleotide biosynthetic process,BP,GUCY1B3
3637,GO:0046390,0.782723059042177,0.624951576420784,1,4,ribose phosphate biosynthetic process,BP,GUCY1B3
4316,GO:0052652,0.782723059042177,0.624951576420784,1,4,cyclic purine nucleotide metabolic process,BP,GUCY1B3
5204,GO:0072522,0.782723059042177,0.624951576420784,1,4,purine-containing compound biosynthetic process,BP,GUCY1B3
5613,GO:1901293,0.782723059042177,0.624951576420784,1,4,nucleoside phosphate biosynthetic process,BP,GUCY1B3
3144,GO:0043229,0.783278740740334,0.310592708645286,44,153,intracellular organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;MBOAT2;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;POU3F1;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;VDR;RAB39A;AMOT;WNT5B;DUSP5;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;TF;PM20D2
2041,GO:0030330,0.783531195741197,0.623827960909111,1,4,DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3070,GO:0042770,0.783531195741197,0.623827960909111,1,4,signal transduction in response to DNA damage,BP,PMAIP1
5260,GO:0090002,0.78451541971994,0.445617688390602,3,13,establishment of protein localization to plasma membrane,BP,CDH1;TSPAN15;SPTBN4
3791,GO:0048286,0.785756798752058,0.620716214766112,1,4,lung alveolus development,BP,BMP4
3662,GO:0046578,0.785812394543982,0.620638155791714,1,4,regulation of Ras protein signal transduction,BP,HRAS
3010,GO:0042472,0.786056606833686,0.620295080980269,1,4,inner ear morphogenesis,BP,FGF8
694,GO:0005874,0.786079129844054,0.620263424570645,1,4,microtubule,CC,RAB3D
1404,GO:0010810,0.788387318524434,0.491389925295933,2,9,regulation of cell-substrate adhesion,BP,FZD7;NOTCH1
145,GO:0001775,0.788856293501007,0.346617059743348,9,35,cell activation,BP,WNT7A;PIK3CG;JAG2;FZD7;PKP1;RAB3D;BMP4;PIK3CA;TPD52
1778,GO:0019216,0.790334952584258,0.437473139422975,3,13,regulation of lipid metabolic process,BP,PIK3CG;BMP6;VDR
4960,GO:0071375,0.790402265724537,0.437378322761355,3,13,cellular response to peptide hormone stimulus,BP,GJB2;INHBB;PIK3CA
5648,GO:1901653,0.790402265724537,0.437378322761355,3,13,cellular response to peptide,BP,GJB2;INHBB;PIK3CA
3487,GO:0045471,0.791324488332138,0.612818515465338,1,4,response to ethanol,BP,CLDN18
953,GO:0007093,0.791390236885097,0.612724270597466,1,4,mitotic cell cycle checkpoint,BP,HRAS
1571,GO:0015844,0.791742451098038,0.612219007229087,1,4,monoamine transport,BP,GDNF
3956,GO:0050432,0.791742451098038,0.612219007229087,1,4,catecholamine secretion,BP,GDNF
3957,GO:0050433,0.791742451098038,0.612219007229087,1,4,regulation of catecholamine secretion,BP,GDNF
4299,GO:0051937,0.791742451098038,0.612219007229087,1,4,catecholamine transport,BP,GDNF
991,GO:0007224,0.792302779811808,0.611413822689361,1,4,smoothened signaling pathway,BP,BMP4
3452,GO:0045177,0.792668805253791,0.434177440694276,3,13,apical part of cell,CC,GJB6;NOTCH1;TF
1978,GO:0030133,0.792980308125383,0.437345602308302,3,12,transport vesicle,CC,SYT5;RAB40B;RAB3D
3202,GO:0043434,0.794032881681967,0.401858991682855,4,17,response to peptide hormone,BP,GJB2;INHBB;PIK3CA;BMP7
2889,GO:0038034,0.794667497649524,0.607997048321294,1,4,signal transduction in absence of ligand,BP,GDNF
5394,GO:0097192,0.794667497649524,0.607997048321294,1,4,extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
946,GO:0007050,0.794947000273205,0.488439440253186,2,8,cell cycle arrest,BP,MAPK12;HRAS
630,GO:0005524,0.796235883576759,0.378347190136315,5,21,ATP binding,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
1302,GO:0010212,0.796845005259577,0.604823742107162,1,4,response to ionizing radiation,BP,HRAS
4984,GO:0071479,0.796845005259577,0.604823742107162,1,4,cellular response to ionizing radiation,BP,HRAS
1131,GO:0008285,0.800466275786287,0.358969238966758,6,24,negative regulation of cell proliferation,BP,GJB6;VDR;HRAS;BMP4;BMP7;NOTCH1
4376,GO:0060048,0.80127807083927,0.472527256931047,2,9,cardiac muscle contraction,BP,PIK3CG;PIK3CA
3595,GO:0045931,0.801450149332595,0.598025617854572,1,4,positive regulation of mitotic cell cycle,BP,FGF8
1813,GO:0019752,0.80199704476786,0.471455846992636,2,9,carboxylic acid metabolic process,BP,GLDC;ACTN3
2489,GO:0032787,0.80199704476786,0.471455846992636,2,9,monocarboxylic acid metabolic process,BP,GLDC;ACTN3
3557,GO:0045786,0.803236778667426,0.39127946843686,4,16,negative regulation of cell cycle,BP,MAPK12;HRAS;BMP4;BMP7
551,GO:0004872,0.803536220529394,0.353602339983707,6,25,receptor activity,MF,FZD7;VDR;AMOT;KCNK6;NOTCH1;GUCY1B3
4395,GO:0060089,0.803536220529394,0.353602339983707,6,25,molecular transducer activity,MF,FZD7;VDR;AMOT;KCNK6;NOTCH1;GUCY1B3
3949,GO:0048872,0.803980722056738,0.468488885588749,2,9,homeostasis of number of cells,BP,PMAIP1;BMP4
3087,GO:0043005,0.804182037468676,0.387638429358535,4,17,neuron projection,CC,SYT5;DRP2;FSTL3;SPTBN4
4093,GO:0051051,0.804235344837686,0.387562971944498,4,17,negative regulation of transport,BP,WNK4;INHBB;BMP7;NOTCH1
2781,GO:0035637,0.806669174626229,0.464442014192489,2,9,multicellular organismal signaling,BP,KCNK6;SPTBN4
2329,GO:0032102,0.80722699684431,0.463598582988107,2,9,negative regulation of response to external stimulus,BP,WNT3;NOTCH1
4114,GO:0051130,0.807806908687732,0.337541475233194,7,28,positive regulation of cellular component organization,BP,WNT7A;WNT3;PMAIP1;FGF8;HRAS;BMP7;TF
3368,GO:0044456,0.811718927215868,0.37688816837621,4,17,synapse part,CC,WNT7A;SYT5;RAB40B;DRP2
1216,GO:0009267,0.813263135354748,0.454387974521995,2,9,cellular response to starvation,BP,PMAIP1;INHBB
3046,GO:0042594,0.813263135354748,0.454387974521995,2,9,response to starvation,BP,PMAIP1;INHBB
35,GO:0000280,0.814434991778109,0.402589147063357,3,13,nuclear division,BP,FGF8;BMP4;BMP7
3790,GO:0048285,0.814434991778109,0.402589147063357,3,13,organelle fission,BP,FGF8;BMP4;BMP7
2080,GO:0030595,0.815483481741727,0.45096062367104,2,9,leukocyte chemotaxis,BP,PIK3CG;CCL20
3592,GO:0045926,0.816619671448466,0.449198465779237,2,9,negative regulation of growth,BP,WNT3;BMP4
5367,GO:0097060,0.817489179468861,0.556522509978344,1,5,synaptic membrane,CC,DRP2
1486,GO:0014069,0.817855756762547,0.5559295718784,1,5,postsynaptic density,CC,DRP2
2361,GO:0032279,0.817855756762547,0.5559295718784,1,5,asymmetric synapse,CC,DRP2
5503,GO:0098984,0.817855756762547,0.5559295718784,1,5,neuron to neuron synapse,CC,DRP2
5524,GO:0099572,0.817855756762547,0.5559295718784,1,5,postsynaptic specialization,CC,DRP2
1831,GO:0019902,0.818233859387904,0.555317113857459,1,5,phosphatase binding,MF,SPTBN4
2611,GO:0033674,0.818523091278716,0.322919133877056,7,28,positive regulation of kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA
3579,GO:0045860,0.818523091278716,0.322919133877056,7,28,positive regulation of protein kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA
4098,GO:0051056,0.819986237677091,0.443943617653264,2,9,regulation of small GTPase mediated signal transduction,BP,AMOT;HRAS
4812,GO:0070252,0.820597384949205,0.551468288752591,1,5,actin-mediated cell contraction,BP,ACTN3
542,GO:0004842,0.821335518175845,0.550259051131727,1,5,ubiquitin-protein transferase activity,MF,RNF144A
1814,GO:0019787,0.821335518175845,0.550259051131727,1,5,ubiquitin-like protein transferase activity,MF,RNF144A
3238,GO:0043549,0.821355408974685,0.310242523683321,8,32,regulation of kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;BMP7
708,GO:0005913,0.821629784052786,0.549776005252575,1,5,cell-cell adherens junction,CC,CDH1
3441,GO:0045121,0.821676821240838,0.549698741057334,1,5,membrane raft,CC,CDH1
5492,GO:0098857,0.821676821240838,0.549698741057334,1,5,membrane microdomain,CC,CDH1
4873,GO:0070661,0.822302354833438,0.440298911843906,2,9,leukocyte proliferation,BP,PIK3CG;BMP4
944,GO:0007045,0.823230257765877,0.547139056926094,1,5,cell-substrate adherens junction assembly,BP,ACTN3
2646,GO:0034333,0.823230257765877,0.547139056926094,1,5,adherens junction assembly,BP,ACTN3
3757,GO:0048041,0.823230257765877,0.547139056926094,1,5,focal adhesion assembly,BP,ACTN3
1010,GO:0007281,0.823244461369117,0.438809416809132,2,9,germ cell development,BP,INHBB;BMP4
4164,GO:0051248,0.824427460837037,0.358375753288767,4,17,negative regulation of protein metabolic process,BP,DUSP5;INHBB;BMP4;BMP7
3569,GO:0045834,0.826534153798157,0.541642956445205,1,5,positive regulation of lipid metabolic process,BP,BMP6
1974,GO:0030100,0.826833926401884,0.433096928413998,2,9,regulation of endocytosis,BP,RAB20;TF
3036,GO:0042578,0.827309777013452,0.54034228696089,1,5,phosphoric ester hydrolase activity,MF,DUSP5
1466,GO:0014013,0.827635673574748,0.539794587223483,1,5,regulation of gliogenesis,BP,NOTCH1
2309,GO:0032006,0.828202543311522,0.538840221749912,1,5,regulation of TOR signaling,BP,PIK3CA
1344,GO:0010565,0.828318561314412,0.5386446323614,1,5,regulation of cellular ketone metabolic process,BP,BMP6
2965,GO:0042180,0.828318561314412,0.5386446323614,1,5,cellular ketone metabolic process,BP,BMP6
146,GO:0001776,0.828889999727609,0.537679953700998,1,5,leukocyte homeostasis,BP,PMAIP1
217,GO:0002027,0.829519066026024,0.53661545023727,1,5,regulation of heart rate,BP,SPTBN4
4028,GO:0050839,0.82964288071721,0.376576691504198,3,14,cell adhesion molecule binding,MF,ACTN3;CDH1;MB21D2
377,GO:0003013,0.829788582795266,0.31703632851424,6,25,circulatory system process,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4;GUCY1B3
1081,GO:0008015,0.829788582795266,0.31703632851424,6,25,blood circulation,BP,PIK3CG;KCNG2;KCNK6;PIK3CA;SPTBN4;GUCY1B3
821,GO:0006629,0.830270754481317,0.305690899428572,7,29,lipid metabolic process,BP,PIK3CG;MBOAT2;BMP6;FGF8;VDR;FGF17;PIK3CA
325,GO:0002682,0.83069653074972,0.305093229855221,7,29,regulation of immune system process,BP,CLDN18;CCL20;HRAS;BMP4;PIK3CA;FSTL3;NOTCH1
168,GO:0001843,0.831516945354154,0.533216861793558,1,5,neural tube closure,BP,BMP4
1097,GO:0008092,0.831708294965378,0.313249189173762,6,26,cytoskeletal protein binding,MF,ACTN3;SPTBN5;CDH1;SPTB;RAB3D;SPTBN4
2039,GO:0030325,0.831991881227651,0.532404940003306,1,5,adrenal gland development,BP,FSTL3
920,GO:0006974,0.832489120517949,0.423973988169471,2,9,cellular response to DNA damage stimulus,BP,PMAIP1;MAPK12
926,GO:0006996,0.833025548977407,0.25961637010515,17,65,organelle organization,BP,SYT5;PMAIP1;AXIN1;SPTBN5;SPTB;FGF8;RAB39A;AMOT;PKP1;HRAS;BMP4;RAB38;BMP7;SPTBN4;NOTCH1;RND3;RAB20
4327,GO:0055013,0.833139394450118,0.530436809148242,1,5,cardiac muscle cell development,BP,BMP4
5477,GO:0098773,0.833870076047647,0.529178844594026,1,5,skin epidermis development,BP,NOTCH1
655,GO:0005730,0.834033797087454,0.528896467623162,1,5,nucleolus,CC,MAGEC2
5047,GO:0071887,0.834117222162734,0.528752508748323,1,5,leukocyte apoptotic process,BP,BMP4
4554,GO:0060603,0.834621012668203,0.527882130469166,1,5,mammary gland duct morphogenesis,BP,VDR
2952,GO:0042113,0.83471755197817,0.527715140547564,1,5,B cell activation,BP,TPD52
4116,GO:0051146,0.834748961562154,0.368652447507563,3,14,striated muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
4225,GO:0051493,0.834858718643943,0.340853877876283,4,18,regulation of cytoskeleton organization,BP,SPTBN5;SPTB;HRAS;SPTBN4
880,GO:0006869,0.835997317983159,0.525495256537723,1,5,lipid transport,BP,BMP6
1427,GO:0010876,0.835997317983159,0.525495256537723,1,5,lipid localization,BP,BMP6
1001,GO:0007265,0.836046896572602,0.41815542152243,2,9,Ras protein signal transduction,BP,RRAS2;HRAS
2260,GO:0031647,0.836117226682313,0.525286670272157,1,5,regulation of protein stability,BP,TF
2444,GO:0032609,0.837357617031276,0.523122963541446,1,5,interferon-gamma production,BP,HRAS
2456,GO:0032649,0.837357617031276,0.523122963541446,1,5,regulation of interferon-gamma production,BP,HRAS
4220,GO:0051480,0.838172877436266,0.521694856345624,1,5,regulation of cytosolic calcium ion concentration,BP,PIK3CG
1141,GO:0008361,0.83928235211571,0.519743679571953,1,5,regulation of cell size,BP,WNT3
3355,GO:0044437,0.839970082910758,0.518529722844881,1,5,vacuolar part,CC,RAB3D
3210,GO:0043473,0.840496167772664,0.517598769599989,1,5,pigmentation,BP,RAB38
386,GO:0003073,0.840595713969346,0.517422386094236,1,5,regulation of systemic arterial blood pressure,BP,KCNK6
3339,GO:0044403,0.841721734759337,0.357666861391726,3,14,symbiosis, encompassing mutualism through parasitism,BP,PMAIP1;CDH1;NOTCH1
3342,GO:0044419,0.841721734759337,0.357666861391726,3,14,interspecies interaction between organisms,BP,PMAIP1;CDH1;NOTCH1
2505,GO:0032868,0.841923197144805,0.403306241422602,2,10,response to insulin,BP,INHBB;PIK3CA
4276,GO:0051785,0.842382191070745,0.514244570998066,1,5,positive regulation of nuclear division,BP,FGF8
3392,GO:0044764,0.843020153867121,0.355599662277451,3,14,multi-organism cellular process,BP,PMAIP1;INHBB;NOTCH1
1958,GO:0030036,0.844676519629032,0.294484515090449,6,26,actin cytoskeleton organization,BP,SPTBN5;SPTB;AMOT;HRAS;SPTBN4;RND3
1230,GO:0009611,0.844731961880071,0.277025829249707,8,33,response to wounding,BP,WNT7A;PIK3CG;FZD7;WNT5B;CCL20;HRAS;PIK3CA;NOTCH1
330,GO:0002687,0.844955189043004,0.509625925962472,1,5,positive regulation of leukocyte migration,BP,CCL20
5509,GO:0099080,0.845842067857049,0.324079958761512,4,18,supramolecular complex,CC,ACTN3;AMOT;PKP1;RAB3D
5510,GO:0099081,0.845842067857049,0.324079958761512,4,18,supramolecular polymer,CC,ACTN3;AMOT;PKP1;RAB3D
5517,GO:0099512,0.845842067857049,0.324079958761512,4,18,supramolecular fiber,CC,ACTN3;AMOT;PKP1;RAB3D
1908,GO:0022406,0.846017707092694,0.507704077725404,1,5,membrane docking,BP,RAB40B
3878,GO:0048661,0.84660204282284,0.506643477483441,1,5,positive regulation of smooth muscle cell proliferation,BP,BMP4
2049,GO:0030424,0.846640832094607,0.506572980248312,1,5,axon,CC,SPTBN4
3607,GO:0045981,0.846952401884036,0.50600630086643,1,5,positive regulation of nucleotide metabolic process,BP,ACTN3
5577,GO:1900544,0.846952401884036,0.50600630086643,1,5,positive regulation of purine nucleotide metabolic process,BP,ACTN3
1049,GO:0007565,0.847629377820566,0.393673732030953,2,10,female pregnancy,BP,GJB2;VDR
4323,GO:0055007,0.848165253714955,0.392760421458386,2,10,cardiac muscle cell differentiation,BP,FZD7;BMP4
4002,GO:0050776,0.848959783321134,0.391403482359243,2,10,regulation of immune response,BP,HRAS;PIK3CA
4004,GO:0050778,0.848959783321134,0.391403482359243,2,10,positive regulation of immune response,BP,HRAS;PIK3CA
5187,GO:0072341,0.848974993524374,0.502309378694749,1,5,modified amino acid binding,MF,SYT5
5185,GO:0072331,0.849293993433724,0.501723397014168,1,5,signal transduction by p53 class mediator,BP,PMAIP1
2216,GO:0031331,0.849814269980285,0.389940398315038,2,10,positive regulation of cellular catabolic process,BP,AXIN1;RNF144A
138,GO:0001755,0.849899534291957,0.500608861081519,1,5,neural crest cell migration,BP,GDNF
376,GO:0003012,0.849937718182498,0.317716630093879,4,18,muscle system process,BP,PIK3CG;ACTN3;GDNF;PIK3CA
907,GO:0006936,0.849937718182498,0.317716630093879,4,18,muscle contraction,BP,PIK3CG;ACTN3;GDNF;PIK3CA
1990,GO:0030168,0.850645424237123,0.388513517231401,2,10,platelet activation,BP,PIK3CG;PIK3CA
743,GO:0006082,0.850731083489127,0.38836625106361,2,10,organic acid metabolic process,BP,GLDC;ACTN3
3203,GO:0043436,0.850731083489127,0.38836625106361,2,10,oxoacid metabolic process,BP,GLDC;ACTN3
3306,GO:0044255,0.851938965541247,0.296714336737349,5,22,cellular lipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA
3319,GO:0044283,0.853218824287352,0.384071967190186,2,10,small molecule biosynthetic process,BP,BMP6;VDR
3074,GO:0042802,0.85380967146986,0.264052989721126,8,33,identical protein binding,MF,TLE1;ACTN3;CLDN18;AXIN1;INHBB;CLDN15;GDNF;TPD52
378,GO:0003014,0.85473261260847,0.381442332189175,2,10,renal system process,BP,WNK4;BMP4
8,GO:0000075,0.854787931523735,0.491504364099462,1,5,cell cycle checkpoint,BP,HRAS
1570,GO:0015837,0.855138751300865,0.490843524996427,1,5,amine transport,BP,GDNF
4301,GO:0051952,0.855138751300865,0.490843524996427,1,5,regulation of amine transport,BP,GDNF
5844,GO:1903531,0.855588005469752,0.379950802208415,2,10,negative regulation of secretion by cell,BP,INHBB;NOTCH1
1069,GO:0007610,0.857414387374858,0.376752484925316,2,10,behavior,BP,GDNF;SPTBN4
758,GO:0006163,0.858364501833601,0.375081224059508,2,10,purine nucleotide metabolic process,BP,ACTN3;GUCY1B3
854,GO:0006753,0.858364501833601,0.375081224059508,2,10,nucleoside phosphate metabolic process,BP,ACTN3;GUCY1B3
1189,GO:0009117,0.858364501833601,0.375081224059508,2,10,nucleotide metabolic process,BP,ACTN3;GUCY1B3
1197,GO:0009150,0.858364501833601,0.375081224059508,2,10,purine ribonucleotide metabolic process,BP,ACTN3;GUCY1B3
1212,GO:0009259,0.858364501833601,0.375081224059508,2,10,ribonucleotide metabolic process,BP,ACTN3;GUCY1B3
1807,GO:0019693,0.858364501833601,0.375081224059508,2,10,ribose phosphate metabolic process,BP,ACTN3;GUCY1B3
4350,GO:0055086,0.858364501833601,0.375081224059508,2,10,nucleobase-containing small molecule metabolic process,BP,ACTN3;GUCY1B3
5203,GO:0072521,0.858364501833601,0.375081224059508,2,10,purine-containing compound metabolic process,BP,ACTN3;GUCY1B3
677,GO:0005789,0.858380018854567,0.375053886894406,2,10,endoplasmic reticulum membrane,CC,MBOAT2;NOTCH1
1955,GO:0030031,0.858620876953312,0.374629378342672,2,10,cell projection assembly,BP,HRAS;NOTCH1
2297,GO:0031967,0.861282599677852,0.369915955015523,2,10,organelle envelope,CC,PMAIP1;RAB40B
2301,GO:0031975,0.861282599677852,0.369915955015523,2,10,envelope,CC,PMAIP1;RAB40B
1362,GO:0010638,0.861392522911711,0.3255808197293,3,14,positive regulation of organelle organization,BP,PMAIP1;FGF8;HRAS
972,GO:0007173,0.861404495812678,0.369699117665407,2,10,epidermal growth factor receptor signaling pathway,BP,HRAS;PIK3CA
2903,GO:0038127,0.861404495812678,0.369699117665407,2,10,ERBB signaling pathway,BP,HRAS;PIK3CA
4947,GO:0071345,0.862954604813715,0.3669340938242,2,10,cellular response to cytokine stimulus,BP,CLDN18;CCL20
2352,GO:0032269,0.863179162970944,0.322581183585404,3,14,negative regulation of cellular protein metabolic process,BP,DUSP5;BMP4;BMP7
2078,GO:0030554,0.86327970795927,0.278061985327363,5,23,adenyl nucleotide binding,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
2434,GO:0032559,0.86327970795927,0.278061985327363,5,23,adenyl ribonucleotide binding,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
2528,GO:0032944,0.863521004133546,0.474745692171855,1,5,regulation of mononuclear cell proliferation,BP,BMP4
3961,GO:0050670,0.863521004133546,0.474745692171855,1,5,regulation of lymphocyte proliferation,BP,BMP4
2083,GO:0030658,0.863897165649577,0.474009048743879,1,5,transport vesicle membrane,CC,SYT5
1833,GO:0019904,0.865905505912726,0.315568474908395,3,15,protein domain specific binding,MF,WNT3;AXIN1;FZD7
5214,GO:0072593,0.867280306573264,0.359142548042255,2,10,reactive oxygen species metabolic process,BP,PMAIP1;BMP7
1914,GO:0022412,0.868817882188063,0.356345714229805,2,10,cellular process involved in reproduction in multicellular organism,BP,INHBB;BMP4
3347,GO:0044425,0.869664063520667,0.200067203025852,29,109,membrane part,CC,SLC2A14;GJB2;PIK3CG;SYT5;RHBDL3;CLDN18;MBOAT2;GJA3;GJB6;JAG2;KCNG2;AXIN1;SPTBN5;CDH1;SPTB;FZD7;FGF8;DSG3;AMOT;TSPAN15;KCNK6;CLDN15;RNF144A;PIK3CA;DRP2;TMEM206;TSPAN13;NOTCH1;TF
959,GO:0007155,0.870466515480114,0.211004236928346,16,64,cell adhesion,BP,PIK3CG;ACTN3;CLDN18;WNT7B;JAG2;CDH1;FZD7;DSG3;PKP1;BMP4;CLDN15;PIK3CA;BMP7;FSTL3;NOTCH1;RND3
1921,GO:0022610,0.870466515480114,0.211004236928346,16,64,biological adhesion,BP,PIK3CG;ACTN3;CLDN18;WNT7B;JAG2;CDH1;FZD7;DSG3;PKP1;BMP4;CLDN15;PIK3CA;BMP7;FSTL3;NOTCH1;RND3
1953,GO:0030029,0.871215962193589,0.244589934655044,7,31,actin filament-based process,BP,ACTN3;SPTBN5;SPTB;AMOT;HRAS;SPTBN4;RND3
1963,GO:0030048,0.872098738488134,0.446160628070016,1,6,actin filament-based movement,BP,ACTN3
2095,GO:0030695,0.876232514687856,0.437628513961076,1,6,GTPase regulator activity,MF,AXIN1
4547,GO:0060589,0.876232514687856,0.437628513961076,1,6,nucleoside-triphosphatase regulator activity,MF,AXIN1
1699,GO:0016788,0.876827605005903,0.436386773160427,1,6,hydrolase activity, acting on ester bonds,MF,DUSP5
4044,GO:0050877,0.876991300065692,0.272475356465127,4,19,neurological system process,BP,GJB2;GJA3;GJB6;SPTBN4
5471,GO:0098742,0.877079191307081,0.272328888141208,4,19,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN18;CDH1;DSG3;CLDN15
2200,GO:0031253,0.877328562675851,0.435338780819904,1,6,cell projection membrane,CC,SPTBN5
5978,GO:1905475,0.877646485350141,0.434672420633167,1,6,regulation of protein localization to membrane,BP,PMAIP1
4082,GO:0051015,0.877795988617621,0.434358721717362,1,6,actin filament binding,MF,SPTB
3166,GO:0043271,0.878758328989232,0.432334194950127,1,6,negative regulation of ion transport,BP,WNK4
260,GO:0002262,0.880227501128324,0.429225668508664,1,6,myeloid cell homeostasis,BP,BMP4
3897,GO:0048708,0.880311572290894,0.429047133574047,1,6,astrocyte differentiation,BP,NOTCH1
2304,GO:0031983,0.880718095610745,0.428182828248739,1,6,vesicle lumen,CC,TF
2701,GO:0034774,0.880718095610745,0.428182828248739,1,6,secretory granule lumen,CC,TF
4419,GO:0060205,0.880718095610745,0.428182828248739,1,6,cytoplasmic vesicle lumen,CC,TF
4112,GO:0051128,0.880736950669157,0.203299994524153,13,53,regulation of cellular component organization,BP,WNT7A;WNT3;PMAIP1;SPTBN5;SPTB;FGF8;HRAS;BMP4;BMP7;SPTBN4;NOTCH1;RAB20;TF
1629,GO:0016311,0.881108833644456,0.4273505086203,1,6,dephosphorylation,BP,DUSP5
3253,GO:0043603,0.882490914542358,0.424394028527021,1,6,cellular amide metabolic process,BP,BMP4
1771,GO:0019207,0.882502092186257,0.424370038065931,1,6,kinase regulator activity,MF,PIK3CA
1613,GO:0016236,0.883205493581894,0.422857741614551,1,6,macroautophagy,BP,PIK3CA
1615,GO:0016241,0.883205493581894,0.422857741614551,1,6,regulation of macroautophagy,BP,PIK3CA
3466,GO:0045216,0.88391245587729,0.284285143509263,3,15,cell-cell junction organization,BP,GJB2;ACTN3;CDH1
5840,GO:1903522,0.884231169273358,0.26029443157698,4,19,regulation of blood circulation,BP,PIK3CG;KCNG2;KCNK6;SPTBN4
4320,GO:0055002,0.884559892694124,0.419931334976385,1,6,striated muscle cell development,BP,BMP4
2193,GO:0031224,0.884715284948265,0.184640255593287,21,82,intrinsic component of membrane,CC,SLC2A14;GJB2;SYT5;RHBDL3;CLDN18;MBOAT2;GJA3;GJB6;JAG2;KCNG2;CDH1;SPTB;FZD7;DSG3;TSPAN15;KCNK6;CLDN15;RNF144A;TMEM206;TSPAN13;NOTCH1
3033,GO:0042552,0.885413013775522,0.41807814210652,1,6,myelination,BP,POU3F1
3562,GO:0045807,0.885850767783777,0.417124238815698,1,6,positive regulation of endocytosis,BP,TF
3008,GO:0042470,0.88606227545483,0.416662614761636,1,6,melanosome,CC,RAB38
3917,GO:0048770,0.88606227545483,0.416662614761636,1,6,pigment granule,CC,RAB38
901,GO:0006914,0.886298473944424,0.319575226924757,2,11,autophagy,BP,RAB39A;PIK3CA
3189,GO:0043393,0.886396547555816,0.415932078167378,1,6,regulation of protein binding,BP,BMP4
3379,GO:0044706,0.888090618942142,0.316096135139651,2,11,multi-multicellular organism process,BP,GJB2;VDR
1678,GO:0016604,0.891696052581413,0.404187517445734,1,6,nuclear body,CC,SPTBN4
2963,GO:0042175,0.892149506220034,0.308130624387325,2,11,nuclear outer membrane-endoplasmic reticulum membrane network,CC,MBOAT2;NOTCH1
4555,GO:0060606,0.892974979697395,0.401306211227122,1,6,tube closure,BP,BMP4
908,GO:0006937,0.893727029906188,0.305001777782421,2,11,regulation of muscle contraction,BP,PIK3CG;ACTN3
5318,GO:0090257,0.893727029906188,0.305001777782421,2,11,regulation of muscle system process,BP,PIK3CG;ACTN3
1289,GO:0010001,0.893978632252134,0.304501011712363,2,11,glial cell differentiation,BP,POU3F1;NOTCH1
2940,GO:0042063,0.893978632252134,0.304501011712363,2,11,gliogenesis,BP,POU3F1;NOTCH1
3764,GO:0048145,0.895135190116819,0.39639662326466,1,6,regulation of fibroblast proliferation,BP,WNT2
3765,GO:0048146,0.895135190116819,0.39639662326466,1,6,positive regulation of fibroblast proliferation,BP,WNT2
3141,GO:0043226,0.895277026836867,0.171586492576443,49,174,organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;MBOAT2;BMP6;WNT3;HEY1;WNT7B;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;VDR;RAB39A;DSG3;AMOT;WNT5B;DUSP5;PKN3;PKP1;TSPAN15;HRAS;RAB3D;RNF144A;RAB38;DRP2;BMP7;FSTL3;TPD52;SPTBN4;NOTCH1;RND3;RAB20;TF;PM20D2
4665,GO:0061041,0.895454963546867,0.395665226771808,1,6,regulation of wound healing,BP,HRAS
5787,GO:1903034,0.895454963546867,0.395665226771808,1,6,regulation of response to wounding,BP,HRAS
757,GO:0006140,0.896512171352299,0.393238522389937,1,6,regulation of nucleotide metabolic process,BP,ACTN3
5575,GO:1900542,0.896512171352299,0.393238522389937,1,6,regulation of purine nucleotide metabolic process,BP,ACTN3
543,GO:0004857,0.896610577141787,0.393011965324477,1,6,enzyme inhibitor activity,MF,NOTCH1
4983,GO:0071478,0.897196149682405,0.391661415485058,1,6,cellular response to radiation,BP,HRAS
5794,GO:1903047,0.897430189199795,0.237447365642406,4,19,mitotic cell cycle process,BP,FGF8;HRAS;BMP4;BMP7
1471,GO:0014032,0.898513750948755,0.388607381392097,1,6,neural crest cell development,BP,GDNF
1472,GO:0014033,0.898513750948755,0.388607381392097,1,6,neural crest cell differentiation,BP,GDNF
4061,GO:0050921,0.899707593675551,0.385821870470671,1,6,positive regulation of chemotaxis,BP,ARTN
942,GO:0007043,0.899934221815919,0.385291105202721,1,6,cell-cell junction assembly,BP,GJB2
4315,GO:0052548,0.900970214056775,0.382856639486571,1,6,regulation of endopeptidase activity,BP,PMAIP1
4165,GO:0051249,0.901234641662883,0.289846840979824,2,11,regulation of lymphocyte activation,BP,BMP4;PIK3CA
1761,GO:0019003,0.901883737689176,0.380698752694384,1,6,GDP binding,MF,HRAS
3020,GO:0042493,0.902040817850875,0.288192597948922,2,11,response to drug,BP,CDH1;FGF8
3462,GO:0045202,0.902259040664818,0.227571336507078,4,20,synapse,CC,WNT7A;SYT5;RAB40B;DRP2
4875,GO:0070663,0.903015362514013,0.378010930857672,1,6,regulation of leukocyte proliferation,BP,BMP4
1361,GO:0010634,0.904687778483741,0.282723004836192,2,11,positive regulation of epithelial cell migration,BP,WNT7A;BMP4
1637,GO:0016338,0.90600208629486,0.279985056773306,2,11,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN18;CLDN15
969,GO:0007167,0.909510415730145,0.16601933069697,11,47,enzyme linked receptor protein signaling pathway,BP,BMP6;MAPK12;FGF8;INHBB;FGF17;HRAS;BMP4;PIK3CA;BMP7;FSTL3;NOTCH1
1588,GO:0016021,0.909600520694515,0.150483700005302,20,80,integral component of membrane,CC,SLC2A14;GJB2;SYT5;RHBDL3;CLDN18;MBOAT2;GJA3;GJB6;JAG2;KCNG2;CDH1;FZD7;DSG3;TSPAN15;KCNK6;CLDN15;RNF144A;TMEM206;TSPAN13;NOTCH1
691,GO:0005856,0.910651818153494,0.175501740280747,8,37,cytoskeleton,CC,ACTN3;SPTBN5;CDH1;SPTB;AMOT;PKP1;RAB3D;SPTBN4
943,GO:0007044,0.910854743732569,0.3510507047783,1,7,cell-substrate junction assembly,BP,ACTN3
1132,GO:0008286,0.911020117185634,0.350639897516747,1,7,insulin receptor signaling pathway,BP,PIK3CA
2019,GO:0030260,0.91145080475046,0.349568234425725,1,7,entry into host cell,BP,CDH1
3341,GO:0044409,0.91145080475046,0.349568234425725,1,7,entry into host,BP,CDH1
4263,GO:0051701,0.91145080475046,0.349568234425725,1,7,interaction with host,BP,CDH1
4279,GO:0051806,0.91145080475046,0.349568234425725,1,7,entry into cell of other organism involved in symbiotic interaction,BP,CDH1
4280,GO:0051828,0.91145080475046,0.349568234425725,1,7,entry into other organism involved in symbiotic interaction,BP,CDH1
5896,GO:1904018,0.912370827098476,0.347270285125182,1,7,positive regulation of vasculature development,BP,NOTCH1
716,GO:0005929,0.912711368814831,0.346416685195388,1,7,cilium,CC,SPTBN5
3359,GO:0044441,0.912711368814831,0.346416685195388,1,7,ciliary part,CC,SPTBN5
2283,GO:0031929,0.915654680927763,0.338969594969023,1,7,TOR signaling,BP,PIK3CA
3568,GO:0045833,0.915810383878848,0.338572120971804,1,7,negative regulation of lipid metabolic process,BP,PIK3CG
1171,GO:0008645,0.917321747786754,0.33469519391602,1,7,hexose transport,BP,SLC2A14
1564,GO:0015749,0.917321747786754,0.33469519391602,1,7,monosaccharide transport,BP,SLC2A14
1565,GO:0015758,0.917321747786754,0.33469519391602,1,7,glucose transport,BP,SLC2A14
1630,GO:0016323,0.917441823394096,0.334385707101367,1,7,basolateral plasma membrane,CC,TF
1979,GO:0030135,0.917856108562236,0.33331623700402,1,7,coated vesicle,CC,TF
1980,GO:0030136,0.917856108562236,0.33331623700402,1,7,clathrin-coated vesicle,CC,TF
4355,GO:0055117,0.918455755546464,0.33176362575741,1,7,regulation of cardiac muscle contraction,BP,PIK3CG
930,GO:0007010,0.919141412621471,0.16164367995358,8,37,cytoskeleton organization,BP,AXIN1;SPTBN5;SPTB;AMOT;PKP1;HRAS;SPTBN4;RND3
34,GO:0000278,0.919175328595369,0.196536824210532,4,20,mitotic cell cycle,BP,FGF8;HRAS;BMP4;BMP7
1159,GO:0008584,0.91941265338932,0.329274562359871,1,7,male gonad development,BP,FSTL3
3661,GO:0046546,0.91941265338932,0.329274562359871,1,7,development of primary male sexual characteristics,BP,FSTL3
3716,GO:0046888,0.919521273694992,0.328991124250703,1,7,negative regulation of hormone secretion,BP,INHBB
658,GO:0005740,0.920053694452814,0.327599138605045,1,7,mitochondrial envelope,CC,PMAIP1
2296,GO:0031966,0.920053694452814,0.327599138605045,1,7,mitochondrial membrane,CC,PMAIP1
872,GO:0006820,0.920551984179813,0.326292353020531,1,7,anion transport,BP,WNK4
1007,GO:0007272,0.920742278577475,0.325792262828898,1,7,ensheathment of neurons,BP,POU3F1
1142,GO:0008366,0.920742278577475,0.325792262828898,1,7,axon ensheathment,BP,POU3F1
554,GO:0004930,0.920969287615207,0.325194935505155,1,7,G-protein coupled receptor activity,MF,FZD7
3366,GO:0044451,0.923161893660079,0.319382904647158,1,7,nucleoplasm part,CC,SPTBN4
5649,GO:1901654,0.923334898599397,0.31892098149283,1,7,response to ketone,BP,GJB2
2619,GO:0034097,0.925087359322015,0.235554910735699,2,12,response to cytokine,BP,CLDN18;CCL20
333,GO:0002694,0.925436327516865,0.23476406850708,2,12,regulation of leukocyte activation,BP,BMP4;PIK3CA
1206,GO:0009187,0.926031409632169,0.311656681024395,1,7,cyclic nucleotide metabolic process,BP,GUCY1B3
3165,GO:0043270,0.926165771266963,0.311291490313267,1,7,positive regulation of ion transport,BP,GDNF
714,GO:0005924,0.926212851488772,0.199949864955323,3,17,cell-substrate adherens junction,CC,ACTN3;RRAS2;RND3
715,GO:0005925,0.926212851488772,0.199949864955323,3,17,focal adhesion,CC,ACTN3;RRAS2;RND3
6103,GO:2000377,0.926553690648424,0.31023539079953,1,7,regulation of reactive oxygen species metabolic process,BP,BMP7
2011,GO:0030234,0.928203803013882,0.195835334457273,3,17,enzyme regulator activity,MF,AXIN1;PIK3CA;NOTCH1
4227,GO:0051495,0.928854299401149,0.30391792036928,1,7,positive regulation of cytoskeleton organization,BP,HRAS
2643,GO:0034330,0.92938253089176,0.193383162631095,3,17,cell junction organization,BP,GJB2;ACTN3;CDH1
909,GO:0006939,0.931745007548984,0.295844704650995,1,7,smooth muscle contraction,BP,GDNF
3876,GO:0048659,0.931818285543808,0.295638036868225,1,7,smooth muscle cell proliferation,BP,BMP4
3877,GO:0048660,0.931818285543808,0.295638036868225,1,7,regulation of smooth muscle cell proliferation,BP,BMP4
5480,GO:0098794,0.936400639497659,0.277055296351555,1,8,postsynapse,CC,DRP2
1762,GO:0019058,0.937010947522221,0.27528443036271,1,8,viral life cycle,BP,NOTCH1
5484,GO:0098802,0.937611010486703,0.27353598508202,1,8,plasma membrane receptor complex,CC,TF
1589,GO:0016032,0.939861927733131,0.19863626450039,2,13,viral process,BP,PMAIP1;NOTCH1
2050,GO:0030425,0.939947129591788,0.266658560694478,1,8,dendrite,CC,DRP2
4268,GO:0051726,0.940378845374552,0.1433923887391,5,25,regulation of cell cycle,BP,MAPK12;FGF8;HRAS;BMP4;BMP7
590,GO:0005178,0.941159607148902,0.263043700043937,1,8,integrin binding,MF,ACTN3
1343,GO:0010564,0.941729813579249,0.166913322521609,3,17,regulation of cell cycle process,BP,FGF8;BMP4;BMP7
2502,GO:0032844,0.941848158741938,0.26097668235965,1,8,regulation of homeostatic process,BP,CLDN18
5526,GO:0099600,0.941856166098946,0.193760172713265,2,13,transmembrane receptor activity,MF,FZD7;KCNK6
1170,GO:0008643,0.942032540440417,0.260421404965954,1,8,carbohydrate transport,BP,SLC2A14
1966,GO:0030055,0.942880424052318,0.163203776763248,3,18,cell-substrate junction,CC,ACTN3;RRAS2;RND3
3674,GO:0046660,0.943966067270972,0.254552661463861,1,8,female sex differentiation,BP,INHBB
2031,GO:0030308,0.946146321745291,0.247831775110584,1,8,negative regulation of cell growth,BP,WNT3
328,GO:0002685,0.946410683128793,0.247009184462427,1,8,regulation of leukocyte migration,BP,CCL20
978,GO:0007186,0.947417286365255,0.153062311810045,3,18,G-protein coupled receptor signaling pathway,BP,PIK3CG;FZD7;CCL20
4167,GO:0051251,0.949797908506103,0.236316513965189,1,8,positive regulation of lymphocyte activation,BP,PIK3CA
2252,GO:0031589,0.952722405533347,0.139954662724249,3,19,cell-substrate adhesion,BP,ACTN3;FZD7;NOTCH1
1218,GO:0009314,0.953152857168376,0.225431053318115,1,8,response to radiation,BP,HRAS
30,GO:0000226,0.953825109228945,0.223212533482913,1,8,microtubule cytoskeleton organization,BP,AXIN1
933,GO:0007017,0.953825109228945,0.223212533482913,1,8,microtubule-based process,BP,AXIN1
1828,GO:0019899,0.954669652430027,0.102613850180452,7,36,enzyme binding,MF,MAGEC2;GLDC;AXIN1;TSPAN15;RNF144A;SPTBN4;NOTCH1
2885,GO:0038023,0.956650094549008,0.154085422739321,2,14,signaling receptor activity,MF,FZD7;VDR
4996,GO:0071559,0.956850458709037,0.153547310337463,2,14,response to transforming growth factor beta,BP,WNT7A;WNT2
4997,GO:0071560,0.956850458709037,0.153547310337463,2,14,cellular response to transforming growth factor beta stimulus,BP,WNT7A;WNT2
2642,GO:0034329,0.958500656902071,0.149086381812665,2,14,cell junction assembly,BP,GJB2;ACTN3
4037,GO:0050865,0.960342109673544,0.144045358225538,2,14,regulation of cell activation,BP,BMP4;PIK3CA
1325,GO:0010506,0.960499439946268,0.196792610984375,1,9,regulation of autophagy,BP,PIK3CA
327,GO:0002684,0.96227338022369,0.117169037958557,3,19,positive regulation of immune system process,BP,CCL20;HRAS;PIK3CA
1610,GO:0016197,0.963062381418867,0.187734465998216,1,9,endosomal transport,BP,RAB38
4045,GO:0050878,0.963871589714352,0.10139124226194,4,24,regulation of body fluid levels,BP,PIK3CG;VDR;WNK4;PIK3CA
335,GO:0002696,0.964479138802581,0.182627305598587,1,9,positive regulation of leukocyte activation,BP,PIK3CA
3370,GO:0044463,0.96491909406093,0.109888992446904,3,20,cell projection part,CC,SPTBN5;FSTL3;SPTBN4
1121,GO:0008217,0.964939124275347,0.180953132303351,1,9,regulation of blood pressure,BP,KCNK6
5601,GO:1901137,0.965283215553554,0.179695519047819,1,9,carbohydrate derivative biosynthetic process,BP,GUCY1B3
5275,GO:0090068,0.966788334874736,0.174140322533363,1,9,positive regulation of cell cycle process,BP,FGF8
971,GO:0007169,0.973121349291597,0.0732805826412014,5,29,transmembrane receptor protein tyrosine kinase signaling pathway,BP,MAPK12;FGF8;FGF17;HRAS;PIK3CA
2195,GO:0031226,0.973989507629008,0.0669162650425234,6,34,intrinsic component of plasma membrane,CC,JAG2;KCNG2;SPTB;TSPAN15;KCNK6;TSPAN13
945,GO:0007049,0.975421054532137,0.0639994039783002,6,33,cell cycle,BP,JAG2;MAPK12;FGF8;HRAS;BMP4;BMP7
4039,GO:0050867,0.975936230629642,0.135820204965045,1,10,positive regulation of cell activation,BP,PIK3CA
1905,GO:0022402,0.976530021082081,0.0654260605639706,5,29,cell cycle process,BP,MAPK12;FGF8;HRAS;BMP4;BMP7
2000,GO:0030198,0.978983229851297,0.0857556756522556,2,17,extracellular matrix organization,BP,CDH1;NOTCH1
3099,GO:0043062,0.978983229851297,0.0857556756522556,2,17,extracellular structure organization,BP,CDH1;NOTCH1
3143,GO:0043228,0.980228287243735,0.0466559270360802,9,48,non-membrane-bounded organelle,CC,MAGEC2;ACTN3;SPTBN5;CDH1;SPTB;AMOT;PKP1;RAB3D;SPTBN4
3147,GO:0043232,0.980228287243735,0.0466559270360802,9,48,intracellular non-membrane-bounded organelle,CC,MAGEC2;ACTN3;SPTBN5;CDH1;SPTB;AMOT;PKP1;RAB3D;SPTBN4
1744,GO:0018108,0.981529752250703,0.0780936685294698,2,16,peptidyl-tyrosine phosphorylation,BP,FGF8;FGF17
1754,GO:0018212,0.981529752250703,0.0780936685294698,2,16,peptidyl-tyrosine modification,BP,FGF8;FGF17
553,GO:0004888,0.982440495768979,0.106004260805394,1,11,transmembrane signaling receptor activity,MF,FZD7
1551,GO:0015630,0.983052152897404,0.103227202478298,1,11,microtubule cytoskeleton,CC,RAB3D
1060,GO:0007596,0.983306523867946,0.0714333766074638,2,17,blood coagulation,BP,PIK3CG;PIK3CA
1061,GO:0007599,0.983306523867946,0.0714333766074638,2,17,hemostasis,BP,PIK3CG;PIK3CA
4021,GO:0050817,0.983306523867946,0.0714333766074638,2,17,coagulation,BP,PIK3CG;PIK3CA
700,GO:0005887,0.989437491166536,0.0327353602532663,5,33,integral component of plasma membrane,CC,JAG2;KCNG2;TSPAN15;KCNK6;TSPAN13
963,GO:0007160,0.989984814618456,0.0673559908813376,1,13,cell-matrix adhesion,BP,ACTN3
5599,GO:1901135,0.991559397239397,0.0405141090381189,2,19,carbohydrate derivative metabolic process,BP,ACTN3;GUCY1B3
3558,GO:0045787,0.9936988862274,0.0468874436597446,1,13,positive regulation of cell cycle,BP,FGF8
97,GO:0001558,0.994494120533748,0.0416238795757545,1,14,regulation of cell growth,BP,WNT3
1593,GO:0016049,0.994494120533748,0.0416238795757545,1,14,cell growth,BP,WNT3
1830,GO:0019901,0.995831266819911,0.0329566958186145,1,15,protein kinase binding,MF,AXIN1
1829,GO:0019900,0.997326243646554,0.0227599935332538,1,16,kinase binding,MF,AXIN1
1,GO:0000002,1,0.711015020328229,0,1,mitochondrial genome maintenance,BP,
3,GO:0000018,1,0.674610601535826,0,1,regulation of DNA recombination,BP,
5,GO:0000045,1,0.687261217406708,0,1,autophagosome assembly,BP,
6,GO:0000060,1,0.331815606605697,0,3,protein import into nucleus, translocation,BP,
7,GO:0000070,1,0.6730929422979,0,1,mitotic sister chromatid segregation,BP,
9,GO:0000077,1,0.31977331103751,0,3,DNA damage checkpoint,BP,
10,GO:0000079,1,0.0936524047252085,0,6,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11,GO:0000082,1,0.0956109611391684,0,6,G1/S transition of mitotic cell cycle,BP,
12,GO:0000086,1,0.346811280986329,0,3,G2/M transition of mitotic cell cycle,BP,
13,GO:0000118,1,0.716995957461558,0,1,histone deacetylase complex,CC,
15,GO:0000132,1,0.64211725735274,0,1,establishment of mitotic spindle orientation,BP,
17,GO:0000145,1,0.687261217406708,0,1,exocyst,CC,
18,GO:0000146,1,0.718786554623569,0,1,microfilament motor activity,MF,
21,GO:0000155,1,0.707215656113447,0,1,phosphorelay sensor kinase activity,MF,
22,GO:0000160,1,0.707215656113447,0,1,phosphorelay signal transduction system,BP,
25,GO:0000185,1,0.662260907860005,0,1,activation of MAPKKK activity,BP,
31,GO:0000228,1,0.716995957461558,0,1,nuclear chromosome,CC,
32,GO:0000242,1,0.675320542642266,0,1,pericentriolar material,CC,
33,GO:0000271,1,0.34228095063387,0,3,polysaccharide biosynthetic process,BP,
36,GO:0000281,1,0.717075982523979,0,1,mitotic cytokinesis,BP,
41,GO:0000307,1,0.685778755049879,0,1,cyclin-dependent protein kinase holoenzyme complex,CC,
44,GO:0000785,1,0.346724295469091,0,3,chromatin,CC,
45,GO:0000790,1,0.716995957461558,0,1,nuclear chromatin,CC,
46,GO:0000792,1,0.710929977208901,0,1,heterochromatin,CC,
47,GO:0000803,1,0.716995957461558,0,1,sex chromosome,CC,
48,GO:0000805,1,0.716995957461558,0,1,X chromosome,CC,
49,GO:0000806,1,0.716995957461558,0,1,Y chromosome,CC,
50,GO:0000819,1,0.6730929422979,0,1,sister chromatid segregation,BP,
53,GO:0000910,1,0.338197443696272,0,3,cytokinesis,BP,
54,GO:0000922,1,0.447848957747919,0,2,spindle pole,CC,
55,GO:0000930,1,0.482446769420789,0,2,gamma-tubulin complex,CC,
57,GO:0000976,1,0.707980062532778,0,1,transcription regulatory region sequence-specific DNA binding,MF,
58,GO:0000977,1,0.707980062532778,0,1,RNA polymerase II regulatory region sequence-specific DNA binding,MF,
59,GO:0000979,1,0.707980062532778,0,1,RNA polymerase II core promoter sequence-specific DNA binding,MF,
61,GO:0000982,1,0.497634903601143,0,2,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
65,GO:0001012,1,0.707980062532778,0,1,RNA polymerase II regulatory region DNA binding,MF,
66,GO:0001046,1,0.707980062532778,0,1,core promoter sequence-specific DNA binding,MF,
71,GO:0001077,1,0.70409479607052,0,1,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
72,GO:0001078,1,0.707980062532778,0,1,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
73,GO:0001085,1,0.707980062532778,0,1,RNA polymerase II transcription factor binding,MF,
75,GO:0001102,1,0.707980062532778,0,1,RNA polymerase II activating transcription factor binding,MF,
79,GO:0001134,1,0.714341024234018,0,1,transcription factor activity, transcription factor recruiting,MF,
80,GO:0001135,1,0.714341024234018,0,1,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
83,GO:0001227,1,0.707980062532778,0,1,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
84,GO:0001228,1,0.70409479607052,0,1,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
90,GO:0001508,1,0.506310676344189,0,2,action potential,BP,
91,GO:0001516,1,0.459513176635729,0,2,prostaglandin biosynthetic process,BP,
92,GO:0001523,1,0.487157880316345,0,2,retinoid metabolic process,BP,
96,GO:0001556,1,0.635388353995092,0,1,oocyte maturation,BP,
102,GO:0001573,1,0.719290773235962,0,1,ganglioside metabolic process,BP,
103,GO:0001578,1,0.481551811082821,0,2,microtubule bundle formation,BP,
104,GO:0001609,1,0.700996267622242,0,1,G-protein coupled adenosine receptor activity,MF,
105,GO:0001618,1,0.181540798490532,0,5,virus receptor activity,MF,
107,GO:0001653,1,0.715502935770821,0,1,peptide receptor activity,MF,
113,GO:0001659,1,0.700996267622242,0,1,temperature homeostasis,BP,
118,GO:0001676,1,0.482577571544334,0,2,long-chain fatty acid metabolic process,BP,
134,GO:0001741,1,0.716995957461558,0,1,XY body,CC,
137,GO:0001754,1,0.718786554623569,0,1,eye photoreceptor cell differentiation,BP,
140,GO:0001757,1,0.708931381661885,0,1,somite specification,BP,
143,GO:0001764,1,0.496324350426014,0,2,neuron migration,BP,
144,GO:0001771,1,0.714643171421448,0,1,immunological synapse formation,BP,
147,GO:0001779,1,0.49477829811891,0,2,natural killer cell differentiation,BP,
148,GO:0001780,1,0.509251832505045,0,2,neutrophil homeostasis,BP,
149,GO:0001784,1,0.51197138028005,0,2,phosphotyrosine binding,MF,
155,GO:0001821,1,0.682927424885784,0,1,histamine secretion,BP,
158,GO:0001824,1,0.710929977208901,0,1,blastocyst development,BP,
159,GO:0001832,1,0.710929977208901,0,1,blastocyst growth,BP,
160,GO:0001833,1,0.710929977208901,0,1,inner cell mass cell proliferation,BP,
180,GO:0001906,1,0.476279856679472,0,2,cell killing,BP,
181,GO:0001909,1,0.700234742383915,0,1,leukocyte mediated cytotoxicity,BP,
182,GO:0001913,1,0.700234742383915,0,1,T cell mediated cytotoxicity,BP,
183,GO:0001917,1,0.718786554623569,0,1,photoreceptor inner segment,CC,
184,GO:0001927,1,0.687261217406708,0,1,exocyst assembly,BP,
185,GO:0001928,1,0.687261217406708,0,1,regulation of exocyst assembly,BP,
186,GO:0001931,1,0.714643171421448,0,1,uropod,CC,
196,GO:0001945,1,0.715812986083774,0,1,lymph vessel development,BP,
199,GO:0001952,1,0.173768356387937,0,5,regulation of cell-matrix adhesion,BP,
200,GO:0001953,1,0.717681530181595,0,1,negative regulation of cell-matrix adhesion,BP,
201,GO:0001954,1,0.496304663504859,0,2,positive regulation of cell-matrix adhesion,BP,
203,GO:0001959,1,0.338127886737618,0,3,regulation of cytokine-mediated signaling pathway,BP,
204,GO:0001960,1,0.693606308666904,0,1,negative regulation of cytokine-mediated signaling pathway,BP,
205,GO:0001961,1,0.338127886737618,0,3,positive regulation of cytokine-mediated signaling pathway,BP,
208,GO:0001972,1,0.688709470596719,0,1,retinoic acid binding,MF,
209,GO:0001973,1,0.700996267622242,0,1,adenosine receptor signaling pathway,BP,
211,GO:0001977,1,0.339370369602584,0,3,renal system process involved in regulation of blood volume,BP,
212,GO:0001990,1,0.682927424885784,0,1,regulation of systemic arterial blood pressure by hormone,BP,
215,GO:0002020,1,0.492806609988364,0,2,protease binding,MF,
216,GO:0002026,1,0.68145664044265,0,1,regulation of the force of heart contraction,BP,
230,GO:0002069,1,0.685778755049879,0,1,columnar/cuboidal epithelial cell maturation,BP,
231,GO:0002070,1,0.685778755049879,0,1,epithelial cell maturation,BP,
232,GO:0002072,1,0.717706347959987,0,1,optic cup morphogenesis involved in camera-type eye development,BP,
233,GO:0002080,1,0.688709470596719,0,1,acrosomal membrane,CC,
236,GO:0002087,1,0.700996267622242,0,1,regulation of respiratory gaseous exchange by neurological system process,BP,
239,GO:0002093,1,0.718786554623569,0,1,auditory receptor cell morphogenesis,BP,
240,GO:0002139,1,0.718786554623569,0,1,stereocilia coupling link,CC,
241,GO:0002140,1,0.718786554623569,0,1,stereocilia tip link,CC,
242,GO:0002159,1,0.700511032597554,0,1,desmosome assembly,BP,
244,GO:0002200,1,0.674610601535826,0,1,somatic diversification of immune receptors,BP,
245,GO:0002204,1,0.674610601535826,0,1,somatic recombination of immunoglobulin genes involved in immune response,BP,
246,GO:0002208,1,0.674610601535826,0,1,somatic diversification of immunoglobulins involved in immune response,BP,
249,GO:0002221,1,0.714575687180326,0,1,pattern recognition receptor signaling pathway,BP,
251,GO:0002224,1,0.714575687180326,0,1,toll-like receptor signaling pathway,BP,
252,GO:0002228,1,0.700234742383915,0,1,natural killer cell mediated immunity,BP,
256,GO:0002251,1,0.678117095355688,0,1,organ or tissue specific immune response,BP,
266,GO:0002285,1,0.234527172179807,0,4,lymphocyte activation involved in immune response,BP,
267,GO:0002286,1,0.494895732070834,0,2,T cell activation involved in immune response,BP,
268,GO:0002287,1,0.707980062532778,0,1,alpha-beta T cell activation involved in immune response,BP,
269,GO:0002292,1,0.707980062532778,0,1,T cell differentiation involved in immune response,BP,
270,GO:0002293,1,0.707980062532778,0,1,alpha-beta T cell differentiation involved in immune response,BP,
271,GO:0002294,1,0.707980062532778,0,1,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
272,GO:0002295,1,0.707980062532778,0,1,T-helper cell lineage commitment,BP,
273,GO:0002312,1,0.477357318102768,0,2,B cell activation involved in immune response,BP,
274,GO:0002313,1,0.708931381661885,0,1,mature B cell differentiation involved in immune response,BP,
275,GO:0002315,1,0.708931381661885,0,1,marginal zone B cell differentiation,BP,
276,GO:0002318,1,0.712690558264192,0,1,myeloid progenitor cell differentiation,BP,
278,GO:0002323,1,0.700234742383915,0,1,natural killer cell activation involved in immune response,BP,
280,GO:0002335,1,0.708931381661885,0,1,mature B cell differentiation,BP,
281,GO:0002360,1,0.707980062532778,0,1,T cell lineage commitment,BP,
282,GO:0002363,1,0.707980062532778,0,1,alpha-beta T cell lineage commitment,BP,
284,GO:0002367,1,0.337393729074605,0,3,cytokine production involved in immune response,BP,
285,GO:0002374,1,0.717706347959987,0,1,cytokine secretion involved in immune response,BP,
287,GO:0002377,1,0.674610601535826,0,1,immunoglobulin production,BP,
288,GO:0002381,1,0.674610601535826,0,1,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
289,GO:0002385,1,0.678117095355688,0,1,mucosal immune response,BP,
290,GO:0002386,1,0.678117095355688,0,1,immune response in mucosal-associated lymphoid tissue,BP,
292,GO:0002414,1,0.678117095355688,0,1,immunoglobulin transcytosis in epithelial cells,BP,
293,GO:0002415,1,0.678117095355688,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
298,GO:0002440,1,0.226270270455521,0,4,production of molecular mediator of immune response,BP,
303,GO:0002449,1,0.471475336394381,0,2,lymphocyte mediated immunity,BP,
304,GO:0002456,1,0.700234742383915,0,1,T cell mediated immunity,BP,
306,GO:0002474,1,0.709785182985047,0,1,antigen processing and presentation of peptide antigen via MHC class I,BP,
307,GO:0002478,1,0.709785182985047,0,1,antigen processing and presentation of exogenous peptide antigen,BP,
308,GO:0002479,1,0.709785182985047,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
311,GO:0002523,1,0.712690558264192,0,1,leukocyte migration involved in inflammatory response,BP,
313,GO:0002544,1,0.674234706311468,0,1,chronic inflammatory response,BP,
315,GO:0002551,1,0.68145664044265,0,1,mast cell chemotaxis,BP,
316,GO:0002562,1,0.674610601535826,0,1,somatic diversification of immune receptors via germline recombination within a single locus,BP,
319,GO:0002637,1,0.674610601535826,0,1,regulation of immunoglobulin production,BP,
320,GO:0002639,1,0.674610601535826,0,1,positive regulation of immunoglobulin production,BP,
322,GO:0002674,1,0.700996267622242,0,1,negative regulation of acute inflammatory response,BP,
329,GO:0002686,1,0.700996267622242,0,1,negative regulation of leukocyte migration,BP,
331,GO:0002688,1,0.239731262994705,0,4,regulation of leukocyte chemotaxis,BP,
332,GO:0002690,1,0.338127886737618,0,3,positive regulation of leukocyte chemotaxis,BP,
336,GO:0002697,1,0.483292601439988,0,2,regulation of immune effector process,BP,
337,GO:0002699,1,0.483292601439988,0,2,positive regulation of immune effector process,BP,
338,GO:0002700,1,0.483292601439988,0,2,regulation of production of molecular mediator of immune response,BP,
339,GO:0002702,1,0.483292601439988,0,2,positive regulation of production of molecular mediator of immune response,BP,
340,GO:0002703,1,0.674610601535826,0,1,regulation of leukocyte mediated immunity,BP,
341,GO:0002705,1,0.674610601535826,0,1,positive regulation of leukocyte mediated immunity,BP,
342,GO:0002706,1,0.674610601535826,0,1,regulation of lymphocyte mediated immunity,BP,
343,GO:0002708,1,0.674610601535826,0,1,positive regulation of lymphocyte mediated immunity,BP,
344,GO:0002712,1,0.674610601535826,0,1,regulation of B cell mediated immunity,BP,
345,GO:0002714,1,0.674610601535826,0,1,positive regulation of B cell mediated immunity,BP,
346,GO:0002718,1,0.717706347959987,0,1,regulation of cytokine production involved in immune response,BP,
347,GO:0002720,1,0.717706347959987,0,1,positive regulation of cytokine production involved in immune response,BP,
348,GO:0002739,1,0.717706347959987,0,1,regulation of cytokine secretion involved in immune response,BP,
349,GO:0002741,1,0.717706347959987,0,1,positive regulation of cytokine secretion involved in immune response,BP,
354,GO:0002763,1,0.511558302346865,0,2,positive regulation of myeloid leukocyte differentiation,BP,
361,GO:0002819,1,0.674610601535826,0,1,regulation of adaptive immune response,BP,
362,GO:0002821,1,0.674610601535826,0,1,positive regulation of adaptive immune response,BP,
363,GO:0002822,1,0.674610601535826,0,1,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
364,GO:0002824,1,0.674610601535826,0,1,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
367,GO:0002889,1,0.674610601535826,0,1,regulation of immunoglobulin mediated immune response,BP,
368,GO:0002891,1,0.674610601535826,0,1,positive regulation of immunoglobulin mediated immune response,BP,
370,GO:0002934,1,0.700511032597554,0,1,desmosome organization,BP,
381,GO:0003018,1,0.031118842750048,0,9,vascular process in circulatory system,BP,
382,GO:0003044,1,0.682927424885784,0,1,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
383,GO:0003062,1,0.707215656113447,0,1,regulation of heart rate by chemical signal,BP,
384,GO:0003064,1,0.707215656113447,0,1,regulation of heart rate by hormone,BP,
385,GO:0003071,1,0.339370369602584,0,3,renal system process involved in regulation of systemic arterial blood pressure,BP,
388,GO:0003091,1,0.4959065131259,0,2,renal water homeostasis,BP,
389,GO:0003093,1,0.339370369602584,0,3,regulation of glomerular filtration,BP,
390,GO:0003094,1,0.339370369602584,0,3,glomerular filtration,BP,
392,GO:0003100,1,0.682927424885784,0,1,regulation of systemic arterial blood pressure by endothelin,BP,
393,GO:0003104,1,0.485866457217169,0,2,positive regulation of glomerular filtration,BP,
415,GO:0003175,1,0.707980062532778,0,1,tricuspid valve development,BP,
423,GO:0003186,1,0.707980062532778,0,1,tricuspid valve morphogenesis,BP,
427,GO:0003195,1,0.707980062532778,0,1,tricuspid valve formation,BP,
453,GO:0003274,1,0.703315452741895,0,1,endocardial cushion fusion,BP,
456,GO:0003283,1,0.49708186108656,0,2,atrial septum development,BP,
457,GO:0003284,1,0.703315452741895,0,1,septum primum development,BP,
458,GO:0003289,1,0.703315452741895,0,1,atrial septum primum morphogenesis,BP,
459,GO:0003298,1,0.682927424885784,0,1,physiological muscle hypertrophy,BP,
460,GO:0003300,1,0.682927424885784,0,1,cardiac muscle hypertrophy,BP,
461,GO:0003301,1,0.682927424885784,0,1,physiological cardiac muscle hypertrophy,BP,
462,GO:0003306,1,0.506245376511713,0,2,Wnt signaling pathway involved in heart development,BP,
463,GO:0003307,1,0.706521730037359,0,1,regulation of Wnt signaling pathway involved in heart development,BP,
464,GO:0003308,1,0.706521730037359,0,1,negative regulation of Wnt signaling pathway involved in heart development,BP,
473,GO:0003382,1,0.659897629360017,0,1,epithelial cell morphogenesis,BP,
475,GO:0003402,1,0.717706347959987,0,1,planar cell polarity pathway involved in axis elongation,BP,
476,GO:0003408,1,0.717706347959987,0,1,optic cup formation involved in camera-type eye development,BP,
477,GO:0003413,1,0.635388353995092,0,1,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
478,GO:0003416,1,0.635388353995092,0,1,endochondral bone growth,BP,
479,GO:0003417,1,0.635388353995092,0,1,growth plate cartilage development,BP,
480,GO:0003418,1,0.635388353995092,0,1,growth plate cartilage chondrocyte differentiation,BP,
481,GO:0003419,1,0.635388353995092,0,1,growth plate cartilage chondrocyte proliferation,BP,
493,GO:0003723,1,0.244899037866518,0,4,RNA binding,MF,
494,GO:0003725,1,0.714643171421448,0,1,double-stranded RNA binding,MF,
495,GO:0003774,1,0.368549414171401,0,3,motor activity,MF,
499,GO:0003873,1,0.71598013520354,0,1,6-phosphofructo-2-kinase activity,MF,
501,GO:0004112,1,0.715703089056377,0,1,cyclic-nucleotide phosphodiesterase activity,MF,
502,GO:0004114,1,0.715703089056377,0,1,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
503,GO:0004115,1,0.715703089056377,0,1,3',5'-cyclic-AMP phosphodiesterase activity,MF,
506,GO:0004312,1,0.719216741957039,0,1,fatty acid synthase activity,MF,
507,GO:0004313,1,0.719216741957039,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
508,GO:0004314,1,0.719216741957039,0,1,[acyl-carrier-protein] S-malonyltransferase activity,MF,
509,GO:0004315,1,0.719216741957039,0,1,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
510,GO:0004316,1,0.719216741957039,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
511,GO:0004317,1,0.719216741957039,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
512,GO:0004319,1,0.719216741957039,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
513,GO:0004320,1,0.719216741957039,0,1,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
514,GO:0004331,1,0.71598013520354,0,1,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
516,GO:0004379,1,0.716841414120058,0,1,glycylpeptide N-tetradecanoyltransferase activity,MF,
518,GO:0004407,1,0.716995957461558,0,1,histone deacetylase activity,MF,
519,GO:0004421,1,0.691115067781905,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
520,GO:0004454,1,0.691405431878985,0,1,ketohexokinase activity,MF,
521,GO:0004467,1,0.717048561252595,0,1,long-chain fatty acid-CoA ligase activity,MF,
523,GO:0004620,1,0.700996267622242,0,1,phospholipase activity,MF,
524,GO:0004629,1,0.700996267622242,0,1,phospholipase C activity,MF,
526,GO:0004673,1,0.707215656113447,0,1,protein histidine kinase activity,MF,
528,GO:0004675,1,0.703315452741895,0,1,transmembrane receptor protein serine/threonine kinase activity,MF,
529,GO:0004690,1,0.716148206052754,0,1,cyclic nucleotide-dependent protein kinase activity,MF,
530,GO:0004691,1,0.716148206052754,0,1,cAMP-dependent protein kinase activity,MF,
534,GO:0004709,1,0.693168134882461,0,1,MAP kinase kinase kinase activity,MF,
535,GO:0004712,1,0.701493568801233,0,1,protein serine/threonine/tyrosine kinase activity,MF,
537,GO:0004714,1,0.509296078888012,0,2,transmembrane receptor protein tyrosine kinase activity,MF,
538,GO:0004716,1,0.714575687180326,0,1,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
541,GO:0004745,1,0.706521730037359,0,1,retinol dehydrogenase activity,MF,
544,GO:0004860,1,0.474789744780224,0,2,protein kinase inhibitor activity,MF,
545,GO:0004861,1,0.685778755049879,0,1,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
546,GO:0004862,1,0.693654765650842,0,1,cAMP-dependent protein kinase inhibitor activity,MF,
547,GO:0004866,1,0.309140551791647,0,3,endopeptidase inhibitor activity,MF,
548,GO:0004867,1,0.688709470596719,0,1,serine-type endopeptidase inhibitor activity,MF,
549,GO:0004869,1,0.450696190759228,0,2,cysteine-type endopeptidase inhibitor activity,MF,
555,GO:0004935,1,0.479899134609722,0,2,adrenergic receptor activity,MF,
556,GO:0004936,1,0.479899134609722,0,2,alpha-adrenergic receptor activity,MF,
557,GO:0004938,1,0.479899134609722,0,2,alpha2-adrenergic receptor activity,MF,
558,GO:0005024,1,0.703315452741895,0,1,transforming growth factor beta-activated receptor activity,MF,
559,GO:0005025,1,0.703315452741895,0,1,transforming growth factor beta receptor activity, type I,MF,
561,GO:0005068,1,0.717681530181595,0,1,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
562,GO:0005080,1,0.487393187420858,0,2,protein kinase C binding,MF,
565,GO:0005092,1,0.348711915689913,0,3,GDP-dissociation inhibitor activity,MF,
571,GO:0005110,1,0.717706347959987,0,1,frizzled-2 binding,MF,
574,GO:0005113,1,0.67829781652277,0,1,patched binding,MF,
575,GO:0005115,1,0.717706347959987,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
578,GO:0005127,1,0.674610601535826,0,1,ciliary neurotrophic factor receptor binding,MF,
579,GO:0005146,1,0.714341024234018,0,1,leukemia inhibitory factor receptor binding,MF,
580,GO:0005154,1,0.492888018518374,0,2,epidermal growth factor receptor binding,MF,
581,GO:0005158,1,0.717681530181595,0,1,insulin receptor binding,MF,
582,GO:0005159,1,0.717681530181595,0,1,insulin-like growth factor receptor binding,MF,
584,GO:0005161,1,0.501410820089643,0,2,platelet-derived growth factor receptor binding,MF,
585,GO:0005165,1,0.717681530181595,0,1,neurotrophin receptor binding,MF,
586,GO:0005167,1,0.717681530181595,0,1,neurotrophin TRK receptor binding,MF,
587,GO:0005168,1,0.717681530181595,0,1,neurotrophin TRKA receptor binding,MF,
588,GO:0005172,1,0.715704383250707,0,1,vascular endothelial growth factor receptor binding,MF,
589,GO:0005173,1,0.717270758028134,0,1,stem cell factor receptor binding,MF,
594,GO:0005201,1,0.486356045747239,0,2,extracellular matrix structural constituent,MF,
597,GO:0005225,1,0.680586525929292,0,1,volume-sensitive anion channel activity,MF,
601,GO:0005245,1,0.693606308666904,0,1,voltage-gated calcium channel activity,MF,
604,GO:0005250,1,0.716482970202505,0,1,A-type (transient outward) potassium channel activity,MF,
606,GO:0005253,1,0.680586525929292,0,1,anion channel activity,MF,
607,GO:0005254,1,0.680586525929292,0,1,chloride channel activity,MF,
609,GO:0005262,1,0.693606308666904,0,1,calcium channel activity,MF,
611,GO:0005351,1,0.709760706330904,0,1,sugar:proton symporter activity,MF,
614,GO:0005402,1,0.709760706330904,0,1,cation:sugar symporter activity,MF,
615,GO:0005484,1,0.698774696748521,0,1,SNAP receptor activity,MF,
619,GO:0005501,1,0.688709470596719,0,1,retinoid binding,MF,
621,GO:0005507,1,0.714638410513241,0,1,copper ion binding,MF,
623,GO:0005513,1,0.698147056906197,0,1,detection of calcium ion,BP,
625,GO:0005516,1,0.239344028149394,0,4,calmodulin binding,MF,
626,GO:0005518,1,0.357312478376779,0,3,collagen binding,MF,
627,GO:0005520,1,0.493895825477361,0,2,insulin-like growth factor binding,MF,
629,GO:0005522,1,0.716234312327688,0,1,profilin binding,MF,
633,GO:0005540,1,0.677240892762295,0,1,hyaluronic acid binding,MF,
637,GO:0005547,1,0.701493568801233,0,1,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
638,GO:0005575,1,0.296255433838236,72,240,cellular_component,CC,MAGEC2;SLC2A14;TJP3;GLDC;RHPN1;TLE1;WNT7A;GJB2;PIK3CG;SYT5;ACTN3;RHBDL3;CLDN18;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;POU3F1;WNT2;SPTBN5;CDH1;RAB40B;RRAS2;SPTB;FZD7;FGF8;VDR;RAB39A;ARTN;DSG3;AMOT;WNT5B;WNK4;DUSP5;INHBB;CCL20;PKN3;PKP1;TSPAN15;FGF17;HRAS;RAB3D;BMP4;KCNK6;CLDN15;GDNF;RNF144A;RAB38;PIK3CA;DRP2;BMP7;FSTL3;TMEM206;TPD52;SPTBN4;TSPAN13;NOTCH1;RND3;PNMT;RAB20;GUCY1B3;TF;PM20D2
641,GO:0005604,1,0.516846448506299,0,2,basement membrane,CC,
642,GO:0005605,1,0.516846448506299,0,2,basal lamina,CC,
643,GO:0005606,1,0.719431898698682,0,1,laminin-1 complex,CC,
644,GO:0005608,1,0.719431898698682,0,1,laminin-3 complex,CC,
645,GO:0005610,1,0.719528553088115,0,1,laminin-5 complex,CC,
651,GO:0005641,1,0.674234706311468,0,1,nuclear envelope lumen,CC,
654,GO:0005694,1,0.346724295469091,0,3,chromosome,CC,
660,GO:0005743,1,0.340561219504742,0,3,mitochondrial inner membrane,CC,
668,GO:0005771,1,0.700234742383915,0,1,multivesicular body,CC,
671,GO:0005775,1,0.696039774295367,0,1,vacuolar lumen,CC,
672,GO:0005776,1,0.469192348764688,0,2,autophagosome,CC,
673,GO:0005777,1,0.717048561252595,0,1,peroxisome,CC,
674,GO:0005778,1,0.717048561252595,0,1,peroxisomal membrane,CC,
678,GO:0005790,1,0.680586525929292,0,1,smooth endoplasmic reticulum,CC,
679,GO:0005791,1,0.682927424885784,0,1,rough endoplasmic reticulum,CC,
683,GO:0005798,1,0.716234312327688,0,1,Golgi-associated vesicle,CC,
684,GO:0005801,1,0.493939715533612,0,2,cis-Golgi network,CC,
686,GO:0005811,1,0.717048561252595,0,1,lipid particle,CC,
687,GO:0005813,1,0.0790461429883631,0,7,centrosome,CC,
688,GO:0005815,1,0.0386502098893447,0,9,microtubule organizing center,CC,
689,GO:0005819,1,0.210018656936236,0,4,spindle,CC,
692,GO:0005859,1,0.718545083727339,0,1,muscle myosin complex,CC,
693,GO:0005865,1,0.716782934115651,0,1,striated muscle thin filament,CC,
695,GO:0005876,1,0.453599059489472,0,2,spindle microtubule,CC,
701,GO:0005891,1,0.49881928510448,0,2,voltage-gated calcium channel complex,CC,
703,GO:0005902,1,0.363725778618783,0,3,microvillus,CC,
704,GO:0005903,1,0.711515581434463,0,1,brush border,CC,
709,GO:0005915,1,0.703744566161763,0,1,zonula adherens,CC,
710,GO:0005916,1,0.715947598747366,0,1,fascia adherens,CC,
721,GO:0005952,1,0.4959065131259,0,2,cAMP-dependent protein kinase complex,CC,
724,GO:0005976,1,0.34228095063387,0,3,polysaccharide metabolic process,BP,
725,GO:0005977,1,0.701493568801233,0,1,glycogen metabolic process,BP,
726,GO:0005978,1,0.701493568801233,0,1,glycogen biosynthetic process,BP,
727,GO:0005979,1,0.701493568801233,0,1,regulation of glycogen biosynthetic process,BP,
729,GO:0006000,1,0.494175609213931,0,2,fructose metabolic process,BP,
730,GO:0006001,1,0.691405431878985,0,1,fructose catabolic process,BP,
731,GO:0006003,1,0.71598013520354,0,1,fructose 2,6-bisphosphate metabolic process,BP,
734,GO:0006022,1,0.236947596501367,0,4,aminoglycan metabolic process,BP,
735,GO:0006023,1,0.339597831303609,0,3,aminoglycan biosynthetic process,BP,
736,GO:0006024,1,0.339597831303609,0,3,glycosaminoglycan biosynthetic process,BP,
737,GO:0006026,1,0.696039774295367,0,1,aminoglycan catabolic process,BP,
738,GO:0006027,1,0.696039774295367,0,1,glycosaminoglycan catabolic process,BP,
739,GO:0006029,1,0.706521730037359,0,1,proteoglycan metabolic process,BP,
741,GO:0006073,1,0.701493568801233,0,1,cellular glucan metabolic process,BP,
744,GO:0006084,1,0.719216741957039,0,1,acetyl-CoA metabolic process,BP,
748,GO:0006094,1,0.711015020328229,0,1,gluconeogenesis,BP,
752,GO:0006111,1,0.711015020328229,0,1,regulation of gluconeogenesis,BP,
753,GO:0006112,1,0.701493568801233,0,1,energy reserve metabolic process,BP,
761,GO:0006171,1,0.682927424885784,0,1,cAMP biosynthetic process,BP,
763,GO:0006195,1,0.715703089056377,0,1,purine nucleotide catabolic process,BP,
764,GO:0006198,1,0.715703089056377,0,1,cAMP catabolic process,BP,
769,GO:0006281,1,0.424225666316347,0,2,DNA repair,BP,
770,GO:0006282,1,0.64211725735274,0,1,regulation of DNA repair,BP,
774,GO:0006310,1,0.674610601535826,0,1,DNA recombination,BP,
775,GO:0006325,1,0.245392136217145,0,4,chromatin organization,BP,
781,GO:0006359,1,0.698321270479589,0,1,regulation of transcription from RNA polymerase III promoter,BP,
785,GO:0006383,1,0.698321270479589,0,1,transcription from RNA polymerase III promoter,BP,
791,GO:0006457,1,0.635388353995092,0,1,protein folding,BP,
794,GO:0006465,1,0.693606308666904,0,1,signal peptide processing,BP,
798,GO:0006473,1,0.714341024234018,0,1,protein acetylation,BP,
799,GO:0006475,1,0.714341024234018,0,1,internal protein amino acid acetylation,BP,
800,GO:0006476,1,0.716995957461558,0,1,protein deacetylation,BP,
802,GO:0006486,1,0.699009950094505,0,1,protein glycosylation,BP,
803,GO:0006493,1,0.699009950094505,0,1,protein O-linked glycosylation,BP,
804,GO:0006497,1,0.51146455618194,0,2,protein lipidation,BP,
805,GO:0006498,1,0.716841414120058,0,1,N-terminal protein lipidation,BP,
806,GO:0006499,1,0.716841414120058,0,1,N-terminal protein myristoylation,BP,
807,GO:0006501,1,0.714638410513241,0,1,C-terminal protein lipidation,BP,
814,GO:0006575,1,0.719216741957039,0,1,cellular modified amino acid metabolic process,BP,
815,GO:0006582,1,0.717706347959987,0,1,melanin metabolic process,BP,
819,GO:0006611,1,0.693606308666904,0,1,protein export from nucleus,BP,
820,GO:0006612,1,0.485336400616196,0,2,protein targeting to membrane,BP,
822,GO:0006631,1,0.115299318665785,0,6,fatty acid metabolic process,BP,
823,GO:0006633,1,0.329304592595775,0,3,fatty acid biosynthetic process,BP,
824,GO:0006635,1,0.497923140405487,0,2,fatty acid beta-oxidation,BP,
825,GO:0006636,1,0.459513176635729,0,2,unsaturated fatty acid biosynthetic process,BP,
826,GO:0006637,1,0.514903481278129,0,2,acyl-CoA metabolic process,BP,
830,GO:0006643,1,0.719290773235962,0,1,membrane lipid metabolic process,BP,
834,GO:0006664,1,0.719290773235962,0,1,glycolipid metabolic process,BP,
835,GO:0006665,1,0.719290773235962,0,1,sphingolipid metabolic process,BP,
836,GO:0006672,1,0.719290773235962,0,1,ceramide metabolic process,BP,
837,GO:0006687,1,0.719290773235962,0,1,glycosphingolipid metabolic process,BP,
838,GO:0006690,1,0.459513176635729,0,2,icosanoid metabolic process,BP,
839,GO:0006692,1,0.459513176635729,0,2,prostanoid metabolic process,BP,
840,GO:0006693,1,0.459513176635729,0,2,prostaglandin metabolic process,BP,
842,GO:0006695,1,0.691115067781905,0,1,cholesterol biosynthetic process,BP,
844,GO:0006702,1,0.714265548502507,0,1,androgen biosynthetic process,BP,
845,GO:0006704,1,0.350982613013452,0,3,glucocorticoid biosynthetic process,BP,
847,GO:0006720,1,0.335439817432269,0,3,isoprenoid metabolic process,BP,
848,GO:0006721,1,0.487157880316345,0,2,terpenoid metabolic process,BP,
853,GO:0006735,1,0.71598013520354,0,1,NADH regeneration,BP,
857,GO:0006767,1,0.505313204178194,0,2,water-soluble vitamin metabolic process,BP,
858,GO:0006771,1,0.703744566161763,0,1,riboflavin metabolic process,BP,
860,GO:0006790,1,0.358711576694647,0,3,sulfur compound metabolic process,BP,
865,GO:0006809,1,0.478173903575527,0,2,nitric oxide biosynthetic process,BP,
875,GO:0006835,1,0.700996267622242,0,1,dicarboxylic acid transport,BP,
878,GO:0006862,1,0.669820056371903,0,1,nucleotide transport,BP,
879,GO:0006865,1,0.700996267622242,0,1,amino acid transport,BP,
884,GO:0006878,1,0.714638410513241,0,1,cellular copper ion homeostasis,BP,
890,GO:0006890,1,0.705299442787258,0,1,retrograde vesicle-mediated transport, Golgi to ER,BP,
891,GO:0006891,1,0.705299442787258,0,1,intra-Golgi vesicle-mediated transport,BP,
898,GO:0006910,1,0.677783369393108,0,1,phagocytosis, recognition,BP,
899,GO:0006911,1,0.677783369393108,0,1,phagocytosis, engulfment,BP,
904,GO:0006924,1,0.701493568801233,0,1,activation-induced cell death of T cells,BP,
910,GO:0006940,1,0.227589016878023,0,4,regulation of smooth muscle contraction,BP,
918,GO:0006970,1,0.71022670342733,0,1,response to osmotic stress,BP,
919,GO:0006972,1,0.71022670342733,0,1,hyperosmotic response,BP,
922,GO:0006977,1,0.45321036602372,0,2,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
923,GO:0006978,1,0.685778755049879,0,1,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
925,GO:0006986,1,0.717681530181595,0,1,response to unfolded protein,BP,
934,GO:0007020,1,0.675320542642266,0,1,microtubule nucleation,BP,
935,GO:0007029,1,0.713363280358565,0,1,endoplasmic reticulum organization,BP,
937,GO:0007032,1,0.700234742383915,0,1,endosome organization,BP,
947,GO:0007051,1,0.6730929422979,0,1,spindle organization,BP,
948,GO:0007052,1,0.6730929422979,0,1,mitotic spindle organization,BP,
949,GO:0007059,1,0.6730929422979,0,1,chromosome segregation,BP,
951,GO:0007080,1,0.6730929422979,0,1,mitotic metaphase plate congression,BP,
954,GO:0007095,1,0.708249234674247,0,1,mitotic G2 DNA damage checkpoint,BP,
955,GO:0007098,1,0.466171970504979,0,2,centrosome cycle,BP,
956,GO:0007126,1,0.248423212926757,0,4,meiotic nuclear division,BP,
957,GO:0007140,1,0.685334411449314,0,1,male meiosis,BP,
961,GO:0007157,1,0.51158926151004,0,2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
970,GO:0007168,1,0.453682751930291,0,2,receptor guanylyl cyclase signaling pathway,BP,
973,GO:0007176,1,0.335185095356051,0,3,regulation of epidermal growth factor-activated receptor activity,BP,
975,GO:0007179,1,0.0552627742467538,0,8,transforming growth factor beta receptor signaling pathway,BP,
979,GO:0007187,1,0.161494989705746,0,5,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
980,GO:0007188,1,0.161494989705746,0,5,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,
981,GO:0007189,1,0.325763794567899,0,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
982,GO:0007193,1,0.700996267622242,0,1,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
983,GO:0007200,1,0.331471734904278,0,3,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
984,GO:0007202,1,0.674401774365491,0,1,activation of phospholipase C activity,BP,
986,GO:0007205,1,0.682927424885784,0,1,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
990,GO:0007223,1,0.717706347959987,0,1,Wnt signaling pathway, calcium modulating pathway,BP,
992,GO:0007229,1,0.0424425192590022,0,9,integrin-mediated signaling pathway,BP,
994,GO:0007252,1,0.701493568801233,0,1,I-kappaB phosphorylation,BP,
998,GO:0007260,1,0.481016297962941,0,2,tyrosine phosphorylation of STAT protein,BP,
1002,GO:0007266,1,0.33327575351216,0,3,Rho protein signal transduction,BP,
1012,GO:0007286,1,0.482533394443604,0,2,spermatid development,BP,
1014,GO:0007338,1,0.319016093923042,0,3,single fertilization,BP,
1015,GO:0007342,1,0.688709470596719,0,1,fusion of sperm to egg plasma membrane,BP,
1017,GO:0007350,1,0.504499607685346,0,2,blastoderm segmentation,BP,
1018,GO:0007351,1,0.504499607685346,0,2,tripartite regional subdivision,BP,
1019,GO:0007354,1,0.70409479607052,0,1,zygotic determination of anterior/posterior axis, embryo,BP,
1020,GO:0007356,1,0.70409479607052,0,1,thorax and anterior abdomen determination,BP,
1023,GO:0007379,1,0.708931381661885,0,1,segment specification,BP,
1039,GO:0007442,1,0.717706347959987,0,1,hindgut morphogenesis,BP,
1041,GO:0007494,1,0.717706347959987,0,1,midgut development,BP,
1047,GO:0007530,1,0.339289561015308,0,3,sex determination,BP,
1050,GO:0007566,1,0.509128166102136,0,2,embryo implantation,BP,
1051,GO:0007567,1,0.682927424885784,0,1,parturition,BP,
1057,GO:0007588,1,0.225590839293214,0,4,excretion,BP,
1064,GO:0007602,1,0.477095520924302,0,2,phototransduction,BP,
1065,GO:0007603,1,0.716841414120058,0,1,phototransduction, visible light,BP,
1067,GO:0007606,1,0.699009950094505,0,1,sensory perception of chemical stimulus,BP,
1068,GO:0007608,1,0.699009950094505,0,1,sensory perception of smell,BP,
1070,GO:0007611,1,0.166766700846098,0,5,learning or memory,BP,
1071,GO:0007612,1,0.476142414834213,0,2,learning,BP,
1072,GO:0007613,1,0.512200131358063,0,2,memory,BP,
1073,GO:0007622,1,0.700996267622242,0,1,rhythmic behavior,BP,
1074,GO:0007623,1,0.700996267622242,0,1,circadian rhythm,BP,
1077,GO:0007631,1,0.701156312252234,0,1,feeding behavior,BP,
1078,GO:0007638,1,0.701156312252234,0,1,mechanosensory behavior,BP,
1083,GO:0008017,1,0.170739542093128,0,5,microtubule binding,MF,
1086,GO:0008037,1,0.346709815668967,0,3,cell recognition,BP,
1090,GO:0008065,1,0.71022670342733,0,1,establishment of blood-nerve barrier,BP,
1094,GO:0008081,1,0.500863054421332,0,2,phosphoric diester hydrolase activity,MF,
1102,GO:0008144,1,0.719216741957039,0,1,drug binding,MF,
1109,GO:0008194,1,0.699009950094505,0,1,UDP-glycosyltransferase activity,MF,
1115,GO:0008203,1,0.691115067781905,0,1,cholesterol metabolic process,BP,
1117,GO:0008209,1,0.714265548502507,0,1,androgen metabolic process,BP,
1118,GO:0008211,1,0.350982613013452,0,3,glucocorticoid metabolic process,BP,
1123,GO:0008227,1,0.479899134609722,0,2,G-protein coupled amine receptor activity,MF,
1128,GO:0008277,1,0.161639854530786,0,5,regulation of G-protein coupled receptor protein signaling pathway,BP,
1134,GO:0008299,1,0.691115067781905,0,1,isoprenoid biosynthetic process,BP,
1135,GO:0008305,1,0.184949030840565,0,5,integrin complex,CC,
1138,GO:0008333,1,0.336911300443587,0,3,endosome to lysosome transport,BP,
1140,GO:0008360,1,0.230907652182569,0,4,regulation of cell shape,BP,
1144,GO:0008375,1,0.699009950094505,0,1,acetylglucosaminyltransferase activity,MF,
1145,GO:0008378,1,0.699009950094505,0,1,galactosyltransferase activity,MF,
1146,GO:0008380,1,0.504482091091315,0,2,RNA splicing,BP,
1148,GO:0008429,1,0.677783369393108,0,1,phosphatidylethanolamine binding,MF,
1150,GO:0008443,1,0.71598013520354,0,1,phosphofructokinase activity,MF,
1151,GO:0008499,1,0.699009950094505,0,1,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
1152,GO:0008506,1,0.709760706330904,0,1,sucrose:proton symporter activity,MF,
1153,GO:0008509,1,0.680586525929292,0,1,anion transmembrane transporter activity,MF,
1154,GO:0008515,1,0.709760706330904,0,1,sucrose transmembrane transporter activity,MF,
1155,GO:0008528,1,0.715502935770821,0,1,G-protein coupled peptide receptor activity,MF,
1156,GO:0008532,1,0.699009950094505,0,1,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1161,GO:0008589,1,0.458921954392672,0,2,regulation of smoothened signaling pathway,BP,
1163,GO:0008595,1,0.504499607685346,0,2,anterior/posterior axis specification, embryo,BP,
1164,GO:0008603,1,0.693654765650842,0,1,cAMP-dependent protein kinase regulator activity,MF,
1167,GO:0008630,1,0.491308006900675,0,2,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
1168,GO:0008631,1,0.701493568801233,0,1,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
1180,GO:0009062,1,0.497923140405487,0,2,fatty acid catabolic process,BP,
1184,GO:0009100,1,0.241993930654456,0,4,glycoprotein metabolic process,BP,
1185,GO:0009101,1,0.344311644736002,0,3,glycoprotein biosynthetic process,BP,
1186,GO:0009108,1,0.514903481278129,0,2,coenzyme biosynthetic process,BP,
1188,GO:0009116,1,0.716234312327688,0,1,nucleoside metabolic process,BP,
1190,GO:0009119,1,0.716234312327688,0,1,ribonucleoside metabolic process,BP,
1199,GO:0009154,1,0.715703089056377,0,1,purine ribonucleotide catabolic process,BP,
1202,GO:0009166,1,0.715703089056377,0,1,nucleotide catabolic process,BP,
1210,GO:0009214,1,0.715703089056377,0,1,cyclic nucleotide catabolic process,BP,
1211,GO:0009250,1,0.701493568801233,0,1,glucan biosynthetic process,BP,
1214,GO:0009261,1,0.715703089056377,0,1,ribonucleotide catabolic process,BP,
1215,GO:0009266,1,0.234753700186739,0,4,response to temperature stimulus,BP,
1219,GO:0009408,1,0.336707182356786,0,3,response to heat,BP,
1220,GO:0009411,1,0.343432550622313,0,3,response to UV,BP,
1221,GO:0009416,1,0.162043755576017,0,5,response to light stimulus,BP,
1223,GO:0009581,1,0.333218811150328,0,3,detection of external stimulus,BP,
1224,GO:0009582,1,0.333218811150328,0,3,detection of abiotic stimulus,BP,
1225,GO:0009583,1,0.477095520924302,0,2,detection of light stimulus,BP,
1226,GO:0009584,1,0.716841414120058,0,1,detection of visible light,BP,
1227,GO:0009593,1,0.698147056906197,0,1,detection of chemical stimulus,BP,
1234,GO:0009620,1,0.68145664044265,0,1,response to fungus,BP,
1237,GO:0009651,1,0.71022670342733,0,1,response to salt stress,BP,
1244,GO:0009744,1,0.691405431878985,0,1,response to sucrose,BP,
1247,GO:0009750,1,0.691405431878985,0,1,response to fructose,BP,
1256,GO:0009886,1,0.718786554623569,0,1,post-embryonic animal morphogenesis,BP,
1273,GO:0009946,1,0.64211725735274,0,1,proximal/distal axis specification,BP,
1278,GO:0009954,1,0.454274511169561,0,2,proximal/distal pattern formation,BP,
1285,GO:0009988,1,0.714643171421448,0,1,cell-cell recognition,BP,
1296,GO:0010043,1,0.691405431878985,0,1,response to zinc ion,BP,
1299,GO:0010165,1,0.685778755049879,0,1,response to X-ray,BP,
1301,GO:0010193,1,0.682927424885784,0,1,response to ozone,BP,
1303,GO:0010224,1,0.685778755049879,0,1,response to UV-B,BP,
1307,GO:0010259,1,0.682927424885784,0,1,multicellular organism aging,BP,
1308,GO:0010288,1,0.71022670342733,0,1,response to lead ion,BP,
1309,GO:0010324,1,0.485146121384876,0,2,membrane invagination,BP,
1311,GO:0010385,1,0.70409479607052,0,1,double-stranded methylated DNA binding,MF,
1312,GO:0010389,1,0.708249234674247,0,1,regulation of G2/M transition of mitotic cell cycle,BP,
1316,GO:0010460,1,0.682927424885784,0,1,positive regulation of heart rate,BP,
1319,GO:0010466,1,0.215612299165656,0,4,negative regulation of peptidase activity,BP,
1322,GO:0010469,1,0.11382618758189,0,6,regulation of receptor activity,BP,
1327,GO:0010508,1,0.161272561747607,0,5,positive regulation of autophagy,BP,
1328,GO:0010511,1,0.701758628672581,0,1,regulation of phosphatidylinositol biosynthetic process,BP,
1329,GO:0010512,1,0.701758628672581,0,1,negative regulation of phosphatidylinositol biosynthetic process,BP,
1330,GO:0010517,1,0.674401774365491,0,1,regulation of phospholipase activity,BP,
1331,GO:0010518,1,0.674401774365491,0,1,positive regulation of phospholipase activity,BP,
1332,GO:0010522,1,0.698147056906197,0,1,regulation of calcium ion transport into cytosol,BP,
1333,GO:0010523,1,0.698147056906197,0,1,negative regulation of calcium ion transport into cytosol,BP,
1334,GO:0010543,1,0.701758628672581,0,1,regulation of platelet activation,BP,
1335,GO:0010544,1,0.701758628672581,0,1,negative regulation of platelet activation,BP,
1339,GO:0010559,1,0.689876795946402,0,1,regulation of glycoprotein biosynthetic process,BP,
1340,GO:0010561,1,0.689876795946402,0,1,negative regulation of glycoprotein biosynthetic process,BP,
1353,GO:0010611,1,0.682927424885784,0,1,regulation of cardiac muscle hypertrophy,BP,
1354,GO:0010613,1,0.682927424885784,0,1,positive regulation of cardiac muscle hypertrophy,BP,
1355,GO:0010623,1,0.717270758028134,0,1,programmed cell death involved in cell development,BP,
1364,GO:0010640,1,0.701758628672581,0,1,regulation of platelet-derived growth factor receptor signaling pathway,BP,
1365,GO:0010642,1,0.701758628672581,0,1,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
1366,GO:0010644,1,0.698147056906197,0,1,cell communication by electrical coupling,BP,
1370,GO:0010649,1,0.698147056906197,0,1,regulation of cell communication by electrical coupling,BP,
1381,GO:0010700,1,0.479899134609722,0,2,negative regulation of norepinephrine secretion,BP,
1384,GO:0010715,1,0.713876788943018,0,1,regulation of extracellular matrix disassembly,BP,
1389,GO:0010724,1,0.707980062532778,0,1,regulation of definitive erythrocyte differentiation,BP,
1390,GO:0010746,1,0.701493568801233,0,1,regulation of plasma membrane long-chain fatty acid transport,BP,
1391,GO:0010748,1,0.701493568801233,0,1,negative regulation of plasma membrane long-chain fatty acid transport,BP,
1392,GO:0010761,1,0.346518464568176,0,3,fibroblast migration,BP,
1393,GO:0010762,1,0.346518464568176,0,3,regulation of fibroblast migration,BP,
1394,GO:0010763,1,0.701493568801233,0,1,positive regulation of fibroblast migration,BP,
1395,GO:0010765,1,0.701493568801233,0,1,positive regulation of sodium ion transport,BP,
1402,GO:0010803,1,0.693606308666904,0,1,regulation of tumor necrosis factor-mediated signaling pathway,BP,
1403,GO:0010804,1,0.693606308666904,0,1,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
1405,GO:0010811,1,0.252514373449704,0,4,positive regulation of cell-substrate adhesion,BP,
1409,GO:0010819,1,0.717706347959987,0,1,regulation of T cell chemotaxis,BP,
1410,GO:0010820,1,0.717706347959987,0,1,positive regulation of T cell chemotaxis,BP,
1413,GO:0010823,1,0.701493568801233,0,1,negative regulation of mitochondrion organization,BP,
1414,GO:0010824,1,0.705299442787258,0,1,regulation of centrosome duplication,BP,
1415,GO:0010827,1,0.255111726740894,0,4,regulation of glucose transport,BP,
1416,GO:0010828,1,0.255111726740894,0,4,positive regulation of glucose transport,BP,
1420,GO:0010838,1,0.64211725735274,0,1,positive regulation of keratinocyte proliferation,BP,
1422,GO:0010861,1,0.716240390769176,0,1,thyroid hormone receptor activator activity,MF,
1424,GO:0010863,1,0.674401774365491,0,1,positive regulation of phospholipase C activity,BP,
1425,GO:0010869,1,0.682927424885784,0,1,regulation of receptor biosynthetic process,BP,
1426,GO:0010870,1,0.682927424885784,0,1,positive regulation of receptor biosynthetic process,BP,
1428,GO:0010880,1,0.698147056906197,0,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1429,GO:0010881,1,0.698147056906197,0,1,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
1430,GO:0010882,1,0.698147056906197,0,1,regulation of cardiac muscle contraction by calcium ion signaling,BP,
1432,GO:0010894,1,0.350982613013452,0,3,negative regulation of steroid biosynthetic process,BP,
1438,GO:0010921,1,0.496357638223706,0,2,regulation of phosphatase activity,BP,
1439,GO:0010922,1,0.706521730037359,0,1,positive regulation of phosphatase activity,BP,
1440,GO:0010923,1,0.703744566161763,0,1,negative regulation of phosphatase activity,BP,
1441,GO:0010927,1,0.172884119968365,0,5,cellular component assembly involved in morphogenesis,BP,
1442,GO:0010934,1,0.496955183044201,0,2,macrophage cytokine production,BP,
1443,GO:0010935,1,0.717706347959987,0,1,regulation of macrophage cytokine production,BP,
1448,GO:0010951,1,0.215612299165656,0,4,negative regulation of endopeptidase activity,BP,
1451,GO:0010962,1,0.701493568801233,0,1,regulation of glucan biosynthetic process,BP,
1452,GO:0010972,1,0.708249234674247,0,1,negative regulation of G2/M transition of mitotic cell cycle,BP,
1458,GO:0010996,1,0.701156312252234,0,1,response to auditory stimulus,BP,
1462,GO:0014002,1,0.500736260457371,0,2,astrocyte development,BP,
1463,GO:0014004,1,0.707514441584964,0,1,microglia differentiation,BP,
1464,GO:0014005,1,0.707514441584964,0,1,microglia development,BP,
1477,GO:0014047,1,0.700996267622242,0,1,glutamate secretion,BP,
1478,GO:0014048,1,0.700996267622242,0,1,regulation of glutamate secretion,BP,
1479,GO:0014050,1,0.700996267622242,0,1,negative regulation of glutamate secretion,BP,
1481,GO:0014060,1,0.479899134609722,0,2,regulation of epinephrine secretion,BP,
1482,GO:0014061,1,0.479899134609722,0,2,regulation of norepinephrine secretion,BP,
1485,GO:0014068,1,0.499793439383881,0,2,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
1489,GO:0014701,1,0.698147056906197,0,1,junctional sarcoplasmic reticulum membrane,CC,
1490,GO:0014704,1,0.51258672070689,0,2,intercalated disc,CC,
1497,GO:0014742,1,0.682927424885784,0,1,positive regulation of muscle hypertrophy,BP,
1498,GO:0014743,1,0.682927424885784,0,1,regulation of muscle hypertrophy,BP,
1500,GO:0014808,1,0.698147056906197,0,1,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1501,GO:0014812,1,0.243683462242436,0,4,muscle cell migration,BP,
1503,GO:0014820,1,0.682927424885784,0,1,tonic smooth muscle contraction,BP,
1506,GO:0014824,1,0.682927424885784,0,1,artery smooth muscle contraction,BP,
1507,GO:0014826,1,0.682927424885784,0,1,vein smooth muscle contraction,BP,
1508,GO:0014829,1,0.455652382824046,0,2,vascular smooth muscle contraction,BP,
1513,GO:0014866,1,0.718545083727339,0,1,skeletal myofibril assembly,BP,
1522,GO:0014896,1,0.682927424885784,0,1,muscle hypertrophy,BP,
1523,GO:0014897,1,0.682927424885784,0,1,striated muscle hypertrophy,BP,
1525,GO:0014909,1,0.243683462242436,0,4,smooth muscle cell migration,BP,
1526,GO:0014910,1,0.343103893176916,0,3,regulation of smooth muscle cell migration,BP,
1527,GO:0014911,1,0.496166451681433,0,2,positive regulation of smooth muscle cell migration,BP,
1532,GO:0015085,1,0.693606308666904,0,1,calcium ion transmembrane transporter activity,MF,
1534,GO:0015095,1,0.66612963031326,0,1,magnesium ion transmembrane transporter activity,MF,
1535,GO:0015103,1,0.680586525929292,0,1,inorganic anion transmembrane transporter activity,MF,
1536,GO:0015108,1,0.680586525929292,0,1,chloride transmembrane transporter activity,MF,
1540,GO:0015154,1,0.709760706330904,0,1,disaccharide transmembrane transporter activity,MF,
1541,GO:0015157,1,0.709760706330904,0,1,oligosaccharide transmembrane transporter activity,MF,
1542,GO:0015232,1,0.712608852725647,0,1,heme transporter activity,MF,
1544,GO:0015271,1,0.716482970202505,0,1,outward rectifier potassium channel activity,MF,
1546,GO:0015291,1,0.709760706330904,0,1,secondary active transmembrane transporter activity,MF,
1547,GO:0015293,1,0.709760706330904,0,1,symporter activity,MF,
1548,GO:0015294,1,0.709760706330904,0,1,solute:cation symporter activity,MF,
1549,GO:0015295,1,0.709760706330904,0,1,solute:proton symporter activity,MF,
1553,GO:0015645,1,0.717048561252595,0,1,fatty acid ligase activity,MF,
1557,GO:0015693,1,0.66612963031326,0,1,magnesium ion transport,BP,
1560,GO:0015711,1,0.166472085690803,0,5,organic anion transport,BP,
1561,GO:0015718,1,0.341688924650271,0,3,monocarboxylic acid transport,BP,
1562,GO:0015732,1,0.682927424885784,0,1,prostaglandin transport,BP,
1563,GO:0015748,1,0.669820056371903,0,1,organophosphate ester transport,BP,
1566,GO:0015766,1,0.709760706330904,0,1,disaccharide transport,BP,
1567,GO:0015770,1,0.709760706330904,0,1,sucrose transport,BP,
1568,GO:0015772,1,0.709760706330904,0,1,oligosaccharide transport,BP,
1572,GO:0015849,1,0.238241572233501,0,4,organic acid transport,BP,
1574,GO:0015858,1,0.700996267622242,0,1,nucleoside transport,BP,
1575,GO:0015865,1,0.669820056371903,0,1,purine nucleotide transport,BP,
1576,GO:0015868,1,0.669820056371903,0,1,purine ribonucleotide transport,BP,
1578,GO:0015874,1,0.479899134609722,0,2,norepinephrine transport,BP,
1579,GO:0015886,1,0.712608852725647,0,1,heme transport,BP,
1580,GO:0015893,1,0.71022670342733,0,1,drug transport,BP,
1581,GO:0015908,1,0.341688924650271,0,3,fatty acid transport,BP,
1582,GO:0015909,1,0.701493568801233,0,1,long-chain fatty acid transport,BP,
1583,GO:0015911,1,0.701493568801233,0,1,plasma membrane long-chain fatty acid transport,BP,
1584,GO:0015931,1,0.468624878308255,0,2,nucleobase-containing compound transport,BP,
1585,GO:0015939,1,0.719216741957039,0,1,pantothenate metabolic process,BP,
1592,GO:0016048,1,0.700996267622242,0,1,detection of temperature stimulus,BP,
1595,GO:0016051,1,0.242109966261779,0,4,carbohydrate biosynthetic process,BP,
1597,GO:0016053,1,0.329304592595775,0,3,organic acid biosynthetic process,BP,
1600,GO:0016056,1,0.716841414120058,0,1,rhodopsin mediated signaling pathway,BP,
1601,GO:0016064,1,0.674610601535826,0,1,immunoglobulin mediated immune response,BP,
1605,GO:0016101,1,0.487157880316345,0,2,diterpenoid metabolic process,BP,
1606,GO:0016125,1,0.691115067781905,0,1,sterol metabolic process,BP,
1607,GO:0016126,1,0.691115067781905,0,1,sterol biosynthetic process,BP,
1608,GO:0016176,1,0.701758628672581,0,1,superoxide-generating NADPH oxidase activator activity,MF,
1612,GO:0016209,1,0.711015020328229,0,1,antioxidant activity,MF,
1614,GO:0016239,1,0.332400561421815,0,3,positive regulation of macroautophagy,BP,
1620,GO:0016266,1,0.699009950094505,0,1,O-glycan processing,BP,
1621,GO:0016295,1,0.719216741957039,0,1,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
1622,GO:0016296,1,0.719216741957039,0,1,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
1623,GO:0016297,1,0.719216741957039,0,1,acyl-[acyl-carrier-protein] hydrolase activity,MF,
1624,GO:0016298,1,0.700996267622242,0,1,lipase activity,MF,
1632,GO:0016327,1,0.448004543082684,0,2,apicolateral plasma membrane,CC,
1638,GO:0016339,1,0.510810570858334,0,2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
1641,GO:0016361,1,0.703315452741895,0,1,activin receptor activity, type I,MF,
1643,GO:0016407,1,0.719216741957039,0,1,acetyltransferase activity,MF,
1644,GO:0016410,1,0.716841414120058,0,1,N-acyltransferase activity,MF,
1646,GO:0016417,1,0.719216741957039,0,1,S-acyltransferase activity,MF,
1647,GO:0016418,1,0.719216741957039,0,1,S-acetyltransferase activity,MF,
1648,GO:0016419,1,0.719216741957039,0,1,S-malonyltransferase activity,MF,
1649,GO:0016420,1,0.719216741957039,0,1,malonyltransferase activity,MF,
1651,GO:0016444,1,0.674610601535826,0,1,somatic cell DNA recombination,BP,
1652,GO:0016445,1,0.674610601535826,0,1,somatic diversification of immunoglobulins,BP,
1653,GO:0016447,1,0.674610601535826,0,1,somatic recombination of immunoglobulin gene segments,BP,
1655,GO:0016459,1,0.368549414171401,0,3,myosin complex,CC,
1656,GO:0016460,1,0.718545083727339,0,1,myosin II complex,CC,
1657,GO:0016461,1,0.718786554623569,0,1,unconventional myosin complex,CC,
1660,GO:0016480,1,0.698321270479589,0,1,negative regulation of transcription from RNA polymerase III promoter,BP,
1661,GO:0016482,1,0.503200468304184,0,2,cytosolic transport,BP,
1665,GO:0016528,1,0.698147056906197,0,1,sarcoplasm,CC,
1666,GO:0016529,1,0.698147056906197,0,1,sarcoplasmic reticulum,CC,
1667,GO:0016538,1,0.685778755049879,0,1,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
1669,GO:0016569,1,0.348401753701086,0,3,covalent chromatin modification,BP,
1670,GO:0016570,1,0.511361539057737,0,2,histone modification,BP,
1671,GO:0016573,1,0.714341024234018,0,1,histone acetylation,BP,
1672,GO:0016575,1,0.716995957461558,0,1,histone deacetylation,BP,
1674,GO:0016580,1,0.716995957461558,0,1,Sin3 complex,CC,
1680,GO:0016607,1,0.223830892539698,0,4,nuclear speck,CC,
1681,GO:0016614,1,0.50731508466208,0,2,oxidoreductase activity, acting on CH-OH group of donors,MF,
1682,GO:0016616,1,0.50731508466208,0,2,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
1683,GO:0016627,1,0.719216741957039,0,1,oxidoreductase activity, acting on the CH-CH group of donors,MF,
1684,GO:0016628,1,0.719216741957039,0,1,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
1687,GO:0016667,1,0.711015020328229,0,1,oxidoreductase activity, acting on a sulfur group of donors,MF,
1688,GO:0016684,1,0.711015020328229,0,1,oxidoreductase activity, acting on peroxide as acceptor,MF,
1693,GO:0016757,1,0.699009950094505,0,1,transferase activity, transferring glycosyl groups,MF,
1694,GO:0016758,1,0.699009950094505,0,1,transferase activity, transferring hexosyl groups,MF,
1697,GO:0016775,1,0.707215656113447,0,1,phosphotransferase activity, nitrogenous group as acceptor,MF,
1700,GO:0016790,1,0.719216741957039,0,1,thiolester hydrolase activity,MF,
1703,GO:0016810,1,0.716995957461558,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
1704,GO:0016811,1,0.716995957461558,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
1708,GO:0016835,1,0.719216741957039,0,1,carbon-oxygen lyase activity,MF,
1709,GO:0016836,1,0.719216741957039,0,1,hydro-lyase activity,MF,
1711,GO:0016853,1,0.674234706311468,0,1,isomerase activity,MF,
1712,GO:0016860,1,0.674234706311468,0,1,intramolecular oxidoreductase activity,MF,
1713,GO:0016874,1,0.717048561252595,0,1,ligase activity,MF,
1714,GO:0016877,1,0.717048561252595,0,1,ligase activity, forming carbon-sulfur bonds,MF,
1715,GO:0016878,1,0.717048561252595,0,1,acid-thiol ligase activity,MF,
1716,GO:0016887,1,0.718786554623569,0,1,ATPase activity,MF,
1717,GO:0016936,1,0.660286711933042,0,1,galactoside binding,MF,
1718,GO:0016941,1,0.715502935770821,0,1,natriuretic peptide receptor activity,MF,
1719,GO:0017002,1,0.703315452741895,0,1,activin-activated receptor activity,MF,
1720,GO:0017015,1,0.338320204932968,0,3,regulation of transforming growth factor beta receptor signaling pathway,BP,
1721,GO:0017016,1,0.261607666184714,0,4,Ras GTPase binding,MF,
1725,GO:0017046,1,0.359379200299562,0,3,peptide hormone binding,MF,
1726,GO:0017048,1,0.718046032902785,0,1,Rho GTPase binding,MF,
1727,GO:0017053,1,0.707980062532778,0,1,transcriptional repressor complex,CC,
1731,GO:0017112,1,0.71396188650386,0,1,Rab guanyl-nucleotide exchange factor activity,MF,
1732,GO:0017124,1,0.503112956116828,0,2,SH3 domain binding,MF,
1733,GO:0017137,1,0.512179083462172,0,2,Rab GTPase binding,MF,
1741,GO:0018008,1,0.716841414120058,0,1,N-terminal peptidyl-glycine N-myristoylation,BP,
1747,GO:0018146,1,0.699009950094505,0,1,keratan sulfate biosynthetic process,BP,
1750,GO:0018201,1,0.716841414120058,0,1,peptidyl-glycine modification,BP,
1751,GO:0018205,1,0.714341024234018,0,1,peptidyl-lysine modification,BP,
1755,GO:0018377,1,0.716841414120058,0,1,protein myristoylation,BP,
1756,GO:0018393,1,0.714341024234018,0,1,internal peptidyl-lysine acetylation,BP,
1757,GO:0018394,1,0.714341024234018,0,1,peptidyl-lysine acetylation,BP,
1758,GO:0018410,1,0.714638410513241,0,1,C-terminal protein amino acid modification,BP,
1763,GO:0019062,1,0.693606308666904,0,1,virion attachment to host cell,BP,
1764,GO:0019064,1,0.693606308666904,0,1,fusion of virus membrane with host plasma membrane,BP,
1766,GO:0019107,1,0.716841414120058,0,1,myristoyltransferase activity,MF,
1767,GO:0019171,1,0.719216741957039,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
1768,GO:0019199,1,0.356991640448234,0,3,transmembrane receptor protein kinase activity,MF,
1769,GO:0019200,1,0.494175609213931,0,2,carbohydrate kinase activity,MF,
1770,GO:0019203,1,0.71598013520354,0,1,carbohydrate phosphatase activity,MF,
1772,GO:0019208,1,0.706521730037359,0,1,phosphatase regulator activity,MF,
1774,GO:0019210,1,0.474789744780224,0,2,kinase inhibitor activity,MF,
1775,GO:0019211,1,0.706521730037359,0,1,phosphatase activator activity,MF,
1776,GO:0019213,1,0.716995957461558,0,1,deacetylase activity,MF,
1779,GO:0019217,1,0.701493568801233,0,1,regulation of fatty acid metabolic process,BP,
1786,GO:0019229,1,0.227752565168256,0,4,regulation of vasoconstriction,BP,
1787,GO:0019233,1,0.32313251483644,0,3,sensory perception of pain,BP,
1789,GO:0019319,1,0.711015020328229,0,1,hexose biosynthetic process,BP,
1792,GO:0019369,1,0.674234706311468,0,1,arachidonic acid metabolic process,BP,
1793,GO:0019371,1,0.674234706311468,0,1,cyclooxygenase pathway,BP,
1794,GO:0019395,1,0.497923140405487,0,2,fatty acid oxidation,BP,
1806,GO:0019682,1,0.691405431878985,0,1,glyceraldehyde-3-phosphate metabolic process,BP,
1809,GO:0019724,1,0.674610601535826,0,1,B cell mediated immunity,BP,
1811,GO:0019730,1,0.68145664044265,0,1,antimicrobial humoral response,BP,
1812,GO:0019748,1,0.717706347959987,0,1,secondary metabolic process,BP,
1816,GO:0019838,1,0.241632976594112,0,4,growth factor binding,MF,
1817,GO:0019840,1,0.688709470596719,0,1,isoprenoid binding,MF,
1819,GO:0019866,1,0.340561219504742,0,3,organelle inner membrane,CC,
1822,GO:0019882,1,0.496162789144351,0,2,antigen processing and presentation,BP,
1823,GO:0019884,1,0.709785182985047,0,1,antigen processing and presentation of exogenous antigen,BP,
1832,GO:0019903,1,0.25500836948429,0,4,protein phosphatase binding,MF,
1835,GO:0019912,1,0.685778755049879,0,1,cyclin-dependent protein kinase activating kinase activity,MF,
1841,GO:0019955,1,0.703315452741895,0,1,cytokine binding,MF,
1855,GO:0021675,1,0.655207167133653,0,1,nerve development,BP,
1856,GO:0021679,1,0.708931381661885,0,1,cerebellar molecular layer development,BP,
1857,GO:0021680,1,0.708931381661885,0,1,cerebellar Purkinje cell layer development,BP,
1861,GO:0021687,1,0.708931381661885,0,1,cerebellar molecular layer morphogenesis,BP,
1862,GO:0021688,1,0.708931381661885,0,1,cerebellar molecular layer formation,BP,
1863,GO:0021692,1,0.708931381661885,0,1,cerebellar Purkinje cell layer morphogenesis,BP,
1864,GO:0021693,1,0.708931381661885,0,1,cerebellar Purkinje cell layer structural organization,BP,
1868,GO:0021698,1,0.708931381661885,0,1,cerebellar cortex structural organization,BP,
1871,GO:0021772,1,0.717706347959987,0,1,olfactory bulb development,BP,
1883,GO:0021885,1,0.714575687180326,0,1,forebrain cell migration,BP,
1884,GO:0021889,1,0.717706347959987,0,1,olfactory bulb interneuron differentiation,BP,
1885,GO:0021891,1,0.717706347959987,0,1,olfactory bulb interneuron development,BP,
1897,GO:0021987,1,0.715947598747366,0,1,cerebral cortex development,BP,
1898,GO:0021988,1,0.717706347959987,0,1,olfactory lobe development,BP,
1904,GO:0022400,1,0.716841414120058,0,1,regulation of rhodopsin mediated signaling pathway,BP,
1912,GO:0022410,1,0.700996267622242,0,1,circadian sleep/wake cycle process,BP,
1923,GO:0022614,1,0.714643171421448,0,1,membrane to membrane docking,BP,
1926,GO:0022804,1,0.709760706330904,0,1,active transmembrane transporter activity,MF,
1937,GO:0022898,1,0.356095771658106,0,3,regulation of transmembrane transporter activity,BP,
1949,GO:0030016,1,0.0814918569081142,0,7,myofibril,CC,
1950,GO:0030017,1,0.118367652477213,0,6,sarcomere,CC,
1951,GO:0030018,1,0.118367652477213,0,6,Z disc,CC,
1956,GO:0030032,1,0.67317649297611,0,1,lamellipodium assembly,BP,
1957,GO:0030035,1,0.716240390769176,0,1,microspike assembly,BP,
1959,GO:0030038,1,0.171603770360023,0,5,contractile actin filament bundle assembly,BP,
1962,GO:0030046,1,0.711515581434463,0,1,parallel actin filament bundle assembly,BP,
1967,GO:0030056,1,0.71761803118789,0,1,hemidesmosome,CC,
1975,GO:0030101,1,0.345242671663121,0,3,natural killer cell activation,BP,
1976,GO:0030104,1,0.351011649179282,0,3,water homeostasis,BP,
1992,GO:0030175,1,0.116602556872107,0,6,filopodium,CC,
1997,GO:0030185,1,0.682927424885784,0,1,nitric oxide transport,BP,
1998,GO:0030193,1,0.330736052887268,0,3,regulation of blood coagulation,BP,
1999,GO:0030195,1,0.330736052887268,0,3,negative regulation of blood coagulation,BP,
2001,GO:0030203,1,0.236947596501367,0,4,glycosaminoglycan metabolic process,BP,
2002,GO:0030212,1,0.491414333171089,0,2,hyaluronan metabolic process,BP,
2003,GO:0030213,1,0.701758628672581,0,1,hyaluronan biosynthetic process,BP,
2007,GO:0030219,1,0.707980062532778,0,1,megakaryocyte differentiation,BP,
2008,GO:0030220,1,0.707980062532778,0,1,platelet formation,BP,
2012,GO:0030235,1,0.701493568801233,0,1,nitric-oxide synthase regulator activity,MF,
2013,GO:0030237,1,0.714265548502507,0,1,female sex determination,BP,
2014,GO:0030238,1,0.67829781652277,0,1,male sex determination,BP,
2015,GO:0030239,1,0.172884119968365,0,5,myofibril assembly,BP,
2016,GO:0030241,1,0.718545083727339,0,1,skeletal muscle myosin thick filament assembly,BP,
2017,GO:0030246,1,0.660286711933042,0,1,carbohydrate binding,MF,
2020,GO:0030274,1,0.716240390769176,0,1,LIM domain binding,MF,
2026,GO:0030285,1,0.677324360429776,0,1,integral component of synaptic vesicle membrane,CC,
2027,GO:0030291,1,0.474789744780224,0,2,protein serine/threonine kinase inhibitor activity,MF,
2029,GO:0030296,1,0.693606308666904,0,1,protein tyrosine kinase activator activity,MF,
2032,GO:0030309,1,0.699009950094505,0,1,poly-N-acetyllactosamine metabolic process,BP,
2033,GO:0030311,1,0.699009950094505,0,1,poly-N-acetyllactosamine biosynthetic process,BP,
2034,GO:0030314,1,0.698147056906197,0,1,junctional membrane complex,CC,
2036,GO:0030318,1,0.501417233444755,0,2,melanocyte differentiation,BP,
2042,GO:0030332,1,0.685778755049879,0,1,cyclin binding,MF,
2046,GO:0030374,1,0.490172326783972,0,2,ligand-dependent nuclear receptor transcription coactivator activity,MF,
2047,GO:0030375,1,0.716240390769176,0,1,thyroid hormone receptor coactivator activity,MF,
2048,GO:0030414,1,0.309140551791647,0,3,peptidase inhibitor activity,MF,
2051,GO:0030426,1,0.716799129544212,0,1,growth cone,CC,
2052,GO:0030427,1,0.716799129544212,0,1,site of polarized growth,CC,
2053,GO:0030431,1,0.700996267622242,0,1,sleep,BP,
2055,GO:0030485,1,0.668594419045675,0,1,smooth muscle contractile fiber,CC,
2056,GO:0030496,1,0.461655863290613,0,2,midbody,CC,
2063,GO:0030512,1,0.678825835365042,0,1,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
2071,GO:0030538,1,0.64211725735274,0,1,embryonic genitalia morphogenesis,BP,
2073,GO:0030540,1,0.228329599550823,0,4,female genitalia development,BP,
2076,GO:0030551,1,0.495596982753701,0,2,cyclic nucleotide binding,MF,
2077,GO:0030552,1,0.495596982753701,0,2,cAMP binding,MF,
2085,GO:0030660,1,0.716234312327688,0,1,Golgi-associated vesicle membrane,CC,
2090,GO:0030669,1,0.494272631073097,0,2,clathrin-coated endocytic vesicle membrane,CC,
2093,GO:0030673,1,0.700996267622242,0,1,axolemma,CC,
2094,GO:0030674,1,0.717681530181595,0,1,protein binding, bridging,MF,
2098,GO:0030799,1,0.148892945825134,0,5,regulation of cyclic nucleotide metabolic process,BP,
2099,GO:0030800,1,0.682927424885784,0,1,negative regulation of cyclic nucleotide metabolic process,BP,
2100,GO:0030801,1,0.219768116879745,0,4,positive regulation of cyclic nucleotide metabolic process,BP,
2101,GO:0030802,1,0.308561816229379,0,3,regulation of cyclic nucleotide biosynthetic process,BP,
2102,GO:0030803,1,0.682927424885784,0,1,negative regulation of cyclic nucleotide biosynthetic process,BP,
2103,GO:0030804,1,0.453682751930291,0,2,positive regulation of cyclic nucleotide biosynthetic process,BP,
2104,GO:0030808,1,0.308561816229379,0,3,regulation of nucleotide biosynthetic process,BP,
2105,GO:0030809,1,0.682927424885784,0,1,negative regulation of nucleotide biosynthetic process,BP,
2106,GO:0030810,1,0.453682751930291,0,2,positive regulation of nucleotide biosynthetic process,BP,
2107,GO:0030814,1,0.293743722855322,0,3,regulation of cAMP metabolic process,BP,
2108,GO:0030815,1,0.682927424885784,0,1,negative regulation of cAMP metabolic process,BP,
2109,GO:0030816,1,0.68145664044265,0,1,positive regulation of cAMP metabolic process,BP,
2110,GO:0030817,1,0.682927424885784,0,1,regulation of cAMP biosynthetic process,BP,
2111,GO:0030818,1,0.682927424885784,0,1,negative regulation of cAMP biosynthetic process,BP,
2112,GO:0030823,1,0.324421142077379,0,3,regulation of cGMP metabolic process,BP,
2113,GO:0030825,1,0.324421142077379,0,3,positive regulation of cGMP metabolic process,BP,
2114,GO:0030826,1,0.453682751930291,0,2,regulation of cGMP biosynthetic process,BP,
2115,GO:0030828,1,0.453682751930291,0,2,positive regulation of cGMP biosynthetic process,BP,
2120,GO:0030836,1,0.716240390769176,0,1,positive regulation of actin filament depolymerization,BP,
2122,GO:0030849,1,0.716995957461558,0,1,autosome,CC,
2124,GO:0030851,1,0.707980062532778,0,1,granulocyte differentiation,BP,
2129,GO:0030859,1,0.51208754973022,0,2,polarized epithelial cell differentiation,BP,
2132,GO:0030865,1,0.716234312327688,0,1,cortical cytoskeleton organization,BP,
2133,GO:0030866,1,0.716234312327688,0,1,cortical actin cytoskeleton organization,BP,
2134,GO:0030868,1,0.680586525929292,0,1,smooth endoplasmic reticulum membrane,CC,
2138,GO:0030888,1,0.461698733703832,0,2,regulation of B cell proliferation,BP,
2139,GO:0030890,1,0.461698733703832,0,2,positive regulation of B cell proliferation,BP,
2140,GO:0030898,1,0.718786554623569,0,1,actin-dependent ATPase activity,MF,
2144,GO:0030903,1,0.717706347959987,0,1,notochord development,BP,
2148,GO:0030947,1,0.458636137655599,0,2,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2149,GO:0030949,1,0.458636137655599,0,2,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
2150,GO:0030957,1,0.708931381661885,0,1,Tat protein binding,MF,
2151,GO:0030968,1,0.717681530181595,0,1,endoplasmic reticulum unfolded protein response,BP,
2152,GO:0030971,1,0.252221727010511,0,4,receptor tyrosine kinase binding,MF,
2153,GO:0031000,1,0.698147056906197,0,1,response to caffeine,BP,
2157,GO:0031023,1,0.466171970504979,0,2,microtubule organizing center organization,BP,
2158,GO:0031032,1,0.0283763619546208,0,10,actomyosin structure organization,BP,
2159,GO:0031033,1,0.718545083727339,0,1,myosin filament organization,BP,
2160,GO:0031034,1,0.718545083727339,0,1,myosin filament assembly,BP,
2164,GO:0031056,1,0.714341024234018,0,1,regulation of histone modification,BP,
2165,GO:0031058,1,0.714341024234018,0,1,positive regulation of histone modification,BP,
2167,GO:0031072,1,0.700996267622242,0,1,heat shock protein binding,MF,
2170,GO:0031091,1,0.237538592663568,0,4,platelet alpha granule,CC,
2171,GO:0031093,1,0.346813010549722,0,3,platelet alpha granule lumen,CC,
2172,GO:0031094,1,0.688709470596719,0,1,platelet dense tubular network,CC,
2176,GO:0031102,1,0.712690558264192,0,1,neuron projection regeneration,BP,
2177,GO:0031103,1,0.712690558264192,0,1,axon regeneration,BP,
2178,GO:0031109,1,0.453599059489472,0,2,microtubule polymerization or depolymerization,BP,
2179,GO:0031110,1,0.6730929422979,0,1,regulation of microtubule polymerization or depolymerization,BP,
2180,GO:0031112,1,0.6730929422979,0,1,positive regulation of microtubule polymerization or depolymerization,BP,
2181,GO:0031113,1,0.6730929422979,0,1,regulation of microtubule polymerization,BP,
2182,GO:0031116,1,0.6730929422979,0,1,positive regulation of microtubule polymerization,BP,
2188,GO:0031177,1,0.719216741957039,0,1,phosphopantetheine binding,MF,
2189,GO:0031201,1,0.698774696748521,0,1,SNARE complex,CC,
2190,GO:0031210,1,0.688709470596719,0,1,phosphatidylcholine binding,MF,
2192,GO:0031223,1,0.701156312252234,0,1,auditory behavior,BP,
2194,GO:0031225,1,0.714638410513241,0,1,anchored component of membrane,CC,
2197,GO:0031234,1,0.503802982116012,0,2,extrinsic component of cytoplasmic side of plasma membrane,CC,
2201,GO:0031254,1,0.714643171421448,0,1,cell trailing edge,CC,
2202,GO:0031256,1,0.50086396386562,0,2,leading edge membrane,CC,
2203,GO:0031267,1,0.261607666184714,0,4,small GTPase binding,MF,
2206,GO:0031300,1,0.677324360429776,0,1,intrinsic component of organelle membrane,CC,
2207,GO:0031301,1,0.677324360429776,0,1,integral component of organelle membrane,CC,
2223,GO:0031348,1,0.500070819547303,0,2,negative regulation of defense response,BP,
2225,GO:0031365,1,0.716841414120058,0,1,N-terminal protein amino acid modification,BP,
2234,GO:0031432,1,0.716240390769176,0,1,titin binding,MF,
2235,GO:0031434,1,0.693168134882461,0,1,mitogen-activated protein kinase kinase binding,MF,
2236,GO:0031477,1,0.718786554623569,0,1,myosin VII complex,CC,
2239,GO:0031491,1,0.683761059890489,0,1,nucleosome binding,MF,
2240,GO:0031492,1,0.683761059890489,0,1,nucleosomal DNA binding,MF,
2242,GO:0031527,1,0.486971547060142,0,2,filopodium membrane,CC,
2243,GO:0031528,1,0.714643171421448,0,1,microvillus membrane,CC,
2246,GO:0031570,1,0.31977331103751,0,3,DNA integrity checkpoint,BP,
2247,GO:0031571,1,0.45321036602372,0,2,mitotic G1 DNA damage checkpoint,BP,
2248,GO:0031572,1,0.708249234674247,0,1,G2 DNA damage checkpoint,BP,
2249,GO:0031581,1,0.71761803118789,0,1,hemidesmosome assembly,BP,
2250,GO:0031583,1,0.682927424885784,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
2251,GO:0031588,1,0.711015020328229,0,1,nucleotide-activated protein kinase complex,CC,
2255,GO:0031638,1,0.693992657957217,0,1,zymogen activation,BP,
2256,GO:0031639,1,0.693992657957217,0,1,plasminogen activation,BP,
2257,GO:0031640,1,0.68145664044265,0,1,killing of cells of other organism,BP,
2258,GO:0031641,1,0.701493568801233,0,1,regulation of myelination,BP,
2259,GO:0031644,1,0.32313251483644,0,3,regulation of neurological system process,BP,
2261,GO:0031648,1,0.706521730037359,0,1,protein destabilization,BP,
2262,GO:0031657,1,0.449484999660112,0,2,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2263,GO:0031659,1,0.449484999660112,0,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2271,GO:0031674,1,0.118367652477213,0,6,I band,CC,
2272,GO:0031683,1,0.700996267622242,0,1,G-protein beta/gamma-subunit complex binding,MF,
2273,GO:0031690,1,0.678909168116302,0,1,adrenergic receptor binding,MF,
2274,GO:0031694,1,0.678909168116302,0,1,alpha-2A adrenergic receptor binding,MF,
2275,GO:0031705,1,0.682927424885784,0,1,bombesin receptor binding,MF,
2276,GO:0031707,1,0.682927424885784,0,1,endothelin A receptor binding,MF,
2277,GO:0031708,1,0.682927424885784,0,1,endothelin B receptor binding,MF,
2279,GO:0031849,1,0.713363280358565,0,1,olfactory receptor binding,MF,
2280,GO:0031901,1,0.677324360429776,0,1,early endosome membrane,CC,
2282,GO:0031903,1,0.717048561252595,0,1,microbody membrane,CC,
2284,GO:0031932,1,0.506412191102895,0,2,TORC2 complex,CC,
2285,GO:0031941,1,0.711515581434463,0,1,filamentous actin,CC,
2286,GO:0031943,1,0.350982613013452,0,3,regulation of glucocorticoid metabolic process,BP,
2287,GO:0031944,1,0.493050003742117,0,2,negative regulation of glucocorticoid metabolic process,BP,
2288,GO:0031945,1,0.714265548502507,0,1,positive regulation of glucocorticoid metabolic process,BP,
2289,GO:0031946,1,0.350982613013452,0,3,regulation of glucocorticoid biosynthetic process,BP,
2290,GO:0031947,1,0.493050003742117,0,2,negative regulation of glucocorticoid biosynthetic process,BP,
2291,GO:0031948,1,0.714265548502507,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
2292,GO:0031952,1,0.701758628672581,0,1,regulation of protein autophosphorylation,BP,
2293,GO:0031954,1,0.701758628672581,0,1,positive regulation of protein autophosphorylation,BP,
2294,GO:0031957,1,0.717048561252595,0,1,very long-chain fatty acid-CoA ligase activity,MF,
2299,GO:0031970,1,0.674234706311468,0,1,organelle envelope lumen,CC,
2306,GO:0031994,1,0.71761803118789,0,1,insulin-like growth factor I binding,MF,
2307,GO:0031998,1,0.701493568801233,0,1,regulation of fatty acid beta-oxidation,BP,
2308,GO:0031999,1,0.701493568801233,0,1,negative regulation of fatty acid beta-oxidation,BP,
2310,GO:0032007,1,0.50900197752392,0,2,negative regulation of TOR signaling,BP,
2315,GO:0032042,1,0.711015020328229,0,1,mitochondrial DNA metabolic process,BP,
2317,GO:0032055,1,0.711015020328229,0,1,negative regulation of translation in response to stress,BP,
2318,GO:0032069,1,0.701493568801233,0,1,regulation of nuclease activity,BP,
2319,GO:0032070,1,0.701493568801233,0,1,regulation of deoxyribonuclease activity,BP,
2320,GO:0032071,1,0.701493568801233,0,1,regulation of endodeoxyribonuclease activity,BP,
2321,GO:0032075,1,0.701493568801233,0,1,positive regulation of nuclease activity,BP,
2322,GO:0032077,1,0.701493568801233,0,1,positive regulation of deoxyribonuclease activity,BP,
2323,GO:0032079,1,0.701493568801233,0,1,positive regulation of endodeoxyribonuclease activity,BP,
2325,GO:0032091,1,0.339618579275653,0,3,negative regulation of protein binding,BP,
2327,GO:0032094,1,0.701493568801233,0,1,response to food,BP,
2332,GO:0032148,1,0.164968990686764,0,5,activation of protein kinase B activity,BP,
2333,GO:0032153,1,0.689979727735358,0,1,cell division site,CC,
2334,GO:0032154,1,0.689979727735358,0,1,cleavage furrow,CC,
2335,GO:0032155,1,0.689979727735358,0,1,cell division site part,CC,
2336,GO:0032182,1,0.716744290017254,0,1,ubiquitin-like protein binding,MF,
2337,GO:0032190,1,0.688709470596719,0,1,acrosin binding,MF,
2338,GO:0032217,1,0.703744566161763,0,1,riboflavin transporter activity,MF,
2339,GO:0032218,1,0.703744566161763,0,1,riboflavin transport,BP,
2341,GO:0032228,1,0.700996267622242,0,1,regulation of synaptic transmission, GABAergic,BP,
2342,GO:0032229,1,0.700996267622242,0,1,negative regulation of synaptic transmission, GABAergic,BP,
2343,GO:0032231,1,0.243439331490617,0,4,regulation of actin filament bundle assembly,BP,
2344,GO:0032233,1,0.340928970103559,0,3,positive regulation of actin filament bundle assembly,BP,
2345,GO:0032239,1,0.700996267622242,0,1,regulation of nucleobase-containing compound transport,BP,
2346,GO:0032241,1,0.700996267622242,0,1,positive regulation of nucleobase-containing compound transport,BP,
2347,GO:0032242,1,0.700996267622242,0,1,regulation of nucleoside transport,BP,
2348,GO:0032244,1,0.700996267622242,0,1,positive regulation of nucleoside transport,BP,
2356,GO:0032273,1,0.6730929422979,0,1,positive regulation of protein polymerization,BP,
2362,GO:0032287,1,0.701493568801233,0,1,peripheral nervous system myelin maintenance,BP,
2364,GO:0032303,1,0.682927424885784,0,1,regulation of icosanoid secretion,BP,
2365,GO:0032305,1,0.682927424885784,0,1,positive regulation of icosanoid secretion,BP,
2366,GO:0032306,1,0.682927424885784,0,1,regulation of prostaglandin secretion,BP,
2367,GO:0032308,1,0.682927424885784,0,1,positive regulation of prostaglandin secretion,BP,
2368,GO:0032309,1,0.682927424885784,0,1,icosanoid secretion,BP,
2369,GO:0032310,1,0.682927424885784,0,1,prostaglandin secretion,BP,
2376,GO:0032345,1,0.493050003742117,0,2,negative regulation of aldosterone metabolic process,BP,
2379,GO:0032348,1,0.493050003742117,0,2,negative regulation of aldosterone biosynthetic process,BP,
2382,GO:0032351,1,0.493050003742117,0,2,negative regulation of hormone metabolic process,BP,
2384,GO:0032353,1,0.493050003742117,0,2,negative regulation of hormone biosynthetic process,BP,
2389,GO:0032369,1,0.701493568801233,0,1,negative regulation of lipid transport,BP,
2395,GO:0032400,1,0.47393615360419,0,2,melanosome localization,BP,
2396,GO:0032401,1,0.47393615360419,0,2,establishment of melanosome localization,BP,
2397,GO:0032402,1,0.47393615360419,0,2,melanosome transport,BP,
2399,GO:0032409,1,0.356095771658106,0,3,regulation of transporter activity,BP,
2400,GO:0032410,1,0.499195326876418,0,2,negative regulation of transporter activity,BP,
2401,GO:0032411,1,0.716240390769176,0,1,positive regulation of transporter activity,BP,
2402,GO:0032412,1,0.356095771658106,0,3,regulation of ion transmembrane transporter activity,BP,
2403,GO:0032413,1,0.499195326876418,0,2,negative regulation of ion transmembrane transporter activity,BP,
2404,GO:0032414,1,0.716240390769176,0,1,positive regulation of ion transmembrane transporter activity,BP,
2406,GO:0032420,1,0.363713520339921,0,3,stereocilium,CC,
2407,GO:0032421,1,0.363713520339921,0,3,stereocilium bundle,CC,
2408,GO:0032426,1,0.711515581434463,0,1,stereocilium tip,CC,
2409,GO:0032427,1,0.716234312327688,0,1,GBD domain binding,MF,
2410,GO:0032433,1,0.680586525929292,0,1,filopodium tip,CC,
2415,GO:0032456,1,0.484817815936672,0,2,endocytic recycling,BP,
2418,GO:0032479,1,0.717671355055457,0,1,regulation of type I interferon production,BP,
2424,GO:0032506,1,0.717075982523979,0,1,cytokinetic process,BP,
2429,GO:0032542,1,0.711015020328229,0,1,sulfiredoxin activity,MF,
2437,GO:0032571,1,0.693606308666904,0,1,response to vitamin K,BP,
2438,GO:0032585,1,0.700234742383915,0,1,multivesicular body membrane,CC,
2439,GO:0032587,1,0.715704383250707,0,1,ruffle membrane,CC,
2440,GO:0032589,1,0.700996267622242,0,1,neuron projection membrane,CC,
2441,GO:0032602,1,0.507294411470433,0,2,chemokine production,BP,
2443,GO:0032606,1,0.717671355055457,0,1,type I interferon production,BP,
2446,GO:0032611,1,0.717706347959987,0,1,interleukin-1 beta production,BP,
2448,GO:0032613,1,0.708931381661885,0,1,interleukin-10 production,BP,
2449,GO:0032623,1,0.715703089056377,0,1,interleukin-2 production,BP,
2451,GO:0032635,1,0.496955183044201,0,2,interleukin-6 production,BP,
2452,GO:0032637,1,0.717706347959987,0,1,interleukin-8 production,BP,
2453,GO:0032640,1,0.496937926004226,0,2,tumor necrosis factor production,BP,
2454,GO:0032642,1,0.507294411470433,0,2,regulation of chemokine production,BP,
2458,GO:0032651,1,0.717706347959987,0,1,regulation of interleukin-1 beta production,BP,
2460,GO:0032653,1,0.708931381661885,0,1,regulation of interleukin-10 production,BP,
2461,GO:0032663,1,0.715703089056377,0,1,regulation of interleukin-2 production,BP,
2462,GO:0032673,1,0.707980062532778,0,1,regulation of interleukin-4 production,BP,
2463,GO:0032675,1,0.496955183044201,0,2,regulation of interleukin-6 production,BP,
2464,GO:0032677,1,0.717706347959987,0,1,regulation of interleukin-8 production,BP,
2465,GO:0032680,1,0.496937926004226,0,2,regulation of tumor necrosis factor production,BP,
2467,GO:0032689,1,0.693606308666904,0,1,negative regulation of interferon-gamma production,BP,
2468,GO:0032692,1,0.693606308666904,0,1,negative regulation of interleukin-1 production,BP,
2469,GO:0032693,1,0.708931381661885,0,1,negative regulation of interleukin-10 production,BP,
2470,GO:0032713,1,0.707980062532778,0,1,negative regulation of interleukin-4 production,BP,
2471,GO:0032715,1,0.693606308666904,0,1,negative regulation of interleukin-6 production,BP,
2472,GO:0032720,1,0.693606308666904,0,1,negative regulation of tumor necrosis factor production,BP,
2473,GO:0032722,1,0.717706347959987,0,1,positive regulation of chemokine production,BP,
2476,GO:0032731,1,0.717706347959987,0,1,positive regulation of interleukin-1 beta production,BP,
2478,GO:0032743,1,0.715703089056377,0,1,positive regulation of interleukin-2 production,BP,
2479,GO:0032755,1,0.717706347959987,0,1,positive regulation of interleukin-6 production,BP,
2480,GO:0032757,1,0.717706347959987,0,1,positive regulation of interleukin-8 production,BP,
2481,GO:0032760,1,0.717681530181595,0,1,positive regulation of tumor necrosis factor production,BP,
2482,GO:0032762,1,0.68145664044265,0,1,mast cell cytokine production,BP,
2486,GO:0032781,1,0.64211725735274,0,1,positive regulation of ATPase activity,BP,
2491,GO:0032795,1,0.700996267622242,0,1,heterotrimeric G-protein binding,MF,
2492,GO:0032800,1,0.682927424885784,0,1,receptor biosynthetic process,BP,
2493,GO:0032801,1,0.71774180231946,0,1,receptor catabolic process,BP,
2494,GO:0032808,1,0.64211725735274,0,1,lacrimal gland development,BP,
2495,GO:0032811,1,0.479899134609722,0,2,negative regulation of epinephrine secretion,BP,
2496,GO:0032814,1,0.693606308666904,0,1,regulation of natural killer cell activation,BP,
2497,GO:0032816,1,0.693606308666904,0,1,positive regulation of natural killer cell activation,BP,
2498,GO:0032823,1,0.693606308666904,0,1,regulation of natural killer cell differentiation,BP,
2499,GO:0032825,1,0.693606308666904,0,1,positive regulation of natural killer cell differentiation,BP,
2501,GO:0032836,1,0.70409479607052,0,1,glomerular basement membrane development,BP,
2504,GO:0032846,1,0.339306070132687,0,3,positive regulation of homeostatic process,BP,
2509,GO:0032873,1,0.701493568801233,0,1,negative regulation of stress-activated MAPK cascade,BP,
2513,GO:0032881,1,0.491414333171089,0,2,regulation of polysaccharide metabolic process,BP,
2514,GO:0032885,1,0.491414333171089,0,2,regulation of polysaccharide biosynthetic process,BP,
2515,GO:0032886,1,0.33223591951352,0,3,regulation of microtubule-based process,BP,
2516,GO:0032890,1,0.333975117578285,0,3,regulation of organic acid transport,BP,
2517,GO:0032891,1,0.490878280128226,0,2,negative regulation of organic acid transport,BP,
2518,GO:0032892,1,0.682927424885784,0,1,positive regulation of organic acid transport,BP,
2519,GO:0032898,1,0.700996267622242,0,1,neurotrophin production,BP,
2520,GO:0032899,1,0.700996267622242,0,1,regulation of neurotrophin production,BP,
2521,GO:0032900,1,0.700996267622242,0,1,negative regulation of neurotrophin production,BP,
2530,GO:0032946,1,0.295110392483164,0,3,positive regulation of mononuclear cell proliferation,BP,
2538,GO:0032982,1,0.718545083727339,0,1,myosin filament,CC,
2544,GO:0033010,1,0.712690558264192,0,1,paranodal junction,CC,
2545,GO:0033017,1,0.698147056906197,0,1,sarcoplasmic reticulum membrane,CC,
2546,GO:0033018,1,0.698147056906197,0,1,sarcoplasmic reticulum lumen,CC,
2547,GO:0033023,1,0.717270758028134,0,1,mast cell homeostasis,BP,
2548,GO:0033024,1,0.717270758028134,0,1,mast cell apoptotic process,BP,
2549,GO:0033025,1,0.717270758028134,0,1,regulation of mast cell apoptotic process,BP,
2550,GO:0033026,1,0.717270758028134,0,1,negative regulation of mast cell apoptotic process,BP,
2551,GO:0033028,1,0.717270758028134,0,1,myeloid cell apoptotic process,BP,
2552,GO:0033032,1,0.717270758028134,0,1,regulation of myeloid cell apoptotic process,BP,
2553,GO:0033033,1,0.717270758028134,0,1,negative regulation of myeloid cell apoptotic process,BP,
2556,GO:0033044,1,0.714341024234018,0,1,regulation of chromosome organization,BP,
2567,GO:0033093,1,0.477312072722649,0,2,Weibel-Palade body,CC,
2568,GO:0033120,1,0.717681530181595,0,1,positive regulation of RNA splicing,BP,
2571,GO:0033139,1,0.714341024234018,0,1,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2572,GO:0033141,1,0.714341024234018,0,1,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
2574,GO:0033158,1,0.474756433337926,0,2,regulation of protein import into nucleus, translocation,BP,
2575,GO:0033159,1,0.693606308666904,0,1,negative regulation of protein import into nucleus, translocation,BP,
2579,GO:0033218,1,0.17213482748979,0,5,amide binding,MF,
2588,GO:0033327,1,0.67829781652277,0,1,Leydig cell differentiation,BP,
2595,GO:0033558,1,0.716995957461558,0,1,protein deacetylase activity,MF,
2596,GO:0033559,1,0.459513176635729,0,2,unsaturated fatty acid metabolic process,BP,
2597,GO:0033561,1,0.71022670342733,0,1,regulation of water loss via skin,BP,
2600,GO:0033574,1,0.487176919842355,0,2,response to testosterone,BP,
2601,GO:0033598,1,0.717706347959987,0,1,mammary gland epithelial cell proliferation,BP,
2603,GO:0033604,1,0.325763794567899,0,3,negative regulation of catecholamine secretion,BP,
2606,GO:0033613,1,0.707980062532778,0,1,activating transcription factor binding,MF,
2609,GO:0033631,1,0.715704383250707,0,1,cell-cell adhesion mediated by integrin,BP,
2612,GO:0033687,1,0.706521730037359,0,1,osteoblast proliferation,BP,
2613,GO:0033688,1,0.706521730037359,0,1,regulation of osteoblast proliferation,BP,
2614,GO:0033690,1,0.706521730037359,0,1,positive regulation of osteoblast proliferation,BP,
2615,GO:0033692,1,0.4894816151021,0,2,cellular polysaccharide biosynthetic process,BP,
2618,GO:0034059,1,0.689437791994975,0,1,response to anoxia,BP,
2628,GO:0034121,1,0.714575687180326,0,1,regulation of toll-like receptor signaling pathway,BP,
2629,GO:0034122,1,0.714575687180326,0,1,negative regulation of toll-like receptor signaling pathway,BP,
2630,GO:0034198,1,0.685778755049879,0,1,cellular response to amino acid starvation,BP,
2631,GO:0034199,1,0.4959065131259,0,2,activation of protein kinase A activity,BP,
2634,GO:0034236,1,0.693654765650842,0,1,protein kinase A catalytic subunit binding,MF,
2641,GO:0034285,1,0.691405431878985,0,1,response to disaccharide,BP,
2644,GO:0034331,1,0.703744566161763,0,1,cell junction maintenance,BP,
2647,GO:0034340,1,0.717706347959987,0,1,response to type I interferon,BP,
2649,GO:0034349,1,0.490853667521622,0,2,glial cell apoptotic process,BP,
2650,GO:0034350,1,0.490853667521622,0,2,regulation of glial cell apoptotic process,BP,
2651,GO:0034351,1,0.490853667521622,0,2,negative regulation of glial cell apoptotic process,BP,
2652,GO:0034390,1,0.682927424885784,0,1,smooth muscle cell apoptotic process,BP,
2653,GO:0034391,1,0.682927424885784,0,1,regulation of smooth muscle cell apoptotic process,BP,
2654,GO:0034392,1,0.682927424885784,0,1,negative regulation of smooth muscle cell apoptotic process,BP,
2655,GO:0034394,1,0.45898132038968,0,2,protein localization to cell surface,BP,
2657,GO:0034405,1,0.701493568801233,0,1,response to fluid shear stress,BP,
2658,GO:0034440,1,0.497923140405487,0,2,lipid oxidation,BP,
2661,GO:0034453,1,0.703744566161763,0,1,microtubule anchoring,BP,
2663,GO:0034505,1,0.67186743586322,0,1,tooth mineralization,BP,
2665,GO:0034605,1,0.481726129999858,0,2,cellular response to heat,BP,
2669,GO:0034620,1,0.717681530181595,0,1,cellular response to unfolded protein,BP,
2671,GO:0034629,1,0.687261217406708,0,1,cellular protein complex localization,BP,
2672,GO:0034637,1,0.4894816151021,0,2,cellular carbohydrate biosynthetic process,BP,
2674,GO:0034644,1,0.491308006900675,0,2,cellular response to UV,BP,
2676,GO:0034650,1,0.350982613013452,0,3,cortisol metabolic process,BP,
2677,GO:0034651,1,0.350982613013452,0,3,cortisol biosynthetic process,BP,
2681,GO:0034667,1,0.716799129544212,0,1,integrin alpha3-beta1 complex,CC,
2682,GO:0034684,1,0.709785182985047,0,1,integrin alphav-beta5 complex,CC,
2683,GO:0034686,1,0.719290773235962,0,1,integrin alphav-beta8 complex,CC,
2684,GO:0034694,1,0.478173903575527,0,2,response to prostaglandin,BP,
2685,GO:0034695,1,0.701493568801233,0,1,response to prostaglandin E,BP,
2686,GO:0034696,1,0.682927424885784,0,1,response to prostaglandin F,BP,
2690,GO:0034704,1,0.49881928510448,0,2,calcium channel complex,CC,
2692,GO:0034707,1,0.680586525929292,0,1,chloride channel complex,CC,
2694,GO:0034755,1,0.680586525929292,0,1,iron ion transmembrane transport,BP,
2696,GO:0034763,1,0.245524602515121,0,4,negative regulation of transmembrane transport,BP,
2697,GO:0034764,1,0.50570530107566,0,2,positive regulation of transmembrane transport,BP,
2699,GO:0034766,1,0.245524602515121,0,4,negative regulation of ion transmembrane transport,BP,
2700,GO:0034767,1,0.50570530107566,0,2,positive regulation of ion transmembrane transport,BP,
2705,GO:0035014,1,0.51197138028005,0,2,phosphatidylinositol 3-kinase regulator activity,MF,
2707,GO:0035023,1,0.716799129544212,0,1,regulation of Rho protein signal transduction,BP,
2708,GO:0035024,1,0.716799129544212,0,1,negative regulation of Rho protein signal transduction,BP,
2711,GO:0035054,1,0.706521730037359,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
2712,GO:0035065,1,0.714341024234018,0,1,regulation of histone acetylation,BP,
2713,GO:0035066,1,0.714341024234018,0,1,positive regulation of histone acetylation,BP,
2714,GO:0035088,1,0.51208754973022,0,2,establishment or maintenance of apical/basal cell polarity,BP,
2715,GO:0035089,1,0.51208754973022,0,2,establishment of apical/basal cell polarity,BP,
2717,GO:0035094,1,0.682927424885784,0,1,response to nicotine,BP,
2720,GO:0035112,1,0.64211725735274,0,1,genitalia morphogenesis,BP,
2727,GO:0035150,1,0.031118842750048,0,9,regulation of tube size,BP,
2728,GO:0035162,1,0.506985281399229,0,2,embryonic hemopoiesis,BP,
2732,GO:0035234,1,0.717270758028134,0,1,ectopic germ cell programmed cell death,BP,
2734,GO:0035249,1,0.700996267622242,0,1,synaptic transmission, glutamatergic,BP,
2735,GO:0035250,1,0.699009950094505,0,1,UDP-galactosyltransferase activity,MF,
2743,GO:0035296,1,0.031118842750048,0,9,regulation of tube diameter,BP,
2744,GO:0035303,1,0.346729032961827,0,3,regulation of dephosphorylation,BP,
2745,GO:0035304,1,0.700996267622242,0,1,regulation of protein dephosphorylation,BP,
2746,GO:0035305,1,0.703744566161763,0,1,negative regulation of dephosphorylation,BP,
2747,GO:0035306,1,0.494411384782149,0,2,positive regulation of dephosphorylation,BP,
2748,GO:0035307,1,0.700996267622242,0,1,positive regulation of protein dephosphorylation,BP,
2753,GO:0035336,1,0.514903481278129,0,2,long-chain fatty-acyl-CoA metabolic process,BP,
2754,GO:0035337,1,0.514903481278129,0,2,fatty-acyl-CoA metabolic process,BP,
2755,GO:0035338,1,0.514903481278129,0,2,long-chain fatty-acyl-CoA biosynthetic process,BP,
2756,GO:0035383,1,0.514903481278129,0,2,thioester metabolic process,BP,
2757,GO:0035384,1,0.514903481278129,0,2,thioester biosynthetic process,BP,
2762,GO:0035455,1,0.693606308666904,0,1,response to interferon-alpha,BP,
2763,GO:0035457,1,0.693606308666904,0,1,cellular response to interferon-alpha,BP,
2764,GO:0035493,1,0.698774696748521,0,1,SNARE complex assembly,BP,
2765,GO:0035502,1,0.70409479607052,0,1,metanephric part of ureteric bud development,BP,
2769,GO:0035579,1,0.339441787821625,0,3,specific granule membrane,CC,
2770,GO:0035580,1,0.700234742383915,0,1,specific granule lumen,CC,
2772,GO:0035586,1,0.700996267622242,0,1,purinergic receptor activity,MF,
2773,GO:0035587,1,0.700996267622242,0,1,purinergic receptor signaling pathway,BP,
2774,GO:0035588,1,0.700996267622242,0,1,G-protein coupled purinergic receptor signaling pathway,BP,
2775,GO:0035591,1,0.717681530181595,0,1,signaling adaptor activity,MF,
2776,GO:0035601,1,0.716995957461558,0,1,protein deacylation,BP,
2777,GO:0035624,1,0.479899134609722,0,2,receptor transactivation,BP,
2778,GO:0035625,1,0.479899134609722,0,2,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
2779,GO:0035630,1,0.706521730037359,0,1,bone mineralization involved in bone maturation,BP,
2783,GO:0035640,1,0.716799129544212,0,1,exploration behavior,BP,
2787,GO:0035655,1,0.491414333171089,0,2,interleukin-18-mediated signaling pathway,BP,
2789,GO:0035690,1,0.23719409662223,0,4,cellular response to drug,BP,
2790,GO:0035701,1,0.693606308666904,0,1,hematopoietic stem cell migration,BP,
2791,GO:0035710,1,0.707980062532778,0,1,CD4-positive, alpha-beta T cell activation,BP,
2792,GO:0035728,1,0.708277251030171,0,1,response to hepatocyte growth factor,BP,
2793,GO:0035729,1,0.708277251030171,0,1,cellular response to hepatocyte growth factor stimulus,BP,
2795,GO:0035754,1,0.693606308666904,0,1,B cell chemotaxis,BP,
2797,GO:0035787,1,0.701758628672581,0,1,cell migration involved in kidney development,BP,
2798,GO:0035788,1,0.701758628672581,0,1,cell migration involved in metanephros development,BP,
2799,GO:0035789,1,0.701758628672581,0,1,metanephric mesenchymal cell migration,BP,
2800,GO:0035791,1,0.701758628672581,0,1,platelet-derived growth factor receptor-beta signaling pathway,BP,
2801,GO:0035793,1,0.701758628672581,0,1,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
2803,GO:0035801,1,0.70409479607052,0,1,adrenal cortex development,BP,
2804,GO:0035802,1,0.70409479607052,0,1,adrenal cortex formation,BP,
2805,GO:0035809,1,0.487765591854893,0,2,regulation of urine volume,BP,
2806,GO:0035810,1,0.487765591854893,0,2,positive regulation of urine volume,BP,
2807,GO:0035812,1,0.340702401592809,0,3,renal sodium excretion,BP,
2808,GO:0035813,1,0.340702401592809,0,3,regulation of renal sodium excretion,BP,
2809,GO:0035814,1,0.700996267622242,0,1,negative regulation of renal sodium excretion,BP,
2810,GO:0035815,1,0.487765591854893,0,2,positive regulation of renal sodium excretion,BP,
2811,GO:0035821,1,0.68145664044265,0,1,modification of morphology or physiology of other organism,BP,
2814,GO:0035855,1,0.707980062532778,0,1,megakaryocyte development,BP,
2815,GO:0035859,1,0.711015020328229,0,1,Seh1-associated complex,CC,
2817,GO:0035878,1,0.71761803118789,0,1,nail development,BP,
2821,GO:0035902,1,0.708249234674247,0,1,response to immobilization stress,BP,
2833,GO:0035966,1,0.717681530181595,0,1,response to topologically incorrect protein,BP,
2834,GO:0035967,1,0.717681530181595,0,1,cellular response to topologically incorrect protein,BP,
2836,GO:0035987,1,0.507168561953994,0,2,endodermal cell differentiation,BP,
2837,GO:0035988,1,0.689437791994975,0,1,chondrocyte proliferation,BP,
2842,GO:0035994,1,0.682927424885784,0,1,response to muscle stretch,BP,
2844,GO:0036010,1,0.714643171421448,0,1,protein localization to endosome,BP,
2845,GO:0036024,1,0.688709470596719,0,1,protein C inhibitor-TMPRSS7 complex,CC,
2846,GO:0036025,1,0.688709470596719,0,1,protein C inhibitor-TMPRSS11E complex,CC,
2847,GO:0036026,1,0.688709470596719,0,1,protein C inhibitor-PLAT complex,CC,
2848,GO:0036027,1,0.688709470596719,0,1,protein C inhibitor-PLAU complex,CC,
2849,GO:0036028,1,0.688709470596719,0,1,protein C inhibitor-thrombin complex,CC,
2850,GO:0036029,1,0.688709470596719,0,1,protein C inhibitor-KLK3 complex,CC,
2851,GO:0036030,1,0.688709470596719,0,1,protein C inhibitor-plasma kallikrein complex,CC,
2853,GO:0036064,1,0.501951958801067,0,2,ciliary basal body,CC,
2855,GO:0036089,1,0.717075982523979,0,1,cleavage furrow formation,BP,
2856,GO:0036091,1,0.711015020328229,0,1,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
2862,GO:0036166,1,0.701758628672581,0,1,phenotypic switching,BP,
2865,GO:0036257,1,0.700234742383915,0,1,multivesicular body organization,BP,
2868,GO:0036296,1,0.685778755049879,0,1,response to increased oxygen levels,BP,
2870,GO:0036312,1,0.717681530181595,0,1,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
2872,GO:0036342,1,0.717706347959987,0,1,post-anal tail morphogenesis,BP,
2873,GO:0036344,1,0.707980062532778,0,1,platelet morphogenesis,BP,
2874,GO:0036379,1,0.716782934115651,0,1,myofilament,CC,
2877,GO:0036473,1,0.701493568801233,0,1,cell death in response to oxidative stress,BP,
2879,GO:0036490,1,0.711015020328229,0,1,regulation of translation in response to endoplasmic reticulum stress,BP,
2880,GO:0036514,1,0.717706347959987,0,1,dopaminergic neuron axon guidance,BP,
2881,GO:0036515,1,0.717706347959987,0,1,serotonergic neuron axon guidance,BP,
2882,GO:0036517,1,0.717706347959987,0,1,chemoattraction of serotonergic neuron axon,BP,
2883,GO:0036518,1,0.717706347959987,0,1,chemorepulsion of dopaminergic neuron axon,BP,
2884,GO:0038001,1,0.701758628672581,0,1,paracrine signaling,BP,
2891,GO:0038061,1,0.701493568801233,0,1,NIK/NF-kappaB signaling,BP,
2892,GO:0038062,1,0.713876788943018,0,1,protein tyrosine kinase collagen receptor activity,MF,
2893,GO:0038063,1,0.713876788943018,0,1,collagen-activated tyrosine kinase receptor signaling pathway,BP,
2894,GO:0038064,1,0.713876788943018,0,1,collagen receptor activity,MF,
2895,GO:0038065,1,0.713876788943018,0,1,collagen-activated signaling pathway,BP,
2896,GO:0038066,1,0.466983616516672,0,2,p38MAPK cascade,BP,
2897,GO:0038083,1,0.713876788943018,0,1,peptidyl-tyrosine autophosphorylation,BP,
2898,GO:0038084,1,0.708931381661885,0,1,vascular endothelial growth factor signaling pathway,BP,
2905,GO:0038132,1,0.71761803118789,0,1,neuregulin binding,MF,
2906,GO:0038166,1,0.716240390769176,0,1,angiotensin-activated signaling pathway,BP,
2907,GO:0038179,1,0.708277251030171,0,1,neurotrophin signaling pathway,BP,
2911,GO:0038201,1,0.506412191102895,0,2,TOR complex,CC,
2912,GO:0038202,1,0.711015020328229,0,1,TORC1 signaling,BP,
2913,GO:0038203,1,0.713405224543974,0,1,TORC2 signaling,BP,
2914,GO:0039663,1,0.693606308666904,0,1,membrane fusion involved in viral entry into host cell,BP,
2916,GO:0040001,1,0.64211725735274,0,1,establishment of mitotic spindle localization,BP,
2926,GO:0040020,1,0.364434198417302,0,3,regulation of meiotic nuclear division,BP,
2929,GO:0040036,1,0.511815900284808,0,2,regulation of fibroblast growth factor receptor signaling pathway,BP,
2930,GO:0040037,1,0.511815900284808,0,2,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
2931,GO:0042033,1,0.717706347959987,0,1,chemokine biosynthetic process,BP,
2934,GO:0042044,1,0.682927424885784,0,1,fluid transport,BP,
2935,GO:0042045,1,0.682927424885784,0,1,epithelial fluid transport,BP,
2937,GO:0042058,1,0.16089813891123,0,5,regulation of epidermal growth factor receptor signaling pathway,BP,
2938,GO:0042059,1,0.693168134882461,0,1,negative regulation of epidermal growth factor receptor signaling pathway,BP,
2944,GO:0042093,1,0.707980062532778,0,1,T-helper cell differentiation,BP,
2945,GO:0042095,1,0.707980062532778,0,1,interferon-gamma biosynthetic process,BP,
2946,GO:0042097,1,0.707980062532778,0,1,interleukin-4 biosynthetic process,BP,
2948,GO:0042100,1,0.461698733703832,0,2,B cell proliferation,BP,
2953,GO:0042116,1,0.717706347959987,0,1,macrophage activation,BP,
2958,GO:0042147,1,0.705299442787258,0,1,retrograde transport, endosome to Golgi,BP,
2960,GO:0042157,1,0.365111659782616,0,3,lipoprotein metabolic process,BP,
2961,GO:0042158,1,0.51146455618194,0,2,lipoprotein biosynthetic process,BP,
2970,GO:0042249,1,0.717706347959987,0,1,establishment of planar polarity of embryonic epithelium,BP,
2971,GO:0042267,1,0.700234742383915,0,1,natural killer cell mediated cytotoxicity,BP,
2972,GO:0042277,1,0.240947547936447,0,4,peptide binding,MF,
2973,GO:0042278,1,0.716234312327688,0,1,purine nucleoside metabolic process,BP,
2974,GO:0042297,1,0.701156312252234,0,1,vocal learning,BP,
2979,GO:0042310,1,0.151032786861962,0,5,vasoconstriction,BP,
2980,GO:0042311,1,0.700996267622242,0,1,vasodilation,BP,
2981,GO:0042313,1,0.682927424885784,0,1,protein kinase C deactivation,BP,
2982,GO:0042321,1,0.700996267622242,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
2983,GO:0042323,1,0.700996267622242,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
2988,GO:0042339,1,0.699009950094505,0,1,keratan sulfate metabolic process,BP,
2996,GO:0042383,1,0.715947598747366,0,1,sarcolemma,CC,
2999,GO:0042417,1,0.715502935770821,0,1,dopamine metabolic process,BP,
3002,GO:0042438,1,0.717706347959987,0,1,melanin biosynthetic process,BP,
3003,GO:0042440,1,0.717706347959987,0,1,pigment metabolic process,BP,
3006,GO:0042461,1,0.718786554623569,0,1,photoreceptor cell development,BP,
3007,GO:0042462,1,0.718786554623569,0,1,eye photoreceptor cell development,BP,
3011,GO:0042474,1,0.682927424885784,0,1,middle ear morphogenesis,BP,
3015,GO:0042482,1,0.322295458255069,0,3,positive regulation of odontogenesis,BP,
3021,GO:0042501,1,0.714341024234018,0,1,serine phosphorylation of STAT protein,BP,
3022,GO:0042503,1,0.481016297962941,0,2,tyrosine phosphorylation of Stat3 protein,BP,
3023,GO:0042508,1,0.714341024234018,0,1,tyrosine phosphorylation of Stat1 protein,BP,
3024,GO:0042509,1,0.481016297962941,0,2,regulation of tyrosine phosphorylation of STAT protein,BP,
3025,GO:0042510,1,0.714341024234018,0,1,regulation of tyrosine phosphorylation of Stat1 protein,BP,
3026,GO:0042511,1,0.714341024234018,0,1,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
3027,GO:0042516,1,0.481016297962941,0,2,regulation of tyrosine phosphorylation of Stat3 protein,BP,
3028,GO:0042517,1,0.481016297962941,0,2,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
3029,GO:0042531,1,0.481016297962941,0,2,positive regulation of tyrosine phosphorylation of STAT protein,BP,
3030,GO:0042538,1,0.71022670342733,0,1,hyperosmotic salinity response,BP,
3031,GO:0042542,1,0.689979727735358,0,1,response to hydrogen peroxide,BP,
3034,GO:0042554,1,0.682927424885784,0,1,superoxide anion generation,BP,
3035,GO:0042562,1,0.359379200299562,0,3,hormone binding,MF,
3037,GO:0042579,1,0.717048561252595,0,1,microbody,CC,
3038,GO:0042581,1,0.236407917622509,0,4,specific granule,CC,
3040,GO:0042583,1,0.68145664044265,0,1,chromaffin granule,CC,
3041,GO:0042587,1,0.719216741957039,0,1,glycogen granule,CC,
3043,GO:0042590,1,0.709785182985047,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
3047,GO:0042623,1,0.718786554623569,0,1,ATPase activity, coupled,MF,
3050,GO:0042634,1,0.717706347959987,0,1,regulation of hair cycle,BP,
3051,GO:0042635,1,0.717706347959987,0,1,positive regulation of hair cycle,BP,
3052,GO:0042640,1,0.717706347959987,0,1,anagen,BP,
3057,GO:0042693,1,0.316083242104977,0,3,muscle cell fate commitment,BP,
3058,GO:0042695,1,0.717706347959987,0,1,thelarche,BP,
3060,GO:0042726,1,0.703744566161763,0,1,flavin-containing compound metabolic process,BP,
3061,GO:0042730,1,0.693992657957217,0,1,fibrinolysis,BP,
3063,GO:0042734,1,0.700996267622242,0,1,presynaptic membrane,CC,
3065,GO:0042745,1,0.700996267622242,0,1,circadian sleep/wake cycle,BP,
3066,GO:0042748,1,0.700996267622242,0,1,circadian sleep/wake cycle, non-REM sleep,BP,
3067,GO:0042749,1,0.700996267622242,0,1,regulation of circadian sleep/wake cycle,BP,
3068,GO:0042752,1,0.700996267622242,0,1,regulation of circadian rhythm,BP,
3069,GO:0042754,1,0.700996267622242,0,1,negative regulation of circadian rhythm,BP,
3071,GO:0042771,1,0.685778755049879,0,1,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
3072,GO:0042772,1,0.685778755049879,0,1,DNA damage response, signal transduction resulting in transcription,BP,
3079,GO:0042953,1,0.666797965191416,0,1,lipoprotein transport,BP,
3090,GO:0043015,1,0.512159860811955,0,2,gamma-tubulin binding,MF,
3092,GO:0043027,1,0.693606308666904,0,1,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
3093,GO:0043028,1,0.693606308666904,0,1,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
3095,GO:0043030,1,0.717706347959987,0,1,regulation of macrophage activation,BP,
3096,GO:0043032,1,0.717706347959987,0,1,positive regulation of macrophage activation,BP,
3097,GO:0043034,1,0.696039774295367,0,1,costamere,CC,
3105,GO:0043083,1,0.719528553088115,0,1,synaptic cleft,CC,
3109,GO:0043112,1,0.489298535659366,0,2,receptor metabolic process,BP,
3110,GO:0043113,1,0.715947598747366,0,1,receptor clustering,BP,
3111,GO:0043114,1,0.715502935770821,0,1,regulation of vascular permeability,BP,
3113,GO:0043123,1,0.47986620034689,0,2,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,
3115,GO:0043125,1,0.717681530181595,0,1,ErbB-3 class receptor binding,MF,
3116,GO:0043130,1,0.716744290017254,0,1,ubiquitin binding,MF,
3117,GO:0043149,1,0.171603770360023,0,5,stress fiber assembly,BP,
3118,GO:0043154,1,0.485682165347663,0,2,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3125,GO:0043179,1,0.682927424885784,0,1,rhythmic excitation,BP,
3126,GO:0043184,1,0.715704383250707,0,1,vascular endothelial growth factor receptor 2 binding,MF,
3128,GO:0043195,1,0.488967871507919,0,2,terminal bouton,CC,
3129,GO:0043197,1,0.255238268681181,0,4,dendritic spine,CC,
3130,GO:0043198,1,0.717335044480693,0,1,dendritic shaft,CC,
3131,GO:0043200,1,0.237481610572143,0,4,response to amino acid,BP,
3132,GO:0043201,1,0.711015020328229,0,1,response to leucine,BP,
3133,GO:0043202,1,0.696039774295367,0,1,lysosomal lumen,CC,
3137,GO:0043209,1,0.249454024653234,0,4,myelin sheath,CC,
3138,GO:0043217,1,0.701493568801233,0,1,myelin maintenance,BP,
3139,GO:0043218,1,0.712690558264192,0,1,compact myelin,CC,
3140,GO:0043220,1,0.712690558264192,0,1,Schmidt-Lanterman incisure,CC,
3151,GO:0043236,1,0.716799129544212,0,1,laminin binding,MF,
3154,GO:0043243,1,0.716240390769176,0,1,positive regulation of protein complex disassembly,BP,
3157,GO:0043255,1,0.348208517327011,0,3,regulation of carbohydrate biosynthetic process,BP,
3158,GO:0043256,1,0.516846448506299,0,2,laminin complex,CC,
3159,GO:0043259,1,0.719528553088115,0,1,laminin-10 complex,CC,
3160,GO:0043260,1,0.719528553088115,0,1,laminin-11 complex,CC,
3161,GO:0043266,1,0.24534841409428,0,4,regulation of potassium ion transport,BP,
3162,GO:0043267,1,0.351838733444207,0,3,negative regulation of potassium ion transport,BP,
3163,GO:0043268,1,0.353286155571505,0,3,positive regulation of potassium ion transport,BP,
3168,GO:0043277,1,0.334083784380792,0,3,apoptotic cell clearance,BP,
3169,GO:0043279,1,0.475882794552244,0,2,response to alkaloid,BP,
3172,GO:0043292,1,0.0380690183782631,0,9,contractile fiber,CC,
3173,GO:0043295,1,0.674234706311468,0,1,glutathione binding,MF,
3175,GO:0043297,1,0.467761980689925,0,2,apical junction assembly,BP,
3179,GO:0043316,1,0.700234742383915,0,1,cytotoxic T cell degranulation,BP,
3180,GO:0043320,1,0.700234742383915,0,1,natural killer cell degranulation,BP,
3181,GO:0043325,1,0.701493568801233,0,1,phosphatidylinositol-3,4-bisphosphate binding,MF,
3182,GO:0043330,1,0.687261217406708,0,1,response to exogenous dsRNA,BP,
3184,GO:0043367,1,0.707980062532778,0,1,CD4-positive, alpha-beta T cell differentiation,BP,
3185,GO:0043368,1,0.707980062532778,0,1,positive T cell selection,BP,
3186,GO:0043369,1,0.707980062532778,0,1,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
3187,GO:0043373,1,0.707980062532778,0,1,CD4-positive, alpha-beta T cell lineage commitment,BP,
3199,GO:0043413,1,0.699009950094505,0,1,macromolecule glycosylation,BP,
3204,GO:0043455,1,0.717706347959987,0,1,regulation of secondary metabolic process,BP,
3206,GO:0043462,1,0.64211725735274,0,1,regulation of ATPase activity,BP,
3213,GO:0043484,1,0.717681530181595,0,1,regulation of RNA splicing,BP,
3228,GO:0043531,1,0.718786554623569,0,1,ADP binding,MF,
3232,GO:0043536,1,0.491414333171089,0,2,positive regulation of blood vessel endothelial cell migration,BP,
3235,GO:0043543,1,0.511250882733883,0,2,protein acylation,BP,
3237,GO:0043548,1,0.512021227817396,0,2,phosphatidylinositol 3-kinase binding,MF,
3239,GO:0043550,1,0.358073981164069,0,3,regulation of lipid kinase activity,BP,
3240,GO:0043551,1,0.358073981164069,0,3,regulation of phosphatidylinositol 3-kinase activity,BP,
3241,GO:0043552,1,0.701758628672581,0,1,positive regulation of phosphatidylinositol 3-kinase activity,BP,
3242,GO:0043555,1,0.711015020328229,0,1,regulation of translation in response to stress,BP,
3243,GO:0043559,1,0.717681530181595,0,1,insulin binding,MF,
3246,GO:0043567,1,0.706521730037359,0,1,regulation of insulin-like growth factor receptor signaling pathway,BP,
3247,GO:0043569,1,0.706521730037359,0,1,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
3248,GO:0043576,1,0.700996267622242,0,1,regulation of respiratory gaseous exchange,BP,
3251,GO:0043585,1,0.701156312252234,0,1,nose morphogenesis,BP,
3257,GO:0043619,1,0.711015020328229,0,1,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3264,GO:0043679,1,0.330696006417979,0,3,axon terminus,CC,
3265,GO:0043687,1,0.714638410513241,0,1,post-translational protein modification,BP,
3266,GO:0043696,1,0.701758628672581,0,1,dedifferentiation,BP,
3267,GO:0043697,1,0.701758628672581,0,1,cell dedifferentiation,BP,
3269,GO:0043901,1,0.635388353995092,0,1,negative regulation of multi-organism process,BP,
3272,GO:0043931,1,0.706521730037359,0,1,ossification involved in bone maturation,BP,
3274,GO:0043954,1,0.503607674500377,0,2,cellular component maintenance,BP,
3275,GO:0043966,1,0.714341024234018,0,1,histone H3 acetylation,BP,
3276,GO:0043974,1,0.714341024234018,0,1,histone H3-K27 acetylation,BP,
3280,GO:0044042,1,0.701493568801233,0,1,glucan metabolic process,BP,
3284,GO:0044062,1,0.340702401592809,0,3,regulation of excretion,BP,
3285,GO:0044065,1,0.700996267622242,0,1,regulation of respiratory system process,BP,
3286,GO:0044070,1,0.225976654345738,0,4,regulation of anion transport,BP,
3289,GO:0044088,1,0.687261217406708,0,1,regulation of vacuole organization,BP,
3291,GO:0044090,1,0.687261217406708,0,1,positive regulation of vacuole organization,BP,
3292,GO:0044091,1,0.715947598747366,0,1,membrane biogenesis,BP,
3311,GO:0044264,1,0.4894816151021,0,2,cellular polysaccharide metabolic process,BP,
3316,GO:0044272,1,0.358711576694647,0,3,sulfur compound biosynthetic process,BP,
3320,GO:0044291,1,0.364135304080783,0,3,cell-cell contact zone,CC,
3324,GO:0044309,1,0.255238268681181,0,4,neuron spine,CC,
3329,GO:0044331,1,0.513025915911194,0,2,cell-cell adhesion mediated by cadherin,BP,
3335,GO:0044364,1,0.68145664044265,0,1,disruption of cells of other organism,BP,
3336,GO:0044381,1,0.51197138028005,0,2,glucose import in response to insulin stimulus,BP,
3340,GO:0044406,1,0.693606308666904,0,1,adhesion of symbiont to host,BP,
3343,GO:0044420,1,0.516846448506299,0,2,extracellular matrix component,CC,
3348,GO:0044427,1,0.346724295469091,0,3,chromosomal part,CC,
3356,GO:0044438,1,0.717048561252595,0,1,microbody part,CC,
3357,GO:0044439,1,0.717048561252595,0,1,peroxisomal part,CC,
3364,GO:0044449,1,0.0380690183782631,0,9,contractile fiber part,CC,
3365,GO:0044450,1,0.482446769420789,0,2,microtubule organizing center part,CC,
3367,GO:0044454,1,0.716995957461558,0,1,nuclear chromosome part,CC,
3372,GO:0044550,1,0.717706347959987,0,1,secondary metabolite biosynthetic process,BP,
3373,GO:0044557,1,0.700996267622242,0,1,relaxation of smooth muscle,BP,
3374,GO:0044650,1,0.693606308666904,0,1,adhesion of symbiont to host cell,BP,
3388,GO:0044729,1,0.70409479607052,0,1,hemi-methylated DNA-binding,MF,
3396,GO:0044770,1,0.0335444153116375,0,9,cell cycle phase transition,BP,
3397,GO:0044772,1,0.0335444153116375,0,9,mitotic cell cycle phase transition,BP,
3398,GO:0044773,1,0.31977331103751,0,3,mitotic DNA damage checkpoint,BP,
3399,GO:0044774,1,0.31977331103751,0,3,mitotic DNA integrity checkpoint,BP,
3401,GO:0044783,1,0.45321036602372,0,2,G1 DNA damage checkpoint,BP,
3403,GO:0044800,1,0.693606308666904,0,1,multi-organism membrane fusion,BP,
3406,GO:0044803,1,0.693606308666904,0,1,multi-organism membrane organization,BP,
3407,GO:0044818,1,0.708249234674247,0,1,mitotic G2/M transition checkpoint,BP,
3408,GO:0044819,1,0.45321036602372,0,2,mitotic G1/S transition checkpoint,BP,
3409,GO:0044839,1,0.346811280986329,0,3,cell cycle G2/M phase transition,BP,
3410,GO:0044843,1,0.0956109611391684,0,6,cell cycle G1/S phase transition,BP,
3411,GO:0044848,1,0.717706347959987,0,1,biological phase,BP,
3412,GO:0044851,1,0.717706347959987,0,1,hair cycle phase,BP,
3414,GO:0044872,1,0.666797965191416,0,1,lipoprotein localization,BP,
3418,GO:0045022,1,0.714643171421448,0,1,early endosome to late endosome transport,BP,
3419,GO:0045023,1,0.487420360920438,0,2,G0 to G1 transition,BP,
3420,GO:0045026,1,0.688709470596719,0,1,plasma membrane fusion,BP,
3421,GO:0045054,1,0.700234742383915,0,1,constitutive secretory pathway,BP,
3423,GO:0045056,1,0.678117095355688,0,1,transcytosis,BP,
3428,GO:0045072,1,0.707980062532778,0,1,regulation of interferon-gamma biosynthetic process,BP,
3429,GO:0045073,1,0.717706347959987,0,1,regulation of chemokine biosynthetic process,BP,
3430,GO:0045078,1,0.707980062532778,0,1,positive regulation of interferon-gamma biosynthetic process,BP,
3431,GO:0045080,1,0.717706347959987,0,1,positive regulation of chemokine biosynthetic process,BP,
3440,GO:0045117,1,0.682927424885784,0,1,azole transport,BP,
3444,GO:0045125,1,0.674401774365491,0,1,bioactive lipid receptor activity,MF,
3445,GO:0045136,1,0.717706347959987,0,1,development of secondary sexual characteristics,BP,
3450,GO:0045168,1,0.708931381661885,0,1,cell-cell signaling involved in cell fate commitment,BP,
3451,GO:0045171,1,0.47663203538524,0,2,intercellular bridge,CC,
3456,GO:0045187,1,0.700996267622242,0,1,regulation of circadian sleep/wake cycle, sleep,BP,
3457,GO:0045188,1,0.700996267622242,0,1,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
3458,GO:0045190,1,0.674610601535826,0,1,isotype switching,BP,
3459,GO:0045191,1,0.674610601535826,0,1,regulation of isotype switching,BP,
3460,GO:0045197,1,0.51208754973022,0,2,establishment or maintenance of epithelial cell apical/basal polarity,BP,
3461,GO:0045198,1,0.51208754973022,0,2,establishment of epithelial cell apical/basal polarity,BP,
3463,GO:0045210,1,0.717771440871286,0,1,FasL biosynthetic process,BP,
3465,GO:0045214,1,0.242221305939065,0,4,sarcomere organization,BP,
3467,GO:0045217,1,0.703744566161763,0,1,cell-cell junction maintenance,BP,
3468,GO:0045218,1,0.703744566161763,0,1,zonula adherens maintenance,BP,
3469,GO:0045294,1,0.500686689260599,0,2,alpha-catenin binding,MF,
3472,GO:0045309,1,0.51197138028005,0,2,protein phosphorylated amino acid binding,MF,
3475,GO:0045334,1,0.494272631073097,0,2,clathrin-coated endocytic vesicle,CC,
3479,GO:0045402,1,0.707980062532778,0,1,regulation of interleukin-4 biosynthetic process,BP,
3480,GO:0045403,1,0.707980062532778,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
3481,GO:0045428,1,0.478173903575527,0,2,regulation of nitric oxide biosynthetic process,BP,
3482,GO:0045429,1,0.478173903575527,0,2,positive regulation of nitric oxide biosynthetic process,BP,
3488,GO:0045494,1,0.714619275856857,0,1,photoreceptor cell maintenance,BP,
3510,GO:0045621,1,0.693606308666904,0,1,positive regulation of lymphocyte differentiation,BP,
3513,GO:0045634,1,0.717270758028134,0,1,regulation of melanocyte differentiation,BP,
3514,GO:0045636,1,0.717270758028134,0,1,positive regulation of melanocyte differentiation,BP,
3517,GO:0045639,1,0.511558302346865,0,2,positive regulation of myeloid cell differentiation,BP,
3518,GO:0045646,1,0.707980062532778,0,1,regulation of erythrocyte differentiation,BP,
3519,GO:0045649,1,0.714341024234018,0,1,regulation of macrophage differentiation,BP,
3520,GO:0045651,1,0.714341024234018,0,1,positive regulation of macrophage differentiation,BP,
3537,GO:0045725,1,0.701493568801233,0,1,positive regulation of glycogen biosynthetic process,BP,
3540,GO:0045736,1,0.685778755049879,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
3541,GO:0045737,1,0.210168461158657,0,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
3542,GO:0045739,1,0.64211725735274,0,1,positive regulation of DNA repair,BP,
3544,GO:0045741,1,0.335185095356051,0,3,positive regulation of epidermal growth factor-activated receptor activity,BP,
3545,GO:0045742,1,0.23385597253755,0,4,positive regulation of epidermal growth factor receptor signaling pathway,BP,
3546,GO:0045744,1,0.71774180231946,0,1,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
3547,GO:0045745,1,0.68145664044265,0,1,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
3551,GO:0045766,1,0.2487160798945,0,4,positive regulation of angiogenesis,BP,
3553,GO:0045777,1,0.700996267622242,0,1,positive regulation of blood pressure,BP,
3559,GO:0045792,1,0.701493568801233,0,1,negative regulation of cell size,BP,
3560,GO:0045793,1,0.682927424885784,0,1,positive regulation of cell size,BP,
3561,GO:0045806,1,0.666797965191416,0,1,negative regulation of endocytosis,BP,
3565,GO:0045823,1,0.318960491279532,0,3,positive regulation of heart contraction,BP,
3566,GO:0045824,1,0.714575687180326,0,1,negative regulation of innate immune response,BP,
3567,GO:0045830,1,0.674610601535826,0,1,positive regulation of isotype switching,BP,
3570,GO:0045835,1,0.714341024234018,0,1,negative regulation of meiotic nuclear division,BP,
3571,GO:0045836,1,0.511815900284808,0,2,positive regulation of meiotic nuclear division,BP,
3580,GO:0045861,1,0.215612299165656,0,4,negative regulation of proteolysis,BP,
3582,GO:0045879,1,0.716148206052754,0,1,negative regulation of smoothened signaling pathway,BP,
3585,GO:0045907,1,0.47534881424579,0,2,positive regulation of vasoconstriction,BP,
3586,GO:0045911,1,0.674610601535826,0,1,positive regulation of DNA recombination,BP,
3591,GO:0045922,1,0.701493568801233,0,1,negative regulation of fatty acid metabolic process,BP,
3597,GO:0045933,1,0.318960491279532,0,3,positive regulation of muscle contraction,BP,
3602,GO:0045939,1,0.350982613013452,0,3,negative regulation of steroid metabolic process,BP,
3608,GO:0045986,1,0.475010338979697,0,2,negative regulation of smooth muscle contraction,BP,
3609,GO:0045987,1,0.682927424885784,0,1,positive regulation of smooth muscle contraction,BP,
3611,GO:0045989,1,0.468904051980933,0,2,positive regulation of striated muscle contraction,BP,
3616,GO:0046039,1,0.716234312327688,0,1,GTP metabolic process,BP,
3617,GO:0046058,1,0.209037574388426,0,4,cAMP metabolic process,BP,
3619,GO:0046128,1,0.716234312327688,0,1,purine ribonucleoside metabolic process,BP,
3620,GO:0046148,1,0.717706347959987,0,1,pigment biosynthetic process,BP,
3624,GO:0046209,1,0.478173903575527,0,2,nitric oxide metabolic process,BP,
3625,GO:0046320,1,0.701493568801233,0,1,regulation of fatty acid oxidation,BP,
3626,GO:0046322,1,0.701493568801233,0,1,negative regulation of fatty acid oxidation,BP,
3627,GO:0046323,1,0.180182725395585,0,5,glucose import,BP,
3628,GO:0046324,1,0.255111726740894,0,4,regulation of glucose import,BP,
3629,GO:0046326,1,0.255111726740894,0,4,positive regulation of glucose import,BP,
3631,GO:0046329,1,0.701493568801233,0,1,negative regulation of JNK cascade,BP,
3633,GO:0046331,1,0.708931381661885,0,1,lateral inhibition,BP,
3635,GO:0046364,1,0.711015020328229,0,1,monosaccharide biosynthetic process,BP,
3638,GO:0046394,1,0.329304592595775,0,3,carboxylic acid biosynthetic process,BP,
3642,GO:0046434,1,0.715703089056377,0,1,organophosphate catabolic process,BP,
3643,GO:0046456,1,0.459513176635729,0,2,icosanoid biosynthetic process,BP,
3644,GO:0046457,1,0.459513176635729,0,2,prostanoid biosynthetic process,BP,
3658,GO:0046541,1,0.64211725735274,0,1,saliva secretion,BP,
3659,GO:0046543,1,0.717706347959987,0,1,development of secondary female sexual characteristics,BP,
3664,GO:0046580,1,0.716799129544212,0,1,negative regulation of Ras protein signal transduction,BP,
3665,GO:0046605,1,0.705299442787258,0,1,regulation of centrosome cycle,BP,
3668,GO:0046626,1,0.717681530181595,0,1,regulation of insulin receptor signaling pathway,BP,
3670,GO:0046631,1,0.707980062532778,0,1,alpha-beta T cell activation,BP,
3671,GO:0046632,1,0.707980062532778,0,1,alpha-beta T cell differentiation,BP,
3679,GO:0046685,1,0.685778755049879,0,1,response to arsenic-containing substance,BP,
3680,GO:0046686,1,0.701493568801233,0,1,response to cadmium ion,BP,
3683,GO:0046717,1,0.477833435261386,0,2,acid secretion,BP,
3684,GO:0046718,1,0.124807673073599,0,6,viral entry into host cell,BP,
3685,GO:0046777,1,0.169106785438038,0,5,protein autophosphorylation,BP,
3686,GO:0046785,1,0.453599059489472,0,2,microtubule polymerization,BP,
3688,GO:0046794,1,0.716841414120058,0,1,transport of virus,BP,
3690,GO:0046813,1,0.693606308666904,0,1,receptor-mediated virion attachment to host cell,BP,
3694,GO:0046825,1,0.693606308666904,0,1,regulation of protein export from nucleus,BP,
3695,GO:0046827,1,0.693606308666904,0,1,positive regulation of protein export from nucleus,BP,
3697,GO:0046835,1,0.494175609213931,0,2,carbohydrate phosphorylation,BP,
3698,GO:0046847,1,0.232624915897263,0,4,filopodium assembly,BP,
3706,GO:0046877,1,0.64211725735274,0,1,regulation of saliva secretion,BP,
3723,GO:0046912,1,0.691115067781905,0,1,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
3728,GO:0046935,1,0.51197138028005,0,2,1-phosphatidylinositol-3-kinase regulator activity,MF,
3730,GO:0046942,1,0.238241572233501,0,4,carboxylic acid transport,BP,
3731,GO:0046949,1,0.514903481278129,0,2,fatty-acyl-CoA biosynthetic process,BP,
3732,GO:0046950,1,0.691115067781905,0,1,cellular ketone body metabolic process,BP,
3733,GO:0046951,1,0.691115067781905,0,1,ketone body biosynthetic process,BP,
3737,GO:0047117,1,0.719216741957039,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
3739,GO:0047451,1,0.719216741957039,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
3740,GO:0047485,1,0.475128291238405,0,2,protein N-terminus binding,MF,
3741,GO:0047676,1,0.717048561252595,0,1,arachidonate-CoA ligase activity,MF,
3742,GO:0048002,1,0.709785182985047,0,1,antigen processing and presentation of peptide antigen,BP,
3743,GO:0048008,1,0.496186159532359,0,2,platelet-derived growth factor receptor signaling pathway,BP,
3744,GO:0048009,1,0.353905586083712,0,3,insulin-like growth factor receptor signaling pathway,BP,
3746,GO:0048011,1,0.708277251030171,0,1,neurotrophin TRK receptor signaling pathway,BP,
3747,GO:0048012,1,0.708277251030171,0,1,hepatocyte growth factor receptor signaling pathway,BP,
3754,GO:0048021,1,0.717706347959987,0,1,regulation of melanin biosynthetic process,BP,
3755,GO:0048022,1,0.717706347959987,0,1,negative regulation of melanin biosynthetic process,BP,
3760,GO:0048070,1,0.717270758028134,0,1,regulation of developmental pigmentation,BP,
3761,GO:0048087,1,0.717270758028134,0,1,positive regulation of developmental pigmentation,BP,
3772,GO:0048179,1,0.703315452741895,0,1,activin receptor complex,CC,
3776,GO:0048237,1,0.682927424885784,0,1,rough endoplasmic reticulum lumen,CC,
3777,GO:0048241,1,0.479899134609722,0,2,epinephrine transport,BP,
3778,GO:0048242,1,0.479899134609722,0,2,epinephrine secretion,BP,
3779,GO:0048243,1,0.479899134609722,0,2,norepinephrine secretion,BP,
3781,GO:0048251,1,0.718545083727339,0,1,elastic fiber assembly,BP,
3785,GO:0048261,1,0.666797965191416,0,1,negative regulation of receptor-mediated endocytosis,BP,
3786,GO:0048262,1,0.703315452741895,0,1,determination of dorsal/ventral asymmetry,BP,
3787,GO:0048263,1,0.703315452741895,0,1,determination of dorsal identity,BP,
3792,GO:0048289,1,0.674610601535826,0,1,isotype switching to IgE isotypes,BP,
3793,GO:0048293,1,0.674610601535826,0,1,regulation of isotype switching to IgE isotypes,BP,
3794,GO:0048295,1,0.674610601535826,0,1,positive regulation of isotype switching to IgE isotypes,BP,
3795,GO:0048306,1,0.698147056906197,0,1,calcium-dependent protein binding,MF,
3801,GO:0048339,1,0.717706347959987,0,1,paraxial mesoderm development,BP,
3802,GO:0048340,1,0.717706347959987,0,1,paraxial mesoderm morphogenesis,BP,
3803,GO:0048341,1,0.717706347959987,0,1,paraxial mesoderm formation,BP,
3809,GO:0048407,1,0.701758628672581,0,1,platelet-derived growth factor binding,MF,
3822,GO:0048512,1,0.700996267622242,0,1,circadian behavior,BP,
3825,GO:0048515,1,0.482533394443604,0,2,spermatid differentiation,BP,
3828,GO:0048520,1,0.701156312252234,0,1,positive regulation of behavior,BP,
3829,GO:0048521,1,0.700996267622242,0,1,negative regulation of behavior,BP,
3833,GO:0048531,1,0.699009950094505,0,1,beta-1,3-galactosyltransferase activity,MF,
3834,GO:0048532,1,0.708931381661885,0,1,anatomical structure arrangement,BP,
3836,GO:0048536,1,0.64211725735274,0,1,spleen development,BP,
3838,GO:0048538,1,0.64211725735274,0,1,thymus development,BP,
3842,GO:0048557,1,0.64211725735274,0,1,embryonic digestive tract morphogenesis,BP,
3844,GO:0048563,1,0.718786554623569,0,1,post-embryonic animal organ morphogenesis,BP,
3846,GO:0048566,1,0.449267832265927,0,2,embryonic digestive tract development,BP,
3848,GO:0048569,1,0.718786554623569,0,1,post-embryonic animal organ development,BP,
3849,GO:0048570,1,0.717706347959987,0,1,notochord morphogenesis,BP,
3879,GO:0048662,1,0.715502935770821,0,1,negative regulation of smooth muscle cell proliferation,BP,
3881,GO:0048665,1,0.708931381661885,0,1,neuron fate specification,BP,
3889,GO:0048678,1,0.712690558264192,0,1,response to axon injury,BP,
3912,GO:0048752,1,0.64211725735274,0,1,semicircular canal morphogenesis,BP,
3919,GO:0048786,1,0.700996267622242,0,1,presynaptic active zone,CC,
3921,GO:0048799,1,0.706521730037359,0,1,animal organ maturation,BP,
3923,GO:0048807,1,0.64211725735274,0,1,female genitalia morphogenesis,BP,
3924,GO:0048808,1,0.64211725735274,0,1,male genitalia morphogenesis,BP,
3927,GO:0048814,1,0.717335044480693,0,1,regulation of dendrite morphogenesis,BP,
3928,GO:0048818,1,0.717706347959987,0,1,positive regulation of hair follicle maturation,BP,
3929,GO:0048819,1,0.717706347959987,0,1,regulation of hair follicle maturation,BP,
3930,GO:0048820,1,0.717706347959987,0,1,hair follicle maturation,BP,
3937,GO:0048850,1,0.717706347959987,0,1,hypophysis morphogenesis,BP,
3938,GO:0048852,1,0.717706347959987,0,1,diencephalon morphogenesis,BP,
3943,GO:0048861,1,0.714341024234018,0,1,leukemia inhibitory factor signaling pathway,BP,
3951,GO:0050000,1,0.6730929422979,0,1,chromosome localization,BP,
3952,GO:0050220,1,0.674234706311468,0,1,prostaglandin-E synthase activity,MF,
3953,GO:0050308,1,0.71598013520354,0,1,sugar-phosphatase activity,MF,
3954,GO:0050321,1,0.716744290017254,0,1,tau-protein kinase activity,MF,
3955,GO:0050431,1,0.703315452741895,0,1,transforming growth factor beta binding,MF,
3958,GO:0050661,1,0.719216741957039,0,1,NADP binding,MF,
3959,GO:0050662,1,0.719216741957039,0,1,coenzyme binding,MF,
3962,GO:0050671,1,0.295110392483164,0,3,positive regulation of lymphocyte proliferation,BP,
3965,GO:0050674,1,0.64211725735274,0,1,urothelial cell proliferation,BP,
3966,GO:0050675,1,0.64211725735274,0,1,regulation of urothelial cell proliferation,BP,
3967,GO:0050677,1,0.64211725735274,0,1,positive regulation of urothelial cell proliferation,BP,
3971,GO:0050701,1,0.496955183044201,0,2,interleukin-1 secretion,BP,
3972,GO:0050702,1,0.717706347959987,0,1,interleukin-1 beta secretion,BP,
3973,GO:0050704,1,0.496955183044201,0,2,regulation of interleukin-1 secretion,BP,
3974,GO:0050706,1,0.717706347959987,0,1,regulation of interleukin-1 beta secretion,BP,
3975,GO:0050707,1,0.496955183044201,0,2,regulation of cytokine secretion,BP,
3978,GO:0050710,1,0.693606308666904,0,1,negative regulation of cytokine secretion,BP,
3979,GO:0050711,1,0.693606308666904,0,1,negative regulation of interleukin-1 secretion,BP,
3981,GO:0050715,1,0.717706347959987,0,1,positive regulation of cytokine secretion,BP,
3982,GO:0050716,1,0.717706347959987,0,1,positive regulation of interleukin-1 secretion,BP,
3983,GO:0050718,1,0.717706347959987,0,1,positive regulation of interleukin-1 beta secretion,BP,
3988,GO:0050728,1,0.500070819547303,0,2,negative regulation of inflammatory response,BP,
3990,GO:0050730,1,0.0105439223504682,0,12,regulation of peptidyl-tyrosine phosphorylation,BP,
3991,GO:0050731,1,0.0105439223504682,0,12,positive regulation of peptidyl-tyrosine phosphorylation,BP,
3992,GO:0050755,1,0.717706347959987,0,1,chemokine metabolic process,BP,
3993,GO:0050764,1,0.327321179247353,0,3,regulation of phagocytosis,BP,
3994,GO:0050766,1,0.327321179247353,0,3,positive regulation of phagocytosis,BP,
4003,GO:0050777,1,0.714575687180326,0,1,negative regulation of immune response,BP,
4010,GO:0050795,1,0.490641306011542,0,2,regulation of behavior,BP,
4013,GO:0050802,1,0.700996267622242,0,1,circadian sleep/wake cycle, sleep,BP,
4016,GO:0050805,1,0.700996267622242,0,1,negative regulation of synaptic transmission,BP,
4022,GO:0050818,1,0.330736052887268,0,3,regulation of coagulation,BP,
4023,GO:0050819,1,0.330736052887268,0,3,negative regulation of coagulation,BP,
4024,GO:0050821,1,0.335456685733984,0,3,protein stabilization,BP,
4025,GO:0050829,1,0.68145664044265,0,1,defense response to Gram-negative bacterium,BP,
4026,GO:0050830,1,0.68145664044265,0,1,defense response to Gram-positive bacterium,BP,
4027,GO:0050832,1,0.68145664044265,0,1,defense response to fungus,BP,
4029,GO:0050840,1,0.716799129544212,0,1,extracellular matrix binding,MF,
4034,GO:0050853,1,0.708277251030171,0,1,B cell receptor signaling pathway,BP,
4036,GO:0050864,1,0.461698733703832,0,2,regulation of B cell activation,BP,
4042,GO:0050871,1,0.461698733703832,0,2,positive regulation of B cell activation,BP,
4043,GO:0050872,1,0.64211725735274,0,1,white fat cell differentiation,BP,
4047,GO:0050880,1,0.031118842750048,0,9,regulation of blood vessel size,BP,
4049,GO:0050885,1,0.512844116292805,0,2,neuromuscular process controlling balance,BP,
4051,GO:0050890,1,0.11585562136797,0,6,cognition,BP,
4052,GO:0050891,1,0.351011649179282,0,3,multicellular organismal water homeostasis,BP,
4056,GO:0050905,1,0.358376616925772,0,3,neuromuscular process,BP,
4057,GO:0050906,1,0.700996267622242,0,1,detection of stimulus involved in sensory perception,BP,
4059,GO:0050919,1,0.717706347959987,0,1,negative chemotaxis,BP,
4067,GO:0050932,1,0.717270758028134,0,1,regulation of pigment cell differentiation,BP,
4068,GO:0050942,1,0.717270758028134,0,1,positive regulation of pigment cell differentiation,BP,
4069,GO:0050951,1,0.700996267622242,0,1,sensory perception of temperature stimulus,BP,
4072,GO:0050957,1,0.512844116292805,0,2,equilibrioception,BP,
4073,GO:0050961,1,0.700996267622242,0,1,detection of temperature stimulus involved in sensory perception,BP,
4074,GO:0050965,1,0.700996267622242,0,1,detection of temperature stimulus involved in sensory perception of pain,BP,
4077,GO:0050996,1,0.711015020328229,0,1,positive regulation of lipid catabolic process,BP,
4078,GO:0050997,1,0.688709470596719,0,1,quaternary ammonium group binding,MF,
4079,GO:0050999,1,0.701493568801233,0,1,regulation of nitric-oxide synthase activity,BP,
4080,GO:0051000,1,0.701493568801233,0,1,positive regulation of nitric-oxide synthase activity,BP,
4081,GO:0051011,1,0.703744566161763,0,1,microtubule minus-end binding,MF,
4083,GO:0051017,1,0.121056867124733,0,6,actin filament bundle assembly,BP,
4084,GO:0051018,1,0.693654765650842,0,1,protein kinase A binding,MF,
4085,GO:0051020,1,0.261607666184714,0,4,GTPase binding,MF,
4086,GO:0051040,1,0.706521730037359,0,1,regulation of calcium-independent cell-cell adhesion,BP,
4087,GO:0051042,1,0.706521730037359,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
4095,GO:0051053,1,0.635388353995092,0,1,negative regulation of DNA metabolic process,BP,
4097,GO:0051055,1,0.24501837311696,0,4,negative regulation of lipid biosynthetic process,BP,
4100,GO:0051058,1,0.716799129544212,0,1,negative regulation of small GTPase mediated signal transduction,BP,
4103,GO:0051092,1,0.717706347959987,0,1,positive regulation of NF-kappaB transcription factor activity,BP,
4110,GO:0051117,1,0.687261217406708,0,1,ATPase binding,MF,
4121,GO:0051151,1,0.496166451681433,0,2,negative regulation of smooth muscle cell differentiation,BP,
4125,GO:0051168,1,0.693606308666904,0,1,nuclear export,BP,
4133,GO:0051180,1,0.492572854921874,0,2,vitamin transport,BP,
4134,GO:0051181,1,0.712608852725647,0,1,cofactor transport,BP,
4135,GO:0051183,1,0.492572854921874,0,2,vitamin transporter activity,MF,
4136,GO:0051184,1,0.712608852725647,0,1,cofactor transporter activity,MF,
4138,GO:0051188,1,0.514903481278129,0,2,cofactor biosynthetic process,BP,
4147,GO:0051208,1,0.698147056906197,0,1,sequestering of calcium ion,BP,
4148,GO:0051209,1,0.698147056906197,0,1,release of sequestered calcium ion into cytosol,BP,
4150,GO:0051219,1,0.51197138028005,0,2,phosphoprotein binding,MF,
4151,GO:0051220,1,0.701493568801233,0,1,cytoplasmic sequestering of protein,BP,
4155,GO:0051233,1,0.666797965191416,0,1,spindle midzone,CC,
4158,GO:0051238,1,0.698147056906197,0,1,sequestering of metal ion,BP,
4175,GO:0051262,1,0.716240390769176,0,1,protein tetramerization,BP,
4179,GO:0051276,1,0.16389997929808,0,5,chromosome organization,BP,
4180,GO:0051279,1,0.698147056906197,0,1,regulation of release of sequestered calcium ion into cytosol,BP,
4181,GO:0051280,1,0.698147056906197,0,1,negative regulation of release of sequestered calcium ion into cytosol,BP,
4182,GO:0051282,1,0.698147056906197,0,1,regulation of sequestering of calcium ion,BP,
4183,GO:0051283,1,0.698147056906197,0,1,negative regulation of sequestering of calcium ion,BP,
4184,GO:0051284,1,0.698147056906197,0,1,positive regulation of sequestering of calcium ion,BP,
4185,GO:0051289,1,0.716240390769176,0,1,protein homotetramerization,BP,
4187,GO:0051293,1,0.64211725735274,0,1,establishment of spindle localization,BP,
4188,GO:0051294,1,0.64211725735274,0,1,establishment of spindle orientation,BP,
4189,GO:0051297,1,0.466171970504979,0,2,centrosome organization,BP,
4190,GO:0051298,1,0.705299442787258,0,1,centrosome duplication,BP,
4193,GO:0051303,1,0.6730929422979,0,1,establishment of chromosome localization,BP,
4194,GO:0051310,1,0.6730929422979,0,1,metaphase plate congression,BP,
4195,GO:0051321,1,0.111088273477603,0,6,meiotic cell cycle,BP,
4204,GO:0051373,1,0.716240390769176,0,1,FATZ binding,MF,
4205,GO:0051379,1,0.479899134609722,0,2,epinephrine binding,MF,
4207,GO:0051385,1,0.321001144770311,0,3,response to mineralocorticoid,BP,
4210,GO:0051412,1,0.685778755049879,0,1,response to corticosterone,BP,
4212,GO:0051428,1,0.635388353995092,0,1,peptide hormone receptor binding,MF,
4215,GO:0051445,1,0.163649878219246,0,5,regulation of meiotic cell cycle,BP,
4216,GO:0051446,1,0.511815900284808,0,2,positive regulation of meiotic cell cycle,BP,
4217,GO:0051447,1,0.323180061401063,0,3,negative regulation of meiotic cell cycle,BP,
4221,GO:0051482,1,0.682927424885784,0,1,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
4222,GO:0051489,1,0.343756608564196,0,3,regulation of filopodium assembly,BP,
4223,GO:0051491,1,0.50878781933507,0,2,positive regulation of filopodium assembly,BP,
4224,GO:0051492,1,0.243439331490617,0,4,regulation of stress fiber assembly,BP,
4228,GO:0051496,1,0.340928970103559,0,3,positive regulation of stress fiber assembly,BP,
4229,GO:0051531,1,0.717681530181595,0,1,NFAT protein import into nucleus,BP,
4230,GO:0051541,1,0.689876795946402,0,1,elastin metabolic process,BP,
4231,GO:0051542,1,0.689876795946402,0,1,elastin biosynthetic process,BP,
4232,GO:0051543,1,0.689876795946402,0,1,regulation of elastin biosynthetic process,BP,
4233,GO:0051545,1,0.689876795946402,0,1,negative regulation of elastin biosynthetic process,BP,
4234,GO:0051546,1,0.442004983612573,0,2,keratinocyte migration,BP,
4235,GO:0051547,1,0.442004983612573,0,2,regulation of keratinocyte migration,BP,
4236,GO:0051549,1,0.442004983612573,0,2,positive regulation of keratinocyte migration,BP,
4242,GO:0051592,1,0.228139796398631,0,4,response to calcium ion,BP,
4243,GO:0051601,1,0.687261217406708,0,1,exocyst localization,BP,
4247,GO:0051606,1,0.231355251836959,0,4,detection of stimulus,BP,
4249,GO:0051608,1,0.682927424885784,0,1,histamine transport,BP,
4250,GO:0051639,1,0.716782934115651,0,1,actin filament network formation,BP,
4257,GO:0051653,1,0.64211725735274,0,1,spindle localization,BP,
4259,GO:0051668,1,0.715947598747366,0,1,localization within membrane,BP,
4262,GO:0051695,1,0.716240390769176,0,1,actin filament uncapping,BP,
4267,GO:0051721,1,0.701493568801233,0,1,protein phosphatase 2A binding,MF,
4272,GO:0051771,1,0.682927424885784,0,1,negative regulation of nitric-oxide synthase biosynthetic process,BP,
4277,GO:0051797,1,0.717706347959987,0,1,regulation of hair follicle development,BP,
4278,GO:0051798,1,0.717706347959987,0,1,positive regulation of hair follicle development,BP,
4281,GO:0051875,1,0.339476782896118,0,3,pigment granule localization,BP,
4283,GO:0051884,1,0.717706347959987,0,1,regulation of timing of anagen,BP,
4284,GO:0051885,1,0.717706347959987,0,1,positive regulation of timing of anagen,BP,
4285,GO:0051893,1,0.496304663504859,0,2,regulation of focal adhesion assembly,BP,
4286,GO:0051894,1,0.496304663504859,0,2,positive regulation of focal adhesion assembly,BP,
4289,GO:0051899,1,0.482091502872415,0,2,membrane depolarization,BP,
4290,GO:0051904,1,0.339476782896118,0,3,pigment granule transport,BP,
4291,GO:0051905,1,0.339476782896118,0,3,establishment of pigment granule localization,BP,
4293,GO:0051926,1,0.698147056906197,0,1,negative regulation of calcium ion transport,BP,
4294,GO:0051928,1,0.701758628672581,0,1,positive regulation of calcium ion transport,BP,
4295,GO:0051930,1,0.32313251483644,0,3,regulation of sensory perception of pain,BP,
4296,GO:0051931,1,0.32313251483644,0,3,regulation of sensory perception,BP,
4297,GO:0051932,1,0.700996267622242,0,1,synaptic transmission, GABAergic,BP,
4302,GO:0051953,1,0.227092648184919,0,4,negative regulation of amine transport,BP,
4304,GO:0051955,1,0.700996267622242,0,1,regulation of amino acid transport,BP,
4305,GO:0051956,1,0.700996267622242,0,1,negative regulation of amino acid transport,BP,
4310,GO:0051964,1,0.717706347959987,0,1,negative regulation of synapse assembly,BP,
4312,GO:0051966,1,0.700996267622242,0,1,regulation of synaptic transmission, glutamatergic,BP,
4313,GO:0051967,1,0.700996267622242,0,1,negative regulation of synaptic transmission, glutamatergic,BP,
4321,GO:0055003,1,0.716782934115651,0,1,cardiac myofibril assembly,BP,
4341,GO:0055070,1,0.714638410513241,0,1,copper ion homeostasis,BP,
4344,GO:0055075,1,0.707215656113447,0,1,potassium ion homeostasis,BP,
4346,GO:0055078,1,0.340702401592809,0,3,sodium ion homeostasis,BP,
4351,GO:0055088,1,0.711015020328229,0,1,lipid homeostasis,BP,
4352,GO:0055090,1,0.711015020328229,0,1,acylglycerol homeostasis,BP,
4353,GO:0055093,1,0.685778755049879,0,1,response to hyperoxia,BP,
4357,GO:0055119,1,0.486847729465658,0,2,relaxation of cardiac muscle,BP,
4359,GO:0055131,1,0.707215656113447,0,1,C3HC4-type RING finger domain binding,MF,
4360,GO:0060019,1,0.458792765507208,0,2,radial glial cell differentiation,BP,
4362,GO:0060024,1,0.682927424885784,0,1,rhythmic synaptic transmission,BP,
4363,GO:0060026,1,0.717706347959987,0,1,convergent extension,BP,
4364,GO:0060027,1,0.717706347959987,0,1,convergent extension involved in gastrulation,BP,
4365,GO:0060028,1,0.717706347959987,0,1,convergent extension involved in axis elongation,BP,
4366,GO:0060029,1,0.717706347959987,0,1,convergent extension involved in organogenesis,BP,
4367,GO:0060031,1,0.717706347959987,0,1,mediolateral intercalation,BP,
4371,GO:0060041,1,0.479482991249966,0,2,retina development in camera-type eye,BP,
4372,GO:0060042,1,0.708931381661885,0,1,retina morphogenesis in camera-type eye,BP,
4385,GO:0060067,1,0.717706347959987,0,1,cervix development,BP,
4386,GO:0060068,1,0.512039003757008,0,2,vagina development,BP,
4390,GO:0060076,1,0.512199201521733,0,2,excitatory synapse,CC,
4393,GO:0060087,1,0.700996267622242,0,1,relaxation of vascular smooth muscle,BP,
4394,GO:0060088,1,0.718786554623569,0,1,auditory receptor cell stereocilium organization,BP,
4396,GO:0060090,1,0.496937926004226,0,2,binding, bridging,MF,
4398,GO:0060117,1,0.718786554623569,0,1,auditory receptor cell development,BP,
4399,GO:0060119,1,0.35574089818349,0,3,inner ear receptor cell development,BP,
4401,GO:0060122,1,0.35574089818349,0,3,inner ear receptor stereocilium organization,BP,
4402,GO:0060126,1,0.714265548502507,0,1,somatotropin secreting cell differentiation,BP,
4406,GO:0060136,1,0.717048561252595,0,1,embryonic process involved in female pregnancy,BP,
4407,GO:0060137,1,0.682927424885784,0,1,maternal process involved in parturition,BP,
4411,GO:0060157,1,0.717706347959987,0,1,urinary bladder development,BP,
4415,GO:0060178,1,0.687261217406708,0,1,regulation of exocyst localization,BP,
4416,GO:0060191,1,0.674401774365491,0,1,regulation of lipase activity,BP,
4417,GO:0060193,1,0.674401774365491,0,1,positive regulation of lipase activity,BP,
4420,GO:0060215,1,0.707980062532778,0,1,primitive hemopoiesis,BP,
4421,GO:0060216,1,0.707980062532778,0,1,definitive hemopoiesis,BP,
4424,GO:0060236,1,0.6730929422979,0,1,regulation of mitotic spindle organization,BP,
4433,GO:0060281,1,0.635388353995092,0,1,regulation of oocyte development,BP,
4434,GO:0060283,1,0.635388353995092,0,1,negative regulation of oocyte development,BP,
4436,GO:0060292,1,0.700996267622242,0,1,long term synaptic depression,BP,
4437,GO:0060297,1,0.682927424885784,0,1,regulation of sarcomere organization,BP,
4438,GO:0060298,1,0.682927424885784,0,1,positive regulation of sarcomere organization,BP,
4439,GO:0060306,1,0.492879334023554,0,2,regulation of membrane repolarization,BP,
4440,GO:0060307,1,0.707215656113447,0,1,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
4441,GO:0060314,1,0.698147056906197,0,1,regulation of ryanodine-sensitive calcium-release channel activity,BP,
4442,GO:0060315,1,0.698147056906197,0,1,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
4444,GO:0060318,1,0.707980062532778,0,1,definitive erythrocyte differentiation,BP,
4445,GO:0060319,1,0.707980062532778,0,1,primitive erythrocyte differentiation,BP,
4448,GO:0060324,1,0.242698131076416,0,4,face development,BP,
4449,GO:0060325,1,0.339883162732915,0,3,face morphogenesis,BP,
4451,GO:0060337,1,0.717706347959987,0,1,type I interferon signaling pathway,BP,
4452,GO:0060338,1,0.717706347959987,0,1,regulation of type I interferon-mediated signaling pathway,BP,
4453,GO:0060340,1,0.717706347959987,0,1,positive regulation of type I interferon-mediated signaling pathway,BP,
4460,GO:0060351,1,0.635388353995092,0,1,cartilage development involved in endochondral bone morphogenesis,BP,
4462,GO:0060374,1,0.707980062532778,0,1,mast cell differentiation,BP,
4463,GO:0060375,1,0.707980062532778,0,1,regulation of mast cell differentiation,BP,
4464,GO:0060377,1,0.707980062532778,0,1,negative regulation of mast cell differentiation,BP,
4471,GO:0060396,1,0.717681530181595,0,1,growth hormone receptor signaling pathway,BP,
4472,GO:0060401,1,0.480438410283716,0,2,cytosolic calcium ion transport,BP,
4473,GO:0060402,1,0.698147056906197,0,1,calcium ion transport into cytosol,BP,
4476,GO:0060413,1,0.49708186108656,0,2,atrial septum morphogenesis,BP,
4478,GO:0060416,1,0.502611037977391,0,2,response to growth hormone,BP,
4485,GO:0060426,1,0.500020505866797,0,2,lung vasculature development,BP,
4488,GO:0060430,1,0.449267832265927,0,2,lung saccule development,BP,
4490,GO:0060432,1,0.64211725735274,0,1,lung pattern specification process,BP,
4492,GO:0060435,1,0.64211725735274,0,1,bronchiole development,BP,
4493,GO:0060436,1,0.64211725735274,0,1,bronchiole morphogenesis,BP,
4494,GO:0060437,1,0.64211725735274,0,1,lung growth,BP,
4503,GO:0060447,1,0.64211725735274,0,1,bud outgrowth involved in lung branching,BP,
4505,GO:0060452,1,0.468904051980933,0,2,positive regulation of cardiac muscle contraction,BP,
4507,GO:0060462,1,0.714341024234018,0,1,lung lobe development,BP,
4508,GO:0060463,1,0.714341024234018,0,1,lung lobe morphogenesis,BP,
4509,GO:0060479,1,0.64211725735274,0,1,lung cell differentiation,BP,
4512,GO:0060487,1,0.64211725735274,0,1,lung epithelial cell differentiation,BP,
4515,GO:0060495,1,0.64211725735274,0,1,cell-cell signaling involved in lung development,BP,
4516,GO:0060496,1,0.64211725735274,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
4520,GO:0060510,1,0.64211725735274,0,1,Type II pneumocyte differentiation,BP,
4530,GO:0060539,1,0.492819004417685,0,2,diaphragm development,BP,
4541,GO:0060574,1,0.685778755049879,0,1,intestinal epithelial cell maturation,BP,
4542,GO:0060575,1,0.685778755049879,0,1,intestinal epithelial cell differentiation,BP,
4543,GO:0060576,1,0.685778755049879,0,1,intestinal epithelial cell development,BP,
4544,GO:0060584,1,0.682927424885784,0,1,regulation of prostaglandin-endoperoxide synthase activity,BP,
4545,GO:0060585,1,0.682927424885784,0,1,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
4549,GO:0060594,1,0.64211725735274,0,1,mammary gland specification,BP,
4550,GO:0060595,1,0.64211725735274,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
4551,GO:0060599,1,0.717706347959987,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
4557,GO:0060615,1,0.64211725735274,0,1,mammary gland bud formation,BP,
4559,GO:0060638,1,0.314638858029122,0,3,mesenchymal-epithelial cell signaling,BP,
4560,GO:0060644,1,0.701493568801233,0,1,mammary gland epithelial cell differentiation,BP,
4561,GO:0060648,1,0.64211725735274,0,1,mammary gland bud morphogenesis,BP,
4562,GO:0060661,1,0.64211725735274,0,1,submandibular salivary gland formation,BP,
4563,GO:0060664,1,0.64211725735274,0,1,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
4564,GO:0060665,1,0.64211725735274,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
4565,GO:0060667,1,0.64211725735274,0,1,branch elongation involved in salivary gland morphogenesis,BP,
4577,GO:0060693,1,0.64211725735274,0,1,regulation of branching involved in salivary gland morphogenesis,BP,
4578,GO:0060706,1,0.500261967913872,0,2,cell differentiation involved in embryonic placenta development,BP,
4579,GO:0060707,1,0.714341024234018,0,1,trophoblast giant cell differentiation,BP,
4580,GO:0060708,1,0.714341024234018,0,1,spongiotrophoblast differentiation,BP,
4581,GO:0060709,1,0.701493568801233,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
4584,GO:0060712,1,0.500261967913872,0,2,spongiotrophoblast layer development,BP,
4589,GO:0060744,1,0.717706347959987,0,1,mammary gland branching involved in thelarche,BP,
4591,GO:0060748,1,0.714265548502507,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
4592,GO:0060749,1,0.713876788943018,0,1,mammary gland alveolus development,BP,
4593,GO:0060750,1,0.717706347959987,0,1,epithelial cell proliferation involved in mammary gland duct elongation,BP,
4594,GO:0060751,1,0.717706347959987,0,1,branch elongation involved in mammary gland duct branching,BP,
4595,GO:0060759,1,0.338127886737618,0,3,regulation of response to cytokine stimulus,BP,
4596,GO:0060760,1,0.338127886737618,0,3,positive regulation of response to cytokine stimulus,BP,
4597,GO:0060761,1,0.693606308666904,0,1,negative regulation of response to cytokine stimulus,BP,
4598,GO:0060762,1,0.717706347959987,0,1,regulation of branching involved in mammary gland duct morphogenesis,BP,
4601,GO:0060775,1,0.717706347959987,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
4604,GO:0060804,1,0.706521730037359,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
4605,GO:0060809,1,0.717706347959987,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
4608,GO:0060831,1,0.716148206052754,0,1,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
4610,GO:0060839,1,0.497752535466941,0,2,endothelial cell fate commitment,BP,
4615,GO:0060844,1,0.708931381661885,0,1,arterial endothelial cell fate commitment,BP,
4616,GO:0060846,1,0.708931381661885,0,1,blood vessel endothelial cell fate commitment,BP,
4617,GO:0060847,1,0.708931381661885,0,1,endothelial cell fate specification,BP,
4618,GO:0060853,1,0.708931381661885,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
4620,GO:0060872,1,0.64211725735274,0,1,semicircular canal development,BP,
4621,GO:0060876,1,0.64211725735274,0,1,semicircular canal formation,BP,
4622,GO:0060879,1,0.64211725735274,0,1,semicircular canal fusion,BP,
4625,GO:0060900,1,0.502385896441876,0,2,embryonic camera-type eye formation,BP,
4626,GO:0060907,1,0.717706347959987,0,1,positive regulation of macrophage cytokine production,BP,
4627,GO:0060911,1,0.494342809198564,0,2,cardiac cell fate commitment,BP,
4629,GO:0060915,1,0.64211725735274,0,1,mesenchymal cell differentiation involved in lung development,BP,
4630,GO:0060923,1,0.494342809198564,0,2,cardiac muscle cell fate commitment,BP,
4634,GO:0060957,1,0.703315452741895,0,1,endocardial cell fate commitment,BP,
4653,GO:0061014,1,0.713405224543974,0,1,positive regulation of mRNA catabolic process,BP,
4658,GO:0061029,1,0.701156312252234,0,1,eyelid development in camera-type eye,BP,
4659,GO:0061032,1,0.70409479607052,0,1,visceral serous pericardium development,BP,
4660,GO:0061033,1,0.64211725735274,0,1,secretion by lung epithelial cell involved in lung growth,BP,
4666,GO:0061045,1,0.234994501674974,0,4,negative regulation of wound healing,BP,
4669,GO:0061049,1,0.682927424885784,0,1,cell growth involved in cardiac muscle cell development,BP,
4670,GO:0061050,1,0.682927424885784,0,1,regulation of cell growth involved in cardiac muscle cell development,BP,
4671,GO:0061051,1,0.682927424885784,0,1,positive regulation of cell growth involved in cardiac muscle cell development,BP,
4673,GO:0061054,1,0.714265548502507,0,1,dermatome development,BP,
4676,GO:0061081,1,0.717706347959987,0,1,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
4677,GO:0061082,1,0.337393729074605,0,3,myeloid leukocyte cytokine production,BP,
4678,GO:0061097,1,0.106305773222993,0,6,regulation of protein tyrosine kinase activity,BP,
4679,GO:0061098,1,0.106305773222993,0,6,positive regulation of protein tyrosine kinase activity,BP,
4681,GO:0061107,1,0.688709470596719,0,1,seminal vesicle development,BP,
4682,GO:0061110,1,0.68145664044265,0,1,dense core granule biogenesis,BP,
4683,GO:0061115,1,0.64211725735274,0,1,lung proximal/distal axis specification,BP,
4684,GO:0061134,1,0.309140551791647,0,3,peptidase regulator activity,MF,
4685,GO:0061135,1,0.309140551791647,0,3,endopeptidase regulator activity,MF,
4688,GO:0061140,1,0.64211725735274,0,1,lung secretory cell differentiation,BP,
4689,GO:0061143,1,0.701156312252234,0,1,alveolar primary septum development,BP,
4697,GO:0061162,1,0.51208754973022,0,2,establishment of monopolar cell polarity,BP,
4699,GO:0061183,1,0.714265548502507,0,1,regulation of dermatome development,BP,
4700,GO:0061184,1,0.714265548502507,0,1,positive regulation of dermatome development,BP,
4701,GO:0061205,1,0.49996745663826,0,2,paramesonephric duct development,BP,
4708,GO:0061245,1,0.51208754973022,0,2,establishment or maintenance of bipolar cell polarity,BP,
4709,GO:0061298,1,0.677602562922532,0,1,retina vasculature development in camera-type eye,BP,
4710,GO:0061299,1,0.677602562922532,0,1,retina vasculature morphogenesis in camera-type eye,BP,
4711,GO:0061302,1,0.49456874906209,0,2,smooth muscle cell-matrix adhesion,BP,
4712,GO:0061303,1,0.460534179240348,0,2,cornea development in camera-type eye,BP,
4722,GO:0061339,1,0.51208754973022,0,2,establishment or maintenance of monopolar cell polarity,BP,
4723,GO:0061341,1,0.717706347959987,0,1,non-canonical Wnt signaling pathway involved in heart development,BP,
4724,GO:0061343,1,0.703315452741895,0,1,cell adhesion involved in heart morphogenesis,BP,
4725,GO:0061346,1,0.717706347959987,0,1,planar cell polarity pathway involved in heart morphogenesis,BP,
4726,GO:0061347,1,0.717706347959987,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
4727,GO:0061348,1,0.717706347959987,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
4728,GO:0061349,1,0.717706347959987,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
4729,GO:0061350,1,0.717706347959987,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
4731,GO:0061354,1,0.717706347959987,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
4732,GO:0061369,1,0.714265548502507,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
4733,GO:0061370,1,0.714265548502507,0,1,testosterone biosynthetic process,BP,
4735,GO:0061377,1,0.713876788943018,0,1,mammary gland lobule development,BP,
4741,GO:0061436,1,0.71022670342733,0,1,establishment of skin barrier,BP,
4746,GO:0061443,1,0.703315452741895,0,1,endocardial cushion cell differentiation,BP,
4747,GO:0061445,1,0.703315452741895,0,1,endocardial cushion cell fate commitment,BP,
4750,GO:0061462,1,0.717039000317044,0,1,protein localization to lysosome,BP,
4752,GO:0061525,1,0.717706347959987,0,1,hindgut development,BP,
4754,GO:0061572,1,0.121056867124733,0,6,actin filament bundle organization,BP,
4755,GO:0061614,1,0.494951260402055,0,2,pri-miRNA transcription from RNA polymerase II promoter,BP,
4756,GO:0061615,1,0.71598013520354,0,1,glycolytic process through fructose-6-phosphate,BP,
4757,GO:0061620,1,0.71598013520354,0,1,glycolytic process through glucose-6-phosphate,BP,
4758,GO:0061621,1,0.71598013520354,0,1,canonical glycolysis,BP,
4759,GO:0061624,1,0.691405431878985,0,1,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
4762,GO:0061640,1,0.717075982523979,0,1,cytoskeleton-dependent cytokinesis,BP,
4763,GO:0061642,1,0.717706347959987,0,1,chemoattraction of axon,BP,
4764,GO:0061643,1,0.717706347959987,0,1,chemorepulsion of axon,BP,
4767,GO:0061700,1,0.711015020328229,0,1,GATOR2 complex,CC,
4768,GO:0061718,1,0.71598013520354,0,1,glucose catabolic process to pyruvate,BP,
4769,GO:0061724,1,0.711015020328229,0,1,lipophagy,BP,
4770,GO:0061772,1,0.71022670342733,0,1,drug transport across blood-nerve barrier,BP,
4778,GO:0070050,1,0.714575687180326,0,1,neuron cellular homeostasis,BP,
4779,GO:0070053,1,0.696039774295367,0,1,thrombospondin receptor activity,MF,
4782,GO:0070075,1,0.64211725735274,0,1,tear secretion,BP,
4783,GO:0070080,1,0.716240390769176,0,1,titin Z domain binding,MF,
4784,GO:0070085,1,0.699009950094505,0,1,glycosylation,BP,
4786,GO:0070099,1,0.682927424885784,0,1,regulation of chemokine-mediated signaling pathway,BP,
4787,GO:0070101,1,0.682927424885784,0,1,positive regulation of chemokine-mediated signaling pathway,BP,
4788,GO:0070141,1,0.701493568801233,0,1,response to UV-A,BP,
4791,GO:0070162,1,0.718519076014421,0,1,adiponectin secretion,BP,
4792,GO:0070163,1,0.718519076014421,0,1,regulation of adiponectin secretion,BP,
4793,GO:0070164,1,0.718519076014421,0,1,negative regulation of adiponectin secretion,BP,
4795,GO:0070168,1,0.693606308666904,0,1,negative regulation of biomineral tissue development,BP,
4797,GO:0070170,1,0.67186743586322,0,1,regulation of tooth mineralization,BP,
4798,GO:0070172,1,0.67186743586322,0,1,positive regulation of tooth mineralization,BP,
4803,GO:0070230,1,0.717706347959987,0,1,positive regulation of lymphocyte apoptotic process,BP,
4807,GO:0070234,1,0.717706347959987,0,1,positive regulation of T cell apoptotic process,BP,
4811,GO:0070245,1,0.717706347959987,0,1,positive regulation of thymocyte apoptotic process,BP,
4813,GO:0070254,1,0.700996267622242,0,1,mucus secretion,BP,
4814,GO:0070255,1,0.700996267622242,0,1,regulation of mucus secretion,BP,
4815,GO:0070256,1,0.700996267622242,0,1,negative regulation of mucus secretion,BP,
4818,GO:0070278,1,0.689437791994975,0,1,extracellular matrix constituent secretion,BP,
4822,GO:0070296,1,0.698147056906197,0,1,sarcoplasmic reticulum calcium ion transport,BP,
4823,GO:0070301,1,0.689979727735358,0,1,cellular response to hydrogen peroxide,BP,
4825,GO:0070303,1,0.701493568801233,0,1,negative regulation of stress-activated protein kinase signaling cascade,BP,
4829,GO:0070316,1,0.487420360920438,0,2,regulation of G0 to G1 transition,BP,
4830,GO:0070317,1,0.708249234674247,0,1,negative regulation of G0 to G1 transition,BP,
4831,GO:0070318,1,0.689437791994975,0,1,positive regulation of G0 to G1 transition,BP,
4832,GO:0070328,1,0.711015020328229,0,1,triglyceride homeostasis,BP,
4833,GO:0070341,1,0.64211725735274,0,1,fat cell proliferation,BP,
4834,GO:0070343,1,0.64211725735274,0,1,white fat cell proliferation,BP,
4835,GO:0070344,1,0.64211725735274,0,1,regulation of fat cell proliferation,BP,
4836,GO:0070346,1,0.64211725735274,0,1,positive regulation of fat cell proliferation,BP,
4837,GO:0070350,1,0.64211725735274,0,1,regulation of white fat cell proliferation,BP,
4838,GO:0070352,1,0.64211725735274,0,1,positive regulation of white fat cell proliferation,BP,
4841,GO:0070373,1,0.714341024234018,0,1,negative regulation of ERK1 and ERK2 cascade,BP,
4844,GO:0070384,1,0.64211725735274,0,1,Harderian gland development,BP,
4846,GO:0070402,1,0.719216741957039,0,1,NADPH binding,MF,
4847,GO:0070405,1,0.688709470596719,0,1,ammonium ion binding,MF,
4849,GO:0070444,1,0.715947598747366,0,1,oligodendrocyte progenitor proliferation,BP,
4850,GO:0070445,1,0.715947598747366,0,1,regulation of oligodendrocyte progenitor proliferation,BP,
4851,GO:0070471,1,0.678909168116302,0,1,uterine smooth muscle contraction,BP,
4852,GO:0070472,1,0.678909168116302,0,1,regulation of uterine smooth muscle contraction,BP,
4853,GO:0070473,1,0.678909168116302,0,1,negative regulation of uterine smooth muscle contraction,BP,
4857,GO:0070507,1,0.33223591951352,0,3,regulation of microtubule cytoskeleton organization,BP,
4858,GO:0070509,1,0.489060375103061,0,2,calcium ion import,BP,
4860,GO:0070528,1,0.502819152112243,0,2,protein kinase C signaling,BP,
4861,GO:0070542,1,0.232007152779002,0,4,response to fatty acid,BP,
4863,GO:0070557,1,0.685778755049879,0,1,PCNA-p21 complex,CC,
4867,GO:0070613,1,0.716148206052754,0,1,regulation of protein processing,BP,
4869,GO:0070633,1,0.682927424885784,0,1,transepithelial transport,BP,
4874,GO:0070662,1,0.717270758028134,0,1,mast cell proliferation,BP,
4877,GO:0070665,1,0.210480430428585,0,4,positive regulation of leukocyte proliferation,BP,
4878,GO:0070666,1,0.717270758028134,0,1,regulation of mast cell proliferation,BP,
4879,GO:0070668,1,0.717270758028134,0,1,positive regulation of mast cell proliferation,BP,
4880,GO:0070670,1,0.719216741957039,0,1,response to interleukin-4,BP,
4881,GO:0070672,1,0.717048561252595,0,1,response to interleukin-15,BP,
4882,GO:0070673,1,0.347819256357154,0,3,response to interleukin-18,BP,
4885,GO:0070724,1,0.706521730037359,0,1,BMP receptor complex,CC,
4887,GO:0070728,1,0.711015020328229,0,1,leucine binding,MF,
4888,GO:0070742,1,0.70409479607052,0,1,C2H2 zinc finger domain binding,MF,
4890,GO:0070821,1,0.484062395444412,0,2,tertiary granule membrane,CC,
4891,GO:0070822,1,0.716995957461558,0,1,Sin3-type complex,CC,
4892,GO:0070830,1,0.467761980689925,0,2,bicellular tight junction assembly,BP,
4895,GO:0070849,1,0.701493568801233,0,1,response to epidermal growth factor,BP,
4898,GO:0070873,1,0.701493568801233,0,1,regulation of glycogen metabolic process,BP,
4899,GO:0070875,1,0.701493568801233,0,1,positive regulation of glycogen metabolic process,BP,
4903,GO:0070915,1,0.674401774365491,0,1,lysophosphatidic acid receptor activity,MF,
4907,GO:0070977,1,0.706521730037359,0,1,bone maturation,BP,
4910,GO:0071062,1,0.715704383250707,0,1,alphav-beta3 integrin-vitronectin complex,CC,
4911,GO:0071071,1,0.701758628672581,0,1,regulation of phospholipid biosynthetic process,BP,
4912,GO:0071072,1,0.701758628672581,0,1,negative regulation of phospholipid biosynthetic process,BP,
4913,GO:0071156,1,0.138296555358236,0,5,regulation of cell cycle arrest,BP,
4914,GO:0071157,1,0.438067321004049,0,2,negative regulation of cell cycle arrest,BP,
4915,GO:0071158,1,0.31977331103751,0,3,positive regulation of cell cycle arrest,BP,
4922,GO:0071230,1,0.50900197752392,0,2,cellular response to amino acid stimulus,BP,
4923,GO:0071233,1,0.711015020328229,0,1,cellular response to leucine,BP,
4927,GO:0071276,1,0.701493568801233,0,1,cellular response to cadmium ion,BP,
4928,GO:0071277,1,0.489274260026454,0,2,cellular response to calcium ion,BP,
4930,GO:0071284,1,0.71022670342733,0,1,cellular response to lead ion,BP,
4935,GO:0071307,1,0.693606308666904,0,1,cellular response to vitamin K,BP,
4937,GO:0071312,1,0.698147056906197,0,1,cellular response to alkaloid,BP,
4938,GO:0071313,1,0.698147056906197,0,1,cellular response to caffeine,BP,
4944,GO:0071335,1,0.64211725735274,0,1,hair follicle cell proliferation,BP,
4945,GO:0071336,1,0.64211725735274,0,1,regulation of hair follicle cell proliferation,BP,
4946,GO:0071338,1,0.64211725735274,0,1,positive regulation of hair follicle cell proliferation,BP,
4950,GO:0071351,1,0.491414333171089,0,2,cellular response to interleukin-18,BP,
4951,GO:0071353,1,0.719216741957039,0,1,cellular response to interleukin-4,BP,
4953,GO:0071357,1,0.717706347959987,0,1,cellular response to type I interferon,BP,
4955,GO:0071360,1,0.687261217406708,0,1,cellular response to exogenous dsRNA,BP,
4957,GO:0071364,1,0.701493568801233,0,1,cellular response to epidermal growth factor stimulus,BP,
4962,GO:0071378,1,0.717681530181595,0,1,cellular response to growth hormone stimulus,BP,
4963,GO:0071379,1,0.701493568801233,0,1,cellular response to prostaglandin stimulus,BP,
4964,GO:0071380,1,0.701493568801233,0,1,cellular response to prostaglandin E stimulus,BP,
4968,GO:0071389,1,0.682927424885784,0,1,cellular response to mineralocorticoid stimulus,BP,
4969,GO:0071394,1,0.714643171421448,0,1,cellular response to testosterone stimulus,BP,
4971,GO:0071398,1,0.338410552647447,0,3,cellular response to fatty acid,BP,
4973,GO:0071415,1,0.698147056906197,0,1,cellular response to purine-containing compound,BP,
4975,GO:0071425,1,0.351786141148821,0,3,hematopoietic stem cell proliferation,BP,
4976,GO:0071435,1,0.707215656113447,0,1,potassium ion export,BP,
4977,GO:0071437,1,0.716799129544212,0,1,invadopodium,CC,
4978,GO:0071438,1,0.716799129544212,0,1,invadopodium membrane,CC,
4986,GO:0071482,1,0.351009363868902,0,3,cellular response to light stimulus,BP,
4987,GO:0071493,1,0.685778755049879,0,1,cellular response to UV-B,BP,
4990,GO:0071505,1,0.701758628672581,0,1,response to mycophenolic acid,BP,
4991,GO:0071506,1,0.701758628672581,0,1,cellular response to mycophenolic acid,BP,
5000,GO:0071616,1,0.514903481278129,0,2,acyl-CoA biosynthetic process,BP,
5003,GO:0071622,1,0.485839996632864,0,2,regulation of granulocyte chemotaxis,BP,
5004,GO:0071624,1,0.682927424885784,0,1,positive regulation of granulocyte chemotaxis,BP,
5008,GO:0071688,1,0.718545083727339,0,1,striated muscle myosin thick filament assembly,BP,
5009,GO:0071695,1,0.506245376511713,0,2,anatomical structure maturation,BP,
5017,GO:0071706,1,0.496937926004226,0,2,tumor necrosis factor superfamily cytokine production,BP,
5018,GO:0071709,1,0.715947598747366,0,1,membrane assembly,BP,
5019,GO:0071715,1,0.682927424885784,0,1,icosanoid transport,BP,
5022,GO:0071733,1,0.707980062532778,0,1,transcriptional activation by promoter-enhancer looping,BP,
5026,GO:0071782,1,0.713363280358565,0,1,endoplasmic reticulum tubular network,CC,
5027,GO:0071786,1,0.713363280358565,0,1,endoplasmic reticulum tubular network organization,BP,
5028,GO:0071800,1,0.714643171421448,0,1,podosome assembly,BP,
5029,GO:0071801,1,0.714643171421448,0,1,regulation of podosome assembly,BP,
5030,GO:0071803,1,0.714643171421448,0,1,positive regulation of podosome assembly,BP,
5036,GO:0071850,1,0.45321036602372,0,2,mitotic cell cycle arrest,BP,
5037,GO:0071855,1,0.682927424885784,0,1,neuropeptide receptor binding,MF,
5038,GO:0071867,1,0.715703089056377,0,1,response to monoamine,BP,
5039,GO:0071868,1,0.715703089056377,0,1,cellular response to monoamine stimulus,BP,
5040,GO:0071869,1,0.715703089056377,0,1,response to catecholamine,BP,
5041,GO:0071870,1,0.715703089056377,0,1,cellular response to catecholamine stimulus,BP,
5042,GO:0071871,1,0.715703089056377,0,1,response to epinephrine,BP,
5043,GO:0071872,1,0.715703089056377,0,1,cellular response to epinephrine stimulus,BP,
5044,GO:0071875,1,0.325763794567899,0,3,adrenergic receptor signaling pathway,BP,
5045,GO:0071880,1,0.325763794567899,0,3,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
5046,GO:0071883,1,0.479899134609722,0,2,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
5048,GO:0071889,1,0.701493568801233,0,1,14-3-3 protein binding,MF,
5050,GO:0071897,1,0.329930222557283,0,3,DNA biosynthetic process,BP,
5055,GO:0071963,1,0.67317649297611,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
5056,GO:0071971,1,0.696039774295367,0,1,extracellular exosome assembly,BP,
5057,GO:0071985,1,0.700234742383915,0,1,multivesicular body sorting pathway,BP,
5065,GO:0072014,1,0.708931381661885,0,1,proximal tubule development,BP,
5069,GO:0072033,1,0.714265548502507,0,1,renal vesicle formation,BP,
5070,GO:0072034,1,0.714265548502507,0,1,renal vesicle induction,BP,
5114,GO:0072126,1,0.701758628672581,0,1,positive regulation of glomerular mesangial cell proliferation,BP,
5126,GO:0072160,1,0.714341024234018,0,1,nephron tubule epithelial cell differentiation,BP,
5128,GO:0072162,1,0.714265548502507,0,1,metanephric mesenchymal cell differentiation,BP,
5131,GO:0072166,1,0.70409479607052,0,1,posterior mesonephric tubule development,BP,
5135,GO:0072173,1,0.714265548502507,0,1,metanephric tubule morphogenesis,BP,
5136,GO:0072174,1,0.714265548502507,0,1,metanephric tubule formation,BP,
5141,GO:0072182,1,0.714341024234018,0,1,regulation of nephron tubule epithelial cell differentiation,BP,
5156,GO:0072209,1,0.701758628672581,0,1,metanephric mesangial cell differentiation,BP,
5161,GO:0072223,1,0.493244084916139,0,2,metanephric glomerular mesangium development,BP,
5162,GO:0072224,1,0.493244084916139,0,2,metanephric glomerulus development,BP,
5165,GO:0072239,1,0.493244084916139,0,2,metanephric glomerulus vasculature development,BP,
5167,GO:0072254,1,0.701758628672581,0,1,metanephric glomerular mesangial cell differentiation,BP,
5168,GO:0072255,1,0.701758628672581,0,1,metanephric glomerular mesangial cell development,BP,
5169,GO:0072257,1,0.714341024234018,0,1,metanephric nephron tubule epithelial cell differentiation,BP,
5170,GO:0072262,1,0.70409479607052,0,1,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
5175,GO:0072298,1,0.70409479607052,0,1,regulation of metanephric glomerulus development,BP,
5176,GO:0072299,1,0.70409479607052,0,1,negative regulation of metanephric glomerulus development,BP,
5177,GO:0072301,1,0.70409479607052,0,1,regulation of metanephric glomerular mesangial cell proliferation,BP,
5178,GO:0072302,1,0.70409479607052,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
5179,GO:0072307,1,0.714341024234018,0,1,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
5182,GO:0072320,1,0.680586525929292,0,1,volume-sensitive chloride channel activity,MF,
5183,GO:0072329,1,0.497923140405487,0,2,monocarboxylic acid catabolic process,BP,
5184,GO:0072330,1,0.329304592595775,0,3,monocarboxylic acid biosynthetic process,BP,
5190,GO:0072395,1,0.45321036602372,0,2,signal transduction involved in cell cycle checkpoint,BP,
5191,GO:0072401,1,0.45321036602372,0,2,signal transduction involved in DNA integrity checkpoint,BP,
5192,GO:0072413,1,0.45321036602372,0,2,signal transduction involved in mitotic cell cycle checkpoint,BP,
5193,GO:0072422,1,0.45321036602372,0,2,signal transduction involved in DNA damage checkpoint,BP,
5194,GO:0072431,1,0.45321036602372,0,2,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
5199,GO:0072509,1,0.461096849207175,0,2,divalent inorganic cation transmembrane transporter activity,MF,
5205,GO:0072523,1,0.715703089056377,0,1,purine-containing compound catabolic process,BP,
5208,GO:0072574,1,0.683624670162167,0,1,hepatocyte proliferation,BP,
5209,GO:0072575,1,0.683624670162167,0,1,epithelial cell proliferation involved in liver morphogenesis,BP,
5210,GO:0072576,1,0.683624670162167,0,1,liver morphogenesis,BP,
5211,GO:0072577,1,0.693606308666904,0,1,endothelial cell apoptotic process,BP,
5213,GO:0072584,1,0.666797965191416,0,1,caveolin-mediated endocytosis,BP,
5216,GO:0072595,1,0.701493568801233,0,1,maintenance of protein localization in organelle,BP,
5218,GO:0072604,1,0.693606308666904,0,1,interleukin-6 secretion,BP,
5219,GO:0072606,1,0.717706347959987,0,1,interleukin-8 secretion,BP,
5221,GO:0072656,1,0.701493568801233,0,1,maintenance of protein location in mitochondrion,BP,
5224,GO:0072661,1,0.693606308666904,0,1,protein targeting to plasma membrane,BP,
5225,GO:0072665,1,0.717039000317044,0,1,protein localization to vacuole,BP,
5230,GO:0075733,1,0.716841414120058,0,1,intracellular transport of virus,BP,
5236,GO:0086001,1,0.506310676344189,0,2,cardiac muscle cell action potential,BP,
5237,GO:0086002,1,0.506310676344189,0,2,cardiac muscle cell action potential involved in contraction,BP,
5238,GO:0086003,1,0.361191648097754,0,3,cardiac muscle cell contraction,BP,
5239,GO:0086004,1,0.512410976404606,0,2,regulation of cardiac muscle cell contraction,BP,
5240,GO:0086005,1,0.506310676344189,0,2,ventricular cardiac muscle cell action potential,BP,
5241,GO:0086008,1,0.707215656113447,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
5242,GO:0086009,1,0.492879334023554,0,2,membrane repolarization,BP,
5243,GO:0086010,1,0.707215656113447,0,1,membrane depolarization during action potential,BP,
5244,GO:0086011,1,0.707215656113447,0,1,membrane repolarization during action potential,BP,
5245,GO:0086013,1,0.707215656113447,0,1,membrane repolarization during cardiac muscle cell action potential,BP,
5246,GO:0086019,1,0.698147056906197,0,1,cell-cell signaling involved in cardiac conduction,BP,
5247,GO:0086023,1,0.68145664044265,0,1,adrenergic receptor signaling pathway involved in heart process,BP,
5248,GO:0086029,1,0.698147056906197,0,1,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
5249,GO:0086030,1,0.68145664044265,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
5250,GO:0086042,1,0.717094335792217,0,1,cardiac muscle cell-cardiac muscle cell adhesion,BP,
5251,GO:0086065,1,0.499792980448055,0,2,cell communication involved in cardiac conduction,BP,
5252,GO:0086068,1,0.698147056906197,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
5253,GO:0086069,1,0.717094335792217,0,1,bundle of His cell to Purkinje myocyte communication,BP,
5254,GO:0086073,1,0.717094335792217,0,1,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
5255,GO:0086080,1,0.717094335792217,0,1,protein binding involved in heterotypic cell-cell adhesion,MF,
5256,GO:0086083,1,0.717094335792217,0,1,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
5257,GO:0086091,1,0.506310676344189,0,2,regulation of heart rate by cardiac conduction,BP,
5258,GO:0086097,1,0.716240390769176,0,1,phospholipase C-activating angiotensin-activated signaling pathway,BP,
5259,GO:0086103,1,0.68145664044265,0,1,G-protein coupled receptor signaling pathway involved in heart process,BP,
5261,GO:0090003,1,0.255940233226224,0,4,regulation of establishment of protein localization to plasma membrane,BP,
5262,GO:0090004,1,0.359095515095364,0,3,positive regulation of establishment of protein localization to plasma membrane,BP,
5263,GO:0090005,1,0.716234312327688,0,1,negative regulation of establishment of protein localization to plasma membrane,BP,
5264,GO:0090009,1,0.717706347959987,0,1,primitive streak formation,BP,
5265,GO:0090022,1,0.485839996632864,0,2,regulation of neutrophil chemotaxis,BP,
5266,GO:0090023,1,0.682927424885784,0,1,positive regulation of neutrophil chemotaxis,BP,
5269,GO:0090032,1,0.493050003742117,0,2,negative regulation of steroid hormone biosynthetic process,BP,
5270,GO:0090036,1,0.717706347959987,0,1,regulation of protein kinase C signaling,BP,
5271,GO:0090037,1,0.717706347959987,0,1,positive regulation of protein kinase C signaling,BP,
5276,GO:0090075,1,0.340058620416321,0,3,relaxation of muscle,BP,
5282,GO:0090102,1,0.717706347959987,0,1,cochlea development,BP,
5283,GO:0090103,1,0.717706347959987,0,1,cochlea morphogenesis,BP,
5284,GO:0090109,1,0.496304663504859,0,2,regulation of cell-substrate junction assembly,BP,
5286,GO:0090131,1,0.668594419045675,0,1,mesenchyme migration,BP,
5290,GO:0090136,1,0.498659745743936,0,2,epithelial cell-cell adhesion,BP,
5291,GO:0090138,1,0.712690558264192,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
5293,GO:0090162,1,0.51208754973022,0,2,establishment of epithelial cell polarity,BP,
5296,GO:0090177,1,0.717706347959987,0,1,establishment of planar polarity involved in neural tube closure,BP,
5297,GO:0090178,1,0.717706347959987,0,1,regulation of establishment of planar polarity involved in neural tube closure,BP,
5298,GO:0090179,1,0.717706347959987,0,1,planar cell polarity pathway involved in neural tube closure,BP,
5308,GO:0090193,1,0.701758628672581,0,1,positive regulation of glomerulus development,BP,
5312,GO:0090201,1,0.701493568801233,0,1,negative regulation of release of cytochrome c from mitochondria,BP,
5313,GO:0090202,1,0.707980062532778,0,1,gene looping,BP,
5316,GO:0090218,1,0.701758628672581,0,1,positive regulation of lipid kinase activity,BP,
5317,GO:0090224,1,0.6730929422979,0,1,regulation of spindle organization,BP,
5322,GO:0090279,1,0.489060375103061,0,2,regulation of calcium ion import,BP,
5323,GO:0090280,1,0.701758628672581,0,1,positive regulation of calcium ion import,BP,
5324,GO:0090281,1,0.698147056906197,0,1,negative regulation of calcium ion import,BP,
5338,GO:0090399,1,0.685778755049879,0,1,replicative senescence,BP,
5339,GO:0090400,1,0.685778755049879,0,1,stress-induced premature senescence,BP,
5345,GO:0090526,1,0.711015020328229,0,1,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
5346,GO:0090557,1,0.71022670342733,0,1,establishment of endothelial intestinal barrier,BP,
5349,GO:0090579,1,0.707980062532778,0,1,dsDNA loop formation,BP,
5351,GO:0090598,1,0.64211725735274,0,1,male anatomical structure morphogenesis,BP,
5352,GO:0090630,1,0.717706347959987,0,1,activation of GTPase activity,BP,
5354,GO:0090677,1,0.701758628672581,0,1,reversible differentiation,BP,
5355,GO:0090678,1,0.701758628672581,0,1,cell dedifferentiation involved in phenotypic switching,BP,
5357,GO:0097011,1,0.701493568801233,0,1,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
5358,GO:0097012,1,0.701493568801233,0,1,response to granulocyte macrophage colony-stimulating factor,BP,
5359,GO:0097017,1,0.693606308666904,0,1,renal protein absorption,BP,
5360,GO:0097018,1,0.693606308666904,0,1,renal albumin absorption,BP,
5362,GO:0097028,1,0.693606308666904,0,1,dendritic cell differentiation,BP,
5363,GO:0097038,1,0.717681530181595,0,1,perinuclear endoplasmic reticulum,CC,
5364,GO:0097048,1,0.693606308666904,0,1,dendritic cell apoptotic process,BP,
5365,GO:0097058,1,0.674610601535826,0,1,CRLF-CLCF1 complex,CC,
5366,GO:0097059,1,0.674610601535826,0,1,CNTFR-CLCF1 complex,CC,
5369,GO:0097062,1,0.716799129544212,0,1,dendritic spine maintenance,BP,
5370,GO:0097070,1,0.701156312252234,0,1,ductus arteriosus closure,BP,
5372,GO:0097091,1,0.715947598747366,0,1,synaptic vesicle clustering,BP,
5374,GO:0097101,1,0.708931381661885,0,1,blood vessel endothelial cell fate specification,BP,
5375,GO:0097102,1,0.708931381661885,0,1,endothelial tip cell fate specification,BP,
5376,GO:0097104,1,0.715947598747366,0,1,postsynaptic membrane assembly,BP,
5377,GO:0097106,1,0.715947598747366,0,1,postsynaptic density organization,BP,
5378,GO:0097110,1,0.50052394660289,0,2,scaffold protein binding,MF,
5379,GO:0097118,1,0.715947598747366,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
5380,GO:0097119,1,0.715947598747366,0,1,postsynaptic density protein 95 clustering,BP,
5386,GO:0097179,1,0.688709470596719,0,1,protease inhibitor complex,CC,
5387,GO:0097180,1,0.688709470596719,0,1,serine protease inhibitor complex,CC,
5388,GO:0097181,1,0.688709470596719,0,1,protein C inhibitor-coagulation factor V complex,CC,
5389,GO:0097182,1,0.688709470596719,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
5390,GO:0097183,1,0.688709470596719,0,1,protein C inhibitor-coagulation factor XI complex,CC,
5391,GO:0097186,1,0.71761803118789,0,1,amelogenesis,BP,
5396,GO:0097194,1,0.701493568801233,0,1,execution phase of apoptosis,BP,
5398,GO:0097205,1,0.242020348835336,0,4,renal filtration,BP,
5400,GO:0097241,1,0.693606308666904,0,1,hematopoietic stem cell migration to bone marrow,BP,
5401,GO:0097252,1,0.693606308666904,0,1,oligodendrocyte apoptotic process,BP,
5402,GO:0097278,1,0.700234742383915,0,1,complement-dependent cytotoxicity,BP,
5407,GO:0097325,1,0.717706347959987,0,1,melanocyte proliferation,BP,
5408,GO:0097338,1,0.716148206052754,0,1,response to clozapine,BP,
5413,GO:0097421,1,0.71022670342733,0,1,liver regeneration,BP,
5414,GO:0097425,1,0.680586525929292,0,1,smooth endoplasmic reticulum part,CC,
5425,GO:0097531,1,0.68145664044265,0,1,mast cell migration,BP,
5426,GO:0097546,1,0.4959065131259,0,2,ciliary base,CC,
5427,GO:0097553,1,0.698147056906197,0,1,calcium ion transmembrane import into cytosol,BP,
5428,GO:0097581,1,0.67317649297611,0,1,lamellipodium organization,BP,
5429,GO:0097610,1,0.689979727735358,0,1,cell surface furrow,CC,
5430,GO:0097623,1,0.707215656113447,0,1,potassium ion export across plasma membrane,BP,
5435,GO:0097711,1,0.716744290017254,0,1,ciliary basal body docking,BP,
5440,GO:0097734,1,0.486514894648307,0,2,extracellular exosome biogenesis,BP,
5441,GO:0097746,1,0.031118842750048,0,9,regulation of blood vessel diameter,BP,
5442,GO:0097755,1,0.444438505617067,0,2,positive regulation of blood vessel diameter,BP,
5443,GO:0097756,1,0.0706182461453198,0,7,negative regulation of blood vessel diameter,BP,
5448,GO:0098563,1,0.677324360429776,0,1,intrinsic component of synaptic vesicle membrane,CC,
5452,GO:0098596,1,0.701156312252234,0,1,imitative learning,BP,
5453,GO:0098597,1,0.701156312252234,0,1,observational learning,BP,
5454,GO:0098598,1,0.701156312252234,0,1,learned vocalization behavior or vocal learning,BP,
5457,GO:0098631,1,0.50149196265164,0,2,protein binding involved in cell adhesion,MF,
5458,GO:0098632,1,0.50149196265164,0,2,protein binding involved in cell-cell adhesion,MF,
5459,GO:0098636,1,0.184949030840565,0,5,protein complex involved in cell adhesion,CC,
5460,GO:0098641,1,0.700511032597554,0,1,cadherin binding involved in cell-cell adhesion,MF,
5462,GO:0098656,1,0.47652809486914,0,2,anion transmembrane transport,BP,
5466,GO:0098661,1,0.680586525929292,0,1,inorganic anion transmembrane transport,BP,
5468,GO:0098668,1,0.707215656113447,0,1,potassium ion export from cell,BP,
5470,GO:0098732,1,0.716995957461558,0,1,macromolecule deacylation,BP,
5483,GO:0098801,1,0.163737234529634,0,5,regulation of renal system process,BP,
5488,GO:0098813,1,0.6730929422979,0,1,nuclear chromosome segregation,BP,
5490,GO:0098827,1,0.713363280358565,0,1,endoplasmic reticulum subcompartment,CC,
5493,GO:0098858,1,0.0411028115420219,0,9,actin-based cell projection,CC,
5494,GO:0098862,1,0.363713520339921,0,3,cluster of actin-based cell projections,CC,
5495,GO:0098868,1,0.635388353995092,0,1,bone growth,BP,
5497,GO:0098900,1,0.717094335792217,0,1,regulation of action potential,BP,
5498,GO:0098901,1,0.717094335792217,0,1,regulation of cardiac muscle cell action potential,BP,
5499,GO:0098911,1,0.717094335792217,0,1,regulation of ventricular cardiac muscle cell action potential,BP,
5500,GO:0098915,1,0.707215656113447,0,1,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
5502,GO:0098927,1,0.714643171421448,0,1,vesicle-mediated transport between endosomal compartments,BP,
5505,GO:0099023,1,0.687261217406708,0,1,tethering complex,CC,
5506,GO:0099024,1,0.485146121384876,0,2,plasma membrane invagination,BP,
5511,GO:0099084,1,0.715947598747366,0,1,postsynaptic specialization organization,BP,
5527,GO:0099622,1,0.707215656113447,0,1,cardiac muscle cell membrane repolarization,BP,
5528,GO:0099623,1,0.707215656113447,0,1,regulation of cardiac muscle cell membrane repolarization,BP,
5529,GO:0099625,1,0.707215656113447,0,1,ventricular cardiac muscle cell membrane repolarization,BP,
5531,GO:0100002,1,0.701493568801233,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
5532,GO:0101002,1,0.716320506927979,0,1,ficolin-1-rich granule,CC,
5534,GO:0102132,1,0.719216741957039,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
5535,GO:0102391,1,0.717048561252595,0,1,decanoate--CoA ligase activity,MF,
5539,GO:1900019,1,0.717706347959987,0,1,regulation of protein kinase C activity,BP,
5540,GO:1900020,1,0.717706347959987,0,1,positive regulation of protein kinase C activity,BP,
5543,GO:1900046,1,0.330736052887268,0,3,regulation of hemostasis,BP,
5544,GO:1900047,1,0.330736052887268,0,3,negative regulation of hemostasis,BP,
5545,GO:1900076,1,0.51197138028005,0,2,regulation of cellular response to insulin stimulus,BP,
5546,GO:1900078,1,0.51197138028005,0,2,positive regulation of cellular response to insulin stimulus,BP,
5547,GO:1900101,1,0.717681530181595,0,1,regulation of endoplasmic reticulum unfolded protein response,BP,
5548,GO:1900103,1,0.717681530181595,0,1,positive regulation of endoplasmic reticulum unfolded protein response,BP,
5551,GO:1900125,1,0.701758628672581,0,1,regulation of hyaluronan biosynthetic process,BP,
5552,GO:1900127,1,0.701758628672581,0,1,positive regulation of hyaluronan biosynthetic process,BP,
5553,GO:1900141,1,0.693606308666904,0,1,regulation of oligodendrocyte apoptotic process,BP,
5554,GO:1900142,1,0.693606308666904,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
5555,GO:1900165,1,0.693606308666904,0,1,negative regulation of interleukin-6 secretion,BP,
5559,GO:1900186,1,0.666797965191416,0,1,negative regulation of clathrin-dependent endocytosis,BP,
5560,GO:1900193,1,0.635388353995092,0,1,regulation of oocyte maturation,BP,
5561,GO:1900194,1,0.635388353995092,0,1,negative regulation of oocyte maturation,BP,
5562,GO:1900238,1,0.701758628672581,0,1,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
5563,GO:1900239,1,0.701758628672581,0,1,regulation of phenotypic switching,BP,
5564,GO:1900241,1,0.701758628672581,0,1,positive regulation of phenotypic switching,BP,
5565,GO:1900274,1,0.674401774365491,0,1,regulation of phospholipase C activity,BP,
5566,GO:1900371,1,0.308561816229379,0,3,regulation of purine nucleotide biosynthetic process,BP,
5567,GO:1900372,1,0.682927424885784,0,1,negative regulation of purine nucleotide biosynthetic process,BP,
5568,GO:1900373,1,0.453682751930291,0,2,positive regulation of purine nucleotide biosynthetic process,BP,
5569,GO:1900376,1,0.717706347959987,0,1,regulation of secondary metabolite biosynthetic process,BP,
5570,GO:1900377,1,0.717706347959987,0,1,negative regulation of secondary metabolite biosynthetic process,BP,
5572,GO:1900408,1,0.701493568801233,0,1,negative regulation of cellular response to oxidative stress,BP,
5573,GO:1900452,1,0.700996267622242,0,1,regulation of long term synaptic depression,BP,
5574,GO:1900453,1,0.700996267622242,0,1,negative regulation of long term synaptic depression,BP,
5578,GO:1900736,1,0.68145664044265,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5579,GO:1900738,1,0.68145664044265,0,1,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
5582,GO:1900744,1,0.466983616516672,0,2,regulation of p38MAPK cascade,BP,
5583,GO:1900745,1,0.466983616516672,0,2,positive regulation of p38MAPK cascade,BP,
5584,GO:1900746,1,0.708931381661885,0,1,regulation of vascular endothelial growth factor signaling pathway,BP,
5585,GO:1900750,1,0.674234706311468,0,1,oligopeptide binding,MF,
5586,GO:1901016,1,0.499195326876418,0,2,regulation of potassium ion transmembrane transporter activity,BP,
5587,GO:1901017,1,0.499195326876418,0,2,negative regulation of potassium ion transmembrane transporter activity,BP,
5588,GO:1901018,1,0.716240390769176,0,1,positive regulation of potassium ion transmembrane transporter activity,BP,
5589,GO:1901019,1,0.49881928510448,0,2,regulation of calcium ion transmembrane transporter activity,BP,
5590,GO:1901020,1,0.698147056906197,0,1,negative regulation of calcium ion transmembrane transporter activity,BP,
5594,GO:1901068,1,0.716234312327688,0,1,guanosine-containing compound metabolic process,BP,
5595,GO:1901077,1,0.486847729465658,0,2,regulation of relaxation of muscle,BP,
5596,GO:1901078,1,0.715703089056377,0,1,negative regulation of relaxation of muscle,BP,
5597,GO:1901079,1,0.68145664044265,0,1,positive regulation of relaxation of muscle,BP,
5600,GO:1901136,1,0.497307729695885,0,2,carbohydrate derivative catabolic process,BP,
5603,GO:1901184,1,0.109951510821,0,6,regulation of ERBB signaling pathway,BP,
5604,GO:1901185,1,0.477302487846472,0,2,negative regulation of ERBB signaling pathway,BP,
5605,GO:1901186,1,0.23385597253755,0,4,positive regulation of ERBB signaling pathway,BP,
5610,GO:1901264,1,0.468624878308255,0,2,carbohydrate derivative transport,BP,
5612,GO:1901292,1,0.715703089056377,0,1,nucleoside phosphate catabolic process,BP,
5614,GO:1901338,1,0.479899134609722,0,2,catecholamine binding,MF,
5621,GO:1901379,1,0.351838733444207,0,3,regulation of potassium ion transmembrane transport,BP,
5622,GO:1901380,1,0.351838733444207,0,3,negative regulation of potassium ion transmembrane transport,BP,
5623,GO:1901381,1,0.50570530107566,0,2,positive regulation of potassium ion transmembrane transport,BP,
5624,GO:1901385,1,0.715703089056377,0,1,regulation of voltage-gated calcium channel activity,BP,
5629,GO:1901550,1,0.680365143943014,0,1,regulation of endothelial cell development,BP,
5630,GO:1901552,1,0.680365143943014,0,1,positive regulation of endothelial cell development,BP,
5634,GO:1901568,1,0.459513176635729,0,2,fatty acid derivative metabolic process,BP,
5635,GO:1901570,1,0.459513176635729,0,2,fatty acid derivative biosynthetic process,BP,
5636,GO:1901571,1,0.682927424885784,0,1,fatty acid derivative transport,BP,
5643,GO:1901620,1,0.716148206052754,0,1,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
5644,GO:1901621,1,0.716148206052754,0,1,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
5645,GO:1901623,1,0.717706347959987,0,1,regulation of lymphocyte chemotaxis,BP,
5646,GO:1901626,1,0.715947598747366,0,1,regulation of postsynaptic membrane organization,BP,
5651,GO:1901657,1,0.716234312327688,0,1,glycosyl compound metabolic process,BP,
5652,GO:1901674,1,0.714341024234018,0,1,regulation of histone H3-K27 acetylation,BP,
5653,GO:1901676,1,0.714341024234018,0,1,positive regulation of histone H3-K27 acetylation,BP,
5654,GO:1901678,1,0.712608852725647,0,1,iron coordination entity transport,BP,
5662,GO:1901724,1,0.701758628672581,0,1,positive regulation of cell proliferation involved in kidney development,BP,
5666,GO:1901841,1,0.715703089056377,0,1,regulation of high voltage-gated calcium channel activity,BP,
5672,GO:1901881,1,0.716240390769176,0,1,positive regulation of protein depolymerization,BP,
5673,GO:1901888,1,0.351294602557425,0,3,regulation of cell junction assembly,BP,
5674,GO:1901890,1,0.351294602557425,0,3,positive regulation of cell junction assembly,BP,
5675,GO:1901897,1,0.486847729465658,0,2,regulation of relaxation of cardiac muscle,BP,
5676,GO:1901898,1,0.715703089056377,0,1,negative regulation of relaxation of cardiac muscle,BP,
5677,GO:1901899,1,0.68145664044265,0,1,positive regulation of relaxation of cardiac muscle,BP,
5680,GO:1901976,1,0.701493568801233,0,1,regulation of cell cycle checkpoint,BP,
5682,GO:1901983,1,0.714341024234018,0,1,regulation of protein acetylation,BP,
5683,GO:1901985,1,0.714341024234018,0,1,positive regulation of protein acetylation,BP,
5684,GO:1901987,1,0.14194933715316,0,5,regulation of cell cycle phase transition,BP,
5685,GO:1901988,1,0.31977331103751,0,3,negative regulation of cell cycle phase transition,BP,
5686,GO:1901990,1,0.14194933715316,0,5,regulation of mitotic cell cycle phase transition,BP,
5687,GO:1901991,1,0.31977331103751,0,3,negative regulation of mitotic cell cycle phase transition,BP,
5689,GO:1902001,1,0.701493568801233,0,1,fatty acid transmembrane transport,BP,
5690,GO:1902010,1,0.711015020328229,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
5691,GO:1902033,1,0.717270758028134,0,1,regulation of hematopoietic stem cell proliferation,BP,
5692,GO:1902035,1,0.717270758028134,0,1,positive regulation of hematopoietic stem cell proliferation,BP,
5695,GO:1902074,1,0.682927424885784,0,1,response to salt,BP,
5699,GO:1902107,1,0.353594834938461,0,3,positive regulation of leukocyte differentiation,BP,
5702,GO:1902115,1,0.230889927033746,0,4,regulation of organelle assembly,BP,
5703,GO:1902117,1,0.230889927033746,0,4,positive regulation of organelle assembly,BP,
5706,GO:1902175,1,0.701493568801233,0,1,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5707,GO:1902176,1,0.701493568801233,0,1,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
5708,GO:1902224,1,0.691115067781905,0,1,ketone body metabolic process,BP,
5713,GO:1902275,1,0.714341024234018,0,1,regulation of chromatin organization,BP,
5714,GO:1902282,1,0.707215656113447,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
5716,GO:1902302,1,0.707215656113447,0,1,regulation of potassium ion export,BP,
5717,GO:1902303,1,0.707215656113447,0,1,negative regulation of potassium ion export,BP,
5723,GO:1902379,1,0.717706347959987,0,1,chemoattractant activity involved in axon guidance,MF,
5724,GO:1902400,1,0.45321036602372,0,2,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
5725,GO:1902402,1,0.45321036602372,0,2,signal transduction involved in mitotic DNA damage checkpoint,BP,
5726,GO:1902403,1,0.45321036602372,0,2,signal transduction involved in mitotic DNA integrity checkpoint,BP,
5730,GO:1902476,1,0.680586525929292,0,1,chloride transmembrane transport,BP,
5736,GO:1902547,1,0.708931381661885,0,1,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
5737,GO:1902554,1,0.341106443141688,0,3,serine/threonine protein kinase complex,CC,
5741,GO:1902581,1,0.716841414120058,0,1,multi-organism cellular localization,BP,
5743,GO:1902583,1,0.716841414120058,0,1,multi-organism intracellular transport,BP,
5746,GO:1902612,1,0.699073839861794,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
5747,GO:1902613,1,0.699073839861794,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
5748,GO:1902622,1,0.485839996632864,0,2,regulation of neutrophil migration,BP,
5749,GO:1902624,1,0.682927424885784,0,1,positive regulation of neutrophil migration,BP,
5750,GO:1902652,1,0.691115067781905,0,1,secondary alcohol metabolic process,BP,
5751,GO:1902653,1,0.691115067781905,0,1,secondary alcohol biosynthetic process,BP,
5752,GO:1902656,1,0.698147056906197,0,1,calcium ion import into cytosol,BP,
5762,GO:1902749,1,0.708249234674247,0,1,regulation of cell cycle G2/M phase transition,BP,
5763,GO:1902750,1,0.708249234674247,0,1,negative regulation of cell cycle G2/M phase transition,BP,
5764,GO:1902806,1,0.201969317550379,0,4,regulation of cell cycle G1/S phase transition,BP,
5765,GO:1902807,1,0.45321036602372,0,2,negative regulation of cell cycle G1/S phase transition,BP,
5766,GO:1902850,1,0.6730929422979,0,1,microtubule cytoskeleton organization involved in mitosis,BP,
5768,GO:1902883,1,0.701493568801233,0,1,negative regulation of response to oxidative stress,BP,
5769,GO:1902893,1,0.494951260402055,0,2,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5770,GO:1902894,1,0.701758628672581,0,1,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5771,GO:1902895,1,0.494951260402055,0,2,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
5772,GO:1902897,1,0.715947598747366,0,1,regulation of postsynaptic density protein 95 clustering,BP,
5775,GO:1902905,1,0.109744033697413,0,6,positive regulation of supramolecular fiber organization,BP,
5776,GO:1902911,1,0.341106443141688,0,3,protein kinase complex,CC,
5779,GO:1902946,1,0.714643171421448,0,1,protein localization to early endosome,BP,
5780,GO:1902965,1,0.714643171421448,0,1,regulation of protein localization to early endosome,BP,
5781,GO:1902966,1,0.714643171421448,0,1,positive regulation of protein localization to early endosome,BP,
5784,GO:1903018,1,0.689876795946402,0,1,regulation of glycoprotein metabolic process,BP,
5785,GO:1903019,1,0.689876795946402,0,1,negative regulation of glycoprotein metabolic process,BP,
5786,GO:1903025,1,0.714341024234018,0,1,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
5788,GO:1903035,1,0.234994501674974,0,4,negative regulation of response to wounding,BP,
5793,GO:1903046,1,0.248423212926757,0,4,meiotic cell cycle process,BP,
5798,GO:1903076,1,0.255940233226224,0,4,regulation of protein localization to plasma membrane,BP,
5799,GO:1903077,1,0.716234312327688,0,1,negative regulation of protein localization to plasma membrane,BP,
5800,GO:1903078,1,0.359095515095364,0,3,positive regulation of protein localization to plasma membrane,BP,
5801,GO:1903115,1,0.512410976404606,0,2,regulation of actin filament-based movement,BP,
5803,GO:1903140,1,0.680365143943014,0,1,regulation of establishment of endothelial barrier,BP,
5804,GO:1903142,1,0.680365143943014,0,1,positive regulation of establishment of endothelial barrier,BP,
5806,GO:1903170,1,0.698147056906197,0,1,negative regulation of calcium ion transmembrane transport,BP,
5807,GO:1903201,1,0.701493568801233,0,1,regulation of oxidative stress-induced cell death,BP,
5808,GO:1903202,1,0.701493568801233,0,1,negative regulation of oxidative stress-induced cell death,BP,
5815,GO:1903313,1,0.713405224543974,0,1,positive regulation of mRNA metabolic process,BP,
5816,GO:1903317,1,0.716148206052754,0,1,regulation of protein maturation,BP,
5819,GO:1903348,1,0.71022670342733,0,1,positive regulation of bicellular tight junction assembly,BP,
5822,GO:1903391,1,0.496304663504859,0,2,regulation of adherens junction organization,BP,
5823,GO:1903393,1,0.496304663504859,0,2,positive regulation of adherens junction organization,BP,
5824,GO:1903409,1,0.333609209286873,0,3,reactive oxygen species biosynthetic process,BP,
5825,GO:1903426,1,0.333609209286873,0,3,regulation of reactive oxygen species biosynthetic process,BP,
5826,GO:1903428,1,0.333609209286873,0,3,positive regulation of reactive oxygen species biosynthetic process,BP,
5827,GO:1903429,1,0.635388353995092,0,1,regulation of cell maturation,BP,
5828,GO:1903430,1,0.635388353995092,0,1,negative regulation of cell maturation,BP,
5829,GO:1903432,1,0.711015020328229,0,1,regulation of TORC1 signaling,BP,
5830,GO:1903433,1,0.700234742383915,0,1,regulation of constitutive secretory pathway,BP,
5831,GO:1903435,1,0.700234742383915,0,1,positive regulation of constitutive secretory pathway,BP,
5835,GO:1903509,1,0.719290773235962,0,1,liposaccharide metabolic process,BP,
5836,GO:1903510,1,0.34228095063387,0,3,mucopolysaccharide metabolic process,BP,
5837,GO:1903514,1,0.698147056906197,0,1,calcium ion transport from endoplasmic reticulum to cytosol,BP,
5842,GO:1903524,1,0.14984305491325,0,5,positive regulation of blood circulation,BP,
5847,GO:1903541,1,0.696039774295367,0,1,regulation of exosomal secretion,BP,
5848,GO:1903543,1,0.696039774295367,0,1,positive regulation of exosomal secretion,BP,
5849,GO:1903544,1,0.71022670342733,0,1,response to butyrate,BP,
5850,GO:1903545,1,0.71022670342733,0,1,cellular response to butyrate,BP,
5851,GO:1903551,1,0.696039774295367,0,1,regulation of extracellular exosome assembly,BP,
5852,GO:1903553,1,0.696039774295367,0,1,positive regulation of extracellular exosome assembly,BP,
5853,GO:1903555,1,0.496937926004226,0,2,regulation of tumor necrosis factor superfamily cytokine production,BP,
5854,GO:1903556,1,0.693606308666904,0,1,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
5855,GO:1903557,1,0.717681530181595,0,1,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
5860,GO:1903649,1,0.714643171421448,0,1,regulation of cytoplasmic transport,BP,
5861,GO:1903651,1,0.714643171421448,0,1,positive regulation of cytoplasmic transport,BP,
5864,GO:1903672,1,0.506556086809951,0,2,positive regulation of sprouting angiogenesis,BP,
5867,GO:1903708,1,0.353594834938461,0,3,positive regulation of hemopoiesis,BP,
5869,GO:1903719,1,0.701493568801233,0,1,regulation of I-kappaB phosphorylation,BP,
5870,GO:1903721,1,0.701493568801233,0,1,positive regulation of I-kappaB phosphorylation,BP,
5871,GO:1903725,1,0.358073981164069,0,3,regulation of phospholipid metabolic process,BP,
5872,GO:1903726,1,0.701758628672581,0,1,negative regulation of phospholipid metabolic process,BP,
5873,GO:1903727,1,0.701758628672581,0,1,positive regulation of phospholipid metabolic process,BP,
5874,GO:1903729,1,0.255940233226224,0,4,regulation of plasma membrane organization,BP,
5877,GO:1903779,1,0.315501160928927,0,3,regulation of cardiac conduction,BP,
5878,GO:1903792,1,0.490878280128226,0,2,negative regulation of anion transport,BP,
5879,GO:1903793,1,0.682927424885784,0,1,positive regulation of anion transport,BP,
5882,GO:1903825,1,0.701493568801233,0,1,organic acid transmembrane transport,BP,
5886,GO:1903830,1,0.66612963031326,0,1,magnesium ion transmembrane transport,BP,
5887,GO:1903844,1,0.338320204932968,0,3,regulation of cellular response to transforming growth factor beta stimulus,BP,
5888,GO:1903845,1,0.678825835365042,0,1,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
5894,GO:1903959,1,0.701493568801233,0,1,regulation of anion transmembrane transport,BP,
5895,GO:1903960,1,0.701493568801233,0,1,negative regulation of anion transmembrane transport,BP,
5900,GO:1904029,1,0.0936524047252085,0,6,regulation of cyclin-dependent protein kinase activity,BP,
5901,GO:1904030,1,0.685778755049879,0,1,negative regulation of cyclin-dependent protein kinase activity,BP,
5902,GO:1904031,1,0.142966050654825,0,5,positive regulation of cyclin-dependent protein kinase activity,BP,
5903,GO:1904035,1,0.693606308666904,0,1,regulation of epithelial cell apoptotic process,BP,
5904,GO:1904036,1,0.693606308666904,0,1,negative regulation of epithelial cell apoptotic process,BP,
5906,GO:1904063,1,0.351838733444207,0,3,negative regulation of cation transmembrane transport,BP,
5907,GO:1904064,1,0.50570530107566,0,2,positive regulation of cation transmembrane transport,BP,
5909,GO:1904262,1,0.711015020328229,0,1,negative regulation of TORC1 signaling,BP,
5910,GO:1904375,1,0.255940233226224,0,4,regulation of protein localization to cell periphery,BP,
5911,GO:1904376,1,0.716234312327688,0,1,negative regulation of protein localization to cell periphery,BP,
5912,GO:1904377,1,0.359095515095364,0,3,positive regulation of protein localization to cell periphery,BP,
5913,GO:1904385,1,0.716240390769176,0,1,cellular response to angiotensin,BP,
5914,GO:1904407,1,0.478173903575527,0,2,positive regulation of nitric oxide metabolic process,BP,
5915,GO:1904502,1,0.711015020328229,0,1,regulation of lipophagy,BP,
5916,GO:1904504,1,0.711015020328229,0,1,positive regulation of lipophagy,BP,
5923,GO:1904705,1,0.701758628672581,0,1,regulation of vascular smooth muscle cell proliferation,BP,
5924,GO:1904707,1,0.701758628672581,0,1,positive regulation of vascular smooth muscle cell proliferation,BP,
5925,GO:1904738,1,0.701758628672581,0,1,vascular associated smooth muscle cell migration,BP,
5929,GO:1904752,1,0.701758628672581,0,1,regulation of vascular associated smooth muscle cell migration,BP,
5930,GO:1904754,1,0.701758628672581,0,1,positive regulation of vascular associated smooth muscle cell migration,BP,
5931,GO:1904813,1,0.716320506927979,0,1,ficolin-1-rich granule lumen,CC,
5934,GO:1904862,1,0.717706347959987,0,1,inhibitory synapse assembly,BP,
5942,GO:1904933,1,0.717706347959987,0,1,regulation of cell proliferation in midbrain,BP,
5943,GO:1904934,1,0.717706347959987,0,1,negative regulation of cell proliferation in midbrain,BP,
5944,GO:1904938,1,0.717706347959987,0,1,planar cell polarity pathway involved in axon guidance,BP,
5950,GO:1904955,1,0.717706347959987,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
5951,GO:1905005,1,0.703315452741895,0,1,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5952,GO:1905007,1,0.703315452741895,0,1,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
5953,GO:1905037,1,0.687261217406708,0,1,autophagosome organization,BP,
5954,GO:1905039,1,0.701493568801233,0,1,carboxylic acid transmembrane transport,BP,
5955,GO:1905063,1,0.701758628672581,0,1,regulation of vascular smooth muscle cell differentiation,BP,
5956,GO:1905064,1,0.701758628672581,0,1,negative regulation of vascular smooth muscle cell differentiation,BP,
5959,GO:1905174,1,0.701758628672581,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
5960,GO:1905176,1,0.701758628672581,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
5964,GO:1905269,1,0.714341024234018,0,1,positive regulation of chromatin organization,BP,
5974,GO:1905438,1,0.717706347959987,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
5979,GO:1905476,1,0.716234312327688,0,1,negative regulation of protein localization to membrane,BP,
5983,GO:1905666,1,0.714643171421448,0,1,regulation of protein localization to endosome,BP,
5984,GO:1905668,1,0.714643171421448,0,1,positive regulation of protein localization to endosome,BP,
5986,GO:1905809,1,0.717706347959987,0,1,negative regulation of synapse organization,BP,
5988,GO:1905874,1,0.715947598747366,0,1,regulation of postsynaptic density organization,BP,
5989,GO:1905879,1,0.635388353995092,0,1,regulation of oogenesis,BP,
5990,GO:1905880,1,0.635388353995092,0,1,negative regulation of oogenesis,BP,
5993,GO:1905939,1,0.502071086325483,0,2,regulation of gonad development,BP,
5994,GO:1905940,1,0.502071086325483,0,2,negative regulation of gonad development,BP,
5995,GO:1905941,1,0.70409479607052,0,1,positive regulation of gonad development,BP,
5998,GO:1905953,1,0.701493568801233,0,1,negative regulation of lipid localization,BP,
6000,GO:1990089,1,0.701493568801233,0,1,response to nerve growth factor,BP,
6001,GO:1990090,1,0.701493568801233,0,1,cellular response to nerve growth factor stimulus,BP,
6005,GO:1990172,1,0.71774180231946,0,1,G-protein coupled receptor catabolic process,BP,
6006,GO:1990182,1,0.486514894648307,0,2,exosomal secretion,BP,
6009,GO:1990262,1,0.699073839861794,0,1,anti-Mullerian hormone signaling pathway,BP,
6011,GO:1990316,1,0.711015020328229,0,1,ATG1/ULK1 kinase complex,CC,
6013,GO:1990418,1,0.701493568801233,0,1,response to insulin-like growth factor stimulus,BP,
6014,GO:1990427,1,0.718786554623569,0,1,stereocilia tip-link density,CC,
6015,GO:1990430,1,0.719290773235962,0,1,extracellular matrix protein binding,MF,
6016,GO:1990435,1,0.718786554623569,0,1,upper tip-link density,CC,
6018,GO:1990578,1,0.717681530181595,0,1,perinuclear endoplasmic reticulum membrane,CC,
6022,GO:1990776,1,0.716240390769176,0,1,response to angiotensin,BP,
6024,GO:1990782,1,0.252221727010511,0,4,protein tyrosine kinase binding,MF,
6025,GO:1990785,1,0.708249234674247,0,1,response to water-immersion restraint stress,BP,
6027,GO:1990841,1,0.708249234674247,0,1,promoter-specific chromatin binding,MF,
6028,GO:1990851,1,0.707048790863928,0,1,Wnt-Frizzled-LRP5/6 complex,CC,
6029,GO:1990874,1,0.701758628672581,0,1,vascular smooth muscle cell proliferation,BP,
6032,GO:1990936,1,0.701758628672581,0,1,vascular smooth muscle cell dedifferentiation,BP,
6038,GO:2000008,1,0.716240390769176,0,1,regulation of protein localization to cell surface,BP,
6039,GO:2000009,1,0.716240390769176,0,1,negative regulation of protein localization to cell surface,BP,
6040,GO:2000015,1,0.703315452741895,0,1,regulation of determination of dorsal identity,BP,
6041,GO:2000017,1,0.703315452741895,0,1,positive regulation of determination of dorsal identity,BP,
6042,GO:2000018,1,0.502071086325483,0,2,regulation of male gonad development,BP,
6043,GO:2000019,1,0.714265548502507,0,1,negative regulation of male gonad development,BP,
6044,GO:2000020,1,0.70409479607052,0,1,positive regulation of male gonad development,BP,
6045,GO:2000021,1,0.236573235611456,0,4,regulation of ion homeostasis,BP,
6049,GO:2000045,1,0.201969317550379,0,4,regulation of G1/S transition of mitotic cell cycle,BP,
6050,GO:2000047,1,0.717706347959987,0,1,regulation of cell-cell adhesion mediated by cadherin,BP,
6051,GO:2000049,1,0.717706347959987,0,1,positive regulation of cell-cell adhesion mediated by cadherin,BP,
6052,GO:2000050,1,0.717706347959987,0,1,regulation of non-canonical Wnt signaling pathway,BP,
6053,GO:2000052,1,0.717706347959987,0,1,positive regulation of non-canonical Wnt signaling pathway,BP,
6056,GO:2000064,1,0.350982613013452,0,3,regulation of cortisol biosynthetic process,BP,
6057,GO:2000065,1,0.493050003742117,0,2,negative regulation of cortisol biosynthetic process,BP,
6058,GO:2000066,1,0.714265548502507,0,1,positive regulation of cortisol biosynthetic process,BP,
6059,GO:2000097,1,0.693992657957217,0,1,regulation of smooth muscle cell-matrix adhesion,BP,
6063,GO:2000108,1,0.717706347959987,0,1,positive regulation of leukocyte apoptotic process,BP,
6067,GO:2000117,1,0.485682165347663,0,2,negative regulation of cysteine-type endopeptidase activity,BP,
6069,GO:2000134,1,0.45321036602372,0,2,negative regulation of G1/S transition of mitotic cell cycle,BP,
6077,GO:2000178,1,0.48977574842132,0,2,negative regulation of neural precursor cell proliferation,BP,
6080,GO:2000191,1,0.478173903575527,0,2,regulation of fatty acid transport,BP,
6081,GO:2000192,1,0.701493568801233,0,1,negative regulation of fatty acid transport,BP,
6082,GO:2000193,1,0.682927424885784,0,1,positive regulation of fatty acid transport,BP,
6083,GO:2000194,1,0.70409479607052,0,1,regulation of female gonad development,BP,
6084,GO:2000195,1,0.70409479607052,0,1,negative regulation of female gonad development,BP,
6086,GO:2000224,1,0.714265548502507,0,1,regulation of testosterone biosynthetic process,BP,
6087,GO:2000225,1,0.714265548502507,0,1,negative regulation of testosterone biosynthetic process,BP,
6095,GO:2000272,1,0.698147056906197,0,1,negative regulation of receptor activity,BP,
6096,GO:2000273,1,0.23883521650075,0,4,positive regulation of receptor activity,BP,
6097,GO:2000278,1,0.480360833425934,0,2,regulation of DNA biosynthetic process,BP,
6098,GO:2000345,1,0.683624670162167,0,1,regulation of hepatocyte proliferation,BP,
6099,GO:2000346,1,0.683624670162167,0,1,negative regulation of hepatocyte proliferation,BP,
6100,GO:2000351,1,0.693606308666904,0,1,regulation of endothelial cell apoptotic process,BP,
6101,GO:2000352,1,0.693606308666904,0,1,negative regulation of endothelial cell apoptotic process,BP,
6102,GO:2000369,1,0.666797965191416,0,1,regulation of clathrin-dependent endocytosis,BP,
6104,GO:2000379,1,0.103852812008821,0,6,positive regulation of reactive oxygen species metabolic process,BP,
6111,GO:2000425,1,0.677783369393108,0,1,regulation of apoptotic cell clearance,BP,
6112,GO:2000427,1,0.677783369393108,0,1,positive regulation of apoptotic cell clearance,BP,
6114,GO:2000479,1,0.492336990832856,0,2,regulation of cAMP-dependent protein kinase activity,BP,
6115,GO:2000480,1,0.693654765650842,0,1,negative regulation of cAMP-dependent protein kinase activity,BP,
6116,GO:2000482,1,0.717706347959987,0,1,regulation of interleukin-8 secretion,BP,
6117,GO:2000484,1,0.717706347959987,0,1,positive regulation of interleukin-8 secretion,BP,
6118,GO:2000505,1,0.708931381661885,0,1,regulation of energy homeostasis,BP,
6119,GO:2000508,1,0.693606308666904,0,1,regulation of dendritic cell chemotaxis,BP,
6120,GO:2000510,1,0.693606308666904,0,1,positive regulation of dendritic cell chemotaxis,BP,
6121,GO:2000532,1,0.693606308666904,0,1,regulation of renal albumin absorption,BP,
6122,GO:2000533,1,0.693606308666904,0,1,negative regulation of renal albumin absorption,BP,
6124,GO:2000573,1,0.701758628672581,0,1,positive regulation of DNA biosynthetic process,BP,
6125,GO:2000586,1,0.701758628672581,0,1,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6126,GO:2000587,1,0.701758628672581,0,1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
6127,GO:2000589,1,0.701758628672581,0,1,regulation of metanephric mesenchymal cell migration,BP,
6128,GO:2000591,1,0.701758628672581,0,1,positive regulation of metanephric mesenchymal cell migration,BP,
6132,GO:2000641,1,0.714643171421448,0,1,regulation of early endosome to late endosome transport,BP,
6133,GO:2000643,1,0.714643171421448,0,1,positive regulation of early endosome to late endosome transport,BP,
6136,GO:2000668,1,0.693606308666904,0,1,regulation of dendritic cell apoptotic process,BP,
6137,GO:2000669,1,0.693606308666904,0,1,negative regulation of dendritic cell apoptotic process,BP,
6142,GO:2000705,1,0.68145664044265,0,1,regulation of dense core granule biogenesis,BP,
6143,GO:2000707,1,0.68145664044265,0,1,positive regulation of dense core granule biogenesis,BP,
6149,GO:2000756,1,0.714341024234018,0,1,regulation of peptidyl-lysine acetylation,BP,
6150,GO:2000758,1,0.714341024234018,0,1,positive regulation of peptidyl-lysine acetylation,BP,
6151,GO:2000785,1,0.687261217406708,0,1,regulation of autophagosome assembly,BP,
6152,GO:2000786,1,0.687261217406708,0,1,positive regulation of autophagosome assembly,BP,
6154,GO:2000807,1,0.715947598747366,0,1,regulation of synaptic vesicle clustering,BP,
6155,GO:2000809,1,0.715947598747366,0,1,positive regulation of synaptic vesicle clustering,BP,
6156,GO:2000810,1,0.71022670342733,0,1,regulation of bicellular tight junction assembly,BP,
6177,GO:2001044,1,0.683624670162167,0,1,regulation of integrin-mediated signaling pathway,BP,
6178,GO:2001046,1,0.683624670162167,0,1,positive regulation of integrin-mediated signaling pathway,BP,
6182,GO:2001057,1,0.478173903575527,0,2,reactive nitrogen species metabolic process,BP,
6183,GO:2001074,1,0.70409479607052,0,1,regulation of metanephric ureteric bud development,BP,
6184,GO:2001076,1,0.70409479607052,0,1,positive regulation of metanephric ureteric bud development,BP,
6185,GO:2001135,1,0.716240390769176,0,1,regulation of endocytic recycling,BP,
6186,GO:2001137,1,0.716240390769176,0,1,positive regulation of endocytic recycling,BP,
6200,GO:2001243,1,0.701493568801233,0,1,negative regulation of intrinsic apoptotic signaling pathway,BP,
6202,GO:2001252,1,0.714341024234018,0,1,positive regulation of chromosome organization,BP,
6203,GO:2001257,1,0.356095771658106,0,3,regulation of cation channel activity,BP,
6204,GO:2001258,1,0.698147056906197,0,1,negative regulation of cation channel activity,BP,
6205,GO:2001259,1,0.716240390769176,0,1,positive regulation of cation channel activity,BP,
6206,GO:2001273,1,0.51197138028005,0,2,regulation of glucose import in response to insulin stimulus,BP,
6207,GO:2001275,1,0.51197138028005,0,2,positive regulation of glucose import in response to insulin stimulus,BP,
6208,GO:2001286,1,0.666797965191416,0,1,regulation of caveolin-mediated endocytosis,BP,
6209,GO:2001287,1,0.666797965191416,0,1,negative regulation of caveolin-mediated endocytosis,BP,
1552,GO:0015631,1,0.121168346990228,0,6,tubulin binding,MF,
